Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Bladder Cancer, January 2021

Free Subscription


Abstracts

Retrieve all available abstracts of the following 2462 articles:
HTML format


 

Single Articles

  1. HUANG ZM, Wang H, Ji ZG
    CircRNA-100284 activates aurora kinase B by inducing methylation of HSP70 via microRNA-217 to promote proliferation of bladder cancer cells.
    J Cancer Res Clin Oncol. 2021 Jan 1. pii: 10.1007/s00432-020-03468.
    Abstract     Related articles   

  2. HASHEM A, Mosbah A, El-Tabey NA, Laymon M, et al
    Holmium Laser En-bloc Resection Versus Conventional Transurethral Resection of Bladder Tumors for Treatment of Non-muscle-invasive Bladder Cancer: A Randomized Clinical Trial.
    Eur Urol Focus. 2020 Dec 29. pii: S2405-4569(20)30303.
    Abstract     Related articles   

  3. SU Y, Feng W, Shi J, Chen L, et al
    Correction to: circRIP2 accelerates bladder cancer progression via miR-1305/Tgf-beta2/smad3 pathway.
    Mol Cancer. 2021;20:1.
    Abstract     Related articles   

  4. ZENG J, Zhang G, Chen C, Li K, et al
    Alterations in Urobiome in Patients With Bladder Cancer and Implications for Clinical Outcome: A Single-Institution Study.
    Front Cell Infect Microbiol. 2020;10:555508.
    Abstract     Related articles   

  5. HAFEEZ S, Webster A, Hansen VN, McNair HA, et al
    Protocol for tumour-focused dose-escalated adaptive radiotherapy for the radical treatment of bladder cancer in a multicentre phase II randomised controlled trial (RAIDER): radiotherapy planning and delivery guidance.
    BMJ Open. 2020;10:e041005.
    Abstract     Related articles   

  6. ZHOU Q, Ding W, Qian Z, Jiang G, et al
    Chronic Unpredictable Mild Stress Accelerates the Growth of Bladder Cancer in a Xenograft Mouse Model.
    Psychol Res Behav Manag. 2020;13:1289-1297.
    Abstract     Related articles   

  7. MIRZAEI S, Gholami MH, Mahabady MK, Nabavi N, et al
    Pre-clinical investigation of STAT3 pathway in bladder cancer: Paving the way for clinical translation.
    Biomed Pharmacother. 2021;133:111077.
    Abstract     Related articles   

  8. GILL J, Prasad V
    Pembrolizumab for Non-Muscle-Invasive Bladder Cancer-A Costly Therapy in Search of Evidence.
    JAMA Oncol. 2020 Dec 30. pii: 2774444. doi: 10.1001/jamaoncol.2020.6142.
    Abstract     Related articles   

  9. CHANG Y, Jin H, Li H, Ma J, et al
    MiRNA-516a promotes bladder cancer metastasis by inhibiting MMP9 protein degradation via the AKT/FOXO3A/SMURF1 axis.
    Clin Transl Med. 2020;10:e263.
    Abstract     Related articles   

  10. HUANG HM, Li HX
    Tumor heterogeneity and the potential role of liquid biopsy in bladder cancer.
    Cancer Commun (Lond). 2020 Dec 30. doi: 10.1002/cac2.12129.
    Abstract     Related articles   

  11. YU H, Yang X, Tang J, Si S, et al
    ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2alpha-Mediated Glycolysis.
    Mol Ther Nucleic Acids. 2020;23:27-41.
    Abstract     Related articles   

  12. WU CT, Huang YC, Chen WC, Chen MF, et al
    The Significance of Neutrophil-to-Lymphocyte Ratio and Combined Chemoradiotherapy in Patients Undergoing Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer.
    Cancer Manag Res. 2020;12:13125-13135.
    Abstract     Related articles   

  13. WOLFS JRE, Hermans TJN, Koldewijn EL, van de Kerkhof D, et al
    Novel urinary biomarkers ADXBLADDER and bladder EpiCheck for diagnostics of bladder cancer: A review.
    Urol Oncol. 2020 Dec 26. pii: S1078-1439(20)30583.
    Abstract     Related articles   

  14. XU C, Liu M, Jia D, Tao T, et al
    lncRNA TINCR SNPs and Expression Levels Are Associated with Bladder Cancer Susceptibility.
    Genet Test Mol Biomarkers. 2020 Dec 28. doi: 10.1089/gtmb.2020.0178.
    Abstract     Related articles   

  15. SIMSEKOGLU MF, Kaleler I, Onal B, Demirdag C, et al
    Do Urinary Mast Cell Mediators Predict Immune Response to BCG in Patients with Primary High-Grade Non-Muscle Invasive Bladder Cancer?
    Int J Clin Pract. 2020 Dec 23:e13959. doi: 10.1111/ijcp.13959.
    Abstract     Related articles   

  16. WITJES JA
    Follow-up in non-muscle invasive bladder cancer: facts and future.
    World J Urol. 2020 Dec 26. pii: 10.1007/s00345-020-03569.
    Abstract     Related articles   

  17. CHI Q, Xu H, Song D, Wang Z, et al
    alpha-E-Catenin (CTNNA1) Inhibits Cell Proliferation, Invasion and EMT of Bladder Cancer.
    Cancer Manag Res. 2020;12:12747-12758.
    Abstract     Related articles   

  18. SIRAJ F, Dulal J, Sharma S, Gupta P, et al
    Benign Mimickers of Urinary Bladder Cancer: a Case Series.
    Indian J Surg Oncol. 2020;11.
    Abstract     Related articles   

  19. LI SL, Li ZF, Cao QW, Wang WZ, et al
    SLC12A8 plays a key role in bladder cancer progression and EMT.
    Open Med (Wars). 2020;16:58-67.
    Abstract     Related articles   

  20. BRAHIM D, Mechergui N, Ben Said H, Cherif D, et al
    Peritoneal mesothelioma associated with bladder cancer and occupational exposure to asbestos: A case report.
    Clin Case Rep. 2020;8:3529-3532.
    Abstract     Related articles   

  21. ZHUANG C, Liu Y, Fu S, Yuan C, et al
    Silencing of lncRNA MIR497HG via CRISPR/Cas13d Induces Bladder Cancer Progression Through Promoting the Crosstalk Between Hippo/Yap and TGF-beta/Smad Signaling.
    Front Mol Biosci. 2020;7:616768.
    Abstract     Related articles   

  22. LI T, Yu Y, Shi H, Cao Y, et al
    Magnesium in Combinatorial With Valproic Acid Suppressed the Proliferation and Migration of Human Bladder Cancer Cells.
    Front Oncol. 2020;10:589112.
    Abstract     Related articles   

  23. LUCAS M, Jansen I, van Leeuwen TG, Oddens JR, et al
    Deep Learning-based Recurrence Prediction in Patients with Non-muscle-invasive Bladder Cancer.
    Eur Urol Focus. 2020 Dec 22. pii: S2405-4569(20)30310.
    Abstract     Related articles   

  24. HOFFMAN-CENSITS J, Choi W, Bivalacqua TJ, Pierorazio P, et al
    Small Cell Bladder Cancer Response to Second-line and Beyond Checkpoint Inhibitor Therapy: Retrospective Experience.
    Clin Genitourin Cancer. 2020 Nov 12. pii: S1558-7673(20)30251.
    Abstract     Related articles   

  25. LYU Q, Lin A, Cao M, Xu A, et al
    Alterations in TP53 Are a Potential Biomarker of Bladder Cancer Patients Who Benefit From Immune Checkpoint Inhibition.
    Cancer Control. 2020;27:1073274820976665.
    Abstract     Related articles   

  26. KUMAR A, Gupta R, Mathur N, Iyer VK, et al
    Microarray based gene expression profiling of advanced gall bladder cancer.
    Exp Oncol. 2020;42:277-284.
    Abstract     Related articles   

  27. GIRARD A, Vila Reyes H, Dercle L, Rouanne M, et al
    "Future role of [18F]-FDG PET/CT in patients with bladder cancer in the new era of neoadjuvant immunotherapy?"
    Urol Oncol. 2020 Dec 19. pii: S1078-1439(20)30632.
    Abstract     Related articles   

  28. ECKE TH, Otto T, Le Calvez-Kelm F
    Evaluating the Utility of Combined Bladder Cancer Biomarkers, the Molecular Prognostication of Tumor Subtypes, or What Else Is Needed to Illuminate Our Vision?
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  29. SUZUKI S, Cohen SM, Arnold LL, Pennington KL, et al
    Cell proliferation of rat bladder urothelium induced by nicotine is suppressed by the NADPH oxidase inhibitor, apocynin.
    Toxicol Lett. 2021;336:32-38.
    Abstract     Related articles   

  30. YANAI Y, Kosaka T, Nakamura K, Aimono E, et al
    CDK12 and HER2 coamplification in two urothelial carcinomas with rapid and aggressive clinical progression.
    Cancer Sci. 2020;111:4652-4655.
    Abstract     Related articles   

  31. FUKAI K, Kojimahara N, Hoshi K, Toyota A, et al
    Combined effects of occupational exposure to hazardous operations and lifestyle-related factors on cancer incidence.
    Cancer Sci. 2020;111:4581-4593.
    Abstract     Related articles   

  32. SMITH ME, Farahani SJ, Chao T, Palmer M, et al
    PD-L1 Positivity Associated With Presence of Tertiary Lymphoid Structures and High-Stage Disease in Upper Tract Urothelial Carcinoma.
    Am J Clin Pathol. 2020;154:802-810.
    Abstract     Related articles   

  33. ZRIBI A, Nasr SB, Msakni I, Karrit S, et al
    Urothelial bladder carcinoma in childhood: a case report.
    Pan Afr Med J. 2020;36:91.
    Abstract     Related articles   

  34. KADOURI Y, Hachem F, Lakssir J, Sayegh H, et al
    [Primitive adenocarcinoma of the bladder: about 6 cases].
    Pan Afr Med J. 2020;36:61.
    Abstract     Related articles   

  35. TAARNHOJ GA, Lindberg H, Dohn LH, Omland LH, et al
    Electronic reporting of patient-reported outcomes in a fragile and comorbid population during cancer therapy - a feasibility study.
    Health Qual Life Outcomes. 2020;18:225.
    Abstract     Related articles   

  36. NASROLLAHI H, Ariafar A, Ahmed F, Mokhtari M, et al
    Isolated schwannoma of the urinary bladder: a case report and review of the literature.
    Pan Afr Med J. 2020;35:108.
    Abstract     Related articles   

  37. KIMURA N, Tsuchiya A, Oda C, Kimura A, et al
    Portal Vein Thrombosis Associated with Trousseau Syndrome due to Urinary Bladder Squamous Cell Carcinoma in a Liver Cirrhosis Patient.
    Intern Med. 2020 May 23. doi: 10.2169/internalmedicine.4112.
    Abstract     Related articles   

  38. PALUMBO C, Knipper S, Pecoraro A, Rosiello G, et al
    Differences in short-term outcomes between open versus robot-assisted radical cystectomy in frail malnourished patients.
    Eur J Surg Oncol. 2020;46:1347-1352.
    Abstract     Related articles   

  39. AREFI SMA, Tsvirkun D, Verdier C, Feng JJ, et al
    A biomechanical model for the transendothelial migration of cancer cells.
    Phys Biol. 2020;17:036004.
    Abstract     Related articles   

  40. WANG B, Huang H, Yang M, Yang W, et al
    Microlocalization and clinical significance of stabilin-1(+) macrophages in treatment-naive patients with urothelial carcinoma of the bladder.
    World J Urol. 2020;38:709-716.
    Abstract     Related articles   

  41. HURLE R, Casale P, Lazzeri M, Paciotti M, et al
    En bloc re-resection of high-risk NMIBC after en bloc resection: results of a multicenter observational study.
    World J Urol. 2020;38:703-708.
    Abstract     Related articles   

  42. STROOBANTS S, Bijnens E, Herbots L
    A mass in the right ventricle.
    Acta Cardiol. 2020;75:167-169.
    Abstract     Related articles   

  43. RHEA LP, Mendez-Marti S, Kim D, Aragon-Ching JB, et al
    Role of immunotherapy in bladder cancer.
    Cancer Treat Res Commun. 2020;26:100296.
    Abstract     Related articles   

  44. MARCQ G, Souhami L, Cury FL, Salimi A, et al
    Phase I Trial of Atezolizumab plus Trimodal Therapy in Patients with localized Muscle-Invasive Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2021 Jan 6. pii: S0360-3016(20)34729.
    Abstract     Related articles   

  45. VANDEKERKHOVE G, Lavoie JM, Annala M, Murtha AJ, et al
    Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer.
    Nat Commun. 2021;12:184.
    Abstract     Related articles   

  46. KOTOLLOSHI R, Holzer M, Gajda M, Grimm MO, et al
    SLC35F2, a Transporter Sporadically Mutated in the Untranslated Region, Promotes Growth, Migration, and Invasion of Bladder Cancer Cells.
    Cells. 2021;10.
    Abstract     Related articles   

  47. GRAHAM CH, Pare JF, Cotechini T, Hopman W, et al
    Innate immune memory is associated with increased disease-free survival in bladder cancer patients treated with bacillus Calmette-Guerin.
    Can Urol Assoc J. 2021 Jan 4. pii: cuaj.7066. doi: 10.5489/cuaj.7066.
    Abstract     Related articles   

  48. WANG X, Zhang R, Wu T, Shi Y, et al
    Successive treatment with naltrexone induces epithelial-mesenchymal transition and facilitates the malignant biological behaviors of bladder cancer cells.
    Acta Biochim Biophys Sin (Shanghai). 2021 Jan 7. pii: 6067264.
    Abstract     Related articles   

  49. YAN Y, Huang Z, Cai J, Tang P, et al
    Identification of a novel immune microenvironment signature predicting survival and therapeutic options for bladder cancer.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  50. ORESTA B, Pozzi C, Braga D, Hurle R, et al
    Mitochondrial metabolic reprogramming controls the induction of immunogenic cell death and efficacy of chemotherapy in bladder cancer.
    Sci Transl Med. 2021;13.
    Abstract     Related articles   

  51. SHAO Y, Hu X, Yang Z, Lia T, et al
    Prognostic factors of non-muscle invasive bladder cancer: a study based on next-generation sequencing.
    Cancer Cell Int. 2021;21:23.
    Abstract     Related articles   

  52. CHEN D, Cheng L, Cao H, Liu W, et al
    Role of microRNA-381 in bladder cancer growth and metastasis with the involvement of BMI1 and the Rho/ROCK axis.
    BMC Urol. 2021;21:5.
    Abstract     Related articles   

  53. XIU W, Luo J
    CXCL9 secreted by tumor-associated dendritic cells up-regulates PD-L1 expression in bladder cancer cells by activating the CXCR3 signaling.
    BMC Immunol. 2021;22:3.
    Abstract     Related articles   

  54. ZHAO M, Zhang M, Wang Y, Yang X, et al
    Prognostic Value of Preoperative Albumin-to-Alkaline Phosphatase Ratio in Patients with Muscle-Invasive Bladder Cancer After Radical Cystectomy.
    Onco Targets Ther. 2020;13:13265-13274.
    Abstract     Related articles   

  55. FERINI G, Cacciola A, Parisi S, Lillo S, et al
    Curative Radiotherapy in Elderly Patients With Muscle Invasive Bladder Cancer: The Prognostic Role of Sarcopenia.
    In Vivo. 2021;35:571-578.
    Abstract     Related articles   

  56. LIEVORE E, Runza L, Ghidini M, Galassi B, et al
    Micropapillary Bladder Cancer Metastatic to the Breast: A Case Report and Brief Literature Review.
    In Vivo. 2021;35:453-459.
    Abstract     Related articles   

  57. GOUTAS D, Tzortzis A, Gakiopoulou H, Vlachodimitropoulos D, et al
    Contemporary Molecular Classification of Urinary Bladder Cancer.
    In Vivo. 2021;35:75-80.
    Abstract     Related articles   

  58. CABAILLE M, Khalifa J, Tessier AM, Belhomme S, et al
    [A review of adaptive radiotherapy for bladder cancer].
    Cancer Radiother. 2021 Jan 2. pii: S1278-3218(20)30331.
    Abstract     Related articles   

  59. GANDI C, Vaccarella L, Bientinesi R, Racioppi M, et al
    Bladder cancer in the time of machine learning: Intelligent tools for diagnosis and management.
    Urologia. 2021 Jan 5:391560320987169. doi: 10.1177/0391560320987169.
    Abstract     Related articles   

  60. LOPEZ-BELTRAN A, Cimadamore A, Blanca A, Massari F, et al
    Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  61. TANG C, Wu Y, Wang X, Chen K, et al
    LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells.
    Hum Cell. 2021 Jan 5. pii: 10.1007/s13577-020-00470.
    Abstract     Related articles   

  62. TAMALUNAS A, Schulz GB, Rodler S, Apfelbeck M, et al
    [Systemic treatment of bladder cancer].
    Urologe A. 2021 Jan 4. pii: 10.1007/s00120-020-01420.
    Abstract     Related articles   

  63. SMELSER WW, Randall JH, Caldwell J, Glavin K, et al
    Characterization of perioperative androgen profiles in men with bladder cancer undergoing radical cystectomy.
    Urol Oncol. 2021 Jan 1. pii: S1078-1439(20)30642.
    Abstract     Related articles   

  64. YANG X, Ye T, Liu H, Lv P, et al
    Expression profiles, biological functions and clinical significance of circRNAs in bladder cancer.
    Mol Cancer. 2021;20:4.
    Abstract     Related articles   

  65. SAMAHA H, Samaha R, Sarkis J, Kattan J, et al
    Maintenance avelumab in metastatic bladder cancer as a step towards sequencing immunotherapy.
    Immunotherapy. 2021 Jan 5. doi: 10.2217/imt-2020-0261.
    Abstract     Related articles   

  66. MATI Q, Qamar S, Ashraf S, Khokhar MA, et al
    Tissue Nuclear Matrix Protein Expression 22 in Various Grades and Stages of Bladder Cancer.
    J Coll Physicians Surg Pak. 2020;30:1321-1325.
    Abstract     Related articles   

  67. SILINA L, Maksut F, Bernard-Pierrot I, Radvanyi F, et al
    Review of Experimental Studies to Improve Radiotherapy Response in Bladder Cancer: Comments and Perspectives.
    Cancers (Basel). 2020;13.
    Abstract     Related articles   

  68. SZARVAS T, Hoffmann MJ, Olah C, Szekely E, et al
    MMP-7 Serum and Tissue Levels Are Associated with Poor Survival in Platinum-Treated Bladder Cancer Patients.
    Diagnostics (Basel). 2020;11.
    Abstract     Related articles   

  69. STEPIEN A, Brudlo M, Stachura T, Marcinek P, et al
    Miliary pulmonary tuberculosis after the first dose of intravesical BCG instillation in a patient with high-grade bladder cancer.
    Adv Respir Med. 2020;88:628-629.
    Abstract     Related articles   

  70. ZHENG Z, Mao S, Zhang W, Liu J, et al
    Dysregulation of the Immune Microenvironment Contributes to Malignant Progression and Has Prognostic Value in Bladder Cancer.
    Front Oncol. 2020;10:542492.
    Abstract     Related articles   

  71. BI H, Yan Y, Wang D, Qin Z, et al
    Predictive value of preoperative lymphocyte-to-monocyte ratio on survival outcomes in bladder cancer patients after radical cystectomy.
    J Cancer. 2021;12:305-315.
    Abstract     Related articles   

  72. LI F, Xie W, Fang Y, Xie K, et al
    HnRNP-F promotes the proliferation of bladder cancer cells mediated by PI3K/AKT/FOXO1.
    J Cancer. 2021;12:281-291.
    Abstract     Related articles   

  73. KHAYAMZADEH M, Aliakbari F, Zolghadr Z, Emadeddin M, et al
    Five-Year Survival Rate of Bladder Cancer in Iran during 2001-2007.
    Iran J Pathol. 2021;16:69-74.
    Abstract     Related articles   

  74. JIANG A, Liu N, Bai S, Wang J, et al
    The Construction and Analysis of Tumor-Infiltrating Immune Cells and ceRNA Networks in Bladder Cancer.
    Front Genet. 2020;11:605767.
    Abstract     Related articles   

  75. WU X, Lv D, Cai C, Zhao Z, et al
    A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer.
    Front Immunol. 2020;11:590618.
    Abstract     Related articles   

  76. ZHENG X, Qiu S, Yang L, Wei Q, et al
    Comparison of survival outcomes between primary and secondary muscle-invasive bladder cancer: An updated meta-analysis.
    Int J Med Sci. 2021;18:505-510.
    Abstract     Related articles   

  77. XIE R, Chen X, Chen Z, Huang M, et al
    Corrigendum to "Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM." [Canc. Lett. 449 (2019) 31-44].
    Cancer Lett. 2020 Dec 31. pii: S0304-3835(20)30687.
    Abstract     Related articles   

  78. CHEN Z, Liu G, Liu G, Bolkov MA, et al
    Defining muscle-invasive bladder cancer immunotypes by introducing tumor mutation burden, CD8+ T cells, and molecular subtypes.
    Hereditas. 2021;158:1.
    Abstract     Related articles   

  79. LENIS AT, Lec PM, Chamie K
    Urinary Diversion.
    JAMA. 2020;324:2222.
    Abstract     Related articles   

  80. BANDINI M, Gibb EA, Gallina A, Raggi D, et al
    Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study().
    Ann Oncol. 2020;31:1755-1763.
    Abstract     Related articles   

  81. YEH BW, Yu LE, Li CC, Yang JC, et al
    The protoapigenone analog WYC0209 targets CD133+ cells: A potential adjuvant agent against cancer stem cells in urothelial cancer therapy.
    Toxicol Appl Pharmacol. 2020;402:115129.
    Abstract     Related articles   

  82. MUSSER ML, Viall AK, Phillips RL, Hostetter JM, et al
    Gene expression of prostaglandin EP4 receptor in three canine carcinomas.
    BMC Vet Res. 2020;16:213.
    Abstract     Related articles   

  83. OLKHOV-MITSEL E, Hodgson A, Liu SK, Vesprini D, et al
    Immune gene expression profiles in high-grade urothelial carcinoma of the bladder: a NanoString study.
    J Clin Pathol. 2021;74:53-57.
    Abstract     Related articles   

  84. WYSOCKA M, Romanowska A, Gruba N, Michalska M, et al
    A Peptidomimetic Fluorescent Probe to Detect the Trypsin beta2 Subunit of the Human 20S Proteasome.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  85. XIANG Y, Zhang Q, Wei S, Huang C, et al
    Paeoniflorin: a monoterpene glycoside from plants of Paeoniaceae family with diverse anticancer activities.
    J Pharm Pharmacol. 2020;72:483-495.
    Abstract     Related articles   

  86. ROSKOSKI R JR
    The role of fibroblast growth factor receptor (FGFR) protein-tyrosine kinase inhibitors in the treatment of cancers including those of the urinary bladder.
    Pharmacol Res. 2020;151:104567.
    Abstract     Related articles   

  87. CHEN YT, Ou Yang WT, Juang HH, Chen CL, et al
    Proteomic characterization of arsenic and cadmium exposure in bladder cells.
    Rapid Commun Mass Spectrom. 2020;34 Suppl 1:e8578.
    Abstract     Related articles   

  88. XUE M, Chen W, Li X
    Extracellular vesicle-transferred long noncoding RNAs in bladder cancer.
    Clin Chim Acta. 2021 Jan 12. pii: S0009-8981(21)00012.
    Abstract     Related articles   

  89. VAN VALENBERG FJP, Brummelhuis ISG, Lindner LH, Kuhnle F, et al
    DPPG2-Based Thermosensitive Liposomes with Encapsulated Doxorubicin Combined with Hyperthermia Lead to Higher Doxorubicin Concentrations in the Bladder Compared to Conventional Application in Pigs: A Rationale for the Treatment of Muscle-Invasive Blad
    Int J Nanomedicine. 2021;16:75-88.
    Abstract     Related articles   

  90. JENSEN BT, Lauridsen SV
    Commentary: Future Directions in Bladder Cancer Care.
    Semin Oncol Nurs. 2021 Jan 11:151117. doi: 10.1016/j.soncn.2020.151117.
    Abstract     Related articles   

  91. NAIR SS, Weil R, Dovey Z, Davis A, et al
    The Tumor Microenvironment and Immunotherapy in Prostate and Bladder Cancer.
    Urol Clin North Am. 2020;47.
    Abstract     Related articles   

  92. STRUCK JP, Hupe MC, Heinisch A, Ozimek T, et al
    RLC score (R status, lymphovascular invasion, C-reactive protein) predicts survival following radical cystectomy for muscle-invasive bladder cancer.
    Aktuelle Urol. 2021 Jan 14. doi: 10.1055/a-1310-3583.
    Abstract     Related articles   

  93. MA X, Mao G, Chang R, Wang F, et al
    Down-regulation of Autophagy-Associated Protein Increased Acquired Radio-Resistance Bladder Cancer Cells Sensitivity to Taxol.
    Int J Radiat Biol. 2021 Jan 14:1-34. doi: 10.1080/09553002.2021.1872812.
    Abstract     Related articles   

  94. VOLLMER T, Schlickeiser S, Amini L, Schulenberg S, et al
    The intratumoral CXCR3 chemokine system is predictive of chemotherapy response in human bladder cancer.
    Sci Transl Med. 2021;13.
    Abstract     Related articles   

  95. GUAN H, Lu J, Qu M, Meng L, et al
    DNA methylation patterns of SOCS1 gene in peripheral blood identifies risk loci associated with Bladder cancer based on principal component analysis.
    Neoplasma. 2021 Jan 14. pii: 200928N1035. doi: 10.4149/neo_2020_200928N1035.
    Abstract     Related articles   

  96. FERRO M, Marchioni M, Lucarelli G, Dorin VM, et al
    Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study.
    Minerva Urol Nefrol. 2021 Jan 13. pii: S0393-2249.20.04076.
    Abstract     Related articles   

  97. ZANG Y, Li X, Cheng Y, Qi F, et al
    An overview of patients with urothelial bladder cancer over the past two decades: a Surveillance, Epidemiology, and End Results (SEER) study.
    Ann Transl Med. 2020;8:1587.
    Abstract     Related articles   

  98. DER STEEN-BANASIK EV, Oosterveld B, Smits G, Atema E, et al
    Perpetual role of brachytherapy in organ-sparing treatment for bladder cancer: a historical review.
    J Contemp Brachytherapy. 2020;12:618-628.
    Abstract     Related articles   

  99. HUSSEIN AA, Elsayed AS, Durrani M, Jing Z, et al
    Investigating the association between the urinary microbiome and bladder cancer: An exploratory study.
    Urol Oncol. 2021 Jan 9. pii: S1078-1439(20)30641.
    Abstract     Related articles   

  100. MCCAW ZR, Odisho AY, Chaparala H, Yin M, et al
    Neoadjuvant chemotherapy in bladder cancer: Clinical benefit observed in prospective trials computed with restricted mean survival times.
    Urol Oncol. 2021 Jan 9. pii: S1078-1439(20)30640.
    Abstract     Related articles   

  101. JENSEN BT, Lauridsen SV
    Introduction: Bladder Cancer.
    Semin Oncol Nurs. 2021 Jan 9:151103. doi: 10.1016/j.soncn.2020.151103.
    Abstract     Related articles   

  102. TAVARES-DA-SILVA E, Pereira E, Pires AS, Neves AR, et al
    Cold Atmospheric Plasma, a Novel Approach against Bladder Cancer, with Higher Sensitivity for the High-Grade Cell Line.
    Biology (Basel). 2021;10.
    Abstract     Related articles   

  103. MENG X, Hu H, Wang Y, Hu D, et al
    Application of bi-planar reduced field-of-view DWI (rFOV DWI) in the assessment of muscle-invasiveness of bladder cancer.
    Eur J Radiol. 2020;136:109486.
    Abstract     Related articles   

  104. LI Q, Cao B, Tan Q, Liu K, et al
    Prediction of muscle invasion of bladder cancer: A comparison between DKI and conventional DWI.
    Eur J Radiol. 2021;136:109522.
    Abstract     Related articles   

  105. STEENBERG CK, Bredberg A, Eiken R
    A man in his seventies with dyspnoea and ataxia after BCG instillation for bladder cancer.
    Tidsskr Nor Laegeforen. 2021;141.
    Abstract     Related articles   

  106. JIANG DM, Gupta S, Kitchlu A, Meraz-Munoz A, et al
    Defining cisplatin eligibility in patients with muscle-invasive bladder cancer.
    Nat Rev Urol. 2021 Jan 11. pii: 10.1038/s41585-020-00404.
    Abstract     Related articles   

  107. MAISCH P, Lunger L, Duwel C, Schmid SC, et al
    Outcomes of palliative cystectomy in patients with locally advanced pT4 bladder cancer.
    Urol Oncol. 2021 Jan 8. pii: S1078-1439(20)30629.
    Abstract     Related articles   

  108. GOLTZ HH, Major JE, Goffney J, Dunn MW, et al
    Collaboration Between Oncology Social Workers and Nurses: A Patient-Centered Interdisciplinary Model of Bladder Cancer Care.
    Semin Oncol Nurs. 2021 Jan 8:151114. doi: 10.1016/j.soncn.2020.151114.
    Abstract     Related articles   

  109. HANSEN TTD, Omland LH, von Heymann A, Johansen C, et al
    Development of Sarcopenia in Patients With Bladder Cancer: A Systematic Review.
    Semin Oncol Nurs. 2021 Jan 8:151108. doi: 10.1016/j.soncn.2020.151108.
    Abstract     Related articles   

  110. JENSEN BT
    Organization Factors in the ERAS Bladder Cancer Pathway: The Multifarious Role of the ERAS Nurse, Why and What Is Important?
    Semin Oncol Nurs. 2021 Jan 8:151106. doi: 10.1016/j.soncn.2020.151106.
    Abstract     Related articles   

  111. MCCONKEY RW, Dowling M
    Supportive Care Needs of Patients on Surveillance and Treatment for Non-Muscle-Invasive Bladder Cancer.
    Semin Oncol Nurs. 2021 Jan 8:151105. doi: 10.1016/j.soncn.2020.151105.
    Abstract     Related articles   

  112. SONG JH, Park J, Park SL, Hwang B, et al
    A Novel Cyclic Pentadepsipeptide, N-Methylsansalvamide, Suppresses Angiogenic Responses and Exhibits Antitumor Efficacy against Bladder Cancer.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  113. SANTOS LL, Santos J, Gouveia MJ, Bernardo C, et al
    Urogenital Schistosomiasis-History, Pathogenesis, and Bladder Cancer.
    J Clin Med. 2021;10.
    Abstract     Related articles   

  114. MOSTAFID H
    No 'one size fits all' approach in the management of high-risk non-muscle invasive bladder cancer.
    Scand J Urol. 2021 Jan 11:1-2. doi: 10.1080/21681805.2020.1866661.
    Abstract     Related articles   

  115. WANG A, Jiang A, Gan X, Wang Z, et al
    EGFR-AS1 Promotes Bladder Cancer Progression by Upregulating EGFR.
    Biomed Res Int. 2020;2020:6665974.
    Abstract     Related articles   

  116. LUO KW, Zhu XH, Zhao T, Zhong J, et al
    EGCG Enhanced the Anti-tumor Effect of Doxorubicine in Bladder Cancer via NF-kappaB/MDM2/p53 Pathway.
    Front Cell Dev Biol. 2020;8:606123.
    Abstract     Related articles   

  117. ZHENG H, Yang C, Tang J
    Cyclic RNA Circ_0000735 sponges miR-502-5p to promote bladder cancer cell proliferation and invasion and inhibit apoptosis.
    Int J Clin Exp Pathol. 2020;13:2994-3003.
    Abstract     Related articles   

  118. OU-YANG S, Liu JH, Wang QZ
    Upregulation of RAC3 in bladder cancer predicts adverse clinical outcome and increased tumor immune response.
    Int J Clin Exp Pathol. 2020;13:2937-2949.
    Abstract     Related articles   

  119. VAN RHIJN BWG, Hentschel AE, Brundl J, Comperat EM, et al
    Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel Study.
    Eur Urol Oncol. 2021 Jan 8. pii: S2588-9311(20)30210.
    Abstract     Related articles   

  120. ELSHABRAWY A, Wang H, Satsangi A, Wheeler K, et al
    Correlates of refusal of radical cystectomy in patients with muscle-invasive bladder cancer.
    Urol Oncol. 2021 Jan 7. pii: S1078-1439(20)30610.
    Abstract     Related articles   

  121. MOHAMED NE, Leung TM, Kata HE, Shah QN, et al
    Identifying Distinct High Unmet-Need Phenotypes and Their Associated Bladder Cancer Patient Demographic, Clinical, Psychosocial, and Functional Characteristics: Results of Two Clustering Methods.
    Semin Oncol Nurs. 2021 Jan 7:151112. doi: 10.1016/j.soncn.2020.151112.
    Abstract     Related articles   

  122. SHAN G, Zhou X, Gu J, Zhou D, et al
    Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/beta-catenin pathway and upregulating PTEN.
    Cell Oncol (Dordr). 2021 Jan 10. pii: 10.1007/s13402-020-00500.
    Abstract     Related articles   

  123. CABAILLE M, Gaston R, Belhomme S, Giraud A, et al
    [Plan of the day adaptive radiotherapy for bladder cancer: Dosimetric and clinical results].
    Cancer Radiother. 2021 Jan 6. pii: S1278-3218(20)30347.
    Abstract     Related articles   

  124. DOHN LH, Omland LH, Stormoen DR, Pappot H, et al
    Status of Metastatic Bladder Cancer Treatment Illustrated by a Case.
    Semin Oncol Nurs. 2021 Jan 6:151113. doi: 10.1016/j.soncn.2020.151113.
    Abstract     Related articles   

  125. KADOURI Y, Ouskri S, Sayegh HE, Benslimane L, et al
    Sarcomatoid carcinoma of the urinary bladder: analysis of five cases and literature review.
    Pan Afr Med J. 2020;36:369.
    Abstract     Related articles   

  126. WU B, Pan C, Yao Z, Zhu X, et al
    A new ureteroileal anastomosis technique in modified ileal orthotopic bladder substitution after radical cystectomy.
    World J Surg Oncol. 2020;18:72.
    Abstract     Related articles   

  127. HSU YP, Yang HW, Li NS, Chen YT, et al
    Instrument-Free Detection of FXYD3 Using Vial-Based Immunosensor for Earlier and Faster Urothelial Carcinoma Diagnosis.
    ACS Sens. 2020;5:928-935.
    Abstract     Related articles   

  128. SIRAJ AK, Bu R, Iqbal K, Parvathareddy SK, et al
    Telomerase reverse transcriptase promoter mutations in cancers derived from multiple organ sites among middle eastern population.
    Genomics. 2020;112:1746-1753.
    Abstract     Related articles   

  129. KIM SH
    Validation of vesical imaging reporting and data system for assessing muscle invasion in bladder tumor.
    Abdom Radiol (NY). 2020;45:491-498.
    Abstract     Related articles   

  130. SELF D, Ranasinghe W, Edirisinghe A, Ruthven S, et al
    Primary squamous cell carcinoma of the bladder presenting with colovesical and vesicocutaneous fistulae in a 29-year-old.
    ANZ J Surg. 2020;90:E34-E37.
    Abstract     Related articles   

  131. AHMED MAH, Ali MH, Abbas HH, Elatrash GA, et al
    Expression of TOMM34 and Its Clinicopathological Correlations in Urothelial Carcinoma of the Bladder.
    Pathol Oncol Res. 2020;26:411-418.
    Abstract     Related articles   

  132. MARVASO G, Nicosia L, Vinciguerra A, Borghetti P, et al
    The role of palliative radiotherapy in the management of elderly and frail patients with advanced bladder cancer: A survey by the AIRO uro-group.
    Med Oncol. 2021;38:14.
    Abstract     Related articles   

  133. FENG R, Li Z, Wang X, Ge G, et al
    Silenced lncRNA SNHG14 restrains the biological behaviors of bladder cancer cells via regulating microRNA-211-3p/ESM1 axis.
    Cancer Cell Int. 2021;21:67.
    Abstract     Related articles   

  134. LIU B, Pan S, Liu J, Kong C, et al
    Cancer-associated fibroblasts and the related Runt-related transcription factor 2 (RUNX2) promote bladder cancer progression.
    Gene. 2021 Jan 19:145451. doi: 10.1016/j.gene.2021.145451.
    Abstract     Related articles   

  135. HU X, Xiang L, He D, Zhu R, et al
    The long noncoding RNA KTN1-AS1 promotes bladder cancer tumorigenesis via KTN1 cis-activation and the consequent initiation of Rho GTPase-mediated signaling.
    Clin Sci (Lond). 2021 Jan 22. pii: 227665. doi: 10.1042/CS20200908.
    Abstract     Related articles   

  136. PYRGIDIS N, Lackner J, Schneidewind L, Sokolakis I, et al
    [Treatment of Ta and T1 intermediate or high risk bladder cancer with intravesical Bacillus Calmette-Guerin or mitomycin C].
    Urologe A. 2021 Jan 22. pii: 10.1007/s00120-021-01443.
    Abstract     Related articles   

  137. TARANTINO G, Crocetto F, Di Vito C, Creta M, et al
    Association of NAFLD and Insulin Resistance with Non Metastatic Bladder Cancer Patients: A Cross-Sectional Retrospective Study.
    J Clin Med. 2021;10.
    Abstract     Related articles   

  138. BOHMER D, Grun A
    Lacking Evidence to Recommend Neoadjuvant Chemotherapy and Definitive Radiotherapy in Muscle-Invasive Bladder Cancer : In response to: Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions published by Di Mar
    Curr Oncol Rep. 2021;23:18.
    Abstract     Related articles   

  139. JIANG S, Gai X, Mao T, Yu H, et al
    Associations of APE1 and OGG1 polymorphisms with onset and prognosis of bladder cancer.
    Panminerva Med. 2021 Jan 20. pii: S0031-0808.20.04245.
    Abstract     Related articles   

  140. CHEN D, Chen T, Guo Y, Wang C, et al
    Suppressive effect of platycodin D on bladder cancer through microRNA-129-5p-mediated PABPC1/PI3K/AKT axis inactivation.
    Braz J Med Biol Res. 2021;54:e10222.
    Abstract     Related articles   

  141. HUANG X, Zhou Q, Wang M, Cao C, et al
    A Light-Inducible Split-dCas9 System for Inhibiting the Progression of Bladder Cancer Cells by Activating p53 and E-cadherin.
    Front Mol Biosci. 2021;7:627848.
    Abstract     Related articles   

  142. OKAZAKI N, Kasahara K, Watanabe M, Wada T, et al
    [A Case of Colorectal Cancer with Bladder Invasion Treated Ileal Neobladder for Urinary Bladder Replacement].
    Gan To Kagaku Ryoho. 2020;47:2074-2076.
    Abstract     Related articles   

  143. TAUBERT H, Eckstein M, Epple E, Jung R, et al
    Immune Cell-Associated Protein Expression Helps to Predict Survival in Muscle-Invasive Urothelial Bladder Cancer Patients after Radical Cystectomy and Optional Adjuvant Chemotherapy.
    Cells. 2021;10.
    Abstract     Related articles   

  144. SCHOLTES MP, de Jong FC, Zuiverloon TCM, Theodorescu D, et al
    Role of Bladder Cancer Metabolic Reprogramming in the Effectiveness of Immunotherapy.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  145. JIN K, Qiu S, Jin D, Zhou X, et al
    Development of prognostic signature based on immune-related genes in muscle-invasive bladder cancer: bioinformatics analysis of TCGA database.
    Aging (Albany NY). 2021;12.
    Abstract     Related articles   

  146. TIAN J, Hu P, Guo H, Xu J, et al
    Effect of transurethral partial cystectomy with 2.0 mum laser in treating superficial bladder cancer.
    J BUON. 2020;25:2714-2720.
    Abstract     Related articles   

  147. TELEKA S, Jochems SHJ, Haggstrom C, Wood AM, et al
    Association between blood pressure and BMI with bladder cancer risk and mortality in 340,000 men in three Swedish cohorts.
    Cancer Med. 2021 Jan 16. doi: 10.1002/cam4.3721.
    Abstract     Related articles   

  148. SONG W, Yang K, Luo J, Gao Z, et al
    Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.
    Aging (Albany NY). 2021;12.
    Abstract     Related articles   

  149. SHEN C, Wang L, Yang X, Liu J, et al
    Construction of a immune-associated genes based prognostic signature in bladder cancer.
    Artif Cells Nanomed Biotechnol. 2021;49:108-119.
    Abstract     Related articles   

  150. PACKIAM VT, Tsivian M, Boorjian SA
    The evolving role of lymphadenectomy for bladder cancer: why, when, and how.
    Transl Androl Urol. 2020;9:3082-3093.
    Abstract     Related articles   

  151. SUNG LH, Yuk HD
    Enhanced recovery after surgery of patients undergoing radical cystectomy for bladder cancer.
    Transl Androl Urol. 2020;9:2986-2996.
    Abstract     Related articles   

  152. KIM IH, Lee HJ
    Perioperative immunotherapy for muscle-invasive bladder cancer.
    Transl Androl Urol. 2020;9:2976-2985.
    Abstract     Related articles   

  153. TIWARI RV, Ngo NT, Lee LS
    The optimal management of variant histology in muscle invasive bladder cancer.
    Transl Androl Urol. 2020;9:2965-2975.
    Abstract     Related articles   

  154. CLINTON TN, Huang C, Goh AC
    Is there an oncological benefit to extended lymphadenectomy for muscle-invasive bladder cancer?
    Transl Androl Urol. 2020;9:2956-2964.
    Abstract     Related articles   

  155. BRODIE A, Kijvikai K, Decaestecker K, Vasdev N, et al
    Review of the evidence for robotic-assisted robotic cystectomy and intra-corporeal urinary diversion in bladder cancer.
    Transl Androl Urol. 2020;9:2946-2955.
    Abstract     Related articles   

  156. PEAK TC, Hemal A
    Partial cystectomy for muscle-invasive bladder cancer: a review of the literature.
    Transl Androl Urol. 2020;9:2938-2945.
    Abstract     Related articles   

  157. THOLOMIER C, Souhami L, Kassouf W
    Bladder-sparing protocols in the treatment of muscle-invasive bladder cancer.
    Transl Androl Urol. 2020;9:2920-2937.
    Abstract     Related articles   

  158. KIM SK
    Role of PET/CT in muscle-invasive bladder cancer.
    Transl Androl Urol. 2020;9:2908-2919.
    Abstract     Related articles   

  159. SIM KC, Sung DJ
    Role of magnetic resonance imaging in tumor staging and follow-up for bladder cancer.
    Transl Androl Urol. 2020;9:2890-2907.
    Abstract     Related articles   

  160. FONG MHY, Feng M, McConkey DJ, Choi W, et al
    Update on bladder cancer molecular subtypes.
    Transl Androl Urol. 2020;9:2881-2889.
    Abstract     Related articles   

  161. KANG HW, Kim WJ, Choi W, Yun SJ, et al
    Tumor heterogeneity in muscle-invasive bladder cancer.
    Transl Androl Urol. 2020;9:2866-2880.
    Abstract     Related articles   

  162. KU JH, Seo HK, Kang SH
    Where are we now and where are we heading in muscle invasive bladder cancer.
    Transl Androl Urol. 2020;9:2864-2865.
    Abstract     Related articles   

  163. PACKIAM VT
    Consensus statements from the EAU-ESMO collaboration for advanced and variant bladder cancer: can we move the needle to improve survival?
    Transl Androl Urol. 2020;9:2488-2492.
    Abstract     Related articles   

  164. POLETAJEW S, Krajewski W, Kryst P
    Behind a personalized therapy with immune check-point inhibitors in metastatic bladder cancer: ready for a primetime?
    Transl Androl Urol. 2020;9:2479-2482.
    Abstract     Related articles   

  165. WONG BS, Duran C, Williams SB
    Vesical imaging reporting and data system (VI-RADS) and impact on identifying depth of invasion with subsequent management in bladder cancer patients: ready for prime time?
    Transl Androl Urol. 2020;9:2467-2470.
    Abstract     Related articles   

  166. ZHOU Q, Wang Z, Zeng H, Zhang H, et al
    Identification and validation of poor prognosis immunoevasive subtype of muscle-invasive bladder cancer with tumor-infiltrating podoplanin(+) cell abundance.
    Oncoimmunology. 2020;9:1747333.
    Abstract     Related articles   

  167. GILL HS, Dasari SP, Pandit S, Ritter TE, et al
    Disseminated M. bovis Infection and Vertebral Osteomyelitis following Immunotherapy for Bladder Cancer.
    Case Rep Infect Dis. 2020;2020:6676163.
    Abstract     Related articles   

  168. SHEN C, Xu T, Sun Y, Wang L, et al
    Construction of an Immune-Associated Gene-Based Signature in Muscle-Invasive Bladder Cancer.
    Dis Markers. 2020;2020:8866730.
    Abstract     Related articles   

  169. REY-CARDENAS M, Guerrero-Ramos F, Gomez de Liano Lista A, Carretero-Gonzalez A, et al
    Recent advances in neoadjuvant immunotherapy for urothelial bladder cancer: What to expect in the near future.
    Cancer Treat Rev. 2021;93:102142.
    Abstract     Related articles   

  170. ZHANG X, Zhang J, Zhang H, Liu Y, et al
    Exploring the five different genes associated with PKCalpha in bladder cancer based on gene expression microarray.
    J Cell Mol Med. 2021 Jan 15. doi: 10.1111/jcmm.16284.
    Abstract     Related articles   

  171. CHANG NT, Chang YH, Huang YT, Chen SC, et al
    Factors Associated with Refusal or Discontinuation of Treatment in Patients with Bladder Cancer: A Cohort Population-Based Study in Taiwan.
    Int J Environ Res Public Health. 2021;18.
    Abstract     Related articles   

  172. KADOURI Y, Boualaoui I, Lachkar S, Sayegh HE, et al
    [Squamous cell carcinoma of the bladder: a retrospective study conducted in a Moroccan University Hospital and literature review].
    Pan Afr Med J. 2020;37:143.
    Abstract     Related articles   

  173. PARK JY, Hong JH, Kim DH, Yu J, et al
    Magnesium and Bladder Discomfort after Transurethral Resection of Bladder Tumor.
    Anesthesiology. 2020;133:64-77.
    Abstract     Related articles   

  174. DAVIDSON PJ, McGeoch G, Shand B
    Assessment of a clinical pathway for investigation of haematuria that reduces the need for cystoscopy.
    N Z Med J. 2020;133:71-82.
    Abstract     Related articles   

  175. LOUREIRO LR, Feldmann A, Bergmann R, Koristka S, et al
    Extended half-life target module for sustainable UniCAR T-cell treatment of STn-expressing cancers.
    J Exp Clin Cancer Res. 2020;39:77.
    Abstract     Related articles   

  176. BOGDAN RUSU C, Bujoreanu CE, Irimie A, Achimas-Cadariu P, et al
    Totally intracorporeal 3D laparoscopic orthotopic neobladder reconstruction following radical cystectomy for infiltrative bladder tumors: the experience of modified Studer and modified Y-shaped ileal reconstruction techniques.
    J BUON. 2020;25:286-294.
    Abstract     Related articles   

  177. CHAE HK, Yang JI, An JH, Lee IH, et al
    Use of oral paclitaxel for the treatment of bladder tumors in dogs.
    J Vet Med Sci. 2020;82:527-530.
    Abstract     Related articles   

  178. GORET CC
    Neuroendocrine tumors of the urinary bladder A case series and review of the literature.
    Ann Ital Chir. 2020;91:65-68.
    Abstract     Related articles   

  179. LIU Y, Ilyas M, Khosa SK, Muhmoudi E, et al
    A Flexible Reduced Logarithmic-X Family of Distributions with Biomedical Analysis.
    Comput Math Methods Med. 2020;2020:4373595.
    Abstract     Related articles   

  180. CHEN Z, Yang L, Chen L, Li J, et al
    miR-190b promotes tumor growth and metastasis via suppressing NLRC3 in bladder carcinoma.
    FASEB J. 2020;34:4072-4084.
    Abstract     Related articles   

  181. HAMZA A, Guo CC
    Perivascular Epithelioid Cell Tumor of the Urinary Bladder: A Systematic Review.
    Int J Surg Pathol. 2020;28:393-400.
    Abstract     Related articles   

  182. OH JS, Park DJ, Byeon KH, Ha YS, et al
    Decrease of Preoperative Serum Albumin-to-Globulin Ratio as a Prognostic Indicator after Radical Cystectomy in Patients with Urothelial Bladder Cancer.
    Urol J. 2021 Jan 30. pii: 6350. doi: 10.22037/uj.v16i7.6350.
    Abstract     Related articles   

  183. WANG S, Jin S, Shu Q, Wu S, et al
    Strategies to Get Drugs across Bladder Penetrating Barriers for Improving Bladder Cancer Therapy.
    Pharmaceutics. 2021;13.
    Abstract     Related articles   

  184. MAHARJAN DK, Thapa PB
    Laparoscopic Extended Cholecystectomy for Early Gall Bladder Cancer.
    J Nepal Health Res Counc. 2021;18:724-728.
    Abstract     Related articles   

  185. BI J, Liu H, Cai Z, Dong W, et al
    Correction for: Circ-BPTF promotes bladder cancer progression and recurrence through the miR-31-5p/RAB27A axis.
    Aging (Albany NY). 2021 Jan 28. pii: 202597. doi: 10.18632/aging.202597.
    Abstract     Related articles   

  186. NIP L, Salmo E, Surange R, Calleary J, et al
    Mixed histology bladder cancer as a complication of clam ileocystoplasty.
    BMJ Case Rep. 2021;14.
    Abstract     Related articles   

  187. JAZZAR U, Bergerot CD, Shan Y, Wallis CJ, et al
    Use of Psychotropic Drugs Among Older Patients with Bladder Cancer in the United States.
    Psychooncology. 2021 Jan 28. doi: 10.1002/pon.5641.
    Abstract     Related articles   

  188. KORNER SK, Dreyer T, Haug ES, Jerlstrom T, et al
    Which data are available in central registries on bladder cancer patients in the five Nordic countries.
    Scand J Urol. 2021 Jan 28:1-7. doi: 10.1080/21681805.2021.1877344.
    Abstract     Related articles   

  189. IKEDA J, Ohe C, Yoshida T, Kuroda N, et al
    Comprehensive pathological assessment of histological subtypes, molecular subtypes based on immunohistochemistry, and tumor-associated immune cell status in muscle-invasive bladder cancer.
    Pathol Int. 2021 Jan 27. doi: 10.1111/pin.13060.
    Abstract     Related articles   

  190. WU J, Xu H, Ji H, Zhai B, et al
    Low Expression of Keratin17 is Related to Poor Prognosis in Bladder Cancer.
    Onco Targets Ther. 2021;14:577-587.
    Abstract     Related articles   

  191. WANG W, Qiu J, Qu P, Chen H, et al
    Regulator of cullins-1 (ROC1) negatively regulates the Gli2 regulator SUFU to activate the hedgehog pathway in bladder cancer.
    Cancer Cell Int. 2021;21:75.
    Abstract     Related articles   

  192. WANG F, Fan M, Zhou X, Yu Y, et al
    A positive feedback loop between TAZ and miR-942-3p modulates proliferation, angiogenesis, epithelial-mesenchymal transition process, glycometabolism and ROS homeostasis in human bladder cancer.
    J Exp Clin Cancer Res. 2021;40:44.
    Abstract     Related articles   

  193. MINKLER S, Lucien F, Kimber MJ, Sahoo DK, et al
    Emerging Roles of Urine-Derived Components for the Management of Bladder Cancer: One Man's Trash Is Another Man's Treasure.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  194. BRUMMELHUIS ISG, Wimper Y, Witjes-van Os HGJM, Arends TJH, et al
    Long-Term Experience with Radiofrequency-Induced Hyperthermia Combined with Intravesical Chemotherapy for Non-Muscle Invasive Bladder Cancer.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  195. QUHAL F, Pradere B, Laukhtina E, Sari Motlagh R, et al
    Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer.
    World J Urol. 2021 Jan 26. pii: 10.1007/s00345-020-03586.
    Abstract     Related articles   

  196. GRUBA N, Stachurski L, Lesner A
    Non-proteasomal Urine Activity in Bladder Cancer.
    Chem Biodivers. 2021 Jan 26. doi: 10.1002/cbdv.202000981.
    Abstract     Related articles   

  197. IRUZUBIETA P, Castiella T, Monleon E, Berga C, et al
    Primary cilia presence and implications in bladder cancer progression and invasiveness.
    Histochem Cell Biol. 2021 Jan 25. pii: 10.1007/s00418-021-01965.
    Abstract     Related articles   

  198. VARUGHESE M, Treece S, Drinkwater K, Williams M, et al
    Failing to Close the Gap between Evidence and Clinical Practice in Radical Bladder Cancer Radiotherapy: A Critical Unmet Need.
    Clin Oncol (R Coll Radiol). 2021 Jan 22. pii: S0936-6555(21)00001.
    Abstract     Related articles   

  199. DONG Y, Hao L, Fang K, Han XX, et al
    A network pharmacology perspective for deciphering potential mechanisms of action of Solanum nigrum L. in bladder cancer.
    BMC Complement Med Ther. 2021;21:45.
    Abstract     Related articles   

  200. FRANCOLINI G, Borghesi S, Fersino S, Magli A, et al
    Treatment of muscle-invasive bladder cancer in patients without comorbidities and fit for surgery: trimodality therapy vs radical cystectomy. Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the
    Crit Rev Oncol Hematol. 2021 Jan 22:103235.
    Abstract     Related articles   

  201. YU X, Li S, Pang M, Du Y, et al
    TSPAN7 Exerts Anti-Tumor Effects in Bladder Cancer Through the PTEN/PI3K/AKT Pathway.
    Front Oncol. 2021;10:613869.
    Abstract     Related articles   

  202. LIANG Z, Guo W, Fang S, Zhang Y, et al
    CircRNAs: Emerging Bladder Cancer Biomarkers and Targets.
    Front Oncol. 2021;10:606485.
    Abstract     Related articles   

  203. CHEN Y, Liu J, Zhang W, Kadier A, et al
    O-GlcNAcylation Enhances NUSAP1 Stability and Promotes Bladder Cancer Aggressiveness.
    Onco Targets Ther. 2021;14:445-454.
    Abstract     Related articles   

  204. GROSSMANN NC, Schuettfort VM, Pradere B, Moschini M, et al
    Further Understanding of Urokinase Plasminogen Activator Overexpression in Urothelial Bladder Cancer Progression, Clinical Outcomes and Potential Therapeutic Targets.
    Onco Targets Ther. 2021;14:315-324.
    Abstract     Related articles   

  205. PACKIAM VT, Labbate CV, Boorjian SA, Tarrell R, et al
    The association of salvage intravesical therapy following BCG with pathologic outcomes and survival after radical cystectomy for patients with high-grade non-muscle invasive bladder cancer: A multi-institution analysis.
    Urol Oncol. 2021 Jan 20. pii: S1078-1439(21)00003.
    Abstract     Related articles   

  206. GRIMBERG DC, Dudinec J, Shah A, Inman BA, et al
    Clinical trial of high dose hyperthermic intravesical mitomycin C for intermediate and high-risk non-muscle invasive bladder cancer during BCG shortage.
    Urol Oncol. 2021 Jan 20. pii: S1078-1439(20)30654.
    Abstract     Related articles   

  207. SCHUBACH K, Diocera M, Lauridsen SV
    Bladder Cancer Nursing Updates (EAUN BC SIG and ANZUP BC SIG): Global Updates and Future Joint Directions.
    Semin Oncol Nurs. 2021 Jan 20:151115. doi: 10.1016/j.soncn.2020.151115.
    Abstract     Related articles   

  208. KOJIMA T
    [.The History of Developing Anticancer Drug for Urothelial Carcinoma and Future Issues].
    Gan To Kagaku Ryoho. 2021;48:41-45.
    Abstract     Related articles   

  209. KRIEGMAIR MC, Hein S, Schoeb DS, Zappe H, et al
    [Enhanced imaging in urological endoscopy].
    Urologe A. 2021;60:8-18.
    Abstract     Related articles   

  210. ERBEN P, Becker C, Tsaur I, Stope MB, et al
    [Molecular subtypes of urothelial carcinoma of the bladder-background and clinical relevance].
    Urologe A. 2021;60:81-88.
    Abstract     Related articles   

  211. FALCAO G, Carneiro C, Pinheiro LC
    Bladder paraganglioma: a case report.
    Pan Afr Med J. 2020;36:339.
    Abstract     Related articles   

  212. PIERCONTI F, Martini M, Cenci T, Fiorentino V, et al
    Methylation study of the Paris system for reporting urinary (TPS) categories.
    J Clin Pathol. 2021;74:102-105.
    Abstract     Related articles   

  213. PRAVEEN B, Varghese J, Krishnamoorthy H, Pillai BS, et al
    A rare case of small cell neuroendocrine tumor of the urinary bladder.
    Indian J Pathol Microbiol. 2020;63:298-300.
    Abstract     Related articles   

  214. ABEDINZADEH M, Moghimi M, Dastgheib SA, Maleki H, et al
    Association of NAD (P) H Quinine Oxidoreductase 1 rs1800566 Polymorphism with Bladder and Prostate Cancers - a Systematic Review and Meta-Analysis.
    Klin Onkol. 2020;33:92-100.
    Abstract     Related articles   

  215. RZEPKA E, Gilis-Januszewska A, Opalinska M, Sowa-Staszczak A, et al
    Difficulties in the diagnosis and treatment of malignant paraganglioma of the urinary bladder.
    Endokrynol Pol. 2020;71:196-197.
    Abstract     Related articles   

  216. HSIEH JJ
    The Gender Issue.
    Clin Genitourin Cancer. 2020;18:77.
    Abstract     Related articles   

  217. MISTRETTA FA, Cyr SJ, Luzzago S, Mazzone E, et al
    Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes.
    Clin Genitourin Cancer. 2020;18:129-137.
    Abstract     Related articles   

  218. KRUGHOFF K, Taylor CE, Snyder PM, Santis WF, et al
    Choriocarcinoma of the Bladder: Case Report and Considerations for Diagnosis.
    Clin Genitourin Cancer. 2020;18:e190-e193.
    Abstract     Related articles   

  219. AKAND M, Muilwijk T, Van Der Aa F, Gevaert T, et al
    Prognostic score predicts overall survival following complete urinary tract extirpation.
    Scand J Urol. 2020;54:70-79.
    Abstract     Related articles   

  220. AZAWI NH, Naeraa SH, Subhi Y, Vasquez JL, et al
    Oncological outcomes of radical nephroureterectomy for upper urinary tract urothelial neoplasia in Denmark.
    Scand J Urol. 2020;54:58-64.
    Abstract     Related articles   

  221. HWANG I, Park I, Yoon SK, Lee JL, et al
    Hyperprogressive Disease in Patients With Urothelial Carcinoma or Renal Cell Carcinoma Treated With PD-1/PD-L1 Inhibitors.
    Clin Genitourin Cancer. 2020;18:e122-e133.
    Abstract     Related articles   

  222. MANNAS MP, Lee T, Forbes CM, Hong T, et al
    Predicting complications following radical cystectomy with the ACS NSQIP universal surgical risk calculator.
    World J Urol. 2020;38:1215-1220.
    Abstract     Related articles   

  223. SYED JS, Abello A, Nguyen J, Lee AJH, et al
    Outcomes for urologic oncology procedures: are there differences between academic and community hospitals?
    World J Urol. 2020;38:1187-1193.
    Abstract     Related articles   

  224. BRASSETTI A, Cacciamani G, Anceschi U, Ferriero M, et al
    Long-term oncologic outcomes of robot-assisted radical cystectomy (RARC) with totally intracorporeal urinary diversion (ICUD): a multi-center study.
    World J Urol. 2020;38:837-843.
    Abstract     Related articles   

  225. CHOUDHURY A, Porta N, Hall E, Song YP, et al
    Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trials.
    Lancet Oncol. 2021;22:246-255.
    Abstract     Related articles   

  226. LABBAN M, Najdi J, Mukherji D, Abou-Kheir W, et al
    Triple-marker immunohistochemical assessment of muscle-invasive bladder cancer: Is there prognostic significance?
    Cancer Rep (Hoboken). 2021 Feb 4:e1313. doi: 10.1002/cnr2.1313.
    Abstract     Related articles   

  227. ZHANG Z, Chen J, Zhu Z, Zhu Z, et al
    CRISPR-Cas13-Mediated Knockdown of lncRNA-GACAT3 Inhibited Cell Proliferation and Motility, and Induced Apoptosis by Increasing p21, Bax, and E-Cadherin Expression in Bladder Cancer.
    Front Mol Biosci. 2021;7:627774.
    Abstract     Related articles   

  228. HU J, Yu A, Othmane B, Qiu D, et al
    Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer.
    Theranostics. 2021;11:3089-3108.
    Abstract     Related articles   

  229. KIM SK, Park SH, Kim YU, Byun YJ, et al
    A Molecular Signature Determines the Prognostic and Therapeutic Subtype of Non-Muscle-Invasive Bladder Cancer Responsive to Intravesical Bacillus Calmette-Guerin Therapy.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  230. FUJIMOTO T, Sakamoto H, Nakashima M, Imai K, et al
    [Complete Transurethral Resection of Large Non-Muscle-Invasive Bladder Cancer Preoperatively Suspected to Be Muscle-Invasive Disease : A Case Report and Literature Review].
    Hinyokika Kiyo. 2021;67:37-41.
    Abstract     Related articles   

  231. SHANG C, Zhu YL, Li YQ, Song GJ, et al
    Autophagy promotes oncolysis of an adenovirus expressing apoptin in human bladder cancer models.
    Invest New Drugs. 2021 Feb 3. pii: 10.1007/s10637-021-01073.
    Abstract     Related articles   

  232. HE T, Hu J, Qiu D, Deng H, et al
    Smoking status and pathological response to neoadjuvant chemotherapy among patients with bladder cancer: a pooled analysis.
    Transl Androl Urol. 2021;10:374-383.
    Abstract     Related articles   

  233. TIAN J, Sun J, Fu G, Xu Z, et al
    Population-based outcome of muscle-invasive bladder cancer following radical cystectomy: who can benefit from adjuvant chemotherapy?
    Transl Androl Urol. 2021;10:356-373.
    Abstract     Related articles   

  234. CAI Z, Jin H, Chen J, Hu J, et al
    Adjuvant chemotherapy in patients with locally advanced bladder cancer after neoadjuvant chemotherapy and radical cystectomy: a systematic review and pooled analysis.
    Transl Androl Urol. 2021;10:283-291.
    Abstract     Related articles   

  235. DU L, Wang X, Yin Y, Zhang Y, et al
    Identification of a potentially functional circRNA-miRNA-mRNA ceRNA regulatory network in bladder cancer by analysis of microarray data.
    Transl Androl Urol. 2021;10:24-36.
    Abstract     Related articles   

  236. ESPER RUEDA JA, Carrion Lopez P, Donate Moreno MJ, Herais Raya L, et al
    Usefulness of neoadjuvant chemotherapy in non-metastatic muscle-invasive bladder cancer.
    Actas Urol Esp. 2021 Jan 30. pii: S0210-4806(20)30248.
    Abstract     Related articles   

  237. ETXANO J, Rodriguez-Vigil B, Perez F, Beardo P, et al
    Vesical Imaging-Reporting and Data System (VI-RADS(R)): Initial experience in the classification of muscle-invasive bladder cancer.
    Actas Urol Esp. 2021 Jan 30. pii: S0210-4806(20)30239.
    Abstract     Related articles   

  238. HE S, Li G, Schatzlein AG, Humphrey PA, et al
    Down-regulation of GP130 signaling sensitizes bladder cancer to cisplatin by impairing Ku70 DNA repair signaling and promoting apoptosis.
    Cell Signal. 2021 Jan 30:109931. doi: 10.1016/j.cellsig.2021.109931.
    Abstract     Related articles   

  239. HACKEMER P, Malkiewicz B, Menzel F, Drabik A, et al
    Determinants of survival in patients with bladder cancer undergoing radical cystectomy: The impact of serum creatinine level.
    Adv Clin Exp Med. 2021;30:77-82.
    Abstract     Related articles   

  240. OKUYAMA A, Hori M
    Age-specific bladder cancer incidence rate in the world.
    Jpn J Clin Oncol. 2021 Feb 3. pii: 6126763. doi: 10.1093.
    Abstract     Related articles   

  241. ZHANG X, Zhang J, Zhao W, Dong X, et al
    Long non-coding RNA LINC02446 suppresses the proliferation and metastasis of bladder cancer cells by binding with EIF3G and regulating the mTOR signalling pathway.
    Cancer Gene Ther. 2021 Feb 2. pii: 10.1038/s41417-020-00285.
    Abstract     Related articles   

  242. MIYAKE M, Nishimura N, Nakai Y, Fujii T, et al
    Photodynamic Diagnosis-Assisted Transurethral Resection Using Oral 5-Aminolevulinic Acid Decreases the Risk of Repeated Recurrence in Non-Muscle-Invasive Bladder Cancer: A Cumulative Incidence Analysis by the Person-Time Method.
    Diagnostics (Basel). 2021;11.
    Abstract     Related articles   

  243. YAN D, Dong W, He Q, Yang M, et al
    Corrigendum to "Circular RNA circPICALM sponges miR-1265 to inhibit bladder cancer metastasis and influence FAK phosphorylation": [EBioMedicine 48 (2019) 316-331].
    EBioMedicine. 2021;64:103226.
    Abstract     Related articles   

  244. ZHAO L, Lian T, Li J, Wei S, et al
    NCR3LG1(B7-H6) is a potential prognostic factor for bladder cancer patients.
    Biomarkers. 2021 Feb 1:1-20. doi: 10.1080/1354750X.2021.1883110.
    Abstract     Related articles   

  245. LI G, Zhang X, Guo X, Li Y, et al
    Propofol Inhibits the Proliferation, Migration, and Stem-like Properties of Bladder Cancer Mainly by Suppressing the Hedgehog Pathway.
    Cell Transplant. 2021;30:963689720985113.
    Abstract     Related articles   

  246. GRIFFIN LE, Kohrt SE, Rathore A, Kay CD, et al
    Microbial Metabolites of Flavanols in Urine are Associated with Enhanced Anti-Proliferative Activity in Bladder Cancer Cells In Vitro.
    Nutr Cancer. 2021 Feb 1:1-17. doi: 10.1080/01635581.2020.1869277.
    Abstract     Related articles   

  247. HAN C, Wang Z, Chen S, Li L, et al
    Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-kappaB Axis.
    Oxid Med Cell Longev. 2021;2021:8851763.
    Abstract     Related articles   

  248. KIBARU J, Kotecha P, Iya AM, Russell B, et al
    Scoping review protocol: bladder cancer in Nigeria: what are the gaps in clinical care and research?
    BMJ Open. 2021;11:e041894.
    Abstract     Related articles   

  249. SHI H, Xie J, Wang K, Li W, et al
    LINC01451 drives epithelial-mesenchymal transition and progression in bladder cancer cells via LIN28/TGF-beta/Smad pathway.
    Cell Signal. 2021 Jan 28:109932. doi: 10.1016/j.cellsig.2021.109932.
    Abstract     Related articles   

  250. PERENNEC T, Supiot S
    [Stereotactic radiotherapy in urologic cancers: Reports from the 3rd international meeting of the Groupe Francophone de Radiotherapie Urologique (GFRU)].
    Bull Cancer. 2021;108:125-128.
    Abstract     Related articles   

  251. LARANJO M, Aguiar MC, Pereira NAM, Brites G, et al
    Platinum(II) ring-fused chlorins as efficient theranostic agents: Dyes for tumor-imaging and photodynamic therapy of cancer.
    Eur J Med Chem. 2020;200:112468.
    Abstract     Related articles   

  252. IBRAHIM SA, Kulshrestha A, Katara GK, Riehl V, et al
    Cancer-associated V-ATPase induces delayed apoptosis of protumorigenic neutrophils.
    Mol Oncol. 2020;14:590-610.
    Abstract     Related articles   

  253. ZHANG C, Shen L, Qi F, Wang J, et al
    Multi-omics analysis of tumor mutation burden combined with immune infiltrates in bladder urothelial carcinoma.
    J Cell Physiol. 2020;235:3849-3863.
    Abstract     Related articles   

  254. BOEGEMANN M, Krabbe LM
    Prognostic Implications of Immunohistochemical Biomarkers in Non-muscle-invasive Blad Cancer and Muscle-invasive Bladder Cancer.
    Mini Rev Med Chem. 2020;20:1133-1152.
    Abstract     Related articles   

  255. LI C, Su H, Ruan C, Li X, et al
    Keratin 17 knockdown suppressed malignancy and cisplatin tolerance of bladder cancer cells, as well as the activation of AKT and ERK pathway.
    Folia Histochem Cytobiol. 2021 Feb 12. pii: VM/OJS/J/71578.
    Abstract     Related articles   

  256. SCHMITZ-DRAGER BJ, Skutetzki A, Rieker RJ, Schwab SA, et al
    Eosinophilic cystitis mimicking bladder cancer-considerations on the management based upon a case report and a review of the literature.
    Virchows Arch. 2021 Feb 12. pii: 10.1007/s00428-021-03049.
    Abstract     Related articles   

  257. WOO S, Panebianco V, Narumi Y, Del Giudice F, et al
    Corrigendum to 'Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis' [European Urology Oncology 3 (2020) 306-315].
    Eur Urol Oncol. 2020;3:811.
    Abstract     Related articles   

  258. MO XC, Zhang ZT, Song MJ, Zhou ZQ, et al
    Screening and identification of hub genes in bladder cancer by bioinformatics analysis and KIF11 is a potential prognostic biomarker.
    Oncol Lett. 2021;21:205.
    Abstract     Related articles   

  259. LEE DH, Jeong JY, Song W
    Prognostic Value of Programmed Death Ligand-1 Expression on Tumor-Infiltrating Immune Cells in Patients Treated with Cisplatin-Based Combination Adjuvant Chemotherapy Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Coh
    Onco Targets Ther. 2021;14:845-855.
    Abstract     Related articles   

  260. MURTHY V, Bakshi G, Manjali JJ, Prakash G, et al
    Locoregional recurrence after cystectomy in muscle invasive bladder cancer: Implications for adjuvant radiotherapy.
    Urol Oncol. 2021 Feb 8. pii: S1078-1439(21)00015.
    Abstract     Related articles   

  261. GUAN X, Wei R, Yang R, Lu Z, et al
    Risk and Prognosis of Secondary Bladder Cancer After Radiation Therapy for Rectal Cancer: A Large Population-Based Cohort Study.
    Front Oncol. 2021;10:586401.
    Abstract     Related articles   

  262. OTAOLA-ARCA H, Seetharam Bhat KR, Patel VR, Moschovas MC, et al
    Totally intracorporeal robot-assisted urinary diversion for bladder cancer (part 2). Review and detailed characterization of the existing intracorporeal orthotopic ileal neobladder.
    Asian J Urol. 2021;8:63-80.
    Abstract     Related articles   

  263. OTAOLA-ARCA H, Coelho R, Patel VR, Orvieto M, et al
    Totally intracorporeal robot-assisted urinary diversion for bladder cancer (Part 1). Review and detailed characterization of ileal conduit and modified Indiana pouch.
    Asian J Urol. 2021;8:50-62.
    Abstract     Related articles   

  264. TAN S, Kang Y, Li H, He HQ, et al
    circST6GALNAC6 suppresses bladder cancer metastasis by sponging miR-200a-3p to modulate the STMN1/EMT axis.
    Cell Death Dis. 2021;12:168.
    Abstract     Related articles   

  265. PIAO XM, Cha EJ, Yun SJ, Kim WJ, et al
    Role of Exosomal miRNA in Bladder Cancer: A Promising Liquid Biopsy Biomarker.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  266. TERRERI S, Mancinelli S, Ferro M, Vitale MC, et al
    Subcellular Localization of uc.8+ as a Prognostic Biomarker in Bladder Cancer Tissue.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  267. CLAUSEN TM, Kumar G, Ibsen EK, Orum-Madsen MS, et al
    A simple method for detecting oncofetal chondroitin sulfate glycosaminoglycans in bladder cancer urine.
    Cell Death Discov. 2020;6:65.
    Abstract     Related articles   

  268. CHENG S, Jiang Z, Xiao J, Guo H, et al
    The prognostic value of six survival-related genes in bladder cancer.
    Cell Death Discov. 2020;6:58.
    Abstract     Related articles   

  269. WANG G, Black PC, Goebell PJ, Ji L, et al
    Prognostic markers in pT3 bladder cancer: A study from the international bladder cancer tissue microarray project.
    Urol Oncol. 2021 Feb 6. pii: S1078-1439(21)00027.
    Abstract     Related articles   

  270. LIU YL, Wang XL, Yang XH, Wu XH, et al
    Pooled analysis of Xpert Bladder Cancer based on the 5 mRNAs for rapid diagnosis of bladder carcinoma.
    World J Surg Oncol. 2021;19:42.
    Abstract     Related articles   

  271. WEYERER V, Eckstein M, Strissel PL, Wullweber A, et al
    TERT Promoter Mutation Analysis of Whole-Organ Mapping Bladder Cancers.
    Genes (Basel). 2021;12.
    Abstract     Related articles   

  272. ROSIELLO G, Palumbo C, Deuker M, Stolzenbach LF, et al
    Sex- and age-related differences in the distribution of bladder cancer metastases.
    Jpn J Clin Oncol. 2021 Feb 9. pii: 6131386. doi: 10.1093.
    Abstract     Related articles   

  273. ALKASSIS M, Sarkis J, Tayeh GA, Kourie HR, et al
    Immunotherapy in neoadjuvant setting in muscle-invasive bladder cancer, what's new?
    Immunotherapy. 2021 Feb 9. doi: 10.2217/imt-2020-0285.
    Abstract     Related articles   

  274. YONEDA K, Kamiya N, Utsumi T, Wakai K, et al
    Impact of Lymphovascular Invasion on Prognosis in the Patients with Bladder Cancer-Comparison of Transurethral Resection and Radical Cystectomy.
    Diagnostics (Basel). 2021;11.
    Abstract     Related articles   

  275. ZHANG L, Li L, Zhan Y, Wang J, et al
    Identification of Immune-Related lncRNA Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer.
    Front Oncol. 2021;10:542140.
    Abstract     Related articles   

  276. KOTERAZAWA S, Watanabe J, Uemura Y, Uegaki M, et al
    A case of infectious thoracic aortic aneurysm after intravesical Bacillus Calmette-Guerin instillation therapy for a superficial bladder cancer.
    Urol Case Rep. 2021;36:101574.
    Abstract     Related articles   

  277. ROSIELLO G, Palumbo C, Deuker M, Stolzenbach LF, et al
    Racial differences in the distribution of bladder cancer metastases: a population-based analysis.
    Cent European J Urol. 2020;73:407-415.
    Abstract     Related articles   

  278. YU L, Li Z, Mei H, Li W, et al
    Patient-derived organoids of bladder cancer recapitulate antigen expression profiles and serve as a personal evaluation model for CAR-T cells in vitro.
    Clin Transl Immunology. 2021;10:e1248.
    Abstract     Related articles   

  279. WANG D, Xie D, Bi L, Wang Y, et al
    Benzidine promotes the stemness of bladder cancer stem cells via activation of the Sonic hedgehog pathway.
    Oncol Lett. 2021;21:146.
    Abstract     Related articles   

  280. XIE X, Li H, Pan J, Han X, et al
    Knockdown of TRIM26 inhibits the proliferation, migration and invasion of bladder cancer cells through the Akt/GSK3beta/beta-catenin pathway.
    Chem Biol Interact. 2021;337:109366.
    Abstract     Related articles   

  281. AHMED SA, Taher MGA, Ali WA, Ebrahem MAES, et al
    Diagnostic performance of contrast-enhanced dynamic and diffusion-weighted MR imaging in the assessment of tumor response to neoadjuvant therapy in muscle-invasive bladder cancer.
    Abdom Radiol (NY). 2021 Feb 6. pii: 10.1007/s00261-021-02963.
    Abstract     Related articles   

  282. RISTE M, Davda P, Smith EG, Wyllie DH, et al
    Prosthetic hip joint infection by Bacillus Calmette-Guerin therapy following intravesical instillation for bladder cancer identified using whole-genome sequencing: a case report.
    BMC Infect Dis. 2021;21:151.
    Abstract     Related articles   

  283. WU Z, Wen Z, Li Z, Yu M, et al
    Identification and prognostic value of a glycolysis-related gene signature in patients with bladder cancer.
    Medicine (Baltimore). 2021;100:e23836.
    Abstract     Related articles   

  284. ZHU J, Luo Y, Zhao Y, Kong Y, et al
    circEHBP1 promotes lymphangiogenesis and lymphatic metastasis of bladder cancer via miR-130a-3p/TGFbetaR1/VEGF-D signaling.
    Mol Ther. 2021 Feb 3. pii: S1525-0016(21)00065.
    Abstract     Related articles   

  285. YANG M, Georgieva MV, Bocharova I, Vembusubramanian M, et al
    The Impact of Progression on Healthcare Resource Utilization and Costs Among Patients with High-Grade Non-Muscle Invasive Bladder Cancer After Bacillus Calmette-Guerin Therapy: A Retrospective SEER-Medicare Analysis.
    Adv Ther. 2021 Jan 11. pii: 10.1007/s12325-020-01616.
    Abstract     Related articles   

  286. BURASCHI S, Morcavallo A, Neill T, Stefanello M, et al
    Discoidin Domain Receptor 1 functionally interacts with the IGF-I system in bladder cancer.
    Matrix Biol Plus. 2020;6-7:100022.
    Abstract     Related articles   

  287. ZHANG Q, Lai Q, Wang S, Meng Q, et al
    Clinical Value of Postoperative Neutrophil-to-Lymphocyte Ratio Change as a Detection Marker of Bladder Cancer Recurrence.
    Cancer Manag Res. 2021;13:849-860.
    Abstract     Related articles   

  288. JOENSEN UN, Maibom SL, Poulsen AM
    Surgical Management of Muscle Invasive Bladder Cancer: A Review of Current Recommendations.
    Semin Oncol Nurs. 2021 Feb 1:151104. doi: 10.1016/j.soncn.2020.151104.
    Abstract     Related articles   

  289. YU YF, Zhou XL, Wang GF, Gu WX, et al
    [Clinicopathological analysis of micropapillary urothelial carcinoma of the bladder].
    Zhonghua Bing Li Xue Za Zhi. 2021;50:125-127.
    Abstract     Related articles   

  290. LARSSON SC, Mason AM, Kar S, Vithayathil M, et al
    Genetically proxied milk consumption and risk of colorectal, bladder, breast, and prostate cancer: a two-sample Mendelian randomization study.
    BMC Med. 2020;18:370.
    Abstract     Related articles   

  291. RAJAIAN S, Murugasen L, Jain D, Chakravarthy Narasimhachar S, et al
    Mullerianosis of the urinary bladder with unilateral complete renal agenesis: a rare coincidental finding causing delayed presentation.
    BMJ Case Rep. 2020;13.
    Abstract     Related articles   

  292. HUSSIEN MT, Helmy E, Elsaba TM, Elkady A, et al
    Assessing CD 10 Expression Level and Its Prognostic Impact in Egyptian Patients with Urothelial Carcinoma.
    Asian Pac J Cancer Prev. 2020;21:1573-1583.
    Abstract     Related articles   

  293. PIRES-LUIS AS, Martinek P, Alaghehbandan R, Trpkov K, et al
    Molecular Genetic Features of Primary Nonurachal Enteric-type Adenocarcinoma, Urachal Adenocarcinoma, Mucinous Adenocarcinoma, and Intestinal Metaplasia/Adenoma: Review of the Literature and Next-generation Sequencing Study.
    Adv Anat Pathol. 2020;27:303-310.
    Abstract     Related articles   

  294. JIA Y, Liu S, Du Y, Yang L, et al
    Intramolecular Coreaction Accelerated Electrochemiluminescence of Polypeptide-Biomineralized Gold Nanoclusters for Targeted Detection of Biomarkers.
    Anal Chem. 2020;92:9179-9187.
    Abstract     Related articles   

  295. MASTERSON AN, Liyanage T, Kaimakliotis H, Gholami Derami H, et al
    Bottom-Up Fabrication of Plasmonic Nanoantenna-Based High-throughput Multiplexing Biosensors for Ultrasensitive Detection of microRNAs Directly from Cancer Patients' Plasma.
    Anal Chem. 2020;92:9295-9304.
    Abstract     Related articles   

  296. SU Q, Sun Y, Zhang Z, Yang Z, et al
    Identification of Prognostic Immune Genes in Bladder Urothelial Carcinoma.
    Biomed Res Int. 2020;2020:7510120.
    Abstract     Related articles   

  297. LIU L, Liu Y, Yan X, Zhou C, et al
    The role of granulocyte colonystimulating factor in breast cancer development: A review.
    Mol Med Rep. 2020;21:2019-2029.
    Abstract     Related articles   

  298. ADNAN A, Basu S
    Comparison of Dual-Tracer PET and CT Features to Conventional Risk Categories in Assessing Response to (177)Lu-PSMA-617 Therapy for Metastatic Prostate Adenocarcinoma with Urinary Bladder Involvement.
    J Nucl Med Technol. 2020;48:148-153.
    Abstract     Related articles   

  299. DEL POZO JIMENEZ G, Herranz Amo F, Arranz Arija JA, Rodriguez Fernandez E, et al
    Effect of adjuvant chemotherapy in locally advanced urothelial carcinoma of the bladder treated with cystectomy.
    Actas Urol Esp. 2020;44:94-102.
    Abstract     Related articles   

  300. SUBIRA-RIOS D, Herranz-Amo F, Moralejo-Garate M, Cano-Velasco J, et al
    Evaluation of laparoscopic approach in radical cystectomy from implementation to consolidation: Internal validation.
    Actas Urol Esp. 2020;44:62-70.
    Abstract     Related articles   

  301. METWALLY MI, Zeed NA, Hamed EM, Elshetry ASF, et al
    The validity, reliability, and reviewer acceptance of VI-RADS in assessing muscle invasion by bladder cancer: a multicenter prospective study.
    Eur Radiol. 2021 Feb 19. pii: 10.1007/s00330-021-07765.
    Abstract     Related articles   

  302. JAMES M, Kalayarasan R, Gnanasekaran S, Pottakkat B, et al
    Laparoscopic hepatopancreatoduodenectomy for locally advanced gall bladder cancer.
    J Minim Access Surg. 2021 Feb 3. pii: 308673. doi: 10.4103.
    Abstract     Related articles   

  303. LI J, Lou Y, Li S, Sheng F, et al
    Identification and Immunocorrelation of Prognosis-Related Genes Associated With Development of Muscle-Invasive Bladder Cancer.
    Front Mol Biosci. 2021;7:598599.
    Abstract     Related articles   

  304. HANNA KS
    Advancements in Therapy for Bladder Cancer: Enfortumab Vedotin.
    J Adv Pract Oncol. 2020;11:412-417.
    Abstract     Related articles   

  305. KURODA K, Tasaki S, Horiguchi A, Ito K, et al
    Postoperative C-reactive protein-to-albumin ratio predicts poor prognosis in patients with bladder cancer undergoing radial cystectomy.
    Mol Clin Oncol. 2021;14:54.
    Abstract     Related articles   

  306. ZHANG R, Jiang M, Lei W, Wang A, et al
    Malignant Acanthosis Nigricans with Recurrent Bladder Cancer: A Case Report and Review of Literature.
    Onco Targets Ther. 2021;14:951-957.
    Abstract     Related articles   

  307. HUANG Z, Yan Y, Tang P, Cai J, et al
    TEAD4 as a Prognostic Marker Promotes Cell Migration and Invasion of Urinary Bladder Cancer via EMT.
    Onco Targets Ther. 2021;14:937-949.
    Abstract     Related articles   

  308. LIU BB, Ma T, Sun W, Gao WY, et al
    Centromere protein U enhances the progression of bladder cancer by promoting mitochondrial ribosomal protein s28 expression.
    Korean J Physiol Pharmacol. 2021;25:119-129.
    Abstract     Related articles   


  309. Expression of Concern: Up-regulated ENO1 promotes the bladder cancer cell growth and proliferation via regulating beta-catenin.
    Biosci Rep. 2021;41.
    Abstract     Related articles   

  310. ZHENG W, Zhang J, Song Q, Xu Y, et al
    Rac Family Small GTPase 3 Correlates with Progression and Poor Prognosis in Bladder Cancer.
    DNA Cell Biol. 2021 Feb 17. doi: 10.1089/dna.2020.5613.
    Abstract     Related articles   

  311. OMORI G, Takada K, Murase K, Hayasaka N, et al
    Successful mycophenolate mofetil treatment of a patient with severe steroid-refractory hepatitis evoked by nivolumab plus ipilimumab treatment for relapsed bladder cancer.
    Clin Case Rep. 2020;9:654-659.
    Abstract     Related articles   

  312. SHI H, Zhang W, Bi X, Wang D, et al
    Neoadjuvant Chemotherapy-Guided Bladder-Sparing Treatment for Muscle-Invasive Bladder Cancer: Results of a Pilot Phase II Study.
    Cancer Res Treat. 2021 Feb 10. pii: crt.2020.1356. doi: 10.4143/crt.2020.1356.
    Abstract     Related articles   

  313. SAVIN Z, Herzberg H, Schreter E, Ben-David R, et al
    Radical cystectomy and perioperative chemotherapy in octogenarians with bladder cancer.
    Can Urol Assoc J. 2021 Feb 12. pii: cuaj.6907. doi: 10.5489/cuaj.6907.
    Abstract     Related articles   

  314. ZANGOUEI AS, Hamidi AA, Rahimi HR, Saburi E, et al
    Chemokines as the critical factors during bladder cancer progression: an overview.
    Int Rev Immunol. 2021 Feb 16:1-15. doi: 10.1080/08830185.2021.1877287.
    Abstract     Related articles   

  315. TEY J, Ho F, Koh WY, Chia D, et al
    Palliative radiotherapy for bladder cancer: a systematic review and meta-analysis.
    Acta Oncol. 2021 Feb 16:1-13. doi: 10.1080/0284186X.2021.1880025.
    Abstract     Related articles   

  316. CHEN M, Zhang R, Lu L, Du J, et al
    Correction for: LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA.
    Aging (Albany NY). 2021 Feb 14. pii: 202683. doi: 10.18632/aging.202683.
    Abstract     Related articles   

  317. RAMALINGAM S, Gunasekaran K, Arora H, Muruganandam M, et al
    Disseminated BCG Infection after intravesical BCG Immunotherapy Of Bladder Cancer.
    QJM. 2021 Feb 15. pii: 6135083. doi: 10.1093.
    Abstract     Related articles   

  318. PENG M, Xiao D, Bu Y, Long J, et al
    Novel Combination Therapies for the Treatment of Bladder Cancer.
    Front Oncol. 2021;10:539527.
    Abstract     Related articles   

  319. LIM CJ, Nguyen PHD, Wasser M, Kumar P, et al
    Immunological Hallmarks for Clinical Response to BCG in Bladder Cancer.
    Front Immunol. 2021;11:615091.
    Abstract     Related articles   

  320. VOSKUILEN CS, van Gennep EJ, Einerhand SMH, Vegt E, et al
    Staging (18)F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Changes Treatment Recommendation in Invasive Bladder Cancer.
    Eur Urol Oncol. 2021 Feb 11. pii: S2588-9311(21)00029.
    Abstract     Related articles   

  321. TESCH ME, Pater JA, Vandekerkhove G, Wang G, et al
    Concurrent germline and somatic pathogenic BAP1 variants in a patient with metastatic bladder cancer.
    NPJ Genom Med. 2020;5:12.
    Abstract     Related articles   

  322. MIYAKE M, Nishimura N, Inoue T, Suzuki S, et al
    Fluorescent cystoscopy-assisted en bloc transurethral resection versus conventional transurethral resection in patients with non-muscle invasive bladder cancer: study protocol of a prospective, open-label, randomized control trial (the FLEBER study).
    Trials. 2021;22:136.
    Abstract     Related articles   

  323. ROGHMANN F, Breyer J, Kriegmair M, Wezel F, et al
    [Quality assessment of radical cystectomy-opportunities, risks, challenges].
    Urologe A. 2021;60:151-161.
    Abstract     Related articles   

  324. SCHULZ GB, Volz Y, Jokisch F, Casuscelli J, et al
    [Enhanced Recovery After Surgery (ERAS(R)) after radical cystectomy-current data].
    Urologe A. 2021;60:162-168.
    Abstract     Related articles   

  325. FISCHER ND, Epple S, Wittenmeier E, Betz U, et al
    [Implementation of Enhanced Recovery after Surgery (ERAS(R)) protocol in radical cystectomy at the University Medical Center Mainz].
    Urologe A. 2021;60:169-177.
    Abstract     Related articles   

  326. LUZZAGO S, Knipper S, Palumbo C, Rosiello G, et al
    Effect of Age on Cancer-specific Mortality in Patients With Urothelial Carcinoma of the Urinary Bladder: A Population-based Competing-risks Analysis Across Disease Stages.
    Am J Clin Oncol. 2020;43:880-888.
    Abstract     Related articles   

  327. IWATA H, Sassa N, Kato M, Murase Y, et al
    UroVysion((R)) predicts intravesical recurrence after radical nephroureterectomy for urothelial carcinoma of the upper urinary tract: a prospective study.
    Int J Clin Oncol. 2021;26:178-185.
    Abstract     Related articles   

  328. SANGOI AR, Chan E, Stohr BA, Kunju LP, et al
    Invasive plasmacytoid urothelial carcinoma: A comparative study of E-cadherin and P120 catenin.
    Hum Pathol. 2020;102:54-59.
    Abstract     Related articles   

  329. DAI Z, Guo J, Xu J, Liu C, et al
    Target-Driven Nanozyme Growth in TiO2 Nanochannels for Improving Selectivity in Electrochemical Biosensing.
    Anal Chem. 2020;92:10033-10041.
    Abstract     Related articles   

  330. KHURRAM R, Khurram A, Chaudhary K
    Index case of synovial metastasis in a patient with transitional cell carcinoma of the bladder.
    BMJ Case Rep. 2020;13.
    Abstract     Related articles   

  331. MALTAGLIATI M, Milandri R, Bocchialini T, Graziotti P, et al
    Validation of the effectiveness of a modified Studer orthotopic neobladder in a single center after 3 years of its application.
    Urologia. 2020;87:167-169.
    Abstract     Related articles   

  332. DU Y, Xue J, Sun X, Wu D, et al
    Oxygen Vacancy-Enhanced Electrochemiluminescence Sensing Strategy Using Luminol Thermally Encapsulated in Apoferritin as a Transducer for Biomarker Immunoassay.
    Anal Chem. 2020;92:8472-8479.
    Abstract     Related articles   

  333. SOUNTOULIDES P, Mutomba WF, Bouras E, Lim J, et al
    How well do we manage non-muscle invasive bladder tumors? A UK audit of real-life practices.
    Urologia. 2020;87:142-148.
    Abstract     Related articles   

  334. RIZZO M, Verzotti E, Di Cosmo G, Cai T, et al
    Perioperative Antimicrobial Prophylaxis for Preventing Infectious Complications After Transurethral Resection of the Bladder: To Use or Not to Use?
    J Endourol. 2020;34:198-202.
    Abstract     Related articles   

  335. ECONOMOPOULOU P, Bamias A
    Combination immunotherapy in metastatic urothelial cancer: time for the next step?
    Chin Clin Oncol. 2020;9:23.
    Abstract     Related articles   

  336. AKCAY A, Yagci AB, Celen S, Ozlulerden Y, et al
    VI-RADS score and tumor contact length in MRI: A potential method for the detection of muscle invasion in bladder cancer.
    Clin Imaging. 2021;77:25-36.
    Abstract     Related articles   

  337. HUANG H, Fan X, Qiao Y, Yang M, et al
    Knockdown of KNTC1 Inhibits the Proliferation, Migration and Tumorigenesis of Human Bladder Cancer Cells and Induces Apoptosis.
    Crit Rev Eukaryot Gene Expr. 2021;31:49-60.
    Abstract     Related articles   

  338. YILDIZ HA, Deger MD, Aslan G
    Prognostic Value of Preoperative Inflammation Markers in Non-Muscle Invasive Bladder Cancer.
    Int J Clin Pract. 2021 Feb 26:e14118. doi: 10.1111/ijcp.14118.
    Abstract     Related articles   

  339. TAO L, Mu X, Chen H, Jin D, et al
    FTO modifies the m6A level of MALAT and promotes bladder cancer progression.
    Clin Transl Med. 2021;11:e310.
    Abstract     Related articles   

  340. CAI EY, Garcia J, Liu Y, Vakar-Lopez F, et al
    A bladder cancer patient-derived xenograft displays aggressive growth dynamics in vivo and in organoid culture.
    Sci Rep. 2021;11:4609.
    Abstract     Related articles   

  341. XIU W, Luo J
    Correction to: CXCL9 secreted by tumor-associated dendritic cells up-regulates PD-L1 expression in bladder cancer cells by activating the CXCR3 signaling.
    BMC Immunol. 2021;22:18.
    Abstract     Related articles   

  342. INGENWERTH M, Nyirady P, Hadaschik B, Szarvas T, et al
    The prognostic value of cytokeratin and extracellular collagen expression in urinary bladder cancer.
    Curr Mol Med. 2021 Feb 24. pii: CMM-EPUB-114544.
    Abstract     Related articles   

  343. CHEN LQ, Yi CL, Liu DC, Wang P, et al
    Hsa_circ_0041103 induces proliferation, migration and invasion in bladder cancer via the miR-107/FOXK1 axis.
    Eur Rev Med Pharmacol Sci. 2021;25:1282-1290.
    Abstract     Related articles   

  344. RUAN Q, Ding D, Wang B, He C, et al
    A multi-institutional retrospective study of hyperthermic plus intravesical chemotherapy versus intravesical chemotherapy treatment alone in intermediate and high risk nonmuscle-invasive bladder cancer.
    Cancer Biol Med. 2021;18:308-317.
    Abstract     Related articles   

  345. TADRIST A, Gondran-Tellier B, McManus R, Al-Balushi K, et al
    Primary Complete Transurethral Resection of Bladder Tumor using Photodynamic Diagnosis for High-risk Non-Muscle Invasive Bladder Cancer: Is a Restaging Photodynamic Transurethral Resection Really Necessary?
    J Endourol. 2021 Feb 25. doi: 10.1089/end.2020.1107.
    Abstract     Related articles   

  346. ZHANG D, Reyes RM, Osta E, Kari S, et al
    Bladder cancer cell-intrinsic PD-L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy.
    Cancer Med. 2021 Feb 24. doi: 10.1002/cam4.3739.
    Abstract     Related articles   

  347. ZHAO Y, Shi Z, Hao Z, Zhou J, et al
    Hypoxia-mediated down-regulation of miRNAs' biogenesis promotes tumor immune escape in bladder cancer.
    Clin Transl Oncol. 2021 Feb 24. pii: 10.1007/s12094-021-02569.
    Abstract     Related articles   

  348. CHOKSI A, Wang S, Phelan M, Mannuel H, et al
    Race as a predictor of pathologic response to neoadjuvant chemotherapy at time of cystectomy for bladder cancer.
    Can J Urol. 2021;28:10547-10555.
    Abstract     Related articles   

  349. ALKASSIS M, Kourie HR, Sarkis J, Nemr E, et al
    Predictive biomarkers in bladder cancer.
    Biomark Med. 2021;15:241-246.
    Abstract     Related articles   

  350. RELIGIONI U, Czerw A, Deptala A
    Assessment of Pain, Acceptance of Illness, Adaptation to Life, and Strategies of Coping With the Disease, in Patients With Bladder Cancer.
    In Vivo. 2021;35:1157-1161.
    Abstract     Related articles   

  351. KAGEYAMA S, Maeda K, Kubota S, Yoshida T, et al
    Single Short Retention Instillation of Pirarubicin Prevents Intravesical Recurrence of Low-risk Non Muscle Invasive Bladder Cancer.
    In Vivo. 2021;35:1141-1145.
    Abstract     Related articles   

  352. NEMOTO Y, Kondo T, Ishihara H, Takagi T, et al
    The Controlling Nutritional Status CONUT Score in Patients With Advanced Bladder Cancer After Radical Cystectomy.
    In Vivo. 2021;35:999-1006.
    Abstract     Related articles   

  353. MINATO A, Noguchi H, Ohnishi R, Tomisaki I, et al
    Reduced Expression Level of GPX2 in T1 Bladder Cancer and its Role in Early-phase Invasion of Bladder Cancer.
    In Vivo. 2021;35:753-759.
    Abstract     Related articles   

  354. GE X, Lan ZK, Chen J, Zhu SY, et al
    Effectiveness of contrast-enhanced ultrasound for detecting the staging and grading of bladder cancer: a systematic review and meta-analysis.
    Med Ultrason. 2021;23:29-35.
    Abstract     Related articles   

  355. GUO Q, Ni P, Dai Y, Hu J, et al
    Long-Chain Noncoding RNA ADAMTS9-AS2 Regulates Proliferation, Migration, and Apoptosis in Bladder Cancer Cells Through Regulating miR-182-5p.
    J Interferon Cytokine Res. 2021;41:60-71.
    Abstract     Related articles   

  356. BOLAT D, Yarimoglu S, Aydin ME
    Monopolar versus bipolar transurethral resection of lateral wall-located bladder cancer under obturator nerve block: a single center prospective randomized study.
    Int Braz J Urol. 2021;47:584-593.
    Abstract     Related articles   

  357. GAO RZ, Wen R, Wen DY, Huang J, et al
    Radiomics Analysis Based on Ultrasound Images to Distinguish the Tumor Stage and Pathological Grade of Bladder Cancer.
    J Ultrasound Med. 2021 Feb 21. doi: 10.1002/jum.15659.
    Abstract     Related articles   

  358. SEKINO Y, Ishikawa H, Kimura T, Kojima T, et al
    Bladder preservation therapy in combination with atezolizumab and radiation therapy for invasive bladder cancer (BPT-ART) - A study protocol for an open-label, phase II, multicenter study.
    Contemp Clin Trials Commun. 2021;21:100724.
    Abstract     Related articles   

  359. YANG C, Mou Z, Zhang Z, Wu S, et al
    Circular RNA RBPMS inhibits bladder cancer progression via miR-330-3p/RAI2 regulation.
    Mol Ther Nucleic Acids. 2021;23:872-886.
    Abstract     Related articles   

  360. GONG M, Song E, Huang G, Ni W, et al
    Enhanced Expression of CNTD2/CCNP Predicts Poor Prognosis in Bladder Cancer Based on the GSE13507.
    Front Genet. 2021;12:579900.
    Abstract     Related articles   

  361. SZABADOS B, Rodriguez-Vida A, Duran I, Crabb SJ, et al
    Toxicity and Surgical Complication Rates of Neoadjuvant Atezolizumab in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy: Updated Safety Results from the ABACUS Trial.
    Eur Urol Oncol. 2021 Feb 18. pii: S2588-9311(20)30206.
    Abstract     Related articles   

  362. SLEVIN F, Henry AM
    Muscle-invasive Bladder Cancer in the Elderly Patient With a Focus on Hypofractionated Radiotherapy.
    Clin Oncol (R Coll Radiol). 2021 Feb 18. pii: S0936-6555(21)00045.
    Abstract     Related articles   

  363. TICONOSCO M, Assumma S, Iseppi A, Benedetti M, et al
    Expression of aquaporins 3 in low grade risk of recurrence primary bladder cancer.
    Urologia. 2021 Feb 21:391560321993588. doi: 10.1177/0391560321993588.
    Abstract     Related articles   

  364. LIU S, Chen X, Lin T
    Lymphatic metastasis of bladder cancer: Molecular mechanisms, diagnosis and targeted therapy.
    Cancer Lett. 2021;505:13-23.
    Abstract     Related articles   

  365. ZHENG D, Liu J, Wu G, Yang S, et al
    Comparison of open and intracorporeal modified ureterosigmoidostomy (Mainz II) after laparoscopic radical cystectomy with bladder cancer.
    World J Surg Oncol. 2021;19:57.
    Abstract     Related articles   

  366. WENG H, Yuan S, Huang Q, Zeng XT, et al
    STAT1 is a key gene in a gene regulatory network related to immune phenotypes in bladder cancer: An integrative analysis of multi-omics data.
    J Cell Mol Med. 2021 Feb 19. doi: 10.1111/jcmm.16395.
    Abstract     Related articles   

  367. AKABANE K, Uchida T, Matsuo S, Hirooka S, et al
    Hybrid operation for infectious thoracic and abdominal aortic aneurysms complicated with Bacillus Calmette-Guerin therapy for bladder cancer: A case report.
    Medicine (Baltimore). 2021;100:e24796.
    Abstract     Related articles   

  368. ROSELLEN J, Steffens J
    Unexplained Lower Abdominal Pain In Cystic Urinary Bladder Tumor.
    Dtsch Arztebl Int. 2020;117:782.
    Abstract     Related articles   

  369. JUNG M, Jang I, Kim K, Moon KC, et al
    Non-Muscle-Invasive Bladder Carcinoma with Respect to Basal Versus Luminal Keratin Expression.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  370. NEUMANN NM, Haffner MC, Argani P, Kao CS, et al
    Histopathologic Characterization of Bladder Perivascular Epithelioid Cell Neoplasms (PEComa): A Series of 11 Cases With a Subset Having TFE3 Rearrangements.
    Am J Surg Pathol. 2021;45:169-177.
    Abstract     Related articles   

  371. SUNIL V N, John K, Nawahirsha S, Iyyadurai R, et al
    Micturition syncope: a rare presentation of bladder paraganglioma.
    BMJ Case Rep. 2020;13.
    Abstract     Related articles   

  372. ORSOLIC N, Odeh D, Jembrek MJ, Knezevic J, et al
    Interactions between Cisplatin and Quercetin at Physiological and Hyperthermic Conditions on Cancer Cells In Vitro and In Vivo.
    Molecules. 2020;25.
    Abstract     Related articles   

  373. STOKKEL LE, Mertens LS, van Rhijn BWG
    ASO Author Reflections: How to Detect Peritoneal Metastases of Urachal Carcinoma? The Value of Diagnostic Laparoscopy and Abdominal Cytology in Staging This Rare Malignancy.
    Ann Surg Oncol. 2020;27:2476-2477.
    Abstract     Related articles   

  374. DANKNER R, Roth J
    More recent, better designed studies have weakened links between antidiabetes medications and cancer risk.
    Diabet Med. 2020;37:194-202.
    Abstract     Related articles   

  375. KARDOUST PARIZI M, Enikeev D, Glybochko PV, Seebacher V, et al
    Prognostic value of T1 substaging on oncological outcomes in patients with non-muscle-invasive bladder urothelial carcinoma: a systematic literature review and meta-analysis.
    World J Urol. 2020;38:1437-1449.
    Abstract     Related articles   

  376. TSCHIRDEWAHN S, Harke NN, Hirner L, Stagge E, et al
    Narrow-band imaging assisted cystoscopy in the follow-up of patients with transitional cell carcinoma of the bladder: a randomized study in comparison with white light cystoscopy.
    World J Urol. 2020;38:1509-1515.
    Abstract     Related articles   

  377. DEL GIUDICE F, Busetto GM, Gross MS, Maggi M, et al
    Efficacy of three BCG strains (Connaught, TICE and RIVM) with or without secondary resection (re-TUR) for intermediate/high-risk non-muscle-invasive bladder cancers: results from a retrospective single-institution cohort analysis.
    J Cancer Res Clin Oncol. 2021 Mar 6. pii: 10.1007/s00432-021-03571.
    Abstract     Related articles   

  378. RAPHAEL MJ, Griffiths R, Peng Y, Gupta S, et al
    Mental Health Resource Use Among Patients Undergoing Curative Intent Treatment for Bladder Cancer.
    J Natl Cancer Inst. 2021 Mar 1. pii: 6154859. doi: 10.1093.
    Abstract     Related articles   

  379. IKEDA S, Sobue T, Kitamura T, Ishihara J, et al
    Dietary Acrylamide Intake and the Risks of Renal Cell, Prostate, and Bladder Cancers: A Japan Public Health Center-Based Prospective Study.
    Nutrients. 2021;13.
    Abstract     Related articles   

  380. TSE RT, Zhao H, Wong CY, Cheng CK, et al
    Urinary Cell-Free DNA in Bladder Cancer Detection.
    Diagnostics (Basel). 2021;11.
    Abstract     Related articles   

  381. PICHLER R, Lindner AK, Schafer G, Tulchiner G, et al
    Expression of ADAM Proteases in Bladder Cancer Patients with BCG Failure: A Pilot Study.
    J Clin Med. 2021;10.
    Abstract     Related articles   

  382. CRETA M, Celentano G, Napolitano L, La Rocca R, et al
    Inhibition of Androgen Signalling Improves the Outcomes of Therapies for Bladder Cancer: Results from a Systematic Review of Preclinical and Clinical Evidence and Meta-Analysis of Clinical Studies.
    Diagnostics (Basel). 2021;11.
    Abstract     Related articles   

  383. HOFFMANN MJ, Meneceur S, Hommel K, Schulz WA, et al
    Downregulation of Cell Cycle and Checkpoint Genes by Class I HDAC Inhibitors Limits Synergism with G2/M Checkpoint Inhibitor MK-1775 in Bladder Cancer Cells.
    Genes (Basel). 2021;12.
    Abstract     Related articles   

  384. KUFUKIHARA R, Kikuchi E, Ogihara K, Shigeta K, et al
    Role of Previous Malignancy History in Clinical Outcomes in Patients with Initially Diagnosed Non-Muscle Invasive Bladder Cancer.
    Ann Surg Oncol. 2021 Mar 5. pii: 10.1245/s10434-021-09750.
    Abstract     Related articles   

  385. MENG J, Lu X, Zhou Y, Zhang M, et al
    Tumor immune microenvironment-based classifications of bladder cancer for enhancing the response rate of immunotherapy.
    Mol Ther Oncolytics. 2021;20:410-421.
    Abstract     Related articles   

  386. CAI YX, Yang X, Lin S, Xu YW, et al
    Low-Coverage Sequencing of Urine Sediment DNA for Detection of Copy Number Aberrations in Bladder Cancer.
    Cancer Manag Res. 2021;13:1943-1953.
    Abstract     Related articles   

  387. XU H, Ju L, Xiong Y, Yu M, et al
    E3 ubiquitin ligase RNF126 affects bladder cancer progression through regulation of PTEN stability.
    Cell Death Dis. 2021;12:239.
    Abstract     Related articles   

  388. HUANG D, Zhou S, Yu Z, Chen J, et al
    Lung protective ventilation strategy to reduce postoperative pulmonary complications (PPCs) in patients undergoing robot-assisted laparoscopic radical cystectomy for bladder cancer: A randomized double blinded clinical trial.
    J Clin Anesth. 2021;71:110156.
    Abstract     Related articles   

  389. CHEN C, Zheng H, Luo Y, Kong Y, et al
    SUMOylation promotes extracellular vesicle-mediated transmission of lncRNA ELNAT1 and lymph node metastasis in bladder cancer.
    J Clin Invest. 2021 Mar 4. pii: 146431. doi: 10.1172/JCI146431.
    Abstract     Related articles   

  390. WULFF-BURCHFIELD EM, Potts M, Glavin K, Mirza M, et al
    A qualitative evaluation of a nurse-led pre-operative stoma education program for bladder cancer patients.
    Support Care Cancer. 2021 Mar 4. pii: 10.1007/s00520-021-06093.
    Abstract     Related articles   

  391. DING T, Yang B, Yang D, Zhang P, et al
    Screening of MicroRNA Biomarkers Related to the Progression of Bladder Cancer.
    Cancer Biother Radiopharm. 2021 Mar 3. doi: 10.1089/cbr.2020.4217.
    Abstract     Related articles   

  392. JIANG DM, Chung P, Kulkarni GS, James ND, et al
    Lack of Evidence Does Not Equal Lack of Benefit: Neoadjuvant Chemotherapy and Trimodality Therapy in Selected Patients with Muscle-Invasive Bladder Cancer : In response to: Dirk Bohmer and Arne Grun. Lacking Evidence to Recommend Neoadjuvant Chemother
    Curr Oncol Rep. 2021;23:36.
    Abstract     Related articles   

  393. SHLYAPNIKOV YM, Malakhova EA, Vinarov AZ, Zamyatnin AA Jr, et al
    Can new immunoassay techniques improve bladder cancer diagnostics With protein biomarkers?
    Front Mol Biosci. 2021;7:620687.
    Abstract     Related articles   

  394. XU Z, Gujar H, Fu G, Ahmadi H, et al
    A Novel DNA Methylation Signature as an Independent Prognostic Factor in Muscle-Invasive Bladder Cancer.
    Front Oncol. 2021;11:614927.
    Abstract     Related articles   

  395. NASSIF EF, Thibault C, Oudard S, Galon J, et al
    Precision immunity: Immunoscore and neoadjuvant treatment in bladder cancer.
    Oncoimmunology. 2021;10:1888488.
    Abstract     Related articles   

  396. TIAN Y, Guan Y, Su Y, Yang T, et al
    TRPM2-AS Promotes Bladder Cancer by Targeting miR-22-3p and Regulating GINS2 mRNA Expression.
    Onco Targets Ther. 2021;14:1219-1237.
    Abstract     Related articles   

  397. WU S, Yang J, Xu H, Wang X, et al
    Circular RNA circGLIS3 promotes bladder cancer proliferation via the miR-1273f/SKP1/Cyclin D1 axis.
    Cell Biol Toxicol. 2021 Mar 3. pii: 10.1007/s10565-021-09591.
    Abstract     Related articles   

  398. ANDINO JJ, Sessine M, Singhal U, Reichert ZR, et al
    Understanding the Barriers to Neoadjuvant Chemotherapy in Patients with Muscle Invasive Bladder Cancer: A Quality Improvement Initiative.
    Urol Pract. 2021;8:217-225.
    Abstract     Related articles   

  399. JI N, Mukherjee N, Reyes RM, Gelfond J, et al
    Rapamycin enhances BCG-specific gammadelta T cells during intravesical BCG therapy for non-muscle invasive bladder cancer: a randomized, double-blind study.
    J Immunother Cancer. 2021;9.
    Abstract     Related articles   

  400. LORENCIN I, Baressi Segota S, Andelic N, Mrzljak V, et al
    On Urinary Bladder Cancer Diagnosis: Utilization of Deep Convolutional Generative Adversarial Networks for Data Augmentation.
    Biology (Basel). 2021;10.
    Abstract     Related articles   

  401. JIANG G, Teramoto Y, Goto T, Mizushima T, et al
    Identification of BXDC2 as a Key Downstream Effector of the Androgen Receptor in Modulating Cisplatin Sensitivity in Bladder Cancer.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  402. SZABO Z, Dezso B, Fodor K, Szegedi K, et al
    Expression of Luteinizing Hormone-Releasing Hormone (LHRH) and Type-I LHRH Receptor in Transitional Cell Carcinoma Type of Human Bladder Cancer.
    Molecules. 2021;26.
    Abstract     Related articles   

  403. GANIEF T, Calder B, Blackburn JM
    Protocols for Preparation and Mass Spectrometry Analysis of Clinical Urine Samples to Identify Candidate Biomarkers of Schistosoma-Associated Bladder Cancer.
    Methods Mol Biol. 2021;2292:143-150.
    Abstract     Related articles   

  404. CASADIO V, Bravaccini S
    Telomerase Activity Analysis In Urine Sediment for Bladder Cancer.
    Methods Mol Biol. 2021;2292:133-141.
    Abstract     Related articles   

  405. COSTANTINI M, Gallo G, Attolini G
    Urinary Biomarkers In Bladder Cancer.
    Methods Mol Biol. 2021;2292:121-131.
    Abstract     Related articles   

  406. NAKANO M, Shinagawa T, Eitaki Y, Omae K, et al
    Risk of bladder cancer in male Japanese workers exposed to ortho-toluidine and other aromatic amines.
    Int Arch Occup Environ Health. 2021 Mar 2. pii: 10.1007/s00420-021-01658.
    Abstract     Related articles   

  407. POLANCO-PUJOL L, Cano-Velasco J, Moralejo-Garate M, Bataller-Monfort V, et al
    [Penile metastasis from urothelial carcinoma: Review of literature.]
    Arch Esp Urol. 2021;74:208-214.
    Abstract     Related articles   

  408. GARCZYK S, Bischoff F, Schneider U, Golz R, et al
    Intratumoral heterogeneity of surrogate molecular subtypes in urothelial carcinoma in situ of the urinary bladder: implications for prognostic stratification of high-risk non-muscle-invasive bladder cancer.
    Virchows Arch. 2021 Mar 1. pii: 10.1007/s00428-021-03054.
    Abstract     Related articles   

  409. DENG J, Peng M, Zhou S, Xiao D, et al
    Metformin targets Clusterin to control lipogenesis and inhibit the growth of bladder cancer cells through SREBP-1c/FASN axis.
    Signal Transduct Target Ther. 2021;6:98.
    Abstract     Related articles   

  410. SANVILLE BC, Kuhn BT
    A 56-Year-Old Male With Weight Loss, Night Sweats, Dyspnea, and Bladder Cancer.
    J Investig Med High Impact Case Rep. 2021;9:2324709621997246.
    Abstract     Related articles   

  411. CHEN D, Xie S, Wu Y, Cui Y, et al
    Reduction of Bladder Cancer Chemosensitivity Induced by the Effect of HOXA-AS3 as a ceRNA for miR-455-5p That Upregulates Notch1.
    Front Oncol. 2021;10:572672.
    Abstract     Related articles   

  412. LI J, Park A, Fulmer BR, Garg T, et al
    Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria.
    Urol Case Rep. 2021;36:101579.
    Abstract     Related articles   

  413. FELDMAN AS, Kulkarni GS, Bivalacqua TJ, Black PC, et al
    Surgical challenges and considerations in Tri-modal therapy for muscle invasive bladder cancer.
    Urol Oncol. 2021 Feb 25. pii: S1078-1439(21)00012.
    Abstract     Related articles   

  414. TRIPATHI A, Khaki AR, Grivas P
    Perioperative Immunotherapy in Muscle-invasive Bladder Cancer.
    Eur Urol Oncol. 2021 Feb 25. pii: S2588-9311(21)00028.
    Abstract     Related articles   

  415. LENIS AT, Fero KE, Ojeaburu L, Lec PM, et al
    The role of neoadjuvant chemotherapy, lymph node dissection, and treatment delay in patients with muscle-invasive bladder cancer undergoing partial cystectomy.
    Urol Oncol. 2021 Feb 24. pii: S1078-1439(21)00016.
    Abstract     Related articles   

  416. ODERDA M, Calleris G, Falcone M, Fasolis G, et al
    How uro-oncology has been affected by COVID-19 emergency? Data from Piedmont/Valle d'Aosta Oncological Network, Italy.
    Urologia. 2021;88:3-8.
    Abstract     Related articles   

  417. ARUNACHALAM P, Sen S, Balaji D, Sam CJ, et al
    Paediatric bladder neurofibroma on bilateral ureterostomy: rare case report-strategic management.
    BMJ Case Rep. 2021;14.
    Abstract     Related articles   

  418. YANG HY, Wu CY, Chen JJ, Lee TH, et al
    Treatment Strategies and Metabolic Pathway Regulation in Urothelial Cell Carcinoma: A Comprehensive Review.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  419. ROVIELLO G, Catalano M, Nobili S, Santi R, et al
    Focus on Biochemical and Clinical Predictors of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma: Where Do We Stand?
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  420. SATHUA K, Srivastava S, Flora SJS
    MiADMSA ameliorate arsenic induced urinary bladder carcinogenesis in vivo and in vitro.
    Biomed Pharmacother. 2020;128:110257.
    Abstract     Related articles   

  421. AHMAD W, Gill SM, Hassan A
    A rare presentation of primary synchronous renal tract tumours on (18F)- fluorodeoxyglucose positron emission tomography- computed tomography.
    J Pak Med Assoc. 2020;70:942-943.
    Abstract     Related articles   

  422. SUN J, Ma X, Shen H, Liu B, et al
    Effects of fluorescent light cystoscopy in non-muscle-invasive bladder cancer: a systematic review and meta-analysis.
    Photodiagnosis Photodyn Ther. 2021 Mar 9:102248.
    Abstract     Related articles   

  423. LV Z, Pang C, Wang J, Xia H, et al
    Identification of a prognostic signature based on immune-related genes in bladder cancer.
    Genomics. 2021 Mar 9. pii: S0888-7543(21)00104.
    Abstract     Related articles   

  424. BENIDIR T, Herrera-Caceres J, Wallis C, Lajkosz K, et al
    Population-based analysis of perioperative chemotherapy use, interventions requiring hospitalization and atheroembolic events among patients with non-metastatic muscle-invasive bladder cancer.
    Cancer Med. 2021 Mar 12. doi: 10.1002/cam4.3805.
    Abstract     Related articles   

  425. ZHOU C, Wang G, Jing W, Tan X, et al
    Anticancer Properties and Mechanisms of Singly-Protonated Dehydronorcantharidin Silver Coordination Polymer in a Bladder Cancer Model.
    Front Pharmacol. 2021;12:618668.
    Abstract     Related articles   

  426. ROUANNE M, Gaillard F, Meunier ME, Soorojebally Y, et al
    Author Correction: Measured glomerular filtration rate (GFR) significantly and rapidly decreases after radical cystectomy for bladder cancer.
    Sci Rep. 2021;11:6155.
    Abstract     Related articles   

  427. RUAN JL, Browning RJ, Yildiz YO, Bau L, et al
    Evaluation of Loading Strategies to Improve Tumor Uptake of Gemcitabine in a Murine Orthotopic Bladder Cancer Model Using Ultrasound and Microbubbles.
    Ultrasound Med Biol. 2021 Mar 8. pii: S0301-5629(21)00058.
    Abstract     Related articles   

  428. PARMAR A, Richardson M, Coyte PC, Cheng S, et al
    A Cost-Utility Analysis of Atezolizumab in the Second-Line Treatment of Patients with Metastatic Bladder Cancer.
    Curr Oncol. 2020;27:386-394.
    Abstract     Related articles   

  429. AL-SARAIREH YM, Alshammari FOFO, Youssef AMM, Al-Sarayreh S, et al
    Profiling of CYP4Z1 and CYP1B1 expression in bladder cancers.
    Sci Rep. 2021;11:5581.
    Abstract     Related articles   

  430. KALUZINSKA Z, Kolat D, Kosla K, Orzechowska M, et al
    In vitro and in silico assessment of the effect of WWOX expression on invasiveness pathways associated with AP-2 transcription factors in bladder cancer.
    BMC Urol. 2021;21:36.
    Abstract     Related articles   

  431. ZHOU X, Liu S, Yao S, Huo Z, et al
    Clinical features and management experience in patients with metastatic spinal bladder cancer: a single-institution 10-year retrospective study.
    Ann Palliat Med. 2021 Mar 9. pii: apm-20-1980. doi: 10.21037/apm-20-1980.
    Abstract     Related articles   

  432. DU S, Sui Y, Ren W, Zhou J, et al
    PYCR1 promotes bladder cancer by affecting the Akt/Wnt/beta-catenin signaling.
    J Bioenerg Biomembr. 2021 Mar 10. pii: 10.1007/s10863-021-09887.
    Abstract     Related articles   

  433. SHENG H, Zhang G, Huang Y, Sun L, et al
    A 5-lncRNA Signature Associated with Smoking Predicts the Overall Survival of Patients with Muscle-Invasive Bladder Cancer.
    Dis Markers. 2021;2021:8839747.
    Abstract     Related articles   

  434. MIKHALEVA LM, Pechnikova VV, Pshikhachev AM, Rogov KA, et al
    Bladder Cancer: Update on Risk Factors, Molecular and Ultrastructural Patterns.
    Curr Med Chem. 2021 Mar 8. pii: CMC-EPUB-114794.
    Abstract     Related articles   

  435. ZHANG HH, Li C, Ren JW, Liu L, et al
    OTUB1 facilitates bladder cancer progression by stabilizing ATF6 in response to ER stress.
    Cancer Sci. 2021 Mar 9. doi: 10.1111/cas.14876.
    Abstract     Related articles   

  436. SCHULZ GB, Elezkurtaj S, Bording T, Schmidt EM, et al
    Therapeutic and prognostic implications of NOTCH and MAPK signaling in bladder cancer.
    Cancer Sci. 2021 Mar 8. doi: 10.1111/cas.14878.
    Abstract     Related articles   

  437. YU EY, Wesselius A, Mehrkanoon S, Goosens M, et al
    Vegetable intake and the risk of bladder cancer in the BLadder Cancer Epidemiology and Nutritional Determinants (BLEND) international study.
    BMC Med. 2021;19:56.
    Abstract     Related articles   

  438. MAO X, Nanzhang, Xiao J, Wu H, et al
    Hypoxia-Induced Autophagy Enhances Cisplatin Resistance in Human Bladder Cancer Cells by Targeting Hypoxia-Inducible Factor-1alpha.
    J Immunol Res. 2021;2021:8887437.
    Abstract     Related articles   

  439. WANG G, Dai Y, Li K, Cheng M, et al
    Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis.
    Front Cell Dev Biol. 2021;9:627706.
    Abstract     Related articles   

  440. NIIMI F, Danno T, Iwata S, Honda S, et al
    Submucosal urothelial bladder cancer: A case report.
    Mol Clin Oncol. 2021;14:77.
    Abstract     Related articles   

  441. MASIERO M, Busacchio D, Guiddi P, Arnaboldi P, et al
    Quality of life and psycho-emotional wellbeing in bladder cancer patients and their caregivers: a comparative analysis between urostomy versus ileal orthotopic neobladder.
    Ecancermedicalscience. 2021;15:1163.
    Abstract     Related articles   

  442. BOBJER J, Hagberg O, Aljabery F, Gardmark T, et al
    A population-based study on the effect of a routine second-look resection on survival in primary stage T1 bladder cancer.
    Scand J Urol. 2021 Mar 6:1-8. doi: 10.1080/21681805.2021.1892179.
    Abstract     Related articles   

  443. HUGAR LA, Yabes JG, Filippou P, Wulff-Burchfield EM, et al
    High-intensity end-of-life care among Medicare beneficiaries with bladder cancer.
    Urol Oncol. 2021 Mar 3. pii: S1078-1439(21)00068.
    Abstract     Related articles   

  444. WISSING MD, O'Flaherty A, Dragomir A, Tanguay S, et al
    The Use of 5-Alpha Reductase Inhibitors and Alpha-1 Blockers Does Not Improve Clinical Outcome in Male Patients Undergoing Radical Cystectomy for Bladder Cancer in Quebec, Canada.
    Clin Genitourin Cancer. 2021 Feb 6. pii: S1558-7673(21)00030.
    Abstract     Related articles   

  445. NEO SH, Lee LS
    A Large Abdominal Mass.
    N Engl J Med. 2021;384:e24.
    Abstract     Related articles   

  446. GALSKY MD, Grande E
    PD-1 inhibitors for urothelial cancer: combination or sequential therapy? - Authors' reply.
    Lancet. 2021;396:1977-1978.
    Abstract     Related articles   

  447. IIZUKA K, Shoji K, Fujiyuki T, Moritoh K, et al
    Antitumor activity of an oncolytic measles virus against canine urinary bladder transitional cell carcinoma cells.
    Res Vet Sci. 2020;133:313-317.
    Abstract     Related articles   

  448. WU K, Liang J, Lu Y
    Risk factors and survival outcomes of metachronous contralateral upper tract urothelial carcinoma.
    Sci Rep. 2020;10:16600.
    Abstract     Related articles   

  449. SAHAN A, Gerin F, Garayev A, Bozkurtlar E, et al
    The impact of tumor invasion to muscularis mucosaevascular plexus on patient outcome in pT1 bladder urothelial carcinoma.
    Arch Ital Urol Androl. 2020;92.
    Abstract     Related articles   

  450. CORONGIU E, Grande P, Liberati E, Iacovelli R, et al
    Clear Cell carcinoma of the urinary bladder, A case report: Surgical and oncological management.
    Arch Ital Urol Androl. 2020;92.
    Abstract     Related articles   

  451. OLIVIERI V, Fortunati V, Bellei L, Massarelli M, et al
    Primary small-cell neuroendocrine carcinoma of the bladder: Case report and literature review.
    Arch Ital Urol Androl. 2020;92.
    Abstract     Related articles   

  452. CHIANCONE F, Carrino M, Fedelini M, Fabiano M, et al
    The role of Protopine associated with Nuciferine in controlling adverse events during hyperthermic intravesical chemotherapy instillations. A nutraceutical approach to control adverse event during intravesical instillations.
    Arch Ital Urol Androl. 2020;92.
    Abstract     Related articles   

  453. D'ANGELO A, Bagby S, Galli IC, Bortoletti C, et al
    Overview of the clinical use of erdafitinib as a treatment option for the metastatic urothelial carcinoma: where do we stand.
    Expert Rev Clin Pharmacol. 2020;13:1139-1146.
    Abstract     Related articles   

  454. PODARALA V, Prasanna Lakshmi M, Venkata SKR, Devalam RP, et al
    Efficacy of BCG vaccine and Mitomycin C for the treatment of ocular squamous cell carcinoma in bovines.
    Res Vet Sci. 2020;133:48-52.
    Abstract     Related articles   

  455. COLL PP, Korc-Grodzicki B, Ristau BT, Shahrokni A, et al
    Cancer Prevention and Screening for Older Adults: Part 1. Lung, Colorectal, Bladder, and Kidney Cancer.
    J Am Geriatr Soc. 2020;68:2399-2406.
    Abstract     Related articles   

  456. FEDELI U, Porreca A, Colicchia M, Schievano E, et al
    Intravescical instillation of Calmette-Guerin bacillus and COVID-19 risk.
    Hum Vaccin Immunother. 2021;17:416-417.
    Abstract     Related articles   

  457. KHAN J, Kamal MS, D'Arcy FT, Dowling C, et al
    Biopsy at flexible cystoscopy: is it worthwhile?
    Ir J Med Sci. 2021;190:437-439.
    Abstract     Related articles   

  458. FENG D, Tang Y, Yang Y, Han P, et al
    Intracorporeal versus extracorporeal urinary diversion after robotic-assisted radical cystectomy: evidence from a systematic review and pooled analysis of observational studies.
    Minerva Urol Nefrol. 2020;72:519-530.
    Abstract     Related articles   

  459. XU S, Zuo L
    Association between methylenetetrahydrofolate reductase gene rs1801131 A/C polymorphism and urinary tumors' susceptibility.
    Hereditas. 2020;157:16.
    Abstract     Related articles   

  460. STOKKEL LE, Mehta AM, Behrendt MA, de Jong J, et al
    Diagnostic Laparoscopy and Abdominal Cytology Reliably Detect Peritoneal Metastases in Patients with Urachal Adenocarcinoma.
    Ann Surg Oncol. 2020;27:2468-2475.
    Abstract     Related articles   

  461. WANG H, Chong T, Tang XY, Zheng WB, et al
    Transurethral resection in women with symptomatic keratinizing squamous metaplasia of urinary bladder: A retrospective study of 92 cases.
    Low Urin Tract Symptoms. 2020;12:137-142.
    Abstract     Related articles   

  462. PASPULATI A, Gupta A, Hill PA, Morgan MA, et al
    The utility of retrograde pyelography to follow up incompletely opacified ureters on CT urography.
    Abdom Radiol (NY). 2020;45:807-811.
    Abstract     Related articles   

  463. SUN YJ, Li AW, Zhang YC, Dai JH, et al
    Evaluation of Urine NDRG1 as Noninvasive Biomarker for Bladder Cancer Diagnosis.
    Clin Lab. 2021;67.
    Abstract     Related articles   

  464. SANGUEDOLCE F, Calo B, Mancini V, Zanelli M, et al
    Non-Muscle Invasive Bladder Cancer with Variant Histology: Biological Features and Clinical Implications.
    Oncology. 2021 Mar 18:1-14. doi: 10.1159/000514759.
    Abstract     Related articles   

  465. MENDES F, Pereira E, Martins D, Tavares-Silva E, et al
    Oxidative stress in bladder cancer: an ally or an enemy?
    Mol Biol Rep. 2021 Mar 17. pii: 10.1007/s11033-021-06266.
    Abstract     Related articles   

  466. ZHANG H, Song J, Dong J, Liu Z, et al
    Tumor Microenvironment Analysis Identified Subtypes Associated With the Prognosis and the Tumor Response to Immunotherapy in Bladder Cancer.
    Front Genet. 2021;12:551605.
    Abstract     Related articles   


  467. MiR-126 Regulates Proliferation and Invasion in the Bladder Cancer BLS Cell Line by Targeting the PIK3R2-Mediated PI3K/Akt Signaling Pathway [Retraction].
    Onco Targets Ther. 2021;14:1859.
    Abstract     Related articles   

  468. CARRASCO R, Izquierdo L, van der Heijden AG, Lozano JJ, et al
    Differential gene expression profile between progressive and de novo muscle invasive bladder cancer and its prognostic implication.
    Sci Rep. 2021;11:6132.
    Abstract     Related articles   

  469. ZENG F, Luo L, Li D, Guo J, et al
    KPNA2 interaction with CBX8 contributes to the development and progression of bladder cancer by mediating the PRDM1/c-FOS pathway.
    J Transl Med. 2021;19:112.
    Abstract     Related articles   

  470. YANG H, Qu H, Huang H, Mu Z, et al
    Exosomes-mediated transfer of long noncoding RNA LINC01133 represses bladder cancer progression via regulating Wnt signaling pathway.
    Cell Biol Int. 2021 Mar 16. doi: 10.1002/cbin.11590.
    Abstract     Related articles   

  471. HAN C, Chen S, Ma H, Wen X, et al
    RPN2 Predicts Poor Prognosis and Promotes Bladder Cancer Growth and Metastasis via the PI3K-Akt Pathway.
    Onco Targets Ther. 2021;14:1643-1657.
    Abstract     Related articles   

  472. WILKINS A, Ost P, Sundahl N
    Is There a Benefit of Combining Immunotherapy and Radiotherapy in Bladder Cancer?
    Clin Oncol (R Coll Radiol). 2021 Mar 13. pii: S0936-6555(21)00085.
    Abstract     Related articles   

  473. DING Z, Ying W, He Y, Chen X, et al
    lncRNA-UCA1 in the diagnosis of bladder cancer: A meta-analysis.
    Medicine (Baltimore). 2021;100:e24805.
    Abstract     Related articles   

  474. SZCZESNY W, Szylberg L, Slupski M, Marszalek A, et al
    An unusual case of a tuberculous granuloma of the liver presenting thirteen years after intravesical BCG - therapy for bladder cancer.
    Pol Przegl Chir. 2020;93:1-5.
    Abstract     Related articles   

  475. FU D, Liu B, Jiang H, Li Z, et al
    Bone marrow mesenchymal stem cells-derived exosomal microRNA-19b-1-5p reduces proliferation and raises apoptosis of bladder cancer cells via targeting ABL2.
    Genomics. 2021 Mar 12. pii: S0888-7543(21)00103.
    Abstract     Related articles   

  476. TOMIYAMA E, Matsuzaki K, Fujita K, Shiromizu T, et al
    Proteomic analysis of urinary and tissue-exudative extracellular vesicles to discover novel bladder cancer biomarkers.
    Cancer Sci. 2021 Mar 15. doi: 10.1111/cas.14881.
    Abstract     Related articles   

  477. LUO G, Zhang Y, Wu Z, Zhang L, et al
    Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell resistance to cisplatin by regulating miR-34b-5p/ABCB1 axis.
    Acta Biochim Biophys Sin (Shanghai). 2021 Mar 15. pii: 6171055.
    Abstract     Related articles   

  478. OCHI A, Harada S, Fukuokaya W, Honma K, et al
    Bladder cancer invasion along a tension-free vaginal mesh.
    IJU Case Rep. 2021;4:104-107.
    Abstract     Related articles   

  479. HIJAB A, Tocco B, Hanson I, Meijer H, et al
    MR-Guided Adaptive Radiotherapy for Bladder Cancer.
    Front Oncol. 2021;11:637591.
    Abstract     Related articles   

  480. KOLAT D, Kaluzinska Z, Pluciennik E
    Fragile Gene WWOX Guides TFAP2A/TFAP2C-Dependent Actions Against Tumor Progression in Grade II Bladder Cancer.
    Front Oncol. 2021;11:621060.
    Abstract     Related articles   

  481. XU Y, Zhang P, Tan Y, Jia Z, et al
    A potential panel of five mRNAs in urinary extracellular vesicles for the detection of bladder cancer.
    Transl Androl Urol. 2021;10:809-820.
    Abstract     Related articles   

  482. FERRO M, Di Mauro M, Cimino S, Morgia G, et al
    Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer.
    Transl Androl Urol. 2021;10:626-635.
    Abstract     Related articles   

  483. SI L, Yang X, Yan X, Wang Y, et al
    Erratum: Isoliquiritigenin induces apoptosis of human bladder cancer T24 cells via a cyclin-dependent kinase-independent mechanism.
    Oncol Lett. 2021;21:268.
    Abstract     Related articles   

  484. DI MAIDA F, Scalici Gesolfo C, Tellini R, Mari A, et al
    Fibronectin urothelial gene expression as a new reliable biomarker for early detection of local toxicity secondary to adjuvant intravesical therapy for non-muscle invasive bladder cancer.
    Ther Adv Urol. 2021;13:1756287221995683.
    Abstract     Related articles   

  485. AYDIN AM, Bunch BL, Beatty M, Hajiran A, et al
    The Factors Affecting Expansion of Reactive Tumor Infiltrating Lymphocytes (TIL) From Bladder Cancer and Potential Therapeutic Applications.
    Front Immunol. 2021;12:628063.
    Abstract     Related articles   

  486. RUAN JL, Browning RJ, Yildiz YO, Gray M, et al
    Ultrasound-Mediated Gemcitabine Delivery Reduces the Normal-Tissue Toxicity of Chemoradiation Therapy in a Muscle-Invasive Bladder Cancer Model.
    Int J Radiat Oncol Biol Phys. 2021;109:1472-1482.
    Abstract     Related articles   

  487. D'ANDREA D, Soria F, Grotenhuis AJ, Cha EK, et al
    Association of patients' sex with treatment outcomes after intravesical bacillus Calmette-Guerin immunotherapy for T1G3/HG bladder cancer.
    World J Urol. 2021 Mar 13. pii: 10.1007/s00345-021-03653.
    Abstract     Related articles   

  488. BRYAN RT, Arnold R, Khanim FL, Shepherd DE, et al
    Establishing the Bladder Cancer Research Centre at the University of Birmingham.
    Nat Rev Urol. 2021 Mar 12. pii: 10.1038/s41585-021-00448.
    Abstract     Related articles   

  489. KRENTEL F, Singer F, Rosano-Gonzalez ML, Gibb EA, et al
    A showcase study on personalized in silico drug response prediction based on the genetic landscape of muscle invasive bladder cancer.
    Sci Rep. 2021;11:5849.
    Abstract     Related articles   

  490. TABER A, Park Y, Lelo A, Prip F, et al
    STAG2 as a prognostic biomarker in low-grade non-muscle invasive bladder cancer.
    Urol Oncol. 2021 Mar 9. pii: S1078-1439(21)00069.
    Abstract     Related articles   

  491. POLOM W, Cytawa W, Polom A, Szurowska E, et al
    Radionuclide-guided sentinel lymph node mapping in urachal cancer.
    Adv Clin Exp Med. 2021;30:203-210.
    Abstract     Related articles   

  492. SHIGETA K, Matsumoto K, Ogihara K, Murakami T, et al
    The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma.
    Cancer Sci. 2021;112:1084-1094.
    Abstract     Related articles   

  493. LIU Y, Xu H, Wu B, Liu S, et al
    Small cell carcinoma of the bladder with coexisting prostate adenocarcinoma: two cases report and literature review.
    BMC Urol. 2020;20:134.
    Abstract     Related articles   

  494. NOMURA S, Suzuki Y, Akatsuka J, Endo Y, et al
    Expression of epithelial-Mesenchymal transition related markers in Plasmacytoid Urothelial carcinoma of the urinary bladder.
    BMC Urol. 2020;20:72.
    Abstract     Related articles   

  495. LATTANZI M, Rosenberg JE
    The emerging role of antibody-drug conjugates in urothelial carcinoma.
    Expert Rev Anticancer Ther. 2020;20:551-561.
    Abstract     Related articles   

  496. TORRES N, Regge MV, Secchiari F, Friedrich AD, et al
    Restoration of antitumor immunity through anti-MICA antibodies elicited with a chimeric protein.
    J Immunother Cancer. 2020;8.
    Abstract     Related articles   

  497. NORMANN CO, Opheim R, Andreassen BK, Bernklev T, et al
    Health-related quality-of-life after radical cystectomy among Norwegian men and women compared to the general population.
    Scand J Urol. 2020;54:181-187.
    Abstract     Related articles   

  498. KAFFASH NAYERI R, Sadri M, Shahrokh H, Abolhasani M, et al
    Small Cell Carcinoma of Bladder; Still A Diagnostic and Therapeutic Challenge: Seven Years of Experience and Follow-up in A Referral Center.
    Urol J. 2020;17:363-369.
    Abstract     Related articles   

  499. AL-SHARAKY DR, Kandil MAE, Aiad HAS, El-Hosary EM, et al
    ROC-1, P21 and CAIX as markers of tumor aggressiveness in bladder carcinoma in Egyptian patients.
    Diagn Pathol. 2020;15:33.
    Abstract     Related articles   

  500. VOSKUILEN CS, Bosschieter J, Nieuwenhuijzen JA, van Rhijn BWG, et al
    Authors' response to Letter to the Editor "Don't forget Arnhem".
    Radiother Oncol. 2020;147:237.
    Abstract     Related articles   

  501. VAN DER STEEN-BANASIK EM, Oosterveld BJ, Smits GA
    Don't forget Arnhem!
    Radiother Oncol. 2020;147:236.
    Abstract     Related articles   

  502. WANG S, Zhang A, Huang S, Ma Y, et al
    Non Functioning Paraganglioma in the Urinary Bladder: a Case Report.
    Urol J. 2020;17:426-428.
    Abstract     Related articles   

  503. ZHANG C, Li Z, Hu J, Qi F, et al
    Identification of five long noncoding RNAs signature and risk score for prognosis of bladder urothelial carcinoma.
    J Cell Biochem. 2020;121:856-866.
    Abstract     Related articles   

  504. CANCEL-TASSIN G, Roupret M, Pinar U, Gaffory C, et al
    Assessment of Xpert Bladder Cancer Monitor test performance for the detection of recurrence during non-muscle invasive bladder cancer follow-up.
    World J Urol. 2021 Mar 26. pii: 10.1007/s00345-021-03629.
    Abstract     Related articles   

  505. SEO WI, Lee CH, Jung SJ, Lee DS, et al
    Expression of VISTA on tumor-infiltrating immune cells correlated with short intravesical recurrence in non-muscle-invasive bladder cancer.
    Cancer Immunol Immunother. 2021 Mar 26. pii: 10.1007/s00262-021-02906.
    Abstract     Related articles   

  506. ZENG J, Xu H, Huang C, Sun Y, et al
    CD46 splice variant enhances translation of specific mRNAs linked to an aggressive tumor cell phenotype in bladder cancer.
    Mol Ther Nucleic Acids. 2021;24:140-153.
    Abstract     Related articles   

  507. TURKER P, Wernroth ML, Malmstrom PU, Segersten U, et al
    Combination of biomarkers for neoadjuvant systemic chemotherapy before cystectomy in patients with urinary bladder cancer.
    Transl Res. 2021 Mar 22. pii: S1931-5244(21)00076.
    Abstract     Related articles   

  508. HAFEEZ S, Lewis R, Hall E, Huddart R, et al
    Advancing Radiotherapy for Bladder Cancer: Randomised Phase II Trial of Adaptive Image-guided Standard or Dose-escalated Tumour Boost Radiotherapy (RAIDER).
    Clin Oncol (R Coll Radiol). 2021 Mar 22. pii: S0936-6555(21)00055.
    Abstract     Related articles   

  509. SHKOLYAR E, Zhao Q, Mach KE, Teslovich NC, et al
    Bladder cancer risk stratification using a urinary mRNA biomarker panel - A path towards cystoscopy triaging.
    Urol Oncol. 2021 Mar 22. pii: S1078-1439(21)00072.
    Abstract     Related articles   

  510. KHAKI AR, Shan Y, Nelson RE, Kaul S, et al
    Cost-effectiveness analysis of neoadjuvant immune checkpoint inhibition vs. cisplatin-based chemotherapy in muscle invasive bladder cancer.
    Urol Oncol. 2021 Mar 22. pii: S1078-1439(21)00114.
    Abstract     Related articles   

  511. BASILE G, Pederzoli F, Bandini M, Raggi D, et al
    Intermediate- and high-risk nonmuscle invasive bladder cancer: Where do we stand?
    Urol Oncol. 2021 Mar 22. pii: S1078-1439(21)00081.
    Abstract     Related articles   

  512. SMRKOLJ T, Cegovnik Primozic U, Fabjan T, Sterpin S, et al
    The performance of the Xpert Bladder Cancer Monitor Test and voided urinary cytology in the follow-up of urinary bladder tumors.
    Radiol Oncol. 2020 Dec 29. pii: raon-2020-0072. doi: 10.2478/raon-2020-0072.
    Abstract     Related articles   

  513. ZUPANCIC D, Romih R
    Immunohistochemistry as a paramount tool in research of normal urothelium, bladder cancer and bladder pain syndrome.
    Eur J Histochem. 2021;65.
    Abstract     Related articles   

  514. IBILIBOR C, Psutka SP, Herrera J, Rivero JR, et al
    The association between sarcopenia and bladder cancer-specific mortality and all-cause mortality after radical cystectomy: A systematic review and meta-analysis.
    Arab J Urol. 2021;19:98-103.
    Abstract     Related articles   

  515. ARORA A, Pugliesi F, Zugail AS, Moschini M, et al
    Higher nodal yield with robot-assisted pelvic lymph node dissection for bladder cancer compared to laparoscopic dissection: implications for more accurate staging.
    Arab J Urol. 2020;19:92-97.
    Abstract     Related articles   

  516. CHIANCONE F, Fabiano M, Carrino M, Fedelini M, et al
    Impact of systemic inflammatory markers on the response to Hyperthermic IntraVEsical Chemotherapy (HIVEC) in patients with non-muscle-invasive bladder cancer after bacillus Calmette-Guerin failure.
    Arab J Urol. 2021;19:86-91.
    Abstract     Related articles   

  517. NOWAK L, Krajewski W, Moschini M, Chorbinska J, et al
    Assessment of the oncological outcomes of three different bacillus Calmette-Guerin strains in patients with high-grade T1 non-muscle-invasive bladder cancer.
    Arab J Urol. 2021;19:78-85.
    Abstract     Related articles   

  518. CARANDO R, Soldini E, Cotrufo S, Zazzara M, et al
    Electro-mediated drug administration of mitomycin C in preventing non-muscle-invasive bladder cancer recurrence and progression after transurethral resection of the bladder tumour in intermediate- and high-risk patients.
    Arab J Urol. 2020;19:71-77.
    Abstract     Related articles   

  519. NOWAK L, Krajewski W, Poterek A, Sliwa A, et al
    The prognostic value of programmed cell death protein ligand 1 in patients with non-muscle-invasive bladder cancer treated with bacille Calmette-Guerin immunotherapy: Current status.
    Arab J Urol. 2020;19:67-70.
    Abstract     Related articles   

  520. VOLZ Y, Eismann L, Pfitzinger PL, Jokisch JF, et al
    Prognostic impact of perioperative blood transfusions on oncological outcomes of patients with bladder cancer undergoing radical cystectomy: A systematic review.
    Arab J Urol. 2020;19:24-30.
    Abstract     Related articles   

  521. ORNAGHI PI, Afferi L, Antonelli A, Cerruto MA, et al
    Frailty impact on postoperative complications and early mortality rates in patients undergoing radical cystectomy for bladder cancer: a systematic review.
    Arab J Urol. 2020;19:9-23.
    Abstract     Related articles   

  522. MARI A, Muto G, Di Maida F, Tellini R, et al
    Oncological impact of inflammatory biomarkers in elderly patients treated with radical cystectomy for urothelial bladder cancer.
    Arab J Urol. 2020;19:2-8.
    Abstract     Related articles   

  523. LIN A, Qiu Z, Zhang J, Luo P, et al
    Effect of NCOR1 Mutations on Immune Microenvironment and Efficacy of Immune Checkpoint Inhibitors in Patient with Bladder Cancer.
    Front Immunol. 2021;12:630773.
    Abstract     Related articles   

  524. LAUKHTINA E, Abufaraj M, Al-Ani A, Ali MR, et al
    Intravesical Therapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis of Disease Recurrence.
    Eur Urol Focus. 2021 Mar 21. pii: S2405-4569(21)00095.
    Abstract     Related articles   

  525. LODHI T, Song YP, West C, Hoskin P, et al
    Hypoxia and its Modification in Bladder Cancer: Current and Future Perspectives.
    Clin Oncol (R Coll Radiol). 2021 Mar 21. pii: S0936-6555(21)00092.
    Abstract     Related articles   

  526. CHOI SJ, Park KJ, Heo C, Park BW, et al
    Radiomics-based model for predicting pathological complete response to neoadjuvant chemotherapy in muscle-invasive bladder cancer.
    Clin Radiol. 2021 Mar 21. pii: S0009-9260(21)00151.
    Abstract     Related articles   

  527. YANG J, Liu X, Dai G, Qu L, et al
    CircNT5E promotes the proliferation and migration of bladder cancer via sponging miR-502-5p.
    J Cancer. 2021;12:2430-2439.
    Abstract     Related articles   

  528. FENG F, Chen AP, Wang XL, Wu GL, et al
    Circ_0061140 promotes metastasis of bladder cancer through adsorbing microRNA-1236.
    Eur Rev Med Pharmacol Sci. 2021;25:2157.
    Abstract     Related articles   

  529. MAFFEZZINI M, Fontana V, Pacchetti A, Dotta F, et al
    Age above 70 years and Charlson Comorbidity Index higher than 3 are associated with reduced survival probabilities after radical cystectomy for bladder cancer. Data from a contemporary series of 334 consecutive patients.
    Arch Ital Urol Androl. 2021;93:15-20.
    Abstract     Related articles   

  530. TRIGO S, Gonzalez K, Di Matteo L, Ismail A, et al
    Bacillus Calmette-Guerin vaccine and bladder cancer incidence: Scoping literature review and preliminary analysis.
    Arch Ital Urol Androl. 2021;93:1-8.
    Abstract     Related articles   

  531. ZHANG X, Liu G, Shi X, Shi X, et al
    Sequential administration of anti-PD-1 and anti-Tim-3 combined with an SA-GM-CSF-anchored vaccine overcomes adaptive immune resistance to reject established bladder cancer.
    J Cancer. 2021;12:2000-2009.
    Abstract     Related articles   

  532. ZHOU JQ, Kang XL, Xu CJ, Liu S, et al
    Construction of Decision Trees Based on Gene Expression Omnibus Data to Classify Bladder Cancer and Its Subtypes.
    Med Sci Monit. 2021;27:e929394.
    Abstract     Related articles   

  533. LOYAL A, Chopra S, Goel M, Mehta S, et al
    Predictors of toxicity after neoadjuvant chemoradiotherapy for locally advanced gall bladder cancer.
    Indian J Cancer. 2021 Jan 27. pii: 308058. doi: 10.4103.
    Abstract     Related articles   

  534. LI HZ, Zheng RS, Du LB, Zhang SW, et al
    [Bladder cancer incidence, mortality and temporal trends in China].
    Zhonghua Zhong Liu Za Zhi. 2021;43:293-298.
    Abstract     Related articles   

  535. ALMEIDA TC, Silva GND
    Resveratrol effects in bladder cancer: A mini review.
    Genet Mol Biol. 2021;44:e20200371.
    Abstract     Related articles   

  536. LIU Y, Wu Y, Zhang P, Xu C, et al
    CXCL12 and CD3E as Indicators for Tumor Microenvironment Modulation in Bladder Cancer and Their Correlations With Immune Infiltration and Molecular Subtypes.
    Front Oncol. 2021;11:636870.
    Abstract     Related articles   

  537. DU Y, Wang B, Jiang X, Cao J, et al
    Identification and Validation of a Stromal EMT Related LncRNA Signature as a Potential Marker to Predict Bladder Cancer Outcome.
    Front Oncol. 2021;11:620674.
    Abstract     Related articles   

  538. DENG Y, Hong X, Yu C, Li H, et al
    Preclinical analysis of novel prognostic transcription factors and immune-related gene signatures for bladder cancer via TCGA-based bioinformatic analysis.
    Oncol Lett. 2021;21:344.
    Abstract     Related articles   

  539. D'ELIA C, Folchini DM, Mian C, Hanspeter E, et al
    Diagnostic value of Xpert((R)) Bladder Cancer Monitor in the follow-up of patients affected by non-muscle invasive bladder cancer: an update.
    Ther Adv Urol. 2021;13:1756287221997183.
    Abstract     Related articles   

  540. MOHSENZADEGAN M, Bavandpour P, Nowroozi MR, Amini E, et al
    The Potential of T Cell Immunoglobulin and Mucin-Domain containing-3 (Tim-3) in Designing Novel Immunotherapy for Bladder Cancer.
    Endocr Metab Immune Disord Drug Targets. 2021 Mar 10. pii: EMIDDT-EPUB-114830.
    Abstract     Related articles   

  541. PAN S, Li S, Xiao M, Chen D, et al
    Significant benefit of everolimus in a patient with urothelial bladder cancer harboring a rare M1043I mutation of PIK3CA.
    Invest New Drugs. 2021 Mar 20. pii: 10.1007/s10637-021-01103.
    Abstract     Related articles   

  542. ROMER E, Esperto F, Dooldeniya M, Cumberbatch MG, et al
    Does minimally invasive surgery for bladder cancer result in unusual sites of metastasis?
    Actas Urol Esp. 2021 Mar 17. pii: S0210-4806(20)30257.
    Abstract     Related articles   

  543. BUERGER M, Kapahnke S, Omran S, Schomaker M, et al
    Aortic aneurysm and aortic graft infection related to Mycobacterium bovis after intravesical Bacille Calmette-Guerin therapy-a case series.
    BMC Surg. 2021;21:138.
    Abstract     Related articles   

  544. MISHRA SJ, Liu W, Beebe K, Banerjee M, et al
    The Development of Hsp90beta-Selective Inhibitors to Overcome Detriments Associated with pan-Hsp90 Inhibition.
    J Med Chem. 2021;64:1545-1557.
    Abstract     Related articles   

  545. KRISHAN A, Bruce A, Khashaba S, Abouelela M, et al
    Safety and Efficacy of Transurethral Resection of Bladder Tumor Comparing Spinal Anesthesia with Spinal Anesthesia with an Obturator Nerve Block: A Systematic Review and Meta-analysis.
    J Endourol. 2021;35:249-258.
    Abstract     Related articles   

  546. PANIAGUA M, Parra V, De Miguel E
    Urinary bladder lipoma: an illustrative case.
    J Radiol Case Rep. 2020;14:15-21.
    Abstract     Related articles   

  547. LI J, Huang S, Zhang Y, Zhuo W, et al
    LINC00460 Enhances Bladder Carcinoma Cell Proliferation and Migration by Modulating miR-612/FOXK1 Axis.
    Pharmacology. 2021;106.
    Abstract     Related articles   

  548. LAI S, Wu P, Diao T, Seery S, et al
    Does Xylinas' nomogram accurately predict intravesical recurrence risk after radical nephroureterectomy for primary upper urinary tract urothelial carcinoma when applied to Asian populations?
    Jpn J Clin Oncol. 2021;51:469-477.
    Abstract     Related articles   

  549. BADA M, De Concilio B, Crocetto F, Creta M, et al
    Laparoscopic radical cystectomy with extracorporeal urinary diversion: an Italian single-center experience with 10-year outcomes.
    Minerva Urol Nefrol. 2020;72:641-643.
    Abstract     Related articles   

  550. DESOUKY E
    BCG versus COVID-19: impact on urology.
    World J Urol. 2021;39:823-827.
    Abstract     Related articles   

  551. ZHANG H, Shan G, Song J, Tian Y, et al
    Extracellular matrix-related genes play an important role in the progression of NMIBC to MIBC: a bioinformatics analysis study.
    Biosci Rep. 2020;40.
    Abstract     Related articles   

  552. OVIEDO RAMIREZ MI, Garzon Arana A
    Nephrogenic adenoma of the bladder. A simulator of urothelial bladder neoplasia.
    Actas Urol Esp. 2020;44:258-259.
    Abstract     Related articles   

  553. DEL POZO JIMENEZ G, Herranz Amo F, Subira Rios D, Rodriguez Fernandez E, et al
    Mortality prediction model for patients with bladder urothelial tumor after radical cystectomy.
    Actas Urol Esp. 2020;44:215-223.
    Abstract     Related articles   

  554. EISSA A, Zoeir A, Ciarlariello S, Sarchi L, et al
    En-bloc resection of bladder tumors for pathological staging: the value of lateral margins analysis.
    Minerva Urol Nefrol. 2020;72:763-769.
    Abstract     Related articles   


  555. Corrigendum to: LMTK3 promotes tumorigenesis in bladder cancer via the ERK/MAPK pathway.
    FEBS Open Bio. 2021;11:1277.
    Abstract     Related articles   

  556. ZHAO Z, Zhang P, Li W, Wang D, et al
    Pegylated Recombinant Human Arginase 1 Induces Autophagy and Apoptosis via the ROS-Activated AKT/mTOR Pathway in Bladder Cancer Cells.
    Oxid Med Cell Longev. 2021;2021:5510663.
    Abstract     Related articles   

  557. WANG J, Luo J, Wu X, Gao Z, et al
    Circular RNA_0000629 Suppresses Bladder Cancer Progression Mediating MicroRNA-1290/CDC73.
    Cancer Manag Res. 2021;13:2701-2715.
    Abstract     Related articles   

  558. ZHU W, Zhao Z, Feng B, Yu W, et al
    CD8+CD39+ T Cells Mediate Anti-Tumor Cytotoxicity in Bladder Cancer.
    Onco Targets Ther. 2021;14:2149-2161.
    Abstract     Related articles   

  559. MORSELLI S, Baria E, Cicchi R, Liaci A, et al
    The feasibility of multimodal fiber optic spectroscopy analysis in bladder cancer detection, grading, and staging.
    Urologia. 2021 Mar 31:3915603211007018. doi: 10.1177/03915603211007018.
    Abstract     Related articles   

  560. WANG JG, Zhu ZW, Fan YF, Zhang XP, et al
    [Clinical outcomes for young patients with muscular invasive bladder cancer who received robot-assisted radical cystectomy].
    Zhonghua Yi Xue Za Zhi. 2021;101:861-865.
    Abstract     Related articles   

  561. SANCHEZ A, Agarwal N
    Quantifying the Costs of Care Among Patients With High-Risk Non-Muscle-Invasive Bladder Cancer Treated in the Veterans Health Administration.
    JAMA Netw Open. 2021;4:e213816.
    Abstract     Related articles   

  562. WILLIAMS SB, Howard LE, Foster ML, Klaassen Z, et al
    Estimated Costs and Long-term Outcomes of Patients With High-Risk Non-Muscle-Invasive Bladder Cancer Treated With Bacillus Calmette-Guerin in the Veterans Affairs Health System.
    JAMA Netw Open. 2021;4:e213800.
    Abstract     Related articles   

  563. LIU S, Shi J, Liu Y, Wang L, et al
    Analysis of mRNA expression differences in bladder cancer metastasis based on TCGA datasets.
    J Int Med Res. 2021;49:300060521996929.
    Abstract     Related articles   

  564. YAKOVLEV PG, Gorbach OI, Khranovska NM, Beliayeva AV, et al
    Changes in expression of TLR-4, TGF-beta, INF-gamma, TNF-alpha in cultured T24/83cells of invasive bladder cancer treated with cisplatin and/or polyphenolic adjuvant melanin.
    Exp Oncol. 2021;43:7-14.
    Abstract     Related articles   

  565. ELSAWY AA, Awadalla A, Abdullateef M, Ahmed AE, et al
    Can repeat biopsy be skipped after initial complete resection of T1 bladder cancer? The role of a novel urinary mRNA biomarker.
    Urol Oncol. 2021 Mar 27. pii: S1078-1439(21)00070.
    Abstract     Related articles   

  566. KORAC-PRLIC J, Degoricija M, Vilovic K, Vujevic S, et al
    BBN-driven urinary bladder cancer mouse model.
    Methods Cell Biol. 2021;163:77-92.
    Abstract     Related articles   

  567. BESSA A, Bosco C, Mehrotra S, Rowland M, et al
    Is there a role for physical activity interventions in the treatment pathway of bladder cancer? A scoping review of the literature.
    BMJ Open Sport Exerc Med. 2021;7:e000951.
    Abstract     Related articles   

  568. HENNING GM, Barashi NS, Smith ZL
    Advances in Biomarkers for Detection, Surveillance, and Prognosis of Bladder Cancer.
    Clin Genitourin Cancer. 2021 Mar 4. pii: S1558-7673(21)00003.
    Abstract     Related articles   

  569. LIAO Y, Tang H, Wang M, Wang K, et al
    The potential diagnosis role of TP53 mutation in advanced bladder cancer: A meta-analysis.
    J Clin Lab Anal. 2021 Mar 29:e23765. doi: 10.1002/jcla.23765.
    Abstract     Related articles   

  570. YANG L, Li A, Liu F, Zhao Q, et al
    Immune Profiling Reveals Molecular Classification and Characteristic in Urothelial Bladder Cancer.
    Front Cell Dev Biol. 2021;9:596484.
    Abstract     Related articles   

  571. MOHAMED MB, Ali MH, Shamaa MA, Shaaban SM, et al
    Single course of intravesical Bacillus Calmette-Guerin versus single course with maintenance therapy in the management of nonmuscle invasive bladder cancer: A prospective randomized study.
    Urol Ann. 2020;12:360-365.
    Abstract     Related articles   

  572. KUFUKIHARA R, Kikuchi E, Ogihara K, Shigeta K, et al
    ASO Author Reflections: Previous History of Non-urothelial Malignancy May Provide Predictive Information of Worse Clinical Outcome for Initially Diagnosed Non-Muscle Invasive Bladder Cancer.
    Ann Surg Oncol. 2021 Mar 27. pii: 10.1245/s10434-021-09787.
    Abstract     Related articles   

  573. TEOH JY, Mayor N, Li KM, Lo KL, et al
    En-bloc resection of bladder tumour as primary treatment for patients with non-muscle-invasive bladder cancer: routine implementation in a multi-centre setting.
    World J Urol. 2021 Mar 28. pii: 10.1007/s00345-021-03675.
    Abstract     Related articles   

  574. LEBACLE C, Loriot Y, Irani J
    BCG-unresponsive high-grade non-muscle invasive bladder cancer: what does the practicing urologist need to know?
    World J Urol. 2021 Mar 27. pii: 10.1007/s00345-021-03666.
    Abstract     Related articles   

  575. GIORDANO G, Kyriazi E, Mavridis C, Persico F, et al
    Oncology and complications.
    Arch Ital Urol Androl. 2021;93:71-76.
    Abstract     Related articles   

  576. SARKIS J, Assaf J
    Re: Updates in the management and future landscape of urothelial carcinoma.
    J Oncol Pharm Pract. 2021;27:514-515.
    Abstract     Related articles   

  577. SIDAWAY P
    Intravesical therapy goes viral.
    Nat Rev Clin Oncol. 2021;18:64.
    Abstract     Related articles   

  578. SUN Z, Jing C, Xiao C, Li T, et al
    An autophagy-related long non-coding RNA prognostic signature accurately predicts survival outcomes in bladder urothelial carcinoma patients.
    Aging (Albany NY). 2020;12:15624-15637.
    Abstract     Related articles   

  579. BAISAKH MR, Tiwari A, Gandhi JS, Naik S, et al
    Primary round cell sarcomas of the urinary bladder with EWSR1 rearrangement: a multi-institutional study of thirteen cases with a review of the literature.
    Hum Pathol. 2020;104:84-95.
    Abstract     Related articles   

  580. KYOYA T, Arnold LL, Pennington KL, Kakiuchi-Kiyota S, et al
    Urinary crystal formation and urothelial effects of pyroxasulfone administered to male rats.
    Toxicol Mech Methods. 2020;30:656-671.
    Abstract     Related articles   

  581. MURATA SI, Kuroda M, Kawamura N, Warigaya K, et al
    Microtubule-organizing center-mediated structural atypia in low- and high-grade urothelial carcinoma.
    Virchows Arch. 2021;478:327-334.
    Abstract     Related articles   

  582. MAZIARZ M, Park JC, Leyme A, Marivin A, et al
    Revealing the Activity of Trimeric G-proteins in Live Cells with a Versatile Biosensor Design.
    Cell. 2020;182:770-785.
    Abstract     Related articles   

  583. LIU L, Zhong X, Cui H, Zhang H, et al
    Identification of an Individualized Prognostic Signature Based on the RWSR Model in Early-Stage Bladder Carcinoma.
    Biomed Res Int. 2020;2020:9186546.
    Abstract     Related articles   

  584. ESPEJO-HERRERA N, Condom-Mundo E
    Yolk sac tumor differentiation in urothelial carcinoma of the urinary bladder: a case report and differential diagnosis.
    Diagn Pathol. 2020;15:68.
    Abstract     Related articles   

  585. NEAL DJ, Amin MB, Smith SC
    CK20 versus AMACR and p53 immunostains in evaluation of Urothelial Carcinoma in Situ and Reactive Atypia.
    Diagn Pathol. 2020;15:61.
    Abstract     Related articles   

  586. MALTAGLIATI M, Varca V, Milandri R, Micali S, et al
    Second-look TURBT: evaluation of anatomopatological and oncologic results in a single center.
    Acta Biomed. 2020;91:322-325.
    Abstract     Related articles   

  587. TOWNSEND S, Regier PJ, More SN
    Successful Treatment of Urinary Bladder Hemangiosarcoma by Partial Cystectomy in a Dog.
    J Am Anim Hosp Assoc. 2020;56:231-235.
    Abstract     Related articles   

  588. ROBERTS JE
    Techniques to Improve Photodynamic Therapy.
    Photochem Photobiol. 2020;96:524-528.
    Abstract     Related articles   

  589. FENG Y, Jiang Y, Wen T, Meng F, et al
    Identifying Potential Prognostic Markers for Muscle-Invasive Bladder Urothelial Carcinoma by Weighted Gene Co-Expression Network Analysis.
    Pathol Oncol Res. 2020;26:1063-1072.
    Abstract     Related articles   

  590. PETRELLI F, Giannatempo P, Maccagnano C, Contieri R, et al
    Active surveillance for non-muscle invasive bladder cancer: A systematic review and pooled-analysis.
    Cancer Treat Res Commun. 2021;27:100369.
    Abstract     Related articles   

  591. RUF P, Bauer HW, Schoberth A, Kellermann C, et al
    First time intravesically administered trifunctional antibody catumaxomab in patients with recurrent non-muscle invasive bladder cancer indicates high tolerability and local immunological activity.
    Cancer Immunol Immunother. 2021 Apr 10. pii: 10.1007/s00262-021-02930.
    Abstract     Related articles   

  592. SANG J, Li W, Diao HJ, Fan RZ, et al
    Jolkinolide B targets thioredoxin and glutathione systems to induce ROS-mediated paraptosis and apoptosis in bladder cancer cells.
    Cancer Lett. 2021 Apr 6. pii: S0304-3835(21)00153.
    Abstract     Related articles   

  593. ABUSHAMMA F, Khayyat Z, Soroghle A, H Zyoud S, et al
    The Impact of Non-Compliance to a Standardized Risk-Adjusted Protocol on Recurrence, Progression, and Mortality in Non-Muscle Invasive Bladder Cancer.
    Cancer Manag Res. 2021;13:2937-2945.
    Abstract     Related articles   

  594. CAO G, Zhang C, Tian X, Jing G, et al
    circCEP128 Knockdown Suppresses Bladder Cancer Progression via Regulating microRNA-515-5p/SDC1 Axis.
    Cancer Manag Res. 2021;13:2885-2896.
    Abstract     Related articles   

  595. XU W, Anwaier A, Ma C, Liu W, et al
    Multi-omics reveals novel prognostic implication of SRC protein expression in bladder cancer and its correlation with immunotherapy response.
    Ann Med. 2021;53:596-610.
    Abstract     Related articles   

  596. YANG WX, Shao YX, Hu X, Xiong SC, et al
    [A Randomized Controlled Study of Intravesical Instillation Therapy of Bacillus Calmette-Guerin vs. Epirubicinin Treating Non-muscular Invasive Bladder Cancer].
    Sichuan Da Xue Xue Bao Yi Xue Ban. 2021;52:326-333.
    Abstract     Related articles   

  597. WANG Y, Yan K, Wang J, Lin J, et al
    M2 Macrophage Co-Expression Factors Correlate With Immune Phenotype and Predict Prognosis of Bladder Cancer.
    Front Oncol. 2021;11:609334.
    Abstract     Related articles   

  598. VALDES A, Bitzios A, Kassa E, Shevchenko G, et al
    Proteomic comparison between different tissue preservation methods for identification of promising biomarkers of urothelial bladder cancer.
    Sci Rep. 2021;11:7595.
    Abstract     Related articles   

  599. HIRASAWA Y, Pagano I, Chen R, Sun Y, et al
    Diagnostic performance of Oncuria, a urinalysis test for bladder cancer.
    J Transl Med. 2021;19:141.
    Abstract     Related articles   


  600. Retraction: High LINC01605 expression predicts poor prognosis and promotes tumor progression via upregulation of MMP9 in bladder cancer.
    Biosci Rep. 2021;41.
    Abstract     Related articles   


  601. Expression of Concern: CircRNA circPDSS1 promotes bladder cancer by downregulating miR-16.
    Biosci Rep. 2021;41.
    Abstract     Related articles   

  602. KOMYAKOV BK, Al-Attar TH, Dorofeev SY, Semeyko DP, et al
    [A total replacement of the both ureters and urinary bladder by ileal conduit in a woman with contracted bladder and Ormonds disease].
    Urologiia. 2021;:107-111.
    Abstract     Related articles   

  603. SARRIO SANZ P, Sanchez Caballero L, Perez Tomas C, Nakdali Kassab B, et al
    [Metabolic alterations and stones in patients with orthotopic ileal diversions. Case description.]
    Arch Esp Urol. 2021;74:351-354.
    Abstract     Related articles   

  604. TRAVASSOS TC, De Oliveira JMI, Selegatto IB, Reis LO, et al
    COVID-19 impact on bladder cancer-orientations for diagnosing, decision making, and treatment.
    Am J Clin Exp Urol. 2021;9:132-139.
    Abstract     Related articles   

  605. ZHUANG C, Zhuang C, Zhou Q, Huang X, et al
    Engineered CRISPR/Cas13d Sensing hTERT Selectively Inhibits the Progression of Bladder Cancer In Vitro.
    Front Mol Biosci. 2021;8:646412.
    Abstract     Related articles   

  606. ZHANG Y, Zhu Y, Xiao M, Cheng Y, et al
    The Long Non-coding RNA TMPO-AS1 Promotes Bladder Cancer Growth and Progression via OTUB1-Induced E2F1 Deubiquitination.
    Front Oncol. 2021;11:643163.
    Abstract     Related articles   

  607. KANG Y, Zhu X, Wang X, Liao S, et al
    Identification and Validation of the Prognostic Stemness Biomarkers in Bladder Cancer Bone Metastasis.
    Front Oncol. 2021;11:641184.
    Abstract     Related articles   

  608. AGRAWAL P, Jain A, Gautam A, Nigam AK, et al
    A retrospective study to assess the risk of bladder cancer in type-2 diabetic patients treated with pioglitazone.
    Perspect Clin Res. 2021;12:9-13.
    Abstract     Related articles   

  609. WANG X, Pan L, Lu Q, Huang H, et al
    A combination of ssGSEA and mass cytometry identifies immune microenvironment in muscle-invasive bladder cancer.
    J Clin Lab Anal. 2021 Apr 4:e23754. doi: 10.1002/jcla.23754.
    Abstract     Related articles   

  610. PINTO J, Carapito A, Amaro F, Lima AR, et al
    Discovery of Volatile Biomarkers for Bladder Cancer Detection and Staging through Urine Metabolomics.
    Metabolites. 2021;11.
    Abstract     Related articles   

  611. HERRANZ R, Oto J, Plana E, Fernandez-Pardo A, et al
    Circulating Cell-Free DNA in Liquid Biopsies as Potential Biomarker for Bladder Cancer: A Systematic Review.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  612. IBRAHIM OM, Basse PH, Jiang W, Guru K, et al
    NFkappaB-Activated COX2/PGE2/EP4 Axis Controls the Magnitude and Selectivity of BCG-Induced Inflammation in Human Bladder Cancer Tissues.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  613. WONG VK, Ganeshan D, Jensen CT, Devine CE, et al
    Imaging and Management of Bladder Cancer.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  614. FERRO M, La Civita E, Liotti A, Cennamo M, et al
    Liquid Biopsy Biomarkers in Urine: A Route towards Molecular Diagnosis and Personalized Medicine of Bladder Cancer.
    J Pers Med. 2021;11.
    Abstract     Related articles   

  615. KIM SY, Hwangbo H, Kim MY, Ji SY, et al
    Betulinic Acid Restricts Human Bladder Cancer Cell Proliferation In Vitro by Inducing Caspase-Dependent Cell Death and Cell Cycle Arrest, and Decreasing Metastatic Potential.
    Molecules. 2021;26.
    Abstract     Related articles   

  616. GLUKHOV A, Potoldykova N, Taratkin M, Gordeev S, et al
    Detection of Urothelial Bladder Cancer Based on Urine and Tissue Telomerase Activity Measured by Novel RT-TRAP-2PCR Method.
    J Clin Med. 2021;10.
    Abstract     Related articles   

  617. STEMPOR PA, Avni D, Leibowitz R, Sidi Y, et al
    Comprehensive Analysis of Correlations in the Expression of miRNA Genes and Immune Checkpoint Genes in Bladder Cancer Cells.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  618. TRATNJEK L, Jeruc J, Romih R, Zupancic D, et al
    Vitamin A and Retinoids in Bladder Cancer Chemoprevention and Treatment: A Narrative Review of Current Evidence, Challenges and Future Prospects.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  619. ABOUELKHEIR RT, Abdelhamid A, Abou El-Ghar M, El-Diasty T, et al
    Imaging of Bladder Cancer: Standard Applications and Future Trends.
    Medicina (Kaunas). 2021;57.
    Abstract     Related articles   

  620. GEORGANTZOGLOU N, Pergaris A, Masaoutis C, Theocharis S, et al
    Extracellular Vesicles as Biomarkers Carriers in Bladder Cancer: Diagnosis, Surveillance, and Treatment.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  621. JOU YC, Wang SC, Dia YC, Wang ST, et al
    Anti-Cancer Effects and Tumor Marker Role of Glutathione S-Transferase Mu 5 in Human Bladder Cancer.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  622. MORALES L, Paramio JM
    Cell Therapies in Bladder Cancer Management.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  623. DE JONG FC, Rutten VC, Zuiverloon TCM, Theodorescu D, et al
    Improving Anti-PD-1/PD-L1 Therapy for Localized Bladder Cancer.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  624. ZHANG H, Zhang J, Guo B, Chen H, et al
    The Antitumor Effects of Plasma-Activated Saline on Muscle-Invasive Bladder Cancer Cells In Vitro and In Vivo Demonstrate Its Feasibility as a Potential Therapeutic Approach.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  625. YANG Y, Zou X, Wang Y, Ma X, et al
    Application of deep learning as a noninvasive tool to differentiate muscle-invasive bladder cancer and non-muscle-invasive bladder cancer with CT.
    Eur J Radiol. 2021;139:109666.
    Abstract     Related articles   

  626. LUO WJ, Tian X, Xu WH, Qu YY, et al
    Construction of an immune-related LncRNA signature with prognostic significance for bladder cancer.
    J Cell Mol Med. 2021 Apr 1. doi: 10.1111/jcmm.16494.
    Abstract     Related articles   

  627. YANG Y, Liu C, Yan X, Li J, et al
    En Bloc Tumor Resection, Optical Molecular Imaging, and the Potential Synergy of the Combination of the Two Techniques in Bladder Cancer.
    Front Oncol. 2021;11:638083.
    Abstract     Related articles   

  628. LARA MOSCOLONI LF, Santarelli M, Spagnuolo J
    Tuberculous epididymo-orchitis secondary to Bacillus Calmette-Guerin (BCG) in non-muscular invasive bladder cancer.
    Urol Case Rep. 2021;37:101629.
    Abstract     Related articles   

  629. WANG Y, Li X, Chen W, Wu W, et al
    The common region of lncRNAs UCA1 and UCA1alpha contributes to the bladder cancer tumorigenesis.
    Eur J Cancer Prev. 2021 Mar 31. pii: 00008469-900000000-99056.
    Abstract     Related articles   

  630. CAUSA ANDRIEU PI, Tzeng M
    Inguinal hernia plugs mimicking abdominal wall invasion of bladder cancer - a potential imaging pitfall.
    Radiologia. 2021 Mar 29. pii: S0033-8338(21)00072.
    Abstract     Related articles   

  631. GALLEGOS H, Rojas PA, Sepulveda F, Zuniga A, et al
    Protective role of intravesical BCG in COVID-19 severity.
    BMC Urol. 2021;21:50.
    Abstract     Related articles   

  632. MUKHERJEE S, Abbaraju J, Russell G, Madaan S, et al
    Bladder-to-bladder metastasis: gallbladder cancer metastasising to the urinary bladder.
    Ann R Coll Surg Engl. 2021;103:e116-e119.
    Abstract     Related articles   

  633. BRISOTTO G, Guerrieri R, Colizzi F, Steffan A, et al
    Long Noncoding RNAs as Innovative Urinary Diagnostic Biomarkers.
    Methods Mol Biol. 2021;2292:73-94.
    Abstract     Related articles   

  634. BRAVACCINI S
    Fluorescence In Situ Hybridization in Urine Samples (UroVysion Kit).
    Methods Mol Biol. 2021;2292:35-48.
    Abstract     Related articles   

  635. O'LEARY K
    MYC inhibition, courtesy of E. coli.
    Nat Rev Cancer. 2021;21:214-215.
    Abstract     Related articles   

  636. HUANG WB, Cheng L
    [Variants of urothelial carcinoma: new molecular insight and differential diagnosis].
    Zhonghua Bing Li Xue Za Zhi. 2021;50:155-158.
    Abstract     Related articles   

  637. TORRES-JIMENEZ J, Albarran-Fernandez V, Pozas J, Roman-Gil MS, et al
    Novel Tyrosine Kinase Targets in Urothelial Carcinoma.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  638. KIM B, Jang I, Kim K, Jung M, et al
    Comprehensive Gene Expression Analyses of Immunohistochemically Defined Subgroups of Muscle-Invasive Urinary Bladder Urothelial Carcinoma.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  639. BONTOUX C, Rialland T, Cussenot O, Comperat E, et al
    A four-antibody immunohistochemical panel can distinguish clinico-pathological clusters of urothelial carcinoma and reveals high concordance between primary tumor and lymph node metastases.
    Virchows Arch. 2021;478:637-645.
    Abstract     Related articles   

  640. REXER H, Bedke J, Merseburger A

    Aktuelle Urol. 2020;51:418-420.
    Abstract     Related articles   

  641. THEN CK, Paillas S, Wang X, Hampson A, et al
    Association of Bacteroides acidifaciens relative abundance with high-fibre diet-associated radiosensitisation.
    BMC Biol. 2020;18:102.
    Abstract     Related articles   

  642. MALLY D, Paffenholz P
    [Complication management for TUR of the bladder].
    Aktuelle Urol. 2020;51:450-455.
    Abstract     Related articles   

  643. ALI MS, Metwally AA, Fahmy RH, Osman R, et al
    Chitosan-coated nanodiamonds: Mucoadhesive platform for intravesical delivery of doxorubicin.
    Carbohydr Polym. 2020;245:116528.
    Abstract     Related articles   

  644. RUDOLPH J, Martini T, Wezel F
    [The impact of radical cystectomy on health-related quality of life and potential for optimisation].
    Aktuelle Urol. 2020;51:363-370.
    Abstract     Related articles   

  645. CIMADAMORE A, Aurilio G, Nole F, Massari F, et al
    Update on Circulating Tumor Cells in Genitourinary Tumors with Focus on Prostate Cancer.
    Cells. 2020;9.
    Abstract     Related articles   

  646. HENNIG MJP, Kramer MW
    [Potential for improvement by new resection and imaging techniques in TUR-B].
    Aktuelle Urol. 2020;51:348-352.
    Abstract     Related articles   

  647. XIA CS, Fan CH, Su M, Wang QS, et al
    Use of the Nuclear Matrix Protein 22 BladderChek Test for the Detection of Primary and Recurrent Urothelial Carcinoma.
    Dis Markers. 2020;2020:3424039.
    Abstract     Related articles   

  648. QIN Q, Patel V, Galsky MD
    Urothelial carcinoma: the development of FGFR inhibitors in combination with immune checkpoint inhibitors.
    Expert Rev Anticancer Ther. 2020;20:503-512.
    Abstract     Related articles   

  649. SCHUETTFORT V, Shariat SF, Rink M
    [Surgery only? Multimodal treatment for urothelial carcinoma of the bladder].
    Aktuelle Urol. 2020;51:353-362.
    Abstract     Related articles   

  650. FREIH-FRAIH A, Munoz-Hernandez P, Gordillo CH, Jimenez-Heffernan JA, et al
    Iatrogenic granulomatous changes in voided urine cytology.
    Diagn Cytopathol. 2020;48:687-689.
    Abstract     Related articles   

  651. GRUNEWALD CM, Hiester A, Niegisch G
    [Systemic therapy for metastatic urothelial carcinoma - Current status and what comes after checkpoint inhibitors?]
    Aktuelle Urol. 2020;51:371-376.
    Abstract     Related articles   

  652. ELDIN ME, Makboul R, Behnsawy HM, Abdelkawi IF, et al
    Comparative Application of Different Substaging Techniques for Non-Muscle Invasive Urothelial Carcinoma.
    Pathol Oncol Res. 2020;26:1823-1831.
    Abstract     Related articles   

  653. LENFANT L, Campi R, Parra J, Graffeille V, et al
    Robotic versus open radical cystectomy throughout the learning phase: insights from a real-life multicenter study.
    World J Urol. 2020;38:1951-1958.
    Abstract     Related articles   

  654. GONTERO P, Pisano F, Palou J, Joniau S, et al
    Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 cases.
    World J Urol. 2020;38:1959-1968.
    Abstract     Related articles   

  655. HOU G, Zheng Y, Zhang L, Lai D, et al
    Development and validation of a prognostic nomogram for patients with intravesical recurrence after radical nephroureterectomy for non-metastatic upper tract urothelial carcinoma.
    World J Urol. 2020;38:1969-1975.
    Abstract     Related articles   

  656. HSIAO BY, Su SY, Jhuang JR, Chiang CJ, et al
    Ensemble forecasting of a continuously decreasing trend in bladder cancer incidence in Taiwan.
    Sci Rep. 2021;11:8373.
    Abstract     Related articles   

  657. LINDSKROG SV, Prip F, Lamy P, Taber A, et al
    An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer.
    Nat Commun. 2021;12:2301.
    Abstract     Related articles   

  658. APPLEYARD SE, Nikapota AD
    Patient-Reported Outcomes and Health-Related Quality of Life Following Radiotherapy for Bladder Cancer.
    Clin Oncol (R Coll Radiol). 2021 Apr 13. pii: S0936-6555(21)00107.
    Abstract     Related articles   

  659. KORKES F, Fernandes E, Gushiken FA, Glina FPA, et al
    Bricker ileal conduit vs. Cutaneous ureterostomy after radical cystectomy for bladder cancer: a systematic review.
    Int Braz J Urol. 2021;47.
    Abstract     Related articles   

  660. CAO Y, Hu Q, Zhang R, Li L, et al
    Knockdown of Long Non-coding RNA SNGH3 by CRISPR-dCas9 Inhibits the Progression of Bladder Cancer.
    Front Mol Biosci. 2021;8:657145.
    Abstract     Related articles   

  661. BOLETO G, Avouac J, Allanore Y
    Rapidly Progressive Systemic Sclerosis-associated Interstitial Lung Disease After Intravesical Bacillus Calmette-Guerin Therapy for Early-stage Bladder Cancer.
    J Rheumatol. 2021 Apr 15. pii: jrheum.201625. doi: 10.3899/jrheum.201625.
    Abstract     Related articles   

  662. WOLDU SL, Souter L, Boorjian SA, Barocas DA, et al
    Urinary-based tumor markers enhance microhematuria risk stratification according to baseline bladder cancer prevalence.
    Urol Oncol. 2021 Apr 12. pii: S1078-1439(21)00132.
    Abstract     Related articles   

  663. IYYANKI T, Zhang B, Wang Q, Hou Y, et al
    Subtype-associated epigenomic landscape and 3D genome structure in bladder cancer.
    Genome Biol. 2021;22:105.
    Abstract     Related articles   

  664. YANG J, Xia A, Zhang H, Liu Q, et al
    Up-Regulating ERIC by CRISPR-dCas9-VPR Inhibits Cell Proliferation and Invasion and Promotes Apoptosis in Human Bladder Cancer.
    Front Mol Biosci. 2021;8:654718.
    Abstract     Related articles   

  665. YANG J, Li C, Tang Y, Guo F, et al
    Diagnostic roles of proliferative markers in pathological Grade of T1 Urothelial Bladder Cancer.
    J Cancer. 2021;12:2498-2506.
    Abstract     Related articles   

  666. XIE F, Huang C, Liu F, Zhang H, et al
    CircPTPRA blocks the recognition of RNA N(6)-methyladenosine through interacting with IGF2BP1 to suppress bladder cancer progression.
    Mol Cancer. 2021;20:68.
    Abstract     Related articles   

  667. CHAI X, Zhang JW, Li SH, Cheng QS, et al
    Xanthoceraside induces cell apoptosis through downregulation of the PI3K/Akt/Bcl-2/Bax signaling pathway in cell lines of human bladder cancer.
    Indian J Pathol Microbiol. 2021;64:294-301.
    Abstract     Related articles   

  668. AURILIO G, Cimadamore A, Lopez-Beltran A, Scarpelli M, et al
    Narrative review: update on immunotherapy and pathological features in patients with bladder cancer.
    Transl Androl Urol. 2021;10:1521-1529.
    Abstract     Related articles   

  669. HUANG M, Long Y, Jin Y, Ya W, et al
    Comprehensive analysis of the lncRNA-miRNA-mRNA regulatory network for bladder cancer.
    Transl Androl Urol. 2021;10:1286-1301.
    Abstract     Related articles   

  670. ZHAO K, Zhang Q, Zeng T, Zhang J, et al
    Identification and validation of a prognostic immune-related lncRNA signature in bladder cancer.
    Transl Androl Urol. 2021;10:1229-1240.
    Abstract     Related articles   

  671. TOMIOKA M, Yoneyama T, Tobisawa Y, Kawase K, et al
    Ghrelin after chemotherapy as a prognostic predictor of progression-free survival in patients with muscle-invasive bladder cancer.
    Transl Androl Urol. 2021;10:1192-1201.
    Abstract     Related articles   

  672. IWAMURA H, Hatakeyama S, Momota M, Kojima Y, et al
    Relationship of frailty with treatment modality selection in patients with muscle-invasive bladder cancer (FRART-BC study).
    Transl Androl Urol. 2021;10:1143-1151.
    Abstract     Related articles   

  673. REYES RM, Deng Y, Zhang D, Ji N, et al
    CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from alphaPD-L1 and include tissue-selective gammadelta T cell activation.
    J Immunother Cancer. 2021;9.
    Abstract     Related articles   

  674. HAMMOUDA K, Khalifa F, Soliman A, Ghazal M, et al
    A multiparametric MRI-based CAD system for accurate diagnosis of bladder cancer staging.
    Comput Med Imaging Graph. 2021;90:101911.
    Abstract     Related articles   

  675. KORKES F
    Editorial Comment: Factors associated with utilization of neoadjuvant chemotherapy in charlson comorbidity zero non-metastatic muscle-invasive bladder cancer patients.
    Int Braz J Urol. 2021;47:819-820.
    Abstract     Related articles   

  676. AU D, Lee EK, Popoola TO, Parker WP, et al
    Factors associated with utilization of neoadjuvant chemotherapy in charlson comorbidity zero non-metastatic muscle-invasive bladder cancer patients.
    Int Braz J Urol. 2021;47:803-818.
    Abstract     Related articles   

  677. DU Y, Zhang X, Zhang H, Chen Y, et al
    Propofol modulates the proliferation, invasion and migration of bladder cancer cells through the miR1455p/TOP2A axis.
    Mol Med Rep. 2021;23.
    Abstract     Related articles   

  678. ZHENG P, Wu K, Gao Z, Li H, et al
    KIF4A promotes the development of bladder cancer by transcriptionally activating the expression of CDCA3.
    Int J Mol Med. 2021;47.
    Abstract     Related articles   

  679. RODRIGUES PESSOA R, Mueller AC, Boxley P, Flaig TW, et al
    Systematic review and meta-analysis of radiation therapy for high-risk non-muscle invasive bladder cancer.
    Urol Oncol. 2021 Apr 10. pii: S1078-1439(21)00118.
    Abstract     Related articles   

  680. WANG G, Dai Y, Li K, Cheng M, et al
    Corrigendum: Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis.
    Front Cell Dev Biol. 2021;9:675417.
    Abstract     Related articles   

  681. ADAMKIEWICZ M, Bryniarski P, Kowalik M, Burzynski B, et al
    Lymphocyte-to-Monocyte Ratio Is the Independent Prognostic Marker of Progression in Patients Undergoing BCG-Immunotherapy for Bladder Cancer.
    Front Oncol. 2021;11:655000.
    Abstract     Related articles   

  682. WU J, Wen JM, Wang YC, Luo WJ, et al
    Prognostic Value of an Immunohistochemical Signature in Patients With Bladder Cancer Undergoing Radical Cystectomy.
    Front Oncol. 2021;11:641385.
    Abstract     Related articles   

  683. YANG J, Lin J, An J, Zhao Y, et al
    TRIB3 Promotes the Malignant Progression of Bladder Cancer: An Integrated Analysis of Bioinformatics and in vitro Experiments.
    Front Genet. 2021;12:649208.
    Abstract     Related articles   

  684. VARUGHESE M
    Overcoming the Chasm Between Evidence and Routine Practice for Bladder Cancer; Just a Quixotic Notion?
    Clin Oncol (R Coll Radiol). 2021 Apr 8. pii: S0936-6555(21)00099.
    Abstract     Related articles   

  685. DOGAN C, Yazici CM, Akgul M, Turker P, et al
    The Evaluation of the Relation between Bladder Cancer and Oxidative Stress Using NRF-2/KEAP-1 Pathway, Zinc and Copper Levels.
    Urol J. 2021 Apr 11:6439. doi: 10.22037/uj.v18i.6439.
    Abstract     Related articles   

  686. RAZZAGHI MR, Mazloomfard MM, Yavar M, Malekian S, et al
    Holmium LASER in Comparison with Transurethral Resection of the Bladder Tumor for Non-muscle Invasive Bladder Cancer: Randomized Clinical Trial with 18-month Follow-up.
    Urol J. 2021 Apr 11. pii: 6319. doi: 10.22037/uj.v18i.6319.
    Abstract     Related articles   

  687. ROYCE TJ, Liu Y, Milowsky MI, Efstathiou JA, et al
    Trimodality Therapy With or Without Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2021 Mar 16. pii: S1558-7673(21)00070.
    Abstract     Related articles   

  688. KOBAYASHI H, Tsuchiyama K, Taga M, Tokunaga T, et al
    Impact of self-decision to stop cancer treatment on advanced genitourinary cancer patients.
    Medicine (Baltimore). 2021;100:e25397.
    Abstract     Related articles   

  689. CHENG K, Yang WR, Jiang SJ, Shen Q, et al
    [Diagnosis of large cell neuroendocrine carcinoma by urine cytology: report of a case].
    Zhonghua Bing Li Xue Za Zhi. 2021;50:408-410.
    Abstract     Related articles   

  690. XIA Y, Liu Y, Yang C, Simeone DM, et al
    Dominant role of CDKN2B/p15INK4B of 9p21.3 tumor suppressor hub in inhibition of cell-cycle and glycolysis.
    Nat Commun. 2021;12:2047.
    Abstract     Related articles   

  691. JENDOUZI O, Boukhlifi Y, Houadfi OE, Essaoudi MA, et al
    Bladder lipoma: Moroccan case report.
    Pan Afr Med J. 2020;37:380.
    Abstract     Related articles   

  692. MA X, Huang R, Wu X, Zhang P, et al
    Dualmarker: a flexible toolset for exploratory analysis of combinatorial dual biomarkers for clinical efficacy.
    BMC Bioinformatics. 2021;22:127.
    Abstract     Related articles   

  693. IKARI R, Mukaisho KI, Kageyama S, Nagasawa M, et al
    Differences in the Central Energy Metabolism of Cancer Cells between Conventional 2D and Novel 3D Culture Systems.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  694. GARCIA-ROJO E, Manfredi C, Santos-Perez-de-la-Blanca R, Tejido-Sanchez A, et al
    Impact of COVID-19 outbreak on urology surgical waiting lists and waiting lists prioritization strategies in the Post-COVID-19 era.
    Actas Urol Esp. 2021;45:207-214.
    Abstract     Related articles   

  695. STRUCK JP, Kramer MW, Katzendorn O, Hupe MC, et al
    Bicentric Retrospective Analysis of en Bloc Resection and Muscularis Mucosae Detection Rate in Non-Muscle Invasive Bladder Tumors: A Real-World Scenario.
    Adv Ther. 2021;38:258-267.
    Abstract     Related articles   

  696. MOLLICA V, Maggio I, Lopez-Beltran A, Montironi R, et al
    Combination therapy in advanced urothelial cancer: the role of PARP, HER-2 and mTOR inhibitors.
    Expert Rev Anticancer Ther. 2020;20:755-763.
    Abstract     Related articles   

  697. CZUB P, Budnik M, Majstrak F, Kochanowski J, et al
    Echocardiographic photorealistic imaging of leiomyomatosis intravascularis.
    Int J Cardiovasc Imaging. 2021;37:109-111.
    Abstract     Related articles   

  698. NIAZI MKK, Yazgan E, Tavolara TE, Li W, et al
    Semantic segmentation to identify bladder layers from H&E Images.
    Diagn Pathol. 2020;15:87.
    Abstract     Related articles   

  699. REN C, Wang X, Yang C, Li S, et al
    Investigation of Atyp.C using UF-5000 flow cytometer in patients with a suspected diagnosis of urothelial carcinoma: a single-center study.
    Diagn Pathol. 2020;15:77.
    Abstract     Related articles   

  700. OSHINA T, Kawai T, Sato Y, Miyakawa J, et al
    Inverted papilloma of the urinary bladder shows fluorescence on photodynamic diagnosis using 5-aminolevulinic acid.
    Photodiagnosis Photodyn Ther. 2020;30:101766.
    Abstract     Related articles   

  701. KIRK PS, Liu X, Borza T, Li BY, et al
    Dynamic readmission prediction using routine postoperative laboratory results after radical cystectomy.
    Urol Oncol. 2020;38:255-261.
    Abstract     Related articles   

  702. NARAYAN VM, Seif MA, Lim AH, Li R, et al
    Radical cystectomy in women: Impact of the robot-assisted versus open approach on surgical outcomes.
    Urol Oncol. 2020;38:247-254.
    Abstract     Related articles   

  703. REESE SW, Ji E, Paciotti M, Leow JJ, et al
    Risk factors and reasons for reoperation after radical cystectomy.
    Urol Oncol. 2020;38:269-277.
    Abstract     Related articles   

  704. LI M, Toniolo J, Nandurkar R, Papa N, et al
    Continuous bladder irrigation after transurethral resection of non-muscle invasive bladder cancer for prevention of tumour recurrence: a systematic review.
    ANZ J Surg. 2021 Apr 23. doi: 10.1111/ans.16740.
    Abstract     Related articles   

  705. VANARSA K, Enan S, Patel P, Strachan B, et al
    Urine protein biomarkers of bladder cancer arising from 16-plex antibody-based screens.
    Oncotarget. 2021;12:783-790.
    Abstract     Related articles   

  706. QU G, Liu Z, Yang G, Xu Y, et al
    Development of a prognostic index and screening of prognosis related genes based on an immunogenomic landscape analysis of bladder cancer.
    Aging (Albany NY). 2021;13.
    Abstract     Related articles   

  707. LEIVO MZ, Tacha DE, Hansel DE
    Expression of Uroplakin II and GATA-3 in Bladder Cancer Mimickers: Caveats in the Use of a Limited Panel to Determine Cell of Origin in Bladder Lesions.
    Hum Pathol. 2021 Apr 19. pii: S0046-8177(21)00057.
    Abstract     Related articles   

  708. MONAGHAN TF, Robins DJ, Suss NR, Miller CD, et al
    Determinants of neoadjuvant chemotherapy for urothelial muscle-invasive bladder cancer: Does location matter?
    Int J Clin Pract. 2021 Apr 22:e14262. doi: 10.1111/ijcp.14262.
    Abstract     Related articles   

  709. CHEN J, Hao L, Zhang S, Zhang Y, et al
    Preoperative Fibrinogen-Albumin Ratio, Potential Prognostic Factors for Bladder Cancer Patients Undergoing Radical Cystectomy: A Two-Center Study.
    Cancer Manag Res. 2021;13:3181-3192.
    Abstract     Related articles   

  710. PIATTI P, Chew YC, Suwoto M, Yamada T, et al
    Clinical evaluation of Bladder CARE, a new epigenetic test for bladder cancer detection in urine samples.
    Clin Epigenetics. 2021;13:84.
    Abstract     Related articles   

  711. LILLY E, El Gharib K
    Immunotherapy and non-muscle-invasive bladder cancer: an idea from the 19(th) century.
    Expert Rev Anticancer Ther. 2021 Apr 21. doi: 10.1080/14737140.2021.1921578.
    Abstract     Related articles   

  712. RAZIK A, Das CJ, Das CJ, Sharma R, et al
    Utility of first order MRI-Texture analysis parameters in the prediction of histologic grade and muscle invasion in urinary bladder cancer: A preliminary study.
    Br J Radiol. 2021 Apr 21:20201114. doi: 10.1259/bjr.20201114.
    Abstract     Related articles   

  713. ZHANG Y, Luo G, You S, Zhang L, et al
    Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell proliferation and invasion by regulating miR-15a-5p/HMGA2 axis.
    Acta Biochim Biophys Sin (Shanghai). 2021 Apr 21. pii: 6244475.
    Abstract     Related articles   

  714. ZALEWSKA-ADAMIEC M, Klonowska P, Malyszko J, Kuzma L, et al
    Primary Takotsubo Syndrome as a Complication of Bladder Cancer Treatment in a 62-Year-Old Woman.
    Am J Case Rep. 2021;22:e930090.
    Abstract     Related articles   

  715. ZHANG H, Xiao X, Wei W, Huang C, et al
    CircLIFR synergizes with MSH2 to attenuate chemoresistance via MutSalpha/ATM-p73 axis in bladder cancer.
    Mol Cancer. 2021;20:70.
    Abstract     Related articles   

  716. YAHYAZADEH R, Bashash D, Ghaffari P, Kord S, et al
    Evaluation of hTERT, KRT7, and survivin in urine for noninvasive detection of bladder cancer using real-time PCR.
    BMC Urol. 2021;21:64.
    Abstract     Related articles   

  717. THAKUR ML, Tripathi SK, Gomella LG, Salmanoglu E, et al
    Imaging urothelial bladder cancer: A VPAC PET targeted approach.
    Can J Urol. 2021;28:10596-10602.
    Abstract     Related articles   

  718. ZHANG C, Hu J, Li H, Ma H, et al
    Emerging Biomarkers for Predicting Bladder Cancer Lymph Node Metastasis.
    Front Oncol. 2021;11:648968.
    Abstract     Related articles   

  719. WAN J, Guo C, Fang H, Xu Z, et al
    Autophagy-Related Long Non-coding RNA Is a Prognostic Indicator for Bladder Cancer.
    Front Oncol. 2021;11:647236.
    Abstract     Related articles   

  720. PAK S, Kim SY, Kim SH, Joung JY, et al
    Association Between Antibiotic Treatment and the Efficacy of Intravesical BCG Therapy in Patients With High-Risk Non-Muscle Invasive Bladder Cancer.
    Front Oncol. 2021;11:570077.
    Abstract     Related articles   

  721. VERMA A, Mittal RD
    Association of miRNA 30c, miRNA 181a and miRNA 570 SNPs with Bladder Cancer Risk in North Indian Population: A Pilot Study.
    Indian J Clin Biochem. 2021;36:194-199.
    Abstract     Related articles   

  722. LONATI C, Baumeister P, Ornaghi PI, Di Trapani E, et al
    Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical Cystectomy.
    Eur Urol Focus. 2021 Apr 15. pii: S2405-4569(21)00111.
    Abstract     Related articles   

  723. SOLANKI AA, Venkatesulu BP, Efstathiou JA
    Will the Use of Biomarkers Improve Bladder Cancer Radiotherapy Delivery?
    Clin Oncol (R Coll Radiol). 2021 Apr 16. pii: S0936-6555(21)00108.
    Abstract     Related articles   

  724. PAK JS, Haas CR, Anderson CB, DeCastro GJ, et al
    Survival and oncologic outcomes of complete transurethral resection of bladder tumor prior to neoadjuvant chemotherapy for muscle-invasive bladder cancer.
    Urol Oncol. 2021 Apr 14. pii: S1078-1439(21)00135.
    Abstract     Related articles   

  725. KATO S, Fushimi K, Yabuki Y, Maru Y, et al
    Precision modeling of gall bladder cancer patients in mice based on orthotopic implantation of organoid-derived tumor buds.
    Oncogenesis. 2021;10:33.
    Abstract     Related articles   

  726. RESNIK N, Tratnjek L, Kreft ME, Kisovec M, et al
    Cytotoxic Activity of LLO Y406A Is Targeted to the Plasma Membrane of Cancer Urothelial Cells.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  727. BERNING L, Schlutermann D, Friedrich A, Berleth N, et al
    Prodigiosin Sensitizes Sensitive and Resistant Urothelial Carcinoma Cells to Cisplatin Treatment.
    Molecules. 2021;26.
    Abstract     Related articles   

  728. RICCETTO CLZ
    Editorial Comment: Combination therapy in overacti-ve bladder-untapped research opportunities: A systematic review of the literature.
    Int Braz J Urol. 2021;47:661-662.
    Abstract     Related articles   

  729. CAPIBARIBE DM, Dal Col LSB, Jalalizadeh M, Reis LO, et al
    How to avert a hidden trap: the severe obturator nerve re-flex.
    Int Braz J Urol. 2021;47:594-595.
    Abstract     Related articles   

  730. KHAN MT, Yang L, More E, Irlam-Jones JJ, et al
    Developing Tumor Radiosensitivity Signatures Using LncRNAs.
    Radiat Res. 2021;195:324-333.
    Abstract     Related articles   

  731. BRADBURY ML, Mullin CM, Gillian SD, Weisse C, et al
    Clinical outcomes of dogs with transitional cell carcinoma receiving medical therapy, with and without partial cystectomy.
    Can Vet J. 2021;62:133-140.
    Abstract     Related articles   

  732. ATLI SEKEROGLU Z, Sekeroglu V, Kontas Yedier S, Ilkun E, et al
    Increased DNA strand breaks and neoplastic transformation in human bladder cells treated with pioglitazone.
    Environ Mol Mutagen. 2021;62:143-154.
    Abstract     Related articles   

  733. HUANG S, Chen H, Li T, Pu X, et al
    Comparison of survival in elderly patients treated with uretero-cutaneostomy or ileal conduit after radical cystectomy.
    BMC Geriatr. 2021;21:49.
    Abstract     Related articles   

  734. GRANT EJ, Yamamura M, Brenner AV, Preston DL, et al
    Radiation Risks for the Incidence of Kidney, Bladder and Other Urinary Tract Cancers: 1958-2009.
    Radiat Res. 2021;195:140-148.
    Abstract     Related articles   

  735. DJORDJEVIC D, Vukovic M
    Functional results of hautmann neobladder with chimney modification and wallace ureteroileal anastomosis: initial experience with 22 patients.
    Int Braz J Urol. 2021;47:426-435.
    Abstract     Related articles   

  736. JOHNSON SM, Khararjian A, Legesse TB, Khani F, et al
    Nested Variant of Urothelial Carcinoma Is a Luminal Bladder Tumor With Distinct Coexpression of the Basal Marker Cytokeratin 5/6.
    Am J Clin Pathol. 2021;155:588-596.
    Abstract     Related articles   

  737. DOS REIS RB, Muglia VF, Rodrigues AA Junior, Viani G, et al
    Editorial Comment: Endoclips as novel fiducial markers in trimodality bladder preserving therapy of muscle-invasive bladder carcinoma: feasibility and patient out-comes.
    Int Braz J Urol. 2021;47:100-102.
    Abstract     Related articles   

  738. CHEN S, Zhang N, Wang T, Zhang E, et al
    Biomarkers of the Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma.
    Front Immunol. 2020;11:1900.
    Abstract     Related articles   

  739. JIANG Y, Wang Y, Li C, Zou Z, et al
    Development of an Immune-Related Risk Signature in Patients with Bladder Urothelial Carcinoma.
    Biomed Res Int. 2020;2020:5848493.
    Abstract     Related articles   

  740. LUO Q, Zhang X
    Construction of Protein-related Risk Score Model in Bladder Urothelial Carcinoma.
    Biomed Res Int. 2020;2020:7147824.
    Abstract     Related articles   

  741. STROCK V, Holmang S
    Is bladder tumour fulguration under local anaesthesia more painful than cystoscopy only?
    Scand J Urol. 2020;54:277-280.
    Abstract     Related articles   

  742. TAKAMA H, Shibata T, Ando Y, Yanagishita T, et al
    Pembrolizumab-induced psoriasis vulgaris successfully treated with apremilast.
    Eur J Dermatol. 2020;30:188-190.
    Abstract     Related articles   

  743. TAN WS, Wang Y, Trinh QD, Preston MA, et al
    Delayed blood transfusion is associated with mortality following radical cystectomy.
    Scand J Urol. 2020;54:290-296.
    Abstract     Related articles   

  744. DEUKER M, Franziska Stolzenbach L, Rosiello G, Luzzago S, et al
    Radical cystectomy improves survival in patients with stage T1 squamous cell carcinoma and neuroendocrine carcinoma of the urinary bladder.
    Eur J Surg Oncol. 2021;47:463-469.
    Abstract     Related articles   

  745. JIN YY, Tong SQ, Tong M
    Erdafitinib exerts the anticancer effect on urothelial carcinoma via induction of authophagy.
    Pharmazie. 2020;75:195-197.
    Abstract     Related articles   

  746. SHAHBAZ M, Ammar A, Wang Y, Farhaj Z, et al
    Endoclips as novel fiducial markers in trimodality bladder-preserving therapy of muscle-invasive bladder carcinoma: feasibility and patient outcomes.
    Int Braz J Urol. 2021;47:93-99.
    Abstract     Related articles   

  747. WU WR, Lin JT, Pan CT, Chan TC, et al
    Amplification-driven BCL6-suppressed cytostasis is mediated by transrepression of FOXO3 and post-translational modifications of FOXO3 in urinary bladder urothelial carcinoma.
    Theranostics. 2020;10:707-724.
    Abstract     Related articles   

  748. LIN C, Yuan H, Wang W, Zhu Z, et al
    Importance of PNO1 for growth and survival of urinary bladder carcinoma: Role in core-regulatory circuitry.
    J Cell Mol Med. 2020;24:1504-1515.
    Abstract     Related articles   

  749. KOCAN H, Kadihasanoglu M
    Age and sex do not affect first year recurrence in patients with non-muscle invasive bladder cancer.
    Folia Med (Plovdiv). 2021;63:242-246.
    Abstract     Related articles   

  750. CHEN S, Jiang L, Zheng X, Shao J, et al
    Clinical use of machine learning-based patho-mics signature for diagnosis and survival prediction of bladder cancer.
    Cancer Sci. 2021 May 1. doi: 10.1111/cas.14927.
    Abstract     Related articles   

  751. WANG S, Cai J, Zhang S, Dong M, et al
    Loss of polarity protein Par3, via transcription factor Snail, promotes bladder cancer metastasis.
    Cancer Sci. 2021 May 1. doi: 10.1111/cas.14920.
    Abstract     Related articles   

  752. ZHU W, Gao F, Zhou H, Jin K, et al
    Knockdown of MCM8 inhibits development and progression of bladder cancer in vitro and in vivo.
    Cancer Cell Int. 2021;21:242.
    Abstract     Related articles   

  753. ZHANG SF, Pang S, Wang FP, Li XY, et al
    Long noncoding RNA OIP5-AS1 exhibits oncogenic activity in bladder cancer through miR-217 and MTDH.
    Eur Rev Med Pharmacol Sci. 2021;25:3211-3220.
    Abstract     Related articles   

  754. GUNDOGAN C, Tatar G, Erkan E, Cakir MS, et al
    The impact of IV contrast enhanced (18)F-FDG PET/CT on the staging of bladder cancer.
    Hell J Nucl Med. 2021;24:75-82.
    Abstract     Related articles   

  755. SYMON N, Mattout J, Lewin R, Hammer L, et al
    Is Ultra Hypofractionated Radiation Therapy a Safe and Effective Treatment for Invasive Bladder Cancer in the Elderly?: A Retrospective Single Institution Review.
    Am J Clin Oncol. 2021 Apr 29. pii: 00000421-900000000-98571.
    Abstract     Related articles   

  756. ZHOU C, Li AH, Liu S, Sun H, et al
    Identification of an 11-Autophagy-Related-Gene Signature as Promising Prognostic Biomarker for Bladder Cancer Patients.
    Biology (Basel). 2021;10.
    Abstract     Related articles   

  757. ROSE M, Noetzel E, Kistermann J, Eschenbruch J, et al
    The ECM Modulator ITIH5 Affects Cell Adhesion, Motility and Chemotherapeutic Response of Basal/Squamous-Like (BASQ) Bladder Cancer Cells.
    Cells. 2021;10.
    Abstract     Related articles   

  758. TING HK, Chen CL, Meng E, Cherng JH, et al
    Inflammatory Regulation by TNF-alpha-Activated Adipose-Derived Stem Cells in the Human Bladder Cancer Microenvironment.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  759. LIN JT, Tsai KW
    Circulating miRNAs Act as Diagnostic Biomarkers for Bladder Cancer in Urine.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  760. KLEIN FG, Granier C, Zhao Y, Pan Q, et al
    Combination of Talazoparib and Palbociclib as a Potent Treatment Strategy in Bladder Cancer.
    J Pers Med. 2021;11.
    Abstract     Related articles   

  761. WIGNER P, Grebowski R, Bijak M, Saluk-Bijak J, et al
    The Interplay between Oxidative Stress, Inflammation and Angiogenesis in Bladder Cancer Development.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  762. MALKIEWICZ B, Kielb P, Gurwin A, Knecht K, et al
    The Usefulness of Lymphadenectomy in Bladder Cancer-Current Status.
    Medicina (Kaunas). 2021;57.
    Abstract     Related articles   

  763. WU YS, Ho JY, Yu CP, Cho CJ, et al
    Ellagic Acid Resensitizes Gemcitabine-Resistant Bladder Cancer Cells by Inhibiting Epithelial-Mesenchymal Transition and Gemcitabine Transporters.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  764. ZHANG X, Taoka R, Liu D, Matsuoka Y, et al
    Knockdown of RRM1 with Adenoviral shRNA Vectors to Inhibit Tumor Cell Viability and Increase Chemotherapeutic Sensitivity to Gemcitabine in Bladder Cancer Cells.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  765. LUCZYKOWSKI K, Warmuzinska N, Operacz S, Stryjak I, et al
    Metabolic Evaluation of Urine from Patients Diagnosed with High Grade (HG) Bladder Cancer by SPME-LC-MS Method.
    Molecules. 2021;26.
    Abstract     Related articles   

  766. MAMOUNI K, Kim J, Lokeshwar BL, Kallifatidis G, et al
    ARRB1 Regulates Metabolic Reprogramming to Promote Glycolysis in Stem Cell-Like Bladder Cancer Cells.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  767. MARTINEZ-ROJO E, Berumen LC, Garcia-Alcocer G, Escobar-Cabrera J, et al
    The Role of Androgens and Androgen Receptor in Human Bladder Cancer.
    Biomolecules. 2021;11.
    Abstract     Related articles   

  768. HERRMANN J, Schmidt H, Nitschke K, Weis CA, et al
    RNA Expression of DNA Damage Response Genes in Muscle-Invasive Bladder Cancer: Influence on Outcome and Response to Adjuvant Cisplatin-Based Chemotherapy.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  769. FORSTER S, Givehchi M, Nitschke K, Mayr T, et al
    Neuropilin-2 and Its Transcript Variants Correlate with Clinical Outcome in Bladder Cancer.
    Genes (Basel). 2021;12.
    Abstract     Related articles   

  770. TULCHINER G, Staudacher N, Fritz J, Radmayr C, et al
    The "COVID-19 Pandemic Gap" and Its Influence on Oncologic Outcomes of Bladder Cancer.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  771. CHARPENTIER M, Gutierrez C, Guillaudeux T, Verhoest G, et al
    Noninvasive Urine-Based Tests to Diagnose or Detect Recurrence of Bladder Cancer.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  772. GAVRIEL CG, Dimitriou N, Brieu N, Nearchou IP, et al
    Assessment of Immunological Features in Muscle-Invasive Bladder Cancer Prognosis Using Ensemble Learning.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  773. JAIN P, Kathuria H, Momin M
    Clinical therapies and nano drug delivery systems for urinary bladder cancer.
    Pharmacol Ther. 2021 Apr 26:107871. doi: 10.1016/j.pharmthera.2021.107871.
    Abstract     Related articles   

  774. TAMABUCHI E, Fujimura T, Lyu C, Aiba S, et al
    Phosphor-signal transducers and activator of transcription (pSTAT)1 signaling in mucosal lichen planus developing from metastatic bladder cancer treated with pembrolizumab.
    Dermatol Ther. 2021 Apr 28:e14961. doi: 10.1111/dth.14961.
    Abstract     Related articles   

  775. ABDELGHANI KB, Nacef L, Miladi S, Sellami M, et al
    Reactive Arthritis following Bacillus Calmette-Guerin Therapy for Bladder Cancer: a Systematic Literature Review.
    Curr Rheumatol Rep. 2021;23:39.
    Abstract     Related articles   

  776. YAVAS G, Yavas C, Arslan G, Onal C, et al
    Comment on Hunt et al, "Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer".
    Clin Transl Radiat Oncol. 2021;28:88-89.
    Abstract     Related articles   

  777. KITAGAWA K, Shigemura K, Ishii A, Nakashima T, et al
    Nanaomycin K inhibited epithelial mesenchymal transition and tumor growth in bladder cancer cells in vitro and in vivo.
    Sci Rep. 2021;11:9217.
    Abstract     Related articles   

  778. HARADA J, Miyata Y, Araki K, Matsuda T, et al
    Pathological Significance and Prognostic Roles of Thrombospondin-3, 4 and 5 in Bladder Cancer.
    In Vivo. 2021;35:1693-1701.
    Abstract     Related articles   

  779. KELLONIEMI E, Jarvinen R, Hellstrom P, Rintala E, et al
    Repeated 5-aminolevulinic Acid Instillations During Follow-up in Non-muscle-invasive Bladder Cancer: A Randomized Study.
    In Vivo. 2021;35:1561-1568.
    Abstract     Related articles   

  780. BOTHIG R, Tiburtius C, Schops W, Zellner M, et al
    Urinary bladder cancer as a late sequela of traumatic spinal cord injury.
    Mil Med Res. 2021;8:29.
    Abstract     Related articles   

  781. DE JONG JJ, Stoop H, Boormans JL, van Leenders GJLH, et al
    PD-L1 expression in urothelial bladder cancer varies more among specimen types than between companion assays.
    Virchows Arch. 2021 Apr 28. pii: 10.1007/s00428-021-03094.
    Abstract     Related articles   

  782. LI S, Liang P, Wang Y, Feng C, et al
    Combining volumetric apparent diffusion coefficient histogram analysis with vesical imaging reporting and data system to predict the muscle invasion of bladder cancer.
    Abdom Radiol (NY). 2021 Apr 28. pii: 10.1007/s00261-021-03091.
    Abstract     Related articles   

  783. XU T, Rao T, Yu WM, Ning JZ, et al
    Upregulation of NFKBIZ affects bladder cancer progression via the PTEN/PI3K/Akt signaling pathway.
    Int J Mol Med. 2021;47.
    Abstract     Related articles   

  784. FABIANO E, Durdux C, Dufour B, Mejean A, et al
    Long-term outcomes after bladder-preserving tri-modality therapy for patients with muscle-invasive bladder cancer.
    Acta Oncol. 2021 Apr 27:1-9. doi: 10.1080/0284186X.2021.1915498.
    Abstract     Related articles   

  785. YANG Y, Jiang D, Zhou Z, Xiong H, et al
    CDK7 blockade suppresses super-enhancer-associated oncogenes in bladder cancer.
    Cell Oncol (Dordr). 2021 Apr 27. pii: 10.1007/s13402-021-00608.
    Abstract     Related articles   

  786. MOHD ARIFFIN K, Abd Ghani F, Hussin H, Md Said S, et al
    Hedgehog signalling molecule, SMO is a poor prognostic marker in bladder cancer.
    Malays J Pathol. 2021;43:49-54.
    Abstract     Related articles   

  787. RUAN W, Chen X, Huang M, Wang H, et al
    A urine-based DNA methylation assay to facilitate early detection and risk stratification of bladder cancer.
    Clin Epigenetics. 2021;13:91.
    Abstract     Related articles   

  788. XIONG Y, Zu X, Wang L, Li Y, et al
    The VIM-AS1/miR-655/ZEB1 axis modulates bladder cancer cell metastasis by regulating epithelial-mesenchymal transition.
    Cancer Cell Int. 2021;21:233.
    Abstract     Related articles   

  789. YANG Y, Zhang H, Liu Z, Zhao F, et al
    EPDR1 is related to stages and metastasize in bladder cancer and can be used as a prognostic biomarker.
    BMC Urol. 2021;21:71.
    Abstract     Related articles   

  790. OWARI T, Iwamoto T, Anai S, Miyake M, et al
    The Sustaining of fluorescence in photodynamic diagnosis after the administration of 5-aminolevulinic acid in carcinogen-induced bladder cancer orthotopic rat model and urothelial cancer cell lines.
    Photodiagnosis Photodyn Ther. 2021 Apr 23:102309.
    Abstract     Related articles   

  791. ARSLAN O, Soylu NK, Akillilar PT, Tazebay UH, et al
    Coiled-coil domain-containing protein-124 (Ccdc124) is a novel RNA binding factor up-regulated in endometrial, ovarian, and urinary bladder cancers.
    Cancer Biomark. 2021 Mar 26. pii: CBM200802. doi: 10.3233/CBM-200802.
    Abstract     Related articles   

  792. SINGH S, Goel S, Iqbal A
    Anatomical segment 4b/5 resection for gall bladder cancer using intraoperative ultrasound.
    J Visc Surg. 2021 Apr 22. pii: S1878-7886(21)00060.
    Abstract     Related articles   

  793. SUN R, Zhang J, Chen L, Zhang N, et al
    Punica granatum Extract Inhibits Bladder Cancer Cell Viability, Invasion and Migration through Down-Regulation of HOXD10 Signalling Pathway.
    Dokl Biochem Biophys. 2021;497:130-136.
    Abstract     Related articles   

  794. KUTWIN P, Borkowska EM, Bogucka P, Jablonowski Z, et al
    Expression profile of microRNAs (106b-3p, 130b-3, 145-3p, 199a-5p) in urine and serum samples from patients with the diagnosis of bladder cancer.
    Pol Merkur Lekarski. 2021;49:103-107.
    Abstract     Related articles   

  795. LOEFFLER CML, Ortiz Bruechle N, Jung M, Seillier L, et al
    Artificial Intelligence-based Detection of FGFR3 Mutational Status Directly from Routine Histology in Bladder Cancer: A Possible Preselection for Molecular Testing?
    Eur Urol Focus. 2021 Apr 21. pii: S2405-4569(21)00113.
    Abstract     Related articles   

  796. MAO M, Yang L, Hu J, Liu B, et al
    OCT3/4 enhances tumor immune response by upregulating the TET1-dependent NRF2/MDM2 axis in bladder cancer.
    Genomics. 2021 Apr 21. pii: S0888-7543(21)00166.
    Abstract     Related articles   



  797. Aktuelle Urol. 2021;52:118-120.
    Abstract     Related articles   



  798. Aktuelle Urol. 2021;52:112-114.
    Abstract     Related articles   

  799. WEZEL F, Lustig J, Azoitei A, Liu J, et al
    Grainyhead-Like 3 Influences Migration and Invasion of Urothelial Carcinoma Cells.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  800. SCHOLTES MP, Alberts AR, Ifle IG, Verhagen PCMS, et al
    Biomarker-Oriented Therapy in Bladder and Renal Cancer.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  801. ZHANG J, Deng X
    Effects of miR-599 targeting YAP1 on proliferation, invasion and apoptosis of bladder urothelial carcinoma cells.
    Exp Mol Pathol. 2021;118:104599.
    Abstract     Related articles   

  802. HUANG XZ, Zhou AY, Liu MW, Zhang Y, et al
    Shear Wave Elasticity Differentiation Between Low- and High-Grade Bladder Urothelial Carcinoma and Correlation With Collagen Fiber Content.
    J Ultrasound Med. 2021;40:113-122.
    Abstract     Related articles   

  803. STAKHOVSKYI O, Tymoshenko A, Voilenko capital O, Cyrillic, Kononenko O, et al
    ILEOSIGMOID POUCH AS A URINARY DIVERSION APPROACH FOLLOWING RADICAL CYSTECTOMY IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER.
    Georgian Med News. 2021;:36-42.
    Abstract     Related articles   

  804. LASHAY A, Taleghani S, Masoumi N
    Comparison of Single Monthly Instillations of Intra-Vesical Bacillus Calmette-Guerin Maintenance Therapy with Southwest Oncology Group Regimen in Non-Muscle Invasive Bladder Cancer Patients-A Retrospective Analysis In a Single Institute.
    Urol J. 2021 May 8. pii: 6491. doi: 10.22037/uj.v18i.6491.
    Abstract     Related articles   

  805. TUMEDEI MM, Ravaioli S, Matteucci F, Celli M, et al
    Spotlight on PSMA as a new theranostic biomarker for bladder cancer.
    Sci Rep. 2021;11:9777.
    Abstract     Related articles   

  806. MAAS M, Rausch S, Guttenberg T, Seiler R, et al
    Receptor Activator of NF Kappa B (RANK) Expression Indicates Favorable Prognosis in Patients with Muscle-invasive Bladder Cancer.
    Eur Urol Focus. 2021 May 4. pii: S2405-4569(21)00121.
    Abstract     Related articles   

  807. WU Q, Zhou X, Li P, Ding M, et al
    ROC1 promotes the malignant progression of bladder cancer by regulating p-IkappaBalpha/NF-kappaB signaling.
    J Exp Clin Cancer Res. 2021;40:158.
    Abstract     Related articles   

  808. SUN X, Zhou Z, Zhang Y, Wang J, et al
    Identification and validation of a hypoxia-related prognostic and immune microenvironment signature in bladder cancer.
    Cancer Cell Int. 2021;21:251.
    Abstract     Related articles   

  809. ZHANG J, Zhang C, Cao P, Zheng X, et al
    A zinc finger protein gene signature enables bladder cancer treatment stratification.
    Aging (Albany NY). 2021;13.
    Abstract     Related articles   

  810. DAI ZT, Xiang Y, Wang Y, Bao LY, et al
    Prognostic value of members of NFAT family for pan-cancer and a prediction model based on NFAT2 in bladder cancer.
    Aging (Albany NY). 2021;13.
    Abstract     Related articles   

  811. CAO R, Ma B, Wang G, Xiong Y, et al
    Identification of autophagy-related genes signature predicts chemotherapeutic and immunotherapeutic efficiency in bladder cancer (BLCA).
    J Cell Mol Med. 2021 May 7. doi: 10.1111/jcmm.16552.
    Abstract     Related articles   

  812. JIN F, Shahid M, Kim J
    Research Progress of Urine Biomarkers in the Diagnosis, Treatment, and Prognosis of Bladder Cancer.
    Adv Exp Med Biol. 2021;1306:61-80.
    Abstract     Related articles   

  813. LI S, Lu S, Liu X, Chen X, et al
    Association Between the Pretreatment Albumin-to-Alkaline Phosphatase Ratio and Clinical Outcomes in Patients With Bladder Cancer Treated With Radical Cystectomy: A Retrospective Cohort Study.
    Front Oncol. 2021;11:664392.
    Abstract     Related articles   

  814. SONPAVDE GP
    Management of Bladder Cancer: The First Inning of a New Era of Rapid Advances.
    Hematol Oncol Clin North Am. 2021;35:xiii-xx.
    Abstract     Related articles   

  815. BANGS R, Quale DZ
    Future Directions in Bladder Cancer Treatment and Research-The Patient Advocates' Perspective.
    Hematol Oncol Clin North Am. 2021;35:655-664.
    Abstract     Related articles   

  816. GUERCIO BJ, Iyer G, Rosenberg JE
    Developing Precision Medicine for Bladder Cancer.
    Hematol Oncol Clin North Am. 2021;35:633-653.
    Abstract     Related articles   

  817. ZHU S, Zhu Z, Ma AH, Sonpavde GP, et al
    Preclinical Models for Bladder Cancer Research.
    Hematol Oncol Clin North Am. 2021;35:613-632.
    Abstract     Related articles   

  818. PFAIL JL, Small AC, Cumarasamy S, Galsky MD, et al
    Real World Outcomes of Patients with Bladder Cancer: Effectiveness Versus Efficacy of Modern Treatment Paradigms.
    Hematol Oncol Clin North Am. 2021;35:597-612.
    Abstract     Related articles   

  819. THIBAULT C, Loriot Y
    Emerging Targeted Therapy for Bladder Cancer.
    Hematol Oncol Clin North Am. 2021;35:585-596.
    Abstract     Related articles   

  820. KONIECZKOWSKI DJ, Efstathiou JA, Mouw KW
    Contemporary and Emerging Approaches to Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer.
    Hematol Oncol Clin North Am. 2021;35:567-584.
    Abstract     Related articles   

  821. AHMADI H, Duddalwar V, Daneshmand S
    Diagnosis and Staging of Bladder Cancer.
    Hematol Oncol Clin North Am. 2021;35:531-541.
    Abstract     Related articles   

  822. BREE KK, Brooks NA, Kamat AM
    Current Therapy and Emerging Intravesical Agents to Treat Non-Muscle Invasive Bladder Cancer.
    Hematol Oncol Clin North Am. 2021;35:513-529.
    Abstract     Related articles   

  823. MA J, Black PC
    Current Perioperative Therapy for Muscle Invasive Bladder Cancer.
    Hematol Oncol Clin North Am. 2021;35:495-511.
    Abstract     Related articles   

  824. MCCONKEY DJ
    Molecular Biology of Bladder Cancer: Potential Implications for Therapy.
    Hematol Oncol Clin North Am. 2021;35:457-468.
    Abstract     Related articles   

  825. MOSSANEN M
    The Epidemiology of Bladder Cancer.
    Hematol Oncol Clin North Am. 2021;35:445-455.
    Abstract     Related articles   

  826. ALLEN BC, Oto A, Akin O, Alexander LF, et al
    ACR Appropriateness Criteria(R) Post-Treatment Surveillance of Bladder Cancer: 2021 Update.
    J Am Coll Radiol. 2021;18.
    Abstract     Related articles   

  827. SUN H, Ou T, Hu J, Yang Z, et al
    Nitazoxanide impairs mitophagy flux through ROS-mediated mitophagy initiation and lysosomal dysfunction in bladder cancer.
    Biochem Pharmacol. 2021 May 3:114588. doi: 10.1016/j.bcp.2021.114588.
    Abstract     Related articles   

  828. KABHA A, Bukchin-Tihomirov A, Shlomi I, Ammar AA, et al
    Biodegradable Controlled-Release Device for Localized Chemotherapeutic Treatment of Bladder Cancer.
    ACS Biomater Sci Eng. 2021 May 6. doi: 10.1021/acsbiomaterials.1c00339.
    Abstract     Related articles   

  829. JEONG H, Park KJ, Lee YJ, Kim HD, et al
    The Prognosis and the Role of Adjuvant Chemotherapy for Node-Positive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by Surgery.
    Cancer Res Treat. 2021 May 6. pii: crt.2021.365. doi: 10.4143/crt.2021.
    Abstract     Related articles   

  830. WU H, Zhang ZY, Zhang Z, Xiao XY, et al
    Prediction of bladder cancer outcome by identifying and validating a mutation-derived genomic instability-associated long noncoding RNA (lncRNA) signature.
    Bioengineered. 2021;12:1725-1738.
    Abstract     Related articles   

  831. FUKUI-KAWAURA S, Kawahara T, Araki Y, Nishimura R, et al
    A higher De Ritis ratio (AST/ALT) is a risk factor for progression in high-risk non-muscle invasive bladder cancer.
    Oncotarget. 2021;12:917-922.
    Abstract     Related articles   

  832. KIM MH, Yang GE, Jeong MS, Mun JY, et al
    VNTR polymorphism in the breakpoint region of ABL1 and susceptibility to bladder cancer.
    BMC Med Genomics. 2021;14:121.
    Abstract     Related articles   

  833. SONG H, Zeng J, Lele S, LaGrange CA, et al
    APE1 and SSRP1 is overexpressed in muscle invasive bladder cancer and associated with poor survival.
    Heliyon. 2021;7:e06756.
    Abstract     Related articles   

  834. WANG X, Qiao G, Jiang N, Morse MA, et al
    Serial assessment of circulating T lymphocyte phenotype and receptor repertoire during treatment of non-muscle invasive bladder cancer with adoptive T cell immunotherapy.
    Am J Cancer Res. 2021;11:1709-1718.
    Abstract     Related articles   

  835. MELO MN, Pereira FM, Rocha MA, Ribeiro JG, et al
    Chitosan and chitosan/PEG nanoparticles loaded with indole-3-carbinol: Characterization, computational study and potential effect on human bladder cancer cells.
    Mater Sci Eng C Mater Biol Appl. 2021;124:112089.
    Abstract     Related articles   

  836. NAGUMO Y, Kandori S, Tanuma K, Nitta S, et al
    PLD1 promotes tumor invasion by regulation of MMP-13 expression via NF-kappaB signaling in bladder cancer.
    Cancer Lett. 2021;511:15-25.
    Abstract     Related articles   

  837. LIU Y, Wang G, Cui T, Lv L, et al
    Adhesion GPR123 is an indicator for recurrence and prognosis in bladder cancer.
    Genes Genomics. 2021 May 4. pii: 10.1007/s13258-021-01108.
    Abstract     Related articles   

  838. BOCCHIALINI T, Ziglioli F, Palmieri G, Barbieri A, et al
    Mullerianosis of the urinary bladder may simulate a bladder cancer: a case report.
    Acta Biomed. 2021;92.
    Abstract     Related articles   

  839. RAZZAGHDOUST A, Ghajari M, Basiri A, Torbati PM, et al
    Association of immunohistochemical markers of tumor subtype with response to neoadjuvant chemotherapy and survival in patients with muscle-invasive bladder cancer.
    Investig Clin Urol. 2021;62:274-281.
    Abstract     Related articles   

  840. PELEGRIN-MATEO FJ, Segui-Moya E, Fernandez-Cruz M, Garcia-Segui A, et al
    [Bladder paraganglioma: Report of two cases and a literature review.]
    Arch Esp Urol. 2021;74:445-449.
    Abstract     Related articles   

  841. MARTINEZ RODRIGUEZ R, Portilla Mediavilla L, Alves Oliveira M, Elias X, et al
    [Can a single value of a perypheric inflammatory response marker predict the response to BCG?]
    Arch Esp Urol. 2021;74:404-410.
    Abstract     Related articles   

  842. DIZMAN N, Meza L, Pal SK
    Biomarker approach harnessed in trials of personalized medicine for bladder cancer.
    Nat Med. 2021 May 3. pii: 10.1038/s41591-021-01300.
    Abstract     Related articles   

  843. BHINDI B, Kool R, Kulkarni GS, Siemens DR, et al
    Canadian Urological Association guideline on the management of non-muscle invasive bladder cancer.
    Can Urol Assoc J. 2021 Apr 26. pii: cuaj.7367. doi: 10.5489/cuaj.7367.
    Abstract     Related articles   

  844. WAN S, Liu X, Hua W, Xi M, et al
    The role of telomerase reverse transcriptase (TERT) promoter mutations in prognosis in bladder cancer.
    Bioengineered. 2021;12:1495-1504.
    Abstract     Related articles   

  845. ZHANG LH, Li LQ, Zhan YH, Zhu ZW, et al
    Identification of an IRGP Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer.
    Front Mol Biosci. 2021;8:607090.
    Abstract     Related articles   

  846. CHEN X, Chen H, He D, Cheng Y, et al
    Analysis of Tumor Microenvironment Characteristics in Bladder Cancer: Implications for Immune Checkpoint Inhibitor Therapy.
    Front Immunol. 2021;12:672158.
    Abstract     Related articles   

  847. SUNG HH, Scherr DS, Slaton J, Liu H, et al
    Phase II multi-center trial of optical coherence tomography as an adjunct to white light cystoscopy for intravesical real time imaging and staging of bladder cancer.
    Urol Oncol. 2021 Apr 29. pii: S1078-1439(21)00136.
    Abstract     Related articles   

  848. XIA Y, Chen S, Cui J, Wang Y, et al
    Berberine suppresses bladder cancer cell proliferation by inhibiting JAK1-STAT3 signaling via upregulation of miR-17-5p.
    Biochem Pharmacol. 2021;188:114575.
    Abstract     Related articles   

  849. HUANG CP, Wu CC, Shyr CR
    Combination of novel intravesical xenogeneic urothelial cell immunotherapy and chemotherapy enhances anti-tumor efficacy in preclinical murine bladder tumor models.
    Cancer Immunol Immunother. 2021;70:1419-1433.
    Abstract     Related articles   

  850. KHADRAOUI W, Tymon-Rosario J, Nagarkatti N, Menderes G, et al
    Robotic Low Anterior Resection and Partial Bladder Resection for Management of Locoregional Endometrial Cancer Recurrence.
    J Minim Invasive Gynecol. 2021;28:176-177.
    Abstract     Related articles   

  851. WANG JZ, Zhu W, Han J, Yang X, et al
    The role of the HIF-1alpha/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer.
    Cancer Commun (Lond). 2021 May 15. doi: 10.1002/cac2.12158.
    Abstract     Related articles   

  852. CHENARD S, Robert Siemens D, Koti M
    The CXCR3alt-CXCL11 axis in bladder cancer: potential for prediction of neoadjuvant chemotherapy response.
    Cell Mol Immunol. 2021 May 14. pii: 10.1038/s41423-021-00692.
    Abstract     Related articles   

  853. SARGOS P, Baumann BC, Faye MD, Fonteyne V, et al
    A Tailored Radiation Therapy Strategy for Older Patients With Localized Bladder Cancer Not Eligible for Curative Treatment.
    Int J Radiat Oncol Biol Phys. 2021;110:425-428.
    Abstract     Related articles   

  854. HUANG H, Du J, Jin B, Pang L, et al
    Combination of Urine Exosomal mRNAs and lncRNAs as Novel Diagnostic Biomarkers for Bladder Cancer.
    Front Oncol. 2021;11:667212.
    Abstract     Related articles   

  855. ISONO M, Okubo K, Asano T, Sato A, et al
    Inhibition of checkpoint kinase 1 potentiates anticancer activity of gemcitabine in bladder cancer cells.
    Sci Rep. 2021;11:10181.
    Abstract     Related articles   

  856. SHINDE-JADHAV S, Mansure JJ, Rayes RF, Marcq G, et al
    Role of neutrophil extracellular traps in radiation resistance of invasive bladder cancer.
    Nat Commun. 2021;12:2776.
    Abstract     Related articles   

  857. TANG C, Yu M, Ma J, Zhu Y, et al
    Metabolic classification of bladder cancer based on multi-omics integrated analysis to predict patient prognosis and treatment response.
    J Transl Med. 2021;19:205.
    Abstract     Related articles   

  858. ZHENG Z, Zheng X, Zhu Y, Yao Z, et al
    IL-6 Promotes the Proliferation and Immunosuppressive Function of Myeloid-Derived Suppressor Cells via the MAPK Signaling Pathway in Bladder Cancer.
    Biomed Res Int. 2021;2021:5535578.
    Abstract     Related articles   

  859. ZHENG Z, Xu F, Gu Z, Yan Y, et al
    Integrating multiparametric MRI radiomics features and the Vesical Imaging-Reporting and Data System (VI-RADS) for bladder cancer grading.
    Abdom Radiol (NY). 2021 May 12. pii: 10.1007/s00261-021-03108.
    Abstract     Related articles   

  860. BITINA-BARLOTE E, Plonis J, Cauce V, Vjaters E, et al
    Bladder cancer trends in Latvia during 1990-2017: incidence, mortality, and survival rates.
    Cent European J Urol. 2021;74:14-23.
    Abstract     Related articles   

  861. GREEN EA, Li R, Albiges L, Choueiri TK, et al
    Clinical Utility of Cell-free and Circulating Tumor DNA in Kidney and Bladder Cancer: A Critical Review of Current Literature.
    Eur Urol Oncol. 2021 May 8. pii: S2588-9311(21)00079.
    Abstract     Related articles   

  862. LU Q, Cai P, Yu Y, Liu Z, et al
    Sema4D correlates with tumour immune infiltration and is a prognostic biomarker in bladder cancer, renal clear cell carcinoma, melanoma and thymoma.
    Autoimmunity. 2021 May 11:1-9. doi: 10.1080/08916934.2021.1925885.
    Abstract     Related articles   

  863. GENG H, Zhou Q, Guo W, Lu L, et al
    Exosomes in bladder cancer: novel biomarkers and targets.
    J Zhejiang Univ Sci B. 2021;22:341-347.
    Abstract     Related articles   

  864. MILLERICK-MAY ML, Wang L, Rice C, Rosenman KD, et al
    Ongoing risk of bladder cancer among former workers at the last benzidine manufacturing facility in the USA.
    Occup Environ Med. 2021 May 10. pii: oemed-2020-106431.
    Abstract     Related articles   

  865. DEUKER M, Krimphove MJ, Stolzenbach LF, Colla Ruvolo C, et al
    Radical Cystectomy vs. Multimodality Treatment in T2N0M0 Bladder Cancer: A Population-based, Age-matched Analysis.
    Clin Genitourin Cancer. 2021 Apr 8. pii: S1558-7673(21)00073.
    Abstract     Related articles   

  866. GARG T, Johns A, Young AJ, Nielsen ME, et al
    Geriatric conditions and treatment burden following diagnosis of non-muscle- invasive bladder Cancer in older adults: A population-based analysis.
    J Geriatr Oncol. 2021 May 7. pii: S1879-4068(21)00104.
    Abstract     Related articles   

  867. BAUMANN BC, Zaghloul MS, Sargos P, Murthy V, et al
    Adjuvant and Neoadjuvant Radiation Therapy for Locally Advanced Bladder Cancer.
    Clin Oncol (R Coll Radiol). 2021;33:391-399.
    Abstract     Related articles   

  868. KONG V, Hansen VN, Hafeez S
    Image-guided Adaptive Radiotherapy for Bladder Cancer.
    Clin Oncol (R Coll Radiol). 2021;33:350-368.
    Abstract     Related articles   

  869. URABE F, Kimura T, Ito K, Yamamoto Y, et al
    Urinary extracellular vesicles: a rising star in bladder cancer management.
    Transl Androl Urol. 2021;10:1878-1889.
    Abstract     Related articles   

  870. PING Q, Shi Y, Yang M, Li H, et al
    LncRNA DANCR regulates lymphatic metastasis of bladder cancer via the miR-335/VEGF-C axis.
    Transl Androl Urol. 2021;10:1743-1753.
    Abstract     Related articles   

  871. POPOV H, Kobakova I, Stoyanov GS, Softova E, et al
    Quantitative Analysis of Tumor-Associated Mast Cells in Recurrent and Non-recurrent Urothelial Bladder Cancer in Stage pTa and pT1.
    Cureus. 2021;13:e14311.
    Abstract     Related articles   

  872. MIR MC, Campi R, Loriot Y, Puente J, et al
    Adjuvant Systemic Therapy for High-risk Muscle-invasive Bladder Cancer After Radical Cystectomy: Current Options and Future Opportunities.
    Eur Urol Oncol. 2021 May 6. pii: S2588-9311(21)00078.
    Abstract     Related articles   

  873. DE NUNZIO C, Franco A, Simone G, Tuderti G, et al
    Validation of the COBRA nomogram for the prediction of cancer specific survival in patients treated with radical cystectomy for bladder cancer: An international wide cohort study.
    Eur J Surg Oncol. 2021 Apr 30. pii: S0748-7983(21)00466.
    Abstract     Related articles   

  874. ALANEE S, Sana S, El-Zawahry A, Peabody J, et al
    Phase I trial of intravesical Bacillus Calmette-Guerin combined with intravenous pembrolizumab in recurrent or persistent high-grade non-muscle-invasive bladder cancer after previous Bacillus Calmette-Guerin treatment.
    World J Urol. 2021 May 8. pii: 10.1007/s00345-021-03716.
    Abstract     Related articles   

  875. GVOZDEV MY, Arefyeva OA, Dzhuraeva MD
    [linical case: enterocele after radical cystectomy with heterotopic bladder plastic surgery].
    Urologiia. 2021;:90-93.
    Abstract     Related articles   

  876. MAESAKA F, Momose H, Nakahama T, Yamada A, et al
    [A Case of Bladder Squamous Cell Carcinoma with Neurogenic Bladder Caused by Myelomeningocele].
    Hinyokika Kiyo. 2021;67:103-107.
    Abstract     Related articles   

  877. CITO G, Santi R, Gemma L, Galli IC, et al
    Angiosarcoma of the Urinary Bladder Following Radiotherapy: Report of a Case and Review of the Literature.
    Medicina (Kaunas). 2021;57.
    Abstract     Related articles   

  878. VARSHNEY B, Choudhary GR, Yadav T, Nalwa A, et al
    Sarcomatoid urothelial carcinoma of the bladder with osseous metaplasia: bone in urinary bladder.
    BMJ Case Rep. 2021;14.
    Abstract     Related articles   

  879. DING Y, Liu N, Chen M, Xu Y, et al
    Overexpressed pseudogene MT1L associated with tumor immune infiltrates and indicates a worse prognosis in BLCA.
    World J Surg Oncol. 2021;19:133.
    Abstract     Related articles   

  880. BUTEA-BOCU MC, Muller G, Brock O, Otto U, et al
    [Metabolic acidosis in neobladder patients : Risk factors and treatment options].
    Urologe A. 2021;60:617-623.
    Abstract     Related articles   

  881. VAN ALLEN J
    A rare case of urachal adenocarcinoma with bone marrow metastasis.
    BMJ Case Rep. 2021;14.
    Abstract     Related articles   

  882. KUMAR S, Thummala Y, Parmar KM, Chandna A, et al
    Bacillus Calmette-Guerin (BCG)-induced balanitis following intravesical immunotherapy for urothelial cancer.
    BMJ Case Rep. 2021;14.
    Abstract     Related articles   

  883. CHENG R, Liu X, Wang Z, Tang K, et al
    ABT737, a Bcl2 family inhibitor, has a synergistic effect with apoptosis by inducing urothelial carcinoma cell necroptosis.
    Mol Med Rep. 2021;23.
    Abstract     Related articles   

  884. CHAUDHARY K, Pareek T, Sharma A, Thirunavukkarasu B, et al
    Lipid-rich variant of urothelial carcinoma: a lethal enigma.
    BMJ Case Rep. 2021;14.
    Abstract     Related articles   

  885. SHAO K, Zhou Z, Xun P, Cohen SM, et al
    Bayesian benchmark dose analysis for inorganic arsenic in drinking water associated with bladder and lung cancer using epidemiological data.
    Toxicology. 2021;455:152752.
    Abstract     Related articles   

  886. YANG L, Zou X, Zou J, Zhang G, et al
    Functions of circular RNAs in bladder, prostate and renal cell cancer (Review).
    Mol Med Rep. 2021;23.
    Abstract     Related articles   

  887. WANG S, Jin S, Li G, Xu M, et al
    Transmucosal Delivery of Self-Assembling Photosensitizer-Nitazoxanide Nanocomplexes with Fluorinated Chitosan for Instillation-Based Photodynamic Therapy of Orthotopic Bladder Tumors.
    ACS Biomater Sci Eng. 2021;7:1485-1495.
    Abstract     Related articles   

  888. HOWE AS, Pearce J, Lian F, Ribbons L, et al
    A Case of Ewing Sarcoma of the Bladder Presenting in Early Infancy.
    J Pediatr Hematol Oncol. 2021;43:e478-e480.
    Abstract     Related articles   

  889. RAPISARDA S, Bada M, Polara A, Crocetto F, et al
    Conservative management of primary malignant melanoma of the bladder: a case report.
    J Med Case Rep. 2021;15:39.
    Abstract     Related articles   

  890. MATZEN M, Offermann A, Tharun L, Perner S, et al
    [Intravesical Gemcitabine instillations following BCG failure and allergy to Mitomycin: A unique case of a patient with an inverted papilloma of the bladder].
    Aktuelle Urol. 2021;52:43-46.
    Abstract     Related articles   

  891. REXER H, Retz M, Kramer M

    Aktuelle Urol. 2021;52:28-29.
    Abstract     Related articles   

  892. DENG M, Wei W, Duan J, Chen R, et al
    ZHX3 promotes the progression of urothelial carcinoma of the bladder via repressing of RGS2 and is a novel substrate of TRIM21.
    Cancer Sci. 2021;112:1758-1771.
    Abstract     Related articles   

  893. MIYAKAWA J, Kawai T, Makino K, Akiyama Y, et al
    Impact of age, body mass index, and renal function for severe hypotension caused by oral 5-aminolevulinic acid administration in patients undergoing transurethral resection of bladder tumor.
    Photodiagnosis Photodyn Ther. 2021;33:102179.
    Abstract     Related articles   

  894. REYNOLDS BR, McCombie S, Botha E, Hawks C, et al
    Ten-year outcomes of the first 'one-stop haematuria clinic' in an Australian public hospital.
    ANZ J Surg. 2021;91:565-570.
    Abstract     Related articles   

  895. LIU H, Mei C, Deng X, Lin W, et al
    Rapid visualizing and pathological grading of bladder tumor tissues by simple nanodiagnostics.
    Biomaterials. 2021;264:120434.
    Abstract     Related articles   

  896. RAVI P, Sonpavde GP
    Considerations in prescribing pharmacotherapy for localized and metastatic urothelial carcinoma.
    Expert Opin Pharmacother. 2021;22:1-4.
    Abstract     Related articles   

  897. UENO Y, Tamada T, Takeuchi M, Sofue K, et al
    Vesicle Imaging and Data Reporting System (VI-RADS): Multi-institutional multi-reader diagnostic accuracy and inter-observer agreement study.
    AJR Am J Roentgenol. 2020 Jul 29. doi: 10.2214/AJR.20.23604.
    Abstract     Related articles   

  898. DRESSLER FF, Dogan S, Hennig M, Frank T, et al
    [Current practice patterns of perioperative cystectomy management in Germany: a questionnaire survey].
    Aktuelle Urol. 2021;52:82-87.
    Abstract     Related articles   

  899. LARENTZAKIS A, Eleftheriou MM, Zografos CG, Manolis IT, et al
    Cyclops' eye-like large ulcerated umbilical mass: a rare presentation of urachal cancer.
    ANZ J Surg. 2021;91.
    Abstract     Related articles   

  900. SPENCER K, Kim LH, Daly T, Lau H, et al
    'Ooosh' haematuria syndrome from eroded and kinked vascular graft in the bladder.
    ANZ J Surg. 2021;91.
    Abstract     Related articles   

  901. YOLDAS M, Turk H, Yoldas TK
    Clinical and pathological factors predictive of bladder cancer recurrence in patients with upper tract primary TCC.
    Niger J Clin Pract. 2021;24:774-777.
    Abstract     Related articles   

  902. CARY C, Militello L, DeChant P, Frankel R, et al
    Barriers to single-dose intravesical chemotherapy in non-muscle invasive bladder cancer: what's the problem?
    Urol Pract. 2021;8:291-297.
    Abstract     Related articles   

  903. BARRY E, Agalliu I, Maiman R, Shreck E, et al
    OUTCOMES OF INTRAVESICAL BACILLUS CALMETTE-GUERIN IN A MULTIRACIAL COHORT WITH NON-MUSCLE-INVASIVE BLADDER CANCER.
    Urol Pract. 2021;8:100-105.
    Abstract     Related articles   

  904. MOKHTAR A, Kong C, Zhang Z, Du Y, et al
    Down-regulation LncRNA-SNHG15 contributes to proliferation and invasion of bladder cancer cells.
    BMC Urol. 2021;21:83.
    Abstract     Related articles   

  905. LU XS, Huang ML, Chen LB, Liu SC, et al
    SCARA5 regulated by MEG3/miR-141 axis attenuates proliferation, migration and invasion of bladder cancer.
    Life Sci. 2021 May 17:119619. doi: 10.1016/j.lfs.2021.119619.
    Abstract     Related articles   

  906. WU J, Hu X, Wang X
    Comment to: Effectiveness of contrast-enhanced ultrasound for detecting the staging and grading of bladder cancer: a systematic review and meta-analysis.
    Med Ultrason. 2021;23:245-247.
    Abstract     Related articles   

  907. BUCHLER J, Gschwend JE, Retz M, Schmid SC, et al
    [Muscle-invasive bladder cancer].
    Urologe A. 2021 May 20. pii: 10.1007/s00120-021-01536.
    Abstract     Related articles   

  908. MAR N, Kalebasty AR
    Adjuvant pembrolizumab in genomically selected high-risk patients with muscle-invasive bladder cancer.
    J Oncol Pharm Pract. 2021 May 20:10781552211016526.
    Abstract     Related articles   

  909. GOYAL A, O'Leary D, Goyal K, Rubin N, et al
    Screening for second malignancies in mycosis fungoides: Non-Hodgkin lymphoma, Hodgkin lymphoma, lung cancer, bladder cancer, and melanoma.
    J Eur Acad Dermatol Venereol. 2021 May 20. doi: 10.1111/jdv.17384.
    Abstract     Related articles   

  910. LI X, Feng J, Sun Y, Li X, et al
    An Exploration of the Tumor Microenvironment Identified a Novel Five-Gene Model for Predicting Outcomes in Bladder Cancer.
    Front Oncol. 2021;11:642527.
    Abstract     Related articles   

  911. DUBOIS J, Rueger J, Haubold B, Far RK, et al
    Transcriptome analyses of urine RNA reveal tumor markers for human bladder cancer: validated amplicons for RT-qPCR-based detection.
    Oncotarget. 2021;12:1011-1023.
    Abstract     Related articles   

  912. DEL FAVERO G, Zeugswetter M, Kiss E, Marko D, et al
    Endoplasmic Reticulum Adaptation and Autophagic Competence Shape Response to Fluid Shear Stress in T24 Bladder Cancer Cells.
    Front Pharmacol. 2021;12:647350.
    Abstract     Related articles   

  913. GARRIS CS, Wong JL, Ravetch JV, Knorr DA, et al
    Dendritic cell targeting with Fc-enhanced CD40 antibody agonists induces durable antitumor immunity in humanized mouse models of bladder cancer.
    Sci Transl Med. 2021;13.
    Abstract     Related articles   

  914. CISAROVSKY C, Latifyan S, Perrinjaquet C, Berthold D, et al
    [Immunotherapy for bladder cancer in 2021].
    Rev Med Suisse. 2021;17:974-977.
    Abstract     Related articles   

  915. KAYAMA E, Shigeta K, Kikuchi E, Ogihara K, et al
    Guideline adherence for radical cystectomy significantly affects survival outcomes in non-muscle-invasive bladder cancer patients.
    Jpn J Clin Oncol. 2021 May 3. pii: 6261378. doi: 10.1093.
    Abstract     Related articles   

  916. GALSKY MD, Hoimes CJ, Necchi A, Shore N, et al
    Perioperative pembrolizumab therapy in muscle-invasive bladder cancer: Phase III KEYNOTE-866 and KEYNOTE-905/EV-303.
    Future Oncol. 2021 May 19. doi: 10.2217/fon-2021-0273.
    Abstract     Related articles   

  917. RICHTERS A, Meijer RP, Mehra N, Boormans JL, et al
    Prospective bladder cancer infrastructure for experimental and observational research on bladder cancer: study protocol for the 'trials within cohorts' study ProBCI.
    BMJ Open. 2021;11:e047256.
    Abstract     Related articles   

  918. LIU L, Cui J, Zhao Y, Liu X, et al
    KDM6A-ARHGDIB axis blocks metastasis of bladder cancer by inhibiting Rac1.
    Mol Cancer. 2021;20:77.
    Abstract     Related articles   

  919. WANG P, Xiao S, Fu W, Song Y, et al
    Robot-assisted radical cystectomy with intracorporeal Mainz rectosigmoid pouch for muscle-invasive bladder cancer.
    Int J Med Robot. 2021 May 18:e2284. doi: 10.1002/rcs.2284.
    Abstract     Related articles   

  920. HAN CT, Bao QY, Cheng SJ, Liu M, et al
    Circular RNA hsa_circ_0017247 acts as an oncogene in bladder cancer by inducing Wnt/beta-catenin signaling pathway.
    Eur Rev Med Pharmacol Sci. 2021;25:3395.
    Abstract     Related articles   

  921. MA W, Ou T, Cui X, Wu K, et al
    HSP47 contributes to angiogenesis by induction of CCL2 in bladder cancer.
    Cell Signal. 2021 May 14:110044. doi: 10.1016/j.cellsig.2021.110044.
    Abstract     Related articles   


  922. Erratum: Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer.
    Bladder Cancer. 2021;7:109.
    Abstract     Related articles   

  923. BLINDHEIM AJ, Fossa SD, Babigumira R, Andreassen BK, et al
    The use of reTURB in T1 bladder cancer: a Norwegian population-based study.
    Scand J Urol. 2021 May 17:1-7. doi: 10.1080/21681805.2021.1917652.
    Abstract     Related articles   

  924. WANG X, Tu N, Sun F, Wen Z, et al
    Detecting Muscle Invasion of Bladder Cancer Using a Proposed Magnetic Resonance Imaging Strategy.
    J Magn Reson Imaging. 2021 May 17. doi: 10.1002/jmri.27676.
    Abstract     Related articles   

  925. YIN Z, Li J, Kang L, Liu X, et al
    Epigallocatechin-3-gallate induces autophagy-related apoptosis associated with LC3B II and Beclin expression of bladder cancer cells.
    J Food Biochem. 2021 May 16:e13758. doi: 10.1111/jfbc.13758.
    Abstract     Related articles   

  926. AALAMI AH, Abdeahad H, Mesgari M, Sathyapalan T, et al
    Urinary Angiogenin as a Marker for Bladder Cancer: A Meta-Analysis.
    Biomed Res Int. 2021;2021:5557309.
    Abstract     Related articles   

  927. ZHANG J, Dai D, Tian J, Li L, et al
    Circulating Tumor DNA Analyses Predict Disease Recurrence in Non-Muscle-Invasive Bladder Cancer.
    Front Oncol. 2021;11:657483.
    Abstract     Related articles   

  928. XIA Y, Chen R, Lu G, Li C, et al
    Natural Phytochemicals in Bladder Cancer Prevention and Therapy.
    Front Oncol. 2021;11:652033.
    Abstract     Related articles   

  929. ROSSER CJ, Tikhonenkov S, Nix JW, Chan OTM, et al
    Safety, Tolerability, and Long-Term Clinical Outcomes of an IL-15 analogue (N-803) Admixed with Bacillus Calmette-Guerin (BCG) for the Treatment of Bladder Cancer.
    Oncoimmunology. 2021;10:1912885.
    Abstract     Related articles   

  930. CHATURVEDI A, Kumar V, Gupta S
    Molecular Oncology of Gall Bladder Cancer.
    Indian J Surg Oncol. 2021;12.
    Abstract     Related articles   

  931. JUE JS, Alameddine M, Gonzalez J, Ciancio G, et al
    Risk factors, management, and survival of bladder cancer after kidney transplantation.
    Actas Urol Esp (Engl Ed). 2021 May 11. pii: S0210-4806(21)00063.
    Abstract     Related articles   

  932. RAVANINI JN, Assato AK, Wakamatsu A, Alves VAF, et al
    Combined use of immunohistochemical markers of basal and luminal subtypes in urothelial carcinoma of the bladder: Association with clinicopathological features and outcomes.
    Clinics (Sao Paulo). 2021;76:e2587.
    Abstract     Related articles   

  933. MAIBOM SL, Joensen UN, Poulsen AM, Kehlet H, et al
    Short-term morbidity and mortality following radical cystectomy: a systematic review.
    BMJ Open. 2021;11:e043266.
    Abstract     Related articles   

  934. KALEMCI S, Kizilay F, Simsir A
    A new technique in the treatment of ureteroenteric anastomosis stricture: Repair of ureteroenteric anastomosis stricture with low lombotomy incision (retroperitoneal approach).
    Int J Clin Pract. 2021;75:e14155.
    Abstract     Related articles   

  935. TRIPATHI K, Goel A, Singhai A, Garg M, et al
    Promoter hypomethylation as potential confounder of Ras gene overexpression and their clinical significance in subsets of urothelial carcinoma of bladder.
    Mol Biol Rep. 2021;48:2183-2199.
    Abstract     Related articles   

  936. SLEIWAH A, Mughal M, Thurairaja R, Khan M, et al
    Reconstructive perineal surgery in the era of robotic surgical systems: Embracing the new technology.
    J Plast Reconstr Aesthet Surg. 2021;74:1101-1160.
    Abstract     Related articles   

  937. ALDHAAM NA, Hussein A, Elsayed AS, Jing Z, et al
    Detailed Analysis of Urinary Tract Infections after Robot-Assisted Radical Cystectomy.
    J Endourol. 2020 Jul 14. doi: 10.1089/end.2020.0316.
    Abstract     Related articles   

  938. TAN SH, Ding HJ, Mei XP, Liu JT, et al
    Propofol suppressed cell proliferation and enhanced apoptosis of bladder cancer cells by regulating the miR-340/CDK2 signal axis.
    Acta Histochem. 2021;123:151728.
    Abstract     Related articles   

  939. SAWAZAKI H, Ito K, Asano T, Kuroda K, et al
    Expressions of P-Glycoprotein, Multidrug Resistance Protein 1 and Annexin A2 as Predictive Factors for Intravesical Recurrence of Bladder Cancer after the Initial Transurethral Resection and Immediate Single Intravesical Instillation of Adriamycin.
    Asian Pac J Cancer Prev. 2021;22:1459-1466.
    Abstract     Related articles   

  940. FERRO M, de Cobelli O, Musi G, Lucarelli G, et al
    Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis.
    Front Oncol. 2021;11:651745.
    Abstract     Related articles   

  941. SOUAID T, Hindy JR, Diab E, Kourie HR, et al
    Are there monogenic hereditary forms of bladder cancer or only genetic susceptibilities?
    Pharmacogenomics. 2021 May 28. doi: 10.2217/pgs-2020-0165.
    Abstract     Related articles   

  942. CHEN Y, Wang HH, Chang HH, Huang YH, et al
    Guggulsterone induces apoptosis and inhibits lysosomal-dependent migration in human bladder cancer cells.
    Phytomedicine. 2021;87:153587.
    Abstract     Related articles   

  943. GE R, Cai H, Yuan X, Qin F, et al
    MD-UNET: Multi-input dilated U-shape neural network for segmentation of bladder cancer.
    Comput Biol Chem. 2021;93:107510.
    Abstract     Related articles   

  944. HAAS M, Burger M, Schnabel MJ
    [Systemic treatment of bladder cancer].
    Urologe A. 2021 May 27. pii: 10.1007/s00120-021-01535.
    Abstract     Related articles   

  945. HUANG Y, Wang T
    Pectin Oligosaccharides Enhance alpha2,6-Sialylation Modification that Promotes Apoptosis of Bladder Cancer Cells by Targeting the Hedgehog Pathway.
    Cell Biochem Biophys. 2021 May 26. pii: 10.1007/s12013-021-00996.
    Abstract     Related articles   

  946. CAI Z, Chen H, Bai J, Zheng Y, et al
    Copy Number Variations of CEP63, FOSL2 and PAQR6 Serve as Novel Signatures for the Prognosis of Bladder Cancer.
    Front Oncol. 2021;11:674933.
    Abstract     Related articles   

  947. TEE JL, Chambers J, Strutton G
    Bladder perivascular epithelioid cell tumour and tuberous sclerosis complex: a rare association.
    BMJ Case Rep. 2021;14.
    Abstract     Related articles   

  948. DIANATINASAB M, Wesselius A, de Loeij T, Salehi-Abargouei A, et al
    The association between meat and fish consumption and bladder cancer risk: a pooled analysis of 11 cohort studies.
    Eur J Epidemiol. 2021 May 25. pii: 10.1007/s10654-021-00762.
    Abstract     Related articles   

  949. MA Y, Huang Z, Jian Z, Wei X, et al
    The association between hepatitis C virus infection and renal cell cancer, prostate cancer, and bladder cancer: a systematic review and meta-analysis.
    Sci Rep. 2021;11:10833.
    Abstract     Related articles   

  950. HUANG Z, Yan Y, Zhu Z, Liu J, et al
    CBX7 suppresses urinary bladder cancer progression via modulating AKR1B10-ERK signaling.
    Cell Death Dis. 2021;12:537.
    Abstract     Related articles   

  951. HUGHES S, Kass-Iliyya A
    Isolated penile metastases secondary to invasive bladder cancer.
    BMJ Case Rep. 2021;14.
    Abstract     Related articles   

  952. JIA W, Luo S, Lai G, Li S, et al
    Homogeneous polyporus polysaccharide inhibits bladder cancer by polarizing macrophages to M1 subtype in tumor microenvironment.
    BMC Complement Med Ther. 2021;21:150.
    Abstract     Related articles   

  953. ELBADAWY M, Sato Y, Mori T, Goto Y, et al
    Anti-tumor effect of trametinib in bladder cancer organoid and the underlying mechanism.
    Cancer Biol Ther. 2021 May 26:1-15. doi: 10.1080/15384047.2021.1919004.
    Abstract     Related articles   

  954. FRAGKOULIS C, Glykas I, Mari V, Lamprou S, et al
    Incidental prostate cancer in patients who underwent radical cystectomy for high risk non muscle invasive bladder cancer: Is it clinically significant?
    Urologia. 2021 May 25:3915603211019989. doi: 10.1177/03915603211019989.
    Abstract     Related articles   

  955. WANG J, Shen C, Zhang J, Zhang Y, et al
    TEAD4 Is an Immune Regulating-Related Prognostic Biomarker for Bladder Cancer and Possesses Generalization Value in Pan-Cancer.
    DNA Cell Biol. 2021 May 24. doi: 10.1089/dna.2021.0164.
    Abstract     Related articles   

  956. SHOU J, Zhang Q, Zhang D
    The prognostic effect of metastasis patterns on overall survival in patients with distant metastatic bladder cancer: a SEER population-based analysis.
    World J Urol. 2021 May 24. pii: 10.1007/s00345-021-03721.
    Abstract     Related articles   

  957. CARDWELL CR, McDowell RD, Hughes CM, Hicks B, et al
    Exposure to Ranitidine and Risk of Bladder Cancer: A Nested Case-Control Study.
    Am J Gastroenterol. 2021 May 21. pii: 00000434-900000000-98771.
    Abstract     Related articles   

  958. HAFEEZ S, Dunlop A, Mitchell A, Nill S, et al
    Comment on Hunt et al., "Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer".
    Clin Transl Radiat Oncol. 2021;29:9-10.
    Abstract     Related articles   

  959. JIANG M, Ren L, Chen Y, Wang H, et al
    Identification of a Hypoxia-Related Signature for Predicting Prognosis and the Immune Microenvironment in Bladder Cancer.
    Front Mol Biosci. 2021;8:613359.
    Abstract     Related articles   

  960. CHEN YS, Xu YP, Liu WH, Li DC, et al
    Long Noncoding RNA KCNMB2-AS1 Promotes SMAD5 by Targeting miR-3194-3p to Induce Bladder Cancer Progression.
    Front Oncol. 2021;11:649778.
    Abstract     Related articles   

  961. SU S, Liu L, Sun C, Nie Y, et al
    Preoperative Serum Gamma-Glutamyltransferase as a Prognostic Biomarker in Patients Undergoing Radical Cystectomy for Bladder Cancer.
    Front Oncol. 2021;11:648904.
    Abstract     Related articles   

  962. SCHUETTFORT VM, Pradere B, Trinh QD, D'Andrea D, et al
    Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer.
    Cancer Immunol Immunother. 2021 May 23. pii: 10.1007/s00262-021-02953.
    Abstract     Related articles   

  963. CRONISE KE, Das S, Hernandez BG, Regan DP, et al
    Characterizing the Molecular and Immune Landscape of Canine Bladder Cancer.
    Vet Comp Oncol. 2021 May 22. doi: 10.1111/vco.12740.
    Abstract     Related articles   

  964. YIN YW, Liu KL, Lu BS, Li W, et al
    RBM24 exacerbates bladder cancer progression by forming a Runx1t1/TCF4/miR-625-5p feedback loop.
    Exp Mol Med. 2021 May 21. pii: 10.1038/s12276-021-00623.
    Abstract     Related articles   

  965. MONOE Y, Jingushi K, Kawase A, Hirono T, et al
    Pharmacological Inhibition of miR-130 Family Suppresses Bladder Tumor Growth by Targeting Various Oncogenic Pathways via PTPN1.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  966. ZHANG Q, Wu J, Chen X, Zhao M, et al
    Upregulation of Versican Associated with Tumor Progression, Metastasis, and Poor Prognosis in Bladder Carcinoma.
    Biomed Res Int. 2021;2021:6949864.
    Abstract     Related articles   

  967. BOHLE A
    [Intravesical gene therapy for patients with BCG-refractory NMIBC?]
    Urologe A. 2021;60:372-373.
    Abstract     Related articles   

  968. LEE JH, Lee KH, Kim JH
    In Silico Inference of Synthetic Cytotoxic Interactions from Paclitaxel Responses.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   



  969. Urologe A. 2021;60:140-141.
    Abstract     Related articles   

  970. EBRAHIM HM, Asaad AM, El Desoky F, Morsi HM, et al
    Bacillus Calmette-Guerin polysaccharide nucleic acid vs Bacillus Calmette-Guerin vaccine in the treatment of warts: A comparative, double-blind, controlled study.
    Dermatol Ther. 2021;34:e14549.
    Abstract     Related articles   

  971. MISTRETTA FA, Musi G, Colla Ruvolo C, Conti A, et al
    Robot-Assisted Radical Cystectomy for Nonmetastatic Urothelial Carcinoma of Urinary Bladder: A Comparison Between Intracorporeal Versus Extracorporeal Orthotopic Ileal Neobladder.
    J Endourol. 2021;35:151-158.
    Abstract     Related articles   

  972. YOU C, Du Y, Wang H, Peng L, et al
    Robot-Assisted Radical Cystectomy with Intracorporeal Urinary Diversion: A New Standard of Urinary Diversion.
    J Endourol. 2021;35:473-482.
    Abstract     Related articles   

  973. VELMAHOS CS, Badgeley M, Lo YC
    Using deep learning to identify bladder cancers with FGFR-activating mutations from histology images.
    Cancer Med. 2021 Jun 10. doi: 10.1002/cam4.4044.
    Abstract     Related articles   

  974. PARK RM, Carreon T, Hanley KW
    Risk assessment for o-toluidine and bladder cancer incidence.
    Am J Ind Med. 2021 Jun 10. doi: 10.1002/ajim.23265.
    Abstract     Related articles   

  975. WU H, Jiang W, Ji G, Xu R, et al
    Exploring microRNA target genes and identifying hub genes in bladder cancer based on bioinformatic analysis.
    BMC Urol. 2021;21:90.
    Abstract     Related articles   

  976. PEIXOTO A, Ferreira D, Azevedo R, Freitas R, et al
    Glycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer.
    J Exp Clin Cancer Res. 2021;40:191.
    Abstract     Related articles   

  977. MORELLI M, Baboudjian M, Vanacore D, Gondran-Tellier B, et al
    Early PDD Cystoscopy after BCG Induction for High-risk Non-Muscle Invasive Bladder Cancer Significantly Increased the Detection of BCG-refractory Tumors.
    J Endourol. 2021 Jun 9. doi: 10.1089/end.2021.0313.
    Abstract     Related articles   

  978. SASAKI Y, Kadoriku F, Fukatani Y, Yamamoto H, et al
    [A Case of Robot-Assisted Radical Cystoprostatectomy for Locally Advanced Prostate Cancer with Bladder Infiltration].
    Hinyokika Kiyo. 2021;67:163-166.
    Abstract     Related articles   

  979. ZUO Y, Xu X, Chen M, Qi L, et al
    The oncogenic role of the cerebral endothelial cell adhesion molecule (CERCAM) in bladder cancer cells in vitro and in vivo.
    Cancer Med. 2021 Jun 8. doi: 10.1002/cam4.3955.
    Abstract     Related articles   

  980. ZHOU L, Xu B, Liu Y, Wang Z, et al
    Tertiary lymphoid structure signatures are associated with survival and immunotherapy response in muscle-invasive bladder cancer.
    Oncoimmunology. 2021;10:1915574.
    Abstract     Related articles   

  981. HAN X, Liu J, Liu Y, Mou L, et al
    LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p.
    Cancer Manag Res. 2021;13:4393-4401.
    Abstract     Related articles   

  982. BRISUDA A, Ho JCS, Kandiyal PS, Ng JT, et al
    Bladder cancer therapy using a conformationally fluid tumoricidal peptide complex.
    Nat Commun. 2021;12:3427.
    Abstract     Related articles   

  983. ISLAM MK, Syed P, Dhondt B, Gidwani K, et al
    Detection of Bladder Cancer with Aberrantly Fucosylated ITGA3.
    Anal Biochem. 2021 Jun 5:114283. doi: 10.1016/j.ab.2021.114283.
    Abstract     Related articles   

  984. PHAM QT, Taniyama D, Akabane S, Harada K, et al
    TDO2 overexpression correlates with poor prognosis, cancer stemness, and resistance to cetuximab in bladder cancer.
    Cancer Rep (Hoboken). 2021 Jun 7:e1417. doi: 10.1002/cnr2.1417.
    Abstract     Related articles   

  985. KOZIKOWSKI M, Suarez-Ibarrola R, Osiecki R, Bilski K, et al
    Role of Radiomics in the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis.
    Eur Urol Focus. 2021 Jun 4. pii: S2405-4569(21)00157.
    Abstract     Related articles   

  986. NOONE AM, Lam CJK, Smith AB, Nielsen ME, et al
    Machine Learning Methods to Identify Missed Cases of Bladder Cancer in Population-Based Registries.
    JCO Clin Cancer Inform. 2021;5:641-653.
    Abstract     Related articles   

  987. PHAM STD, Lee A, Struminger JS, Belkoff KM, et al
    Mycotic infrarenal aortic aneurysm due to mycobacterium after intravesical treatment for bladder cancer.
    J Vasc Surg Cases Innov Tech. 2021;7:354-356.
    Abstract     Related articles   

  988. LIU J, Ma H, Meng L, Liu X, et al
    Construction and External Validation of a Ferroptosis-Related Gene Signature of Predictive Value for the Overall Survival in Bladder Cancer.
    Front Mol Biosci. 2021;8:675651.
    Abstract     Related articles   

  989. EPAILLARD N, Parent P, Loriot Y, Lavaud P, et al
    Treatments Outcomes in Histological Variants and Non-Urothelial Bladder Cancer: Results of a Multicenter Retrospective Study.
    Front Oncol. 2021;11:671969.
    Abstract     Related articles   

  990. LI Y, Sun L, Guo X, Mo N, et al
    Frontiers in Bladder Cancer Genomic Research.
    Front Oncol. 2021;11:670729.
    Abstract     Related articles   

  991. GUPTA S, Singh B, Bhatt H, Singh S, et al
    A Case of Systemic Toxicity Related to Intravesical Bacillus Calmette-Guerin for the Treatment of Bladder Cancer.
    Cureus. 2021;13:e15321.
    Abstract     Related articles   

  992. SHIH KW, Chen WC, Chang CH, Tai TE, et al
    Non-Muscular Invasive Bladder Cancer: Re-envisioning Therapeutic Journey from Traditional to Regenerative Interventions.
    Aging Dis. 2021;12:868-885.
    Abstract     Related articles   

  993. LIU Z, Liu X, Cai R, Liu M, et al
    Identification of a tumor microenvironment-associated prognostic gene signature in bladder cancer by integrated bioinformatic analysis.
    Int J Clin Exp Pathol. 2021;14:551-566.
    Abstract     Related articles   

  994. JOBCZYK M, Stawiski K, Kaszkowiak M, Rajwa P, et al
    Deep Learning-based Recalibration of the CUETO and EORTC Prediction Tools for Recurrence and Progression of Non-muscle-invasive Bladder Cancer.
    Eur Urol Oncol. 2021 Jun 3. pii: S2588-9311(21)00112.
    Abstract     Related articles   

  995. STEINBERG RL, Packiam VT, Thomas LJ, Brooks N, et al
    Intravesical sequential gemcitabine and docetaxel versus bacillus calmette-guerin (BCG) plus interferon in patients with recurrent non-muscle invasive bladder cancer following a single induction course of BCG.
    Urol Oncol. 2021 Jun 3. pii: S1078-1439(21)00134.
    Abstract     Related articles   

  996. LIN JY, Juo BR, Yeh YH, Fu SH, et al
    Putative markers for the detection of early-stage bladder cancer selected by urine metabolomics.
    BMC Bioinformatics. 2021;22:305.
    Abstract     Related articles   

  997. LAI WH, Fang CY, Chou MC, Lin MC, et al
    Peptide-guided JC polyomavirus-like particles specifically target bladder cancer cells for gene therapy.
    Sci Rep. 2021;11:11889.
    Abstract     Related articles   

  998. KIM HS, Seo HK
    Emerging treatments for bacillus Calmette-Guerin-unresponsive non-muscle-invasive bladder cancer.
    Investig Clin Urol. 2021 May 27. pii: 62.e49. doi: 10.4111/icu.20200602.
    Abstract     Related articles   

  999. EL-SHAL AS, Shalaby SM, Abouhashem SE, Elbary EHA, et al
    Urinary exosomal microRNA-96-5p and microRNA-183-5p expression as potential biomarkers of bladder cancer.
    Mol Biol Rep. 2021 Jun 4. pii: 10.1007/s11033-021-06451.
    Abstract     Related articles   

  1000. STERN R, Roscoe C, Misch EA
    Mycobacterium bovis BCG osteoarticular infection complicating immune therapy for bladder cancer: a case report.
    J Bone Jt Infect. 2021;6:107-110.
    Abstract     Related articles   

  1001. SHANTHARAM G, Amin A, Pereira J, Kott O, et al
    Intravesical docetaxel for high-risk non-muscle invasive bladder cancer after Bacillus Calmette-Guerin failure.
    Curr Urol. 2021;15:33-38.
    Abstract     Related articles   

  1002. SCIARRA A, Di Lascio G, Del Giudice F, Leoncini PP, et al
    Comparison of the clinical usefulness of different urinary tests for the initial detection of bladder cancer: a systematic review.
    Curr Urol. 2021;15:22-32.
    Abstract     Related articles   

  1003. MATSUOKA Y, Taoka R, Kohashiguchi K, Tohi Y, et al
    Efficacy and toxicity of intravesical Bacillus Calmette-Guerin therapy in elderly patients with non-muscle-invasive bladder cancer.
    Curr Urol. 2021;15:16-21.
    Abstract     Related articles   

  1004. MOHAMED DO, Sayed MM, Abdelkawi IF, Elshoieby MH, et al
    Bladder preservation versus radical cystectomy in transitional cell carcinoma and squamous cell carcinoma muscle invasive bladder cancer.
    Curr Urol. 2021;15:11-15.
    Abstract     Related articles   

  1005. EL KHATIB S
    In vivo photobleaching kinetics and epithelial biodistribution of hexylaminolevulinate-induced protoporphyrin IX in rat bladder cancer.
    Curr Urol. 2021;15:2-10.
    Abstract     Related articles   

  1006. QI Y, Tang D
    Commentary: Bladder cancer.
    Curr Urol. 2021;15:1.
    Abstract     Related articles   

  1007. HEKTOEN HH, Robsahm TE, Stenehjem JS, Axcrona K, et al
    Vitamin D and Vitamin D-binding protein and risk of bladder cancer: A nested case-control study in the Norwegian Janus Serum Bank Cohort.
    Cancer Med. 2021 Jun 3. doi: 10.1002/cam4.3960.
    Abstract     Related articles   

  1008. AIZCORBE GOMEZ M, Gutierrez Zurimendi G, Arruza Echevarria A
    [Clinicopathologic analysis of 5 cases of urachal adenocarcinoma.]
    Arch Esp Urol. 2021;74:535-540.
    Abstract     Related articles   

  1009. SANCHEZ VERDES P, Fernandez-Pello S, Gonzalez Rodriguez I, Salgado Plonski JJ, et al
    [Gross hematuria and usefulness of urinary cytology: Experience at hematuria one stop clinic.]
    Arch Esp Urol. 2021;74:470-476.
    Abstract     Related articles   

  1010. CAI Q, Wen Z, Huang Y, Li M, et al
    Investigation of Synthetic Magnetic Resonance Imaging Applied in the Evaluation of the Tumor Grade of Bladder Cancer.
    J Magn Reson Imaging. 2021 Jun 3. doi: 10.1002/jmri.27770.
    Abstract     Related articles   

  1011. BASU M, Chatterjee A, Chakraborty B, Chatterjee E, et al
    High nuclear expression of HIF1alpha, synergizing with inactivation of LIMD1 and VHL, portray worst prognosis among the bladder cancer patients: association with arsenic prevalence.
    J Cancer Res Clin Oncol. 2021 Jun 2. pii: 10.1007/s00432-021-03661.
    Abstract     Related articles   

  1012. SEGATTO NV, Bender CB, Seixas FK, Schachtschneider K, et al
    Perspective: Humanized Pig Models of Bladder Cancer.
    Front Mol Biosci. 2021;8:681044.
    Abstract     Related articles   

  1013. JIANG LR, Zhang N, Chen ST, He J, et al
    PD-1-Positive Tumor-Associated Macrophages Define Poor Clinical Outcomes in Patients With Muscle Invasive Bladder Cancer Through Potential CD68/PD-1 Complex Interactions.
    Front Oncol. 2021;11:679928.
    Abstract     Related articles   

  1014. XU A, Yang GG, Zhang Y, Zhao ST, et al
    Heptaphylline suppresses the proliferation and migration of human bladder cancer cells via induction of intrinsic apoptosis, autophagy and inhibition of beta-catenin signalling pathway.
    J BUON. 2021;26:646.
    Abstract     Related articles   

  1015. SERRETTA V, Berardinis E, Simonato A, Guarneri A, et al
    A prospective observational study on oral administration of Ellagic Acid and Annona Muricata in patients affected by non-muscle invasive bladder cancer not undergoing maintenance after 6-week intravesical prophylaxis.
    Urologia. 2021 Jun 2:3915603211022285. doi: 10.1177/03915603211022285.
    Abstract     Related articles   

  1016. ULAMEC M, Murgic J, Novosel L, Tomic M, et al
    New Insights into the Diagnosis, Molecular Taxonomy, and Treatment of Bladder Cancer.
    Acta Med Acad. 2021;50:143-156.
    Abstract     Related articles   

  1017. HEMMINKI K, Forsti A, Hemminki A, Ljungberg B, et al
    Incidence trends in lung and bladder cancers in the Nordic Countries before and after the smoking epidemic.
    Eur J Cancer Prev. 2021 Jun 1. pii: 00008469-900000000-99039.
    Abstract     Related articles   

  1018. ZHENG XN, Qiu S, Tang LS, Ai JZ, et al
    Tumor microenvironment-based drug discovery: a novel insight into bladder cancer immunotherapy.
    Chin Med J (Engl). 2021 Jun 2. pii: 00029330-900000000-98594.
    Abstract     Related articles   

  1019. MIYAKE M, Nishimura N, Iida K, Fujii T, et al
    Intravesical Bacillus Calmette-Guerin Treatment for T1 High-Grade Non-Muscle Invasive Bladder Cancer with Divergent Differentiation or Variant Morphologies.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  1020. JUTTE H, Reike M, Wirtz RM, Kriegmair M, et al
    KRT20, KRT5, ESR1 and ERBB2 Expression Can Predict Pathologic Outcome in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer.
    J Pers Med. 2021;11.
    Abstract     Related articles   

  1021. LORAS A, Segovia C, Ruiz-Cerda JL
    Epigenomic and Metabolomic Integration Reveals Dynamic Metabolic Regulation in Bladder Cancer.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  1022. SCHNEIDER L, Liu J, Zhang C, Azoitei A, et al
    The Role of Interleukin-1-Receptor-Antagonist in Bladder Cancer Cell Migration and Invasion.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  1023. ZHAO Z, Wang Y, Zhang JJ, Huang XY, et al
    Fascin Inhibitors Decrease Cell Migration and Adhesion While Increase Overall Survival of Mice Bearing Bladder Cancers.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  1024. NIK AB KADIR MN, Mohd Hairon S, Yaacob NM, Ab Manan A, et al
    Survival and Characteristics of Bladder Cancer: Analysis of the Malaysian National Cancer Registry.
    Int J Environ Res Public Health. 2021;18.
    Abstract     Related articles   

  1025. PONES M, D'Andrea D, Mori K, Abufraj M, et al
    Differential Prognosis and Response of Denovo vs. Secondary Muscle-Invasive Bladder Cancer: An Updated Systematic Review and Meta-Analysis.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  1026. IDE H, Miyamoto H
    Sex Hormone Receptor Signaling in Bladder Cancer: A Potential Target for Enhancing the Efficacy of Conventional Non-Surgical Therapy.
    Cells. 2021;10.
    Abstract     Related articles   

  1027. KLINGER D, Hill BL, Barda N, Halperin E, et al
    Bladder Cancer Immunotherapy by BCG Is Associated with a Significantly Reduced Risk of Alzheimer's Disease and Parkinson's Disease.
    Vaccines (Basel). 2021;9.
    Abstract     Related articles   

  1028. CUCCURULLO V, Di Stasio GD, Manti F, Arcuri P, et al
    The Role of Molecular Imaging in a Muscle-Invasive Bladder Cancer Patient: A Narrative Review in the Era of Multimodality Treatment.
    Diagnostics (Basel). 2021;11.
    Abstract     Related articles   

  1029. CANNON-ALBRIGHT LA, Teerlink CC, Stevens J, Huang FW, et al
    A Rare Variant in ERF (rs144812092) Predisposes to Prostate and Bladder Cancers in an Extended Pedigree.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  1030. BARANI M, Hosseinikhah SM, Rahdar A, Farhoudi L, et al
    Nanotechnology in Bladder Cancer: Diagnosis and Treatment.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  1031. HOFFMAN-CENSITS J, Kanesvaran R, Bangs R, Fashoyin-Aje L, et al
    Breaking Barriers: Addressing Issues of Inequality in Trial Enrollment and Clinical Outcomes for Patients With Kidney and Bladder Cancer.
    Am Soc Clin Oncol Educ Book. 2021;41:e174-e181.
    Abstract     Related articles   

  1032. HUANG J, Zhao L, Wang K, Sun J, et al
    Controlling Nutritional Status Score Evaluates Prognosis in Patients With Non-Muscle Invasive Bladder Cancer.
    Cancer Control. 2021;28:10732748211021078.
    Abstract     Related articles   

  1033. CONTIERI R, Paciotti M, Lughezzani G, Buffi NM, et al
    Long-term Follow-up and Factors Associated with Active Surveillance Failure for Patients with Non-muscle-invasive Bladder Cancer: The Bladder Cancer Italian Active Surveillance (BIAS) Experience.
    Eur Urol Oncol. 2021 May 28. pii: S2588-9311(21)00108.
    Abstract     Related articles   

  1034. MOUSSA M, Chakra MA, Saad W, Dellis A, et al
    The role of 18F-FDG PET/CT scan compared to CT-scan alone for lymph node staging before radical cystectomy in patients with bladder cancer.
    Urol Oncol. 2021 May 29. pii: S1078-1439(21)00183.
    Abstract     Related articles   

  1035. ZHAO X, Li G, Chong T, Xue L, et al
    TMEM88 exhibits an antiproliferative and anti-invasive effect in bladder cancer by downregulating Wnt/beta-catenin signaling.
    J Biochem Mol Toxicol. 2021 May 31:e22835. doi: 10.1002/jbt.22835.
    Abstract     Related articles   

  1036. BEINFELD M, Atlas SJ, Touchette D, McKenna A, et al
    The effectiveness and value of nadofaragene firadenovec, oportuzumab monatox, and pembrolizumab for BCG-unresponsive non-muscle-invasive bladder cancer.
    J Manag Care Spec Pharm. 2021;27:797-804.
    Abstract     Related articles   

  1037. YE W, Chen L, Feng C, Liang T, et al
    CircMYLK promotes the growth, migration, invasion, and survival of bladder cancer cells by upregulating CCND3 level via competitively binding to miR-34a.
    Drug Dev Res. 2021 May 30. doi: 10.1002/ddr.21835.
    Abstract     Related articles   

  1038. CHAI CA, Yeoh WS, Rajandram R, Aung KP, et al
    Comparing CxBladder to Urine Cytology as Adjunct to Cystoscopy in Surveillance of Non-muscle Invasive Bladder Cancer-A Pilot Study.
    Front Surg. 2021;8:659292.
    Abstract     Related articles   

  1039. GUO C, Li X, Xie J, Liu D, et al
    Long Noncoding RNA SNHG1 Activates Autophagy and Promotes Cell Invasion in Bladder Cancer.
    Front Oncol. 2021;11:660551.
    Abstract     Related articles   

  1040. ZHENG Z, Xu F, Gu Z, Yan Y, et al
    Combining Multiparametric MRI Radiomics Signature With the Vesical Imaging-Reporting and Data System (VI-RADS) Score to Preoperatively Differentiate Muscle Invasion of Bladder Cancer.
    Front Oncol. 2021;11:619893.
    Abstract     Related articles   

  1041. CHAO Y, Ou Q, Shang J
    Expression and prognostic value of SULT1A2 in bladder cancer.
    Exp Ther Med. 2021;22:779.
    Abstract     Related articles   

  1042. BRATU O, Marcu D, Anghel R, Spinu D, et al
    Tumoral markers in bladder cancer (Review).
    Exp Ther Med. 2021;22:773.
    Abstract     Related articles   

  1043. MATULEWICZ RS, Ravvaz K, Weissert JA, Porten S, et al
    Association of smoking status and recurrence of non-muscle invasive bladder cancer among patients managed with blue light cystoscopy.
    Urol Oncol. 2021 May 27. pii: S1078-1439(21)00185.
    Abstract     Related articles   

  1044. DU Y, Jiang X, Wang B, Cao J, et al
    The cancer-associated fibroblasts related gene CALD1 is a prognostic biomarker and correlated with immune infiltration in bladder cancer.
    Cancer Cell Int. 2021;21:283.
    Abstract     Related articles   

  1045. BALAR AV, Kamat AM, Kulkarni GS, Uchio EM, et al
    Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study.
    Lancet Oncol. 2021 May 26. pii: S1470-2045(21)00147.
    Abstract     Related articles   

  1046. ALKASSIS M, Abi Tayeh G, Khalil N, Mansour R, et al
    The Safety and Efficacy of Bacillus Calmette-Guerin Intravesical Therapy in Kidney Transplant Recipients with Superficial Bladder Cancer.
    Clin Transplant. 2021 May 29:e14377. doi: 10.1111/ctr.14377.
    Abstract     Related articles   

  1047. CLAPS F, Rai S, Mir MC, van Rhijn BWG, et al
    Prognostic value of preoperative albumin-to-fibrinogen ratio (AFR) in patients with bladder cancer treated with radical cystectomy.
    Urol Oncol. 2021 May 25. pii: S1078-1439(21)00184.
    Abstract     Related articles   

  1048. GRIVAS P, Agarwal N, Pal S, Kalebasty AR, et al
    Avelumab first-line maintenance in locally advanced or metastatic urothelial carcinoma: Applying clinical trial findings to clinical practice.
    Cancer Treat Rev. 2021;97:102187.
    Abstract     Related articles   

  1049. LIM JX, Chan SKS, Hwang PYK
    Trans-sulcal parafascicular approach to subcortical lesions.
    J Clin Neurosci. 2021;86:45-49.
    Abstract     Related articles   

  1050. ROSENBERG JE
    New treatments for patients with progressive metastatic urothelial carcinoma.
    Clin Adv Hematol Oncol. 2021;19:180-183.
    Abstract     Related articles   

  1051. ANNO T, Kikuchi E, Shigeta K, Ogihara K, et al
    Site-specific differences in survival among upper and lower tract urothelial carcinoma patients treated with radical surgery.
    Jpn J Clin Oncol. 2021;51:984-991.
    Abstract     Related articles   

  1052. WANG L, Tao H, Li Z, Lei Y, et al
    Preparation of Composite Cypate Nanoparticles and Its Application in the Treatment of Pediatric Bladder Tumors.
    J Nanosci Nanotechnol. 2021;21:868-877.
    Abstract     Related articles   

  1053. APPLEMAN LJ
    Multifactorial, Biomarker-Based Predictive Models for Immunotherapy Response Enter the Arena.
    J Natl Cancer Inst. 2021;113:7-8.
    Abstract     Related articles   

  1054. DENG G, Wang R, Sun Y, Huang CP, et al
    Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARgamma/MMP-9 signals.
    Cell Death Differ. 2021 Jun 14. pii: 10.1038/s41418-021-00743.
    Abstract     Related articles   

  1055. LAUKHTINA E, Rajwa P, Mori K, Moschini M, et al
    Accuracy of Frozen Section Analysis of Urethral and Ureteral Margins During Radical Cystectomy for Bladder Cancer: A Systematic Review and Diagnostic Meta-Analysis.
    Eur Urol Focus. 2021 Jun 11. pii: S2405-4569(21)00162.
    Abstract     Related articles   

  1056. HAN MA, Maisch P, Jung JH, Hwang JE, et al
    Intravesical gemcitabine for non-muscle invasive bladder cancer.
    Cochrane Database Syst Rev. 2021;6:CD009294.
    Abstract     Related articles   

  1057. THOMSEN JA, Nielsen Dominiak H, Lindgren MS, Jensen JB, et al
    Adverse events of hyperthermic intravesical chemotherapy for non-muscle invasive bladder cancer patients.
    Scand J Urol. 2021 Jun 14:1-6. doi: 10.1080/21681805.2021.1938664.
    Abstract     Related articles   

  1058. ASATANI S, Kanda T, Honda M, Ishii T, et al
    Occurrence of hepatitis in an elderly woman during the treatment of pembrolizumab for right advanced renal pelvis, ureteral cancer, and bladder cancer.
    JGH Open. 2021;5:722-724.
    Abstract     Related articles   

  1059. GENG Z, Geng Q
    Risk of Urinary Bladder Cancer in Patients With Inflammatory Bowel Diseases: A Meta-Analysis.
    Front Surg. 2021;8:636791.
    Abstract     Related articles   

  1060. ZANG J, Ye K, Fei Y, Zhang R, et al
    Immunotherapy in the Treatment of Urothelial Bladder Cancer: Insights From Single-Cell Analysis.
    Front Oncol. 2021;11:696716.
    Abstract     Related articles   

  1061. BOGEN JP, Grzeschik J, Jakobsen J, Bahre A, et al
    Treating Bladder Cancer: Engineering of Current and Next Generation Antibody-, Fusion Protein-, mRNA-, Cell- and Viral-Based Therapeutics.
    Front Oncol. 2021;11:672262.
    Abstract     Related articles   

  1062. XIAO J, Gong L, Xiao M, He D, et al
    LINC00467 Promotes Tumor Progression via Regulation of the NF-kb Signal Axis in Bladder Cancer.
    Front Oncol. 2021;11:652206.
    Abstract     Related articles   

  1063. ZHOU Z, Cui Y, Huang S, Chen Z, et al
    The Efficacy of Intra-Arterial Plus Intravesical Chemotherapy Versus Intravesical Chemotherapy Alone After Bladder-Sparing Surgery in High-Risk Bladder Cancer: A Systematic Review and Meta-Analysis of Comparative Study.
    Front Oncol. 2021;11:651657.
    Abstract     Related articles   

  1064. DONG D, Yao Y, Song J, Sun L, et al
    Cancer-Associated Fibroblasts Regulate Bladder Cancer Invasion and Metabolic Phenotypes through Autophagy.
    Dis Markers. 2021;2021:6645220.
    Abstract     Related articles   

  1065. ZHANG F, Wang X, Bai Y, Hu H, et al
    Development and Validation of a Hypoxia-Related Signature for Predicting Survival Outcomes in Patients With Bladder Cancer.
    Front Genet. 2021;12:670384.
    Abstract     Related articles   

  1066. KOCAK SY, Kudu A, Apaydin S
    Bacillus Calmette-Guerin-induced perinuclear antineutrophil cytoplasmic antibodies associated vasculitis in bladder cancer.
    J Cancer Res Ther. 2021;17:609-612.
    Abstract     Related articles   

  1067. CULPAN M, Turan T, Ozkanli SS, Zenginkinet T, et al
    Prognostic and clinicopathologic value of ki-67 and profilin 1 immunohistochemical expression in primary pT1 urothelial bladder cancer.
    J Cancer Res Ther. 2021;17:434-442.
    Abstract     Related articles   

  1068. KIM DK, Kim YH, Lee HY, Lee S, et al
    Diagnostic accuracy of Raman spectroscopy for the diagnosis of bladder cancer: A systematic review and meta-analysis.
    J Cancer Res Ther. 2021;17:426-433.
    Abstract     Related articles   

  1069. KAMAKURA M, Okazaki A, Ito K, Kin F, et al
    Concomitant Pulmonary and Cerebral Tumor Embolism and Intracardiac Metastasis from Bladder Cancer.
    Intern Med. 2021 Jun 12. doi: 10.2169/internalmedicine.6765.
    Abstract     Related articles   

  1070. KARKIN K, Izol V, Kaplan M, Deger M, et al
    Demonstration of Advanced Glycation End product (AGE) Expression in Bladder Cancer Tissue in Type 2 Diabetic and Non-diabetic Patients and the Relationship between AGE Accumulation and Endoplasmic Reticulum Stress (ERS) with Bladder Cancer.
    Int J Clin Pract. 2021 Jun 13:e14526. doi: 10.1111/ijcp.14526.
    Abstract     Related articles   

  1071. KIMURA K, Yoshida S, Tsuchiya J, Yamada I, et al
    Usefulness of texture features of apparent diffusion coefficient maps in predicting chemoradiotherapy response in muscle-invasive bladder cancer.
    Eur Radiol. 2021 Jun 13. pii: 10.1007/s00330-021-08110.
    Abstract     Related articles   

  1072. SEYYEDSALEHI MS, Mohebbi E, Sasanfar B, Toorang F, et al
    Dietary N-nitroso compounds intake and bladder cancer risk: A systematic review and meta-analysis.
    Nitric Oxide. 2021;115:1-7.
    Abstract     Related articles   

  1073. SHI S, Ma T, Xi Y
    Characterization of the immune cell infiltration landscape in bladder cancer to aid immunotherapy.
    Arch Biochem Biophys. 2021;708:108950.
    Abstract     Related articles   

  1074. BREE KK, Hensley PJ, Brooks N, Matulay J, et al
    Impact of sex on response to BCG in non-muscle invasive bladder cancer patients: a contemporary review from a tertiary care center.
    World J Urol. 2021 Jun 12. pii: 10.1007/s00345-021-03755.
    Abstract     Related articles   

  1075. CULPAN M, Keser F, Acar HC, Otunctemur A, et al
    Impact of delay in cystoscopic surveillance on recurrence and progression rates in non-muscle invasive bladder cancer patients during COVID-19 pandemic.
    Int J Clin Pract. 2021 Jun 12:e14490. doi: 10.1111/ijcp.14490.
    Abstract     Related articles   

  1076. KIM JI, Zhu D, Barry E, Kovac E, et al
    Intravesical Bacillus Calmette-Guerin Treatment Is Inversely Associated With the Risk of Developing Alzheimer Disease or Other Dementia Among Patients With Non-muscle-invasive Bladder Cancer.
    Clin Genitourin Cancer. 2021 May 17. pii: S1558-7673(21)00096.
    Abstract     Related articles   

  1077. LIN G, Zhang J, Wu Y, Zhu S, et al
    Signatures and Prognostic Values of N6-methyladenosine (m6A) - related Immune Genes in Bladder Cancer.
    Bioengineered. 2021;12:2649-2663.
    Abstract     Related articles   

  1078. REXER H, Kubler H, Retz M

    Aktuelle Urol. 2021;52:220-221.
    Abstract     Related articles   

  1079. LAMPEL A, Schultz-Lampel D
    [Urinary diversion after uro-oncologic interventions in women: the right procedure for the right patient].
    Aktuelle Urol. 2021;52:268-275.
    Abstract     Related articles   

  1080. GRUBA N, Stachurski L, Lesner A
    Elastolytic activity is associated with inflammation in bladder cancer.
    J Biochem. 2021 Jun 24. pii: 6308946. doi: 10.1093.
    Abstract     Related articles   

  1081. CAO J, Li J, Yang X, Li P, et al
    Integrative analysis of immune molecular subtypes and microenvironment characteristics of bladder cancer.
    Cancer Med. 2021 Jun 24. doi: 10.1002/cam4.4071.
    Abstract     Related articles   

  1082. KIM HJ, Chun J, Kim TH, Yang G, et al
    Patterns of Locoregional Recurrence after Radical Cystectomy for Stage T3-4 Bladder Cancer: A Radiation Oncologist's Point of View.
    Yonsei Med J. 2021;62:569-576.
    Abstract     Related articles   

  1083. MONTAZERI K, Dranitsaris G, Thomas JD, Curran C, et al
    An economic analysis comparing health care resource use and cost of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin versus gemcitabine and cisplatin as neoadjuvant therapy for muscle invasive bladder cancer.
    Urol Oncol. 2021 Jun 20. pii: S1078-1439(21)00190.
    Abstract     Related articles   

  1084. KUKREJA JB, Schroeck FR, Lotan Y, Gore JL, et al
    Discomfort and relieving factors among patients with bladder cancer undergoing office-based cystoscopy.
    Urol Oncol. 2021 Jun 20. pii: S1078-1439(21)00215.
    Abstract     Related articles   

  1085. PEKALA KR, Yabes JG, Bandari J, Yu M, et al
    The centralization of bladder cancer care and its implications for patient travel distance.
    Urol Oncol. 2021 Jun 20. pii: S1078-1439(21)00187.
    Abstract     Related articles   

  1086. LIU J, Zhang Y, Zeng H, Wang L, et al
    Fe-doped chrysotile nanotubes containing siRNAs to silence SPAG5 to treat bladder cancer.
    J Nanobiotechnology. 2021;19:189.
    Abstract     Related articles   

  1087. PLYUSHCHENKO IV, Fedorova ES, Potoldykova NV, Polyakovskiy KA, et al
    Omics Untargeted Key Script: R-Based Software Toolbox for Untargeted Metabolomics with Bladder Cancer Biomarkers Discovery Case Study.
    J Proteome Res. 2021 Jun 23. doi: 10.1021/acs.jproteome.1c00392.
    Abstract     Related articles   

  1088. GROBET-JEANDIN E, Pinar U, Loriot Y, Roupret M, et al
    ["Treatment of bladder cancer with immune checkpoints inhibitors"].
    Rev Prat. 2021;71:391-395.
    Abstract     Related articles   

  1089. FU Y, Sun S, Bi J, Kong C, et al
    Construction and analysis of a ceRNA network and patterns of immune infiltration in bladder cancer.
    Transl Androl Urol. 2021;10:1939-1955.
    Abstract     Related articles   

  1090. WILLIAMS SB, Gavaghan MB, Fernandez A, Daneshmand S, et al
    Macro and microeconomics of blue light cystoscopy with CYSVIEW(R) in non-muscle invasive bladder cancer.
    Urol Oncol. 2021 Jun 20. pii: S1078-1439(21)00231.
    Abstract     Related articles   

  1091. DE JONG JJ, Narayan VM, Cronican AA, Gupta S, et al
    Gene Expression Profiling of Muscle-Invasive Bladder Cancer With Secondary Variant Histology.
    Am J Clin Pathol. 2021 Jun 22. pii: 6307930. doi: 10.1093.
    Abstract     Related articles   

  1092. PLASEK J, Weissert J, Downs T, Richards K, et al
    Clinicopathological Criteria Predictive of Recurrence Following Bacillus Calmette-Guerin Therapy Initiation in Non-Muscle-Invasive Bladder Cancer: Retrospective Cohort Study.
    JMIR Cancer. 2021;7:e25800.
    Abstract     Related articles   

  1093. KORKES F, Spiess PE, Garcia-Perdomo HA, Necchi A, et al
    Challenging dilemmas of low grade, non-invasive bladder cancer: a narrative review.
    Int Braz J Urol. 2021;47.
    Abstract     Related articles   

  1094. IGEL DA, Lee EK
    The role of technology in the perioperative management of bladder cancer patients.
    Urol Oncol. 2021 Jun 18. pii: S1078-1439(21)00179.
    Abstract     Related articles   

  1095. ZHANG J, Zhou Q, Xie K, Cheng L, et al
    Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer.
    J Exp Clin Cancer Res. 2021;40:203.
    Abstract     Related articles   

  1096. KHALIFA MK, Bakr NM, Ramadan A, Abd Elwahab KM, et al
    Implications of targeted next-generation sequencing for bladder cancer: report of four cases.
    J Genet Eng Biotechnol. 2021;19:91.
    Abstract     Related articles   

  1097. YE R, Zeng H, Liu Z, Jin K, et al
    Latency-associated peptide identifies therapeutically resistant muscle-invasive bladder cancer with poor prognosis.
    Cancer Immunol Immunother. 2021 Jun 21. pii: 10.1007/s00262-021-02987.
    Abstract     Related articles   

  1098. DU Y, Miao W, Jiang X, Cao J, et al
    The Epithelial to Mesenchymal Transition Related Gene Calumenin Is an Adverse Prognostic Factor of Bladder Cancer Correlated With Tumor Microenvironment Remodeling, Gene Mutation, and Ferroptosis.
    Front Oncol. 2021;11:683951.
    Abstract     Related articles   

  1099. LUO C, Ye W, Hu J, Othmane B, et al
    A Poliovirus Receptor (CD155)-Related Risk Signature Predicts the Prognosis of Bladder Cancer.
    Front Oncol. 2021;11:660273.
    Abstract     Related articles   

  1100. MATSUI Y
    A case of inflammatory myofibroblastic tumor of the urinary bladder with emergency clinical symptoms similar to bladder cancer.
    Urol Case Rep. 2021;38:101740.
    Abstract     Related articles   

  1101. ZHANG P, Yang Q
    Overexpression of SHMT2 Predicts a Poor Prognosis and Promotes Tumor Cell Growth in Bladder Cancer.
    Front Genet. 2021;12:682856.
    Abstract     Related articles   

  1102. ZHOU Q, Qian Z, Ding W, Jiang G, et al
    Chronic psychological stress attenuates the efficacy of anti-PD-L1 immunotherapy for bladder cancer in immunocompetent mice.
    Cancer Invest. 2021 Jun 19:1-28. doi: 10.1080/07357907.2021.1943746.
    Abstract     Related articles   

  1103. GIANNARINI G, Agarwal N, Apolo AB, Briganti A, et al
    Urologists, You'll Never Walk Alone! How Novel Immunotherapy and Modern Imaging May Change the Management of Non-muscle-invasive Bladder Cancer.
    Eur Urol Oncol. 2021 Jun 16. pii: S2588-9311(21)00114.
    Abstract     Related articles   

  1104. JUE JS, Alameddine M, Gonzale J, Cianci G, et al
    Risk factors, management, and survival of bladder cancer after kidney transplantation.
    Actas Urol Esp (Engl Ed). 2021 Jun 16. pii: S2173-5786(21)00075.
    Abstract     Related articles   

  1105. BENMERZOUG S, Chevalier MF, Verardo M, Nguyen S, et al
    Siglec-6 as a New Potential Immune Checkpoint for Bladder Cancer Patients.
    Eur Urol Focus. 2021 Jun 16. pii: S2405-4569(21)00163.
    Abstract     Related articles   

  1106. ZHANG L, Hsieh MC, Allison C, Devane M, et al
    Racial differences in the risk of second primary bladder cancer following radiation therapy among localized prostate cancer patients.
    Cancer Epidemiol. 2021;73:101967.
    Abstract     Related articles   

  1107. SADETSKY N, Chuo CY, Davidoff AJ
    Development and evaluation of a proxy for baseline ECOG PS in advanced non-small cell lung cancer, bladder cancer, and melanoma: An electronic health record study.
    Pharmacoepidemiol Drug Saf. 2021 Jun 18. doi: 10.1002/pds.5309.
    Abstract     Related articles   

  1108. CIMADAMORE A, Lopez-Beltran A, Scarpelli M, Cheng L, et al
    Re: Bas W.G. van Rhijn, Anouk E. Hentschel, Johannes Brundl, et al. Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology No
    Eur Urol Oncol. 2021 Jun 15. pii: S2588-9311(21)00117.
    Abstract     Related articles   

  1109. OKUBO K, Miyai K, Kato K, Asano T, et al
    Simvastatin-romidepsin combination kills bladder cancer cells synergistically.
    Transl Oncol. 2021;14:101154.
    Abstract     Related articles   

  1110. KATAYAMA S, Mori K, Pradere B, Laukhtina E, et al
    Prognostic value of the systemic immune-inflammation index in non-muscle invasive bladder cancer.
    World J Urol. 2021 Jun 18. pii: 10.1007/s00345-021-03740.
    Abstract     Related articles   

  1111. IONOV NS, Baryshnikova MA, Bocharov EV, Pogodin PV, et al
    [Possibilities of in silico estimations for the development of pharmaceutical composition phytoladaptogene cytotoxic for bladder cancer cells].
    Biomed Khim. 2021;67:278-288.
    Abstract     Related articles   

  1112. CHOU KY, Chang AC, Ho CY, Tsai TF, et al
    Thrombospondin-4 promotes bladder cancer cell migration and invasion via MMP2 production.
    J Cell Mol Med. 2021 Jun 17. doi: 10.1111/jcmm.16463.
    Abstract     Related articles   

  1113. LU JL, Xia QD, Sun Y, Xun Y, et al
    Toll-Like Receptor 4 as a Favorable Prognostic Marker in Bladder Cancer: A Multi-Omics Analysis.
    Front Cell Dev Biol. 2021;9:651560.
    Abstract     Related articles   

  1114. BOTHIG R, Kowald B, Fiebag K, Balzer O, et al
    Bladder management, severity of injury and period of latency: a descriptive study on 135 patients with spinal cord injury and bladder cancer.
    Spinal Cord. 2021 Jun 17. pii: 10.1038/s41393-021-00651.
    Abstract     Related articles   

  1115. CIVELEK AC, Niglio SA, Malayeri AA, Lin J, et al
    Clinical value of (18)FDG PET/MRI in muscle-invasive, locally advanced, and metastatic bladder cancer.
    Urol Oncol. 2021 Jun 14. pii: S1078-1439(21)00181.
    Abstract     Related articles   

  1116. IQBAL U, Elsayed AS, Jing Z, Stoeckle M, et al
    Upstaging and Survival Outcomes for Non-Muscle Invasive Bladder Cancer After Radical Cystectomy: Results from the International Robotic Cystectomy Consortium.
    J Endourol. 2021 Jun 17. doi: 10.1089/end.2021.0013.
    Abstract     Related articles   

  1117. NIE Z, Chen M, Wen X, Gao Y, et al
    Endoplasmic Reticulum Stress and Tumor Microenvironment in Bladder Cancer: The Missing Link.
    Front Cell Dev Biol. 2021;9:683940.
    Abstract     Related articles   

  1118. GAO J, Tian DW, Zhou DS, Wu CL, et al
    Flexible cystoscopy can improve anxiety and subjective feelings of bladder cancer patients during follow-up.
    Wideochir Inne Tech Maloinwazyjne. 2021;16:397-402.
    Abstract     Related articles   

  1119. TIAN X, Zhu Q, Zhang Z
    Durable Clinical Response to Immune and Targeted Therapies in an Elderly Man with Synchronous Gastric (HER2+) and Bladder Cancers: Case Report and Literature Review.
    Onco Targets Ther. 2021;14:3701-3708.
    Abstract     Related articles   

  1120. CHOU WH, McGregor B, Schmidt A, Carvalho FLF, et al
    Cyclophosphamide-associated bladder cancers and considerations for survivorship care: A systematic review.
    Urol Oncol. 2021 Jun 13. pii: S1078-1439(21)00223.
    Abstract     Related articles   

  1121. NITSCHKE K, Worst TS, von Rhade SM, Thaqi B, et al
    High IL-22RA1 gene expression is associated with poor outcome in muscle invasive bladder cancer.
    Urol Oncol. 2021 Jun 13. pii: S1078-1439(21)00216.
    Abstract     Related articles   

  1122. GRICE P, O'Dowd S, Parkinson R, Bazo A, et al
    Bladder leiomyoma masquerading as a ureterocele.
    BMJ Case Rep. 2021;14.
    Abstract     Related articles   

  1123. BAJORIN DF, Witjes JA, Gschwend JE, Schenker M, et al
    Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma.
    N Engl J Med. 2021;384:2102-2114.
    Abstract     Related articles   

  1124. JERMAN UD, Visnjar T, Bratkovic IH, Resnik N, et al
    Attachment of Cancer Urothelial Cells to the Bladder Epithelium Occurs on Uroplakin-Negative Cells and Is Mediated by Desmosomal and Not by Classical Cadherins.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  1125. OZKAPTAN O, Cubuk A, Dincer E, Ipek OM, et al
    Adenocarcinoma in Orthotopic Neobladder 19 Years After Radical Cystoprostatectomy.
    J Coll Physicians Surg Pak. 2021;30:588-590.
    Abstract     Related articles   

  1126. WITZKE KE, Grosserueschkamp F, Gerwert K, Sitek B, et al
    Application of Label-Free Proteomics for Quantitative Analysis of Urothelial Carcinoma and Cystitis Tissue.
    Methods Mol Biol. 2021;2228:283-292.
    Abstract     Related articles   

  1127. DENG C, Guo H, Yan D, Liang T, et al
    Pancancer Analysis of Neurovascular-Related NRP Family Genes as Potential Prognostic Biomarkers of Bladder Urothelial Carcinoma.
    Biomed Res Int. 2021;2021:5546612.
    Abstract     Related articles   

  1128. CHEN CJ, Chou CY, Shu KH, Chen HC, et al
    Discovery of Novel Protein Biomarkers in Urine for Diagnosis of Urothelial Cancer Using iTRAQ Proteomics.
    J Proteome Res. 2021;20:2953-2963.
    Abstract     Related articles   

  1129. SOBERON JR, Awoniyi CA, Perez MA, Vasilopoulos T, et al
    Obturator Nerve Blockade vs. Neuromuscular Blockade for the Prevention of Adductor Spasm in Patients Undergoing Transurethral Resection of Bladder Tumors: A Randomized Controlled Trial.
    Pain Med. 2021;22:1253-1260.
    Abstract     Related articles   

  1130. ETANI T, Asaoka M, Kondo S, Wachino C, et al
    Efficacy of fosfomycin in the prevention of postoperative infection following transurethral resection of bladder tumor during periods of limited cefazolin, cefotiam, and cefmetazole supply.
    J Infect Chemother. 2021;27:625-631.
    Abstract     Related articles   

  1131. ORELLANA FM, Traete PL, de Toledo LGM
    Voiding dysfunction due to female urethral carcinoma.
    Int Urogynecol J. 2021;32:219-222.
    Abstract     Related articles   

  1132. LIU X, Li H, Che N, Zheng Y, et al
    HBXIP accelerates glycolysis and promotes cancer angiogenesis via AKT/mTOR pathway in bladder cancer.
    Exp Mol Pathol. 2021 Jun 30:104665. doi: 10.1016/j.yexmp.2021.104665.
    Abstract     Related articles   

  1133. BARON P, Khene Z, Lannes F, Pignot G, et al
    Multicenter external validation of the radical cystectomy pentafecta in a European cohort of patients undergoing robot-assisted radical cystectomy with intracorporeal urinary diversion for bladder cancer.
    World J Urol. 2021 Jul 3. pii: 10.1007/s00345-021-03753.
    Abstract     Related articles   

  1134. NAGAKAWA S, Shiota M, Fujimoto N, Yamamoto Y, et al
    The impact of single-nucleotide polymorphisms on intravesical recurrence after bacillus Calmette-Guerin therapy for non-muscle invasive bladder cancer in a genome-wide association study.
    Urol Oncol. 2021 Jun 29. pii: S1078-1439(21)00254.
    Abstract     Related articles   

  1135. MIRANDA AF, Howard JM, McLaughlin M, Meng X, et al
    Metastasis-directed radiation therapy after radical cystectomy for bladder cancer.
    Urol Oncol. 2021 Jun 29. pii: S1078-1439(21)00212.
    Abstract     Related articles   

  1136. KAGAWA M, Kawakami S, Yamamoto A, Suzuki O, et al
    Identification of Lynch syndrome-associated DNA mismatch repair-deficient bladder cancer in a Japanese hospital-based population.
    Int J Clin Oncol. 2021 Jul 2. pii: 10.1007/s10147-021-01922.
    Abstract     Related articles   

  1137. LU J, Luo JH, Pang J, Cao JZ, et al
    [Corrigendum] Lentivirusmediated RNA interference of clusterin enhances the chemosensitivity of EJ bladder cancer cells to epirubicin in vitro.
    Mol Med Rep. 2021;24.
    Abstract     Related articles   

  1138. BLOMQVIST M, Koskinen I, Loyttyniemi E, Mirtti T, et al
    Prognostic and predictive value of ALDH1, SOX2 and SSEA-4 in bladder cancer.
    Sci Rep. 2021;11:13684.
    Abstract     Related articles   

  1139. WANG Y, Wu J, Luo W, Zhang H, et al
    ALPK2 acts as tumor promotor in development of bladder cancer through targeting DEPDC1A.
    Cell Death Dis. 2021;12:661.
    Abstract     Related articles   

  1140. ELDH M, Mints M, Hiltbrunner S, Ladjevardi S, et al
    Proteomic Profiling of Tissue Exosomes Indicates Continuous Release of Malignant Exosomes in Urinary Bladder Cancer Patients, Even with Pathologically Undetectable Tumour.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  1141. SIKIC D, Taubert H, Wirtz RM, Breyer J, et al
    High Androgen Receptor mRNA Expression Is Associated with Improved Outcome in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer.
    Life (Basel). 2021;11.
    Abstract     Related articles   

  1142. CHIEN TM, Wu KH, Chuang YT, Yeh YC, et al
    Withaferin A Triggers Apoptosis and DNA Damage in Bladder Cancer J82 Cells through Oxidative Stress.
    Antioxidants (Basel). 2021;10.
    Abstract     Related articles   

  1143. WANG P, Zhou R, Thomas P, Zhao L, et al
    Epithelial-to-Mesenchymal Transition Enhances Cancer Cell Sensitivity to Cytotoxic Effects of Cold Atmospheric Plasmas in Breast and Bladder Cancer Systems.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  1144. ZHANG C, Berndt-Paetz M, Neuhaus J
    A Comprehensive Bioinformatics Analysis of Notch Pathways in Bladder Cancer.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  1145. KOLAT D, Kaluzinska Z, Bednarek AK, Pluciennik E, et al
    WWOX Loses the Ability to Regulate Oncogenic AP-2gamma and Synergizes with Tumor Suppressor AP-2alpha in High-Grade Bladder Cancer.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  1146. RINALDI F, Maurizi L, Forte J, Marazzato M, et al
    Resveratrol-Loaded Nanoemulsions: In Vitro Activity on Human T24 Bladder Cancer Cells.
    Nanomaterials (Basel). 2021;11.
    Abstract     Related articles   

  1147. SURMAN M, Kedracka-Krok S, Jankowska U, Drozdz A, et al
    Proteomic Profiling of Ectosomes Derived from Paired Urothelial Bladder Cancer and Normal Cells Reveals the Presence of Biologically-Relevant Molecules.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  1148. BOTTA C, Agostino RM, Dattola V, Cianci V, et al
    Myositis/Myasthenia after Pembrolizumab in a Bladder Cancer Patient with an Autoimmunity-Associated HLA: Immune-Biological Evaluation and Case Report.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  1149. CHUNG DY, Kang DH, Kim JW, Ha JS, et al
    Comparison of Oncologic Outcomes of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (ddMVAC) with Gemcitabine and Cisplatin (GC) as Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Systematic Review and Meta-Analysis.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  1150. CLAPS F, van de Kamp MW, Mayr R, Bostrom PJ, et al
    Risk factors associated with positive surgical margins' location at radical cystectomy and their impact on bladder cancer survival.
    World J Urol. 2021 Jul 1. pii: 10.1007/s00345-021-03776.
    Abstract     Related articles   

  1151. XIA QD, Hu J, Liu Z, Li C, et al
    Sex differences resulted differential morbidity and mortality in bladder cancer: smoke, hormone or urobiome?
    World J Urol. 2021 Jul 1. pii: 10.1007/s00345-021-03775.
    Abstract     Related articles   

  1152. WANG W, Ying Y, Xie H, Li J, et al
    miR-665 inhibits epithelial-to-mesenchymal transition in bladder cancer via the SMAD3/SNAIL axis.
    Cell Cycle. 2021 Jul 1:1-12. doi: 10.1080/15384101.2021.1929677.
    Abstract     Related articles   

  1153. ANZELA A, Min M, Knesl M, Buddle N, et al
    Concurrent carbogen and nicotinamide with radiation therapy in muscle invasive bladder cancer: A report on feasibility in the Australian setting.
    J Med Imaging Radiat Oncol. 2021 Jun 30. doi: 10.1111/1754-9485.13265.
    Abstract     Related articles   

  1154. SMITH L, Carrie A, Tully M, Barnett Y, et al
    The CADENCE pilot trial - Promoting physical activity in bladder cancer survivors: A protocol paper.
    Contemp Clin Trials Commun. 2021;22:100809.
    Abstract     Related articles   


  1155. Adjuvant Immunotherapy Best for ctDNA(+) Bladder Cancer.
    Cancer Discov. 2021 Jun 30. pii: 2159-8290.CD-NB2021-0365.
    Abstract     Related articles   

  1156. PETRYLAK DP, Powles T, Rosenberg JE
    Enfortumab Vedotin in Advanced Urothelial Carcinoma. Reply.
    N Engl J Med. 2021;385:93-94.
    Abstract     Related articles   

  1157. YEON SH, Lee HJ
    Enfortumab Vedotin in Advanced Urothelial Carcinoma.
    N Engl J Med. 2021;385:93.
    Abstract     Related articles   

  1158. YAKOVLEV PG, Gorbach OI, Ostapchenko LI, Garmanchuk LV, et al
    Expression of TLR4 and major inflammatory cytokines in patients with bladder cancer of different grade and stage.
    Exp Oncol. 2021;43:142-148.
    Abstract     Related articles   

  1159. SUH J, Jung JH, Kwak C, Kim HH, et al
    Stratifying risk for multiple, recurrent, and large (>/=3 cm) Ta, G1/G2 tumors in non-muscle-invasive bladder cancer.
    Investig Clin Urol. 2021;62:408-415.
    Abstract     Related articles   

  1160. ALHUBAISHY B, Mathes J, Knoll T
    Primary Urothelial Bladder Cancer in a Young Patient: A Case Report and Review of the Literature.
    Cureus. 2021;13:e15864.
    Abstract     Related articles   

  1161. ZHU J, Huang Z, Zhang M, Wang W, et al
    Erratum: HIF-1alpha promotes ZEB1 expression and EMT in a human bladder cancer lung metastasis animal model.
    Oncol Lett. 2021;22:599.
    Abstract     Related articles   

  1162. AHDOOT M, Theodorescu D
    Immunotherapy of high risk non-muscle invasive bladder cancer.
    Expert Rev Clin Pharmacol. 2021 Jun 30. doi: 10.1080/17512433.2021.1950531.
    Abstract     Related articles   

  1163. YAN X, Chen M, Xiao C, Fu J, et al
    Effect of unfolded protein response on the immune infiltration and prognosis of transitional cell bladder cancer.
    Ann Med. 2021;53:1047-1057.
    Abstract     Related articles   

  1164. MU X, Wu K, Zhu Y, Zhu Y, et al
    Intra-arterial infusion chemotherapy utilizing cisplatin inhibits bladder cancer by decreasing the fi brocytic myeloid-derived suppressor cells in an m6A-dependent manner.
    Mol Immunol. 2021;137:28-40.
    Abstract     Related articles   

  1165. LU X, Meng J, Zhu J, Zhou Y, et al
    Prognosis stratification and personalized treatment in bladder cancer through a robust immune gene pair-based signature.
    Clin Transl Med. 2021;11:e453.
    Abstract     Related articles   

  1166. ERKOC M, Otunctemur A, Bozkurt M, Can O, et al
    The efficacy and reliability of VI-RADS in determining candidates for repeated transurethral resection in patients with high-risk non-muscle invasive bladder cancer.
    Int J Clin Pract. 2021 Jun 29:e14584. doi: 10.1111/ijcp.14584.
    Abstract     Related articles   

  1167. MUILWIJK T, Akand M, Van der Aa F, De Coninck V, et al
    Cytokeratin 5 and cytokeratin 20 inversely correlate with tumour grading in Ta non-muscle-invasive bladder cancer.
    J Cell Mol Med. 2021 Jun 29. doi: 10.1111/jcmm.16712.
    Abstract     Related articles   

  1168. ZHAO R, Shan J, Nie L, Yang X, et al
    The predictive value of the ratio of the product of neutrophils and hemoglobin to lymphocytes in non-muscular invasive bladder cancer patients with postoperative recurrence.
    J Clin Lab Anal. 2021 Jun 29:e23883. doi: 10.1002/jcla.23883.
    Abstract     Related articles   

  1169. EL GHARIB K, Lilly E, Chebel R
    Checkpoint inhibitors in BCG-unresponsive nonmuscle invasive bladder cancer: can they help spare the bladder?
    Immunotherapy. 2021 Jun 29. doi: 10.2217/imt-2021-0030.
    Abstract     Related articles   

  1170. CAO B, Li Q, Xu P, Chen W, et al
    Preliminary Exploration of the Application of Vesical Imaging-Reporting and Data System (VI-RADS) in Post-treatment Patients With Bladder Cancer: A Prospective Single-Center Study.
    J Magn Reson Imaging. 2021 Jun 28. doi: 10.1002/jmri.27807.
    Abstract     Related articles   

  1171. LI R, Zhang J, Gilbert SM, Conejo-Garcia J, et al
    Using oncolytic viruses to ignite the tumour immune microenvironment in bladder cancer.
    Nat Rev Urol. 2021 Jun 28. pii: 10.1038/s41585-021-00483.
    Abstract     Related articles   

  1172. AIBARA N, Miyata Y, Araki K, Sagara Y, et al
    Detection of Novel Urine Markers Using Immune Complexome Analysis in Bladder Cancer Patients: A Preliminary Study.
    In Vivo. 2021;35:2073-2080.
    Abstract     Related articles   

  1173. BURNS JE, Hurst CD, Knowles MA, Phillips RM, et al
    The Warburg effect as a therapeutic target for bladder cancers and intratumoral heterogeneity in associated molecular targets.
    Cancer Sci. 2021 Jun 28. doi: 10.1111/cas.15047.
    Abstract     Related articles   

  1174. GORDETSKY JB, Montgomery KW, Giannico GA, Rais-Bahrami S, et al
    The Significance of Squamous Histology on Clinical Outcomes and PD-L1 Expression in Bladder Cancer.
    Int J Surg Pathol. 2021 Jun 28:10668969211027264. doi: 10.1177/10668969211027264
    Abstract     Related articles   

  1175. KARIKALAN B, Pasupati T, George SM
    Primary Mucinous Adenocarcinoma of the Urinary Bladder: A Rare Entity.
    West Afr J Med. 2021;38:604-606.
    Abstract     Related articles   

  1176. ZHENG H, Chen C
    Downregulation of CacyBP by CRISPR/dCas9-KRAB Prevents Bladder Cancer Progression.
    Front Mol Biosci. 2021;8:692941.
    Abstract     Related articles   

  1177. FU G, Cheng KS, Chen A, Xu Z, et al
    Microfluidic Assaying of Circulating Tumor Cells and Its Application in Risk Stratification of Urothelial Bladder Cancer.
    Front Oncol. 2021;11:701298.
    Abstract     Related articles   

  1178. ZHANG G, Wu Z, Xu L, Zhang X, et al
    Deep Learning on Enhanced CT Images Can Predict the Muscular Invasiveness of Bladder Cancer.
    Front Oncol. 2021;11:654685.
    Abstract     Related articles   

  1179. CAO C, Fu Z, Liu Y, Zhou A, et al
    A Muscle-Invasive Bladder Cancer Patient With High Tumor Mutational Burden and RB1 Mutation Achieved Bladder Preservation Following Chemotherapy Combined With Immunotherapy: A Case Report.
    Front Immunol. 2021;12:684879.
    Abstract     Related articles   

  1180. SUGAYA A, Shimazui T, Kitamura N, Tokita T, et al
    Intra-Abdominal Hypertension-Induced Gastroesophageal Intussusception: A Rare Complication of Transurethral Resection of a Bladder Tumor.
    Am J Case Rep. 2021;22:e930426.
    Abstract     Related articles   

  1181. FAN L, Yang J, Shen C, Wu Z, et al
    Circ_0030586 inhibits cell proliferation and stemness in bladder cancer by inactivating the ERK signaling via miR-665/NR4A3 axis.
    Acta Histochem. 2021;123:151745.
    Abstract     Related articles   

  1182. MICHELS CTJ, Wijburg CJ, Hannink G, Witjes JA, et al
    Robot-assisted Versus Open Radical Cystectomy in Bladder Cancer: An Economic Evaluation Alongside a Multicentre Comparative Effectiveness Study.
    Eur Urol Focus. 2021 Jun 23. pii: S2405-4569(21)00166.
    Abstract     Related articles   

  1183. ISMAEEL N, Patil D, Alemozaffar M, Filson CP, et al
    Palliative care use among bladder cancer patients treated with radical cystectomy.
    Urol Oncol. 2021 Jun 23. pii: S1078-1439(21)00186.
    Abstract     Related articles   

  1184. OURFALI S, Matillon X, Ricci E, Fassi-Fehri H, et al
    Prognostic Implications of Treatment Delays for Patients with Non-muscle-invasive Bladder Cancer.
    Eur Urol Focus. 2021 Jun 22. pii: S2405-4569(21)00169.
    Abstract     Related articles   

  1185. HAFIZAR, Hamid ARAH, Saraswati M
    Cystoscopy-assisted laparoscopic partial cystectomy for muscle-invasive bladder cancer: Initial experience in Cipto Mangunkusumo Hospital, Jakarta.
    Int J Surg Case Rep. 2021;84:106083.
    Abstract     Related articles   

  1186. BIN RIAZ I, Khan AM, Catto JW, Hussain SA, et al
    Bladder cancer: shedding light on the most promising investigational drugs in clinical trials.
    Expert Opin Investig Drugs. 2021 Jun 25. doi: 10.1080/13543784.2021.1948999.
    Abstract     Related articles   

  1187. MA W, Zhang W, Shen L, Liu J, et al
    Can Smoking Cause Differences in Urine Microbiome in Male Patients With Bladder Cancer? A Retrospective Study.
    Front Oncol. 2021;11:677605.
    Abstract     Related articles   

  1188. SHORE ND, Palou Redorta J, Robert G, Hutson TE, et al
    Non-muscle-invasive bladder cancer: An overview of potential new treatment options.
    Urol Oncol. 2021 Jun 21. pii: S1078-1439(21)00221.
    Abstract     Related articles   

  1189. NAKATANI S, Ida M, Wang X, Naito Y, et al
    Oral 5-aminolevulinic acid administration prior to transurethral resection of bladder tumor causes intraoperative hypotension: Propensity score analysis.
    Photodiagnosis Photodyn Ther. 2021;34:102342.
    Abstract     Related articles   

  1190. OKCU O, Hacihasanoglu E, Koparal MY
    Lymphoepithelioma like carcinoma of the urinary bladder, treated with transurethral resection and intravesical Bacillus Calmette Guerin therapy only: A case report.
    Acta Biomed. 2021;92:e2021031.
    Abstract     Related articles   

  1191. BUTTY EM, Hahn S, Labato MA
    Presumptive malignant transformation of chronic polypoid cystitis into an apical transitional cell carcinoma without BRAF mutation in a young female dog.
    J Vet Intern Med. 2021;35:1551-1557.
    Abstract     Related articles   

  1192. PAGLIARONE AC, Castaneda ED, Santana JPP, de Oliveira CAB, et al
    Mitochondrial heat shock protein mortalin as potential target for therapies based on oxidative stress.
    Photodiagnosis Photodyn Ther. 2021;34:102256.
    Abstract     Related articles   

  1193. PATEL NH, Miranda G, Cai J, Desai M, et al
    Robotic Radical Cystectomy Outcomes after Intervention for Prostate Cancer.
    J Endourol. 2021;35:633-638.
    Abstract     Related articles   

  1194. ABDALLAH MM, Wahbbah MA, Selem M, Abdou AG, et al
    Correlation between immunohistochemical expression of Ki-67and P63 and aggressiveness of urinary bladder urothelial carcinoma.
    J Immunoassay Immunochem. 2021;42:188-201.
    Abstract     Related articles   

  1195. YANG Z, Shen Z, Jin D, Zhang N, et al
    Mutations of METTL3 predict response to neoadjuvant chemotherapy in muscle-invasive bladder cancer.
    J Clin Transl Res. 2021;7:386-413.
    Abstract     Related articles   

  1196. ZHOU R, Liang J, Tian H, Chen Q, et al
    Development of a Ferroptosis-Related lncRNA Signature to Predict the Prognosis and Immune Landscape of Bladder Cancer.
    Dis Markers. 2021;2021:1031906.
    Abstract     Related articles   

  1197. WU Y, Liu Z, Wei X, Feng H, et al
    Identification of the Functions and Prognostic Values of RNA Binding Proteins in Bladder Cancer.
    Front Genet. 2021;12:574196.
    Abstract     Related articles   

  1198. SHAN L, Liu W, Zhan Y
    LncRNA HAND2-AS1 exerts anti-oncogenic effects on bladder cancer via restoration of RARB as a sponge of microRNA-146.
    Cancer Cell Int. 2021;21:361.
    Abstract     Related articles   

  1199. WANG N
    Editorial for "Investigation of Synthetic MRI Applied in the Evaluation of the Tumor Grade of Bladder Cancer".
    J Magn Reson Imaging. 2021 Jul 8. doi: 10.1002/jmri.27826.
    Abstract     Related articles   

  1200. XU S, Cao P, Wang K, Wu T, et al
    Clinical outcomes of reresection in patients with high-risk nonmuscle-invasive bladder cancer treated with en bloc transurethral resection: a retrospective study with a 1-year follow-up.
    J Endourol. 2021 Jul 8. doi: 10.1089/end.2021.0008.
    Abstract     Related articles   

  1201. CAI Z, Hu J, Othmane B, Li H, et al
    Effects of Fibrin Clot Inhibitors and Statins on the Intravesical Bacille Calmette-Guerin Therapy for Bladder Cancer: A Systematic Review and Meta-Analysis.
    Front Oncol. 2021;11:614041.
    Abstract     Related articles   

  1202. SANGANI V, Pokal M, Balla M, Merugu GP, et al
    Pembrolizumab related Guillain barre syndrome, a rare presentation in a patient with a history of lupus and bladder cancer.
    J Community Hosp Intern Med Perspect. 2021;11:388-392.
    Abstract     Related articles   

  1203. JIANG L, Wang Y, Tang H, Li X, et al
    CircCA12 Promotes Malignant Process via Sponging miR-1184 and Upregulating RAS Family in Bladder Cancer.
    Front Genet. 2021;12:663982.
    Abstract     Related articles   

  1204. ARAGON-CHING JB
    Pembrolizumab use in bladder cancer: a tale of two trials.
    Nat Rev Urol. 2021 Jul 6. pii: 10.1038/s41585-021-00499.
    Abstract     Related articles   

  1205. HAJJAR M, Rezazadeh A, Naja F, Kardoust Parizi M, et al
    Association of the Healthy Nordic Food Index with risk of bladder cancer: a case-control study.
    Eur J Clin Nutr. 2021 Jul 6. pii: 10.1038/s41430-021-00971.
    Abstract     Related articles   

  1206. OK S, Seo H, Park Y, Kim J, et al
    Curative resection of bladder cancer pancreas head metastasis.
    Ann Hepatobiliary Pancreat Surg. 2021;25.
    Abstract     Related articles   

  1207. XIE S, Zhao Z, Feng B, Zhang S, et al
    A comparative study of perioperative and survival outcomes of robot-assisted radical cystectomy in patients over 80 and under 80 years old.
    World J Surg Oncol. 2021;19:202.
    Abstract     Related articles   

  1208. OTT OJ
    [Moderate hypofractionated radiotherapy for bladder cancer-a new standard of care?]
    Strahlenther Onkol. 2021 Jul 6. pii: 10.1007/s00066-021-01804.
    Abstract     Related articles   

  1209. OHADIAN MOGHADAM S, Abbasi B, Nowroozi A, Amini E, et al
    A possible protective role for Bacillus Calmette-Guerin therapy in urinary bladder cancer in the era of COVID-19: a brief report.
    Clin Exp Vaccine Res. 2021;10:191-195.
    Abstract     Related articles   

  1210. CHEN S, Jiang L, Zhang E, Hu S, et al
    A Novel Nomogram Based on Machine Learning-Pathomics Signature and Neutrophil to Lymphocyte Ratio for Survival Prediction of Bladder Cancer Patients.
    Front Oncol. 2021;11:703033.
    Abstract     Related articles   

  1211. WANG W, Liu J, Liu L
    Development and Validation of a Prognostic Model for Predicting Overall Survival in Patients With Bladder Cancer: A SEER-Based Study.
    Front Oncol. 2021;11:692728.
    Abstract     Related articles   

  1212. TIAN Z, Meng L, Wang X, Diao T, et al
    Predictive Nomogram and Risk Factors for Lymph Node Metastasis in Bladder Cancer.
    Front Oncol. 2021;11:690324.
    Abstract     Related articles   

  1213. YAN X, Wu HH, Chen Z, Du GW, et al
    Construction and Validation of an Autophagy-Related Prognostic Signature and a Nomogram for Bladder Cancer.
    Front Oncol. 2021;11:632387.
    Abstract     Related articles   

  1214. YANG K, Shen J, Tan FQ, Zheng XY, et al
    Antitumor Activity of Small Activating RNAs Induced PAWR Gene Activation in Human Bladder Cancer Cells.
    Int J Med Sci. 2021;18:3039-3049.
    Abstract     Related articles   

  1215. XIAO C, Wang Y, Hua M, Zhang W, et al
    Complete transperitoneal laparoscopic nephroureterectomy in a single position for upper urinary tract urothelial carcinoma and comparative outcomes.
    World J Surg Oncol. 2021;19:195.
    Abstract     Related articles   

  1216. WIGNALL D, Sawant R, Gkentzis A, Lee L, et al
    An unusual presentation of synchronous bladder metastases from an oesophageal adenocarcinoma.
    Ann R Coll Surg Engl. 2021;103:e227-e230.
    Abstract     Related articles   

  1217. XIE H, Chun FK, Rutz J, Blaheta RA, et al
    Sulforaphane Impact on Reactive Oxygen Species (ROS) in Bladder Carcinoma.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  1218. SHENG F, Chen KX, Liu J, Li JX, et al
    Chromium (VI) promotes EMT by regulating FLNA in BLCA.
    Environ Toxicol. 2021;36:1694-1701.
    Abstract     Related articles   

  1219. OZER MS, Yildiz HA, Incir C, Deger MD, et al
    Urinary microbiota; Which non-invasive urine collection method should we use?
    Int J Clin Pract. 2021;75:e14193.
    Abstract     Related articles   

  1220. MEKA VM, Wankhar B, Ojili V, Batchala PP, et al
    Papillary Urothelial Carcinoma of Urinary Bladder Identified on 18F-Fluciclovine PET/CT.
    Clin Nucl Med. 2021 Mar 16. pii: 00003072-900000000-96157.
    Abstract     Related articles   

  1221. HUANG RSP, Haberberger J, Harries L, Severson E, et al
    Clinicopathologic and Genomic Characterization of PD-L1 Positive Urothelial Carcinomas.
    Oncologist. 2021;26:375-382.
    Abstract     Related articles   

  1222. MIURA N, Mori K, Laukhtina E, Schuettfort VM, et al
    Prognostic value of the preoperative albumin-globulin ratio in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration.
    Jpn J Clin Oncol. 2021;51:1149-1157.
    Abstract     Related articles   

  1223. BROWN JT, Liu Y, Shabto JM, Martini DJ, et al
    Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors.
    Oncologist. 2021;26:397-405.
    Abstract     Related articles   

  1224. LAI S, Long X, Wu P, Liu J, et al
    Developing a nomogram for predicting intravesical recurrence after radical nephroureterectomy: a retrospective cohort study of mainland Chinese patients.
    Jpn J Clin Oncol. 2021;51:1132-1141.
    Abstract     Related articles   

  1225. LU Y, Sun J, Wang Y
    Acute urinary retention with a missed bladder neck leiomyoma.
    Int Urogynecol J. 2021;32:1321-1324.
    Abstract     Related articles   

  1226. XU G, Lu Y
    Optimal Time Point for 68Ga-PSMA-11 PET/CT Imaging in the Assessment of Suspected Metastatic Prostate Cancer in the Bladder of Postprostatectomy Patient.
    Clin Nucl Med. 2021 Feb 9. pii: 00003072-900000000-96219.
    Abstract     Related articles   

  1227. ROJAS PA, Gonzalez C, Mendez GP, Majerson A, et al
    Bladder squamous cell carcinoma in a pregnant woman: case report and review of the literature.
    BMC Urol. 2021;21:4.
    Abstract     Related articles   

  1228. ZENG S, Ou H, Gao Z, Zhang J, et al
    HCPT-peptide prodrug with tumor microenvironment -responsive morphology transformable characteristic for boosted bladder tumor chemotherapy.
    J Control Release. 2021;330:715-725.
    Abstract     Related articles   

  1229. MIHAI IM, Olteanu GE, Herman D, Anderco D, et al
    Analysis of Tumor Depth Invasion With Anti-Smoothelin Antibody in Equivocal Transurethral Resection of Urinary Bladder Tumor Surgical Specimens.
    Int J Surg Pathol. 2021;29:54-63.
    Abstract     Related articles   

  1230. BANERJEE S, Semper K, Skarparis K, Naisby J, et al
    Patient perspectives of vigorous intensity aerobic interval exercise prehabilitation prior to radical cystectomy: a qualitative focus group study.
    Disabil Rehabil. 2019 Aug 14:1-8. doi: 10.1080/09638288.2019.1651907.
    Abstract     Related articles   

  1231. CHEN MK, Zhou JH, Wang P, Ye YL, et al
    BMI1 activates P-glycoprotein via transcription repression of miR-3682-3p and enhances chemoresistance of bladder cancer cell.
    Aging (Albany NY). 2021;13.
    Abstract     Related articles   

  1232. BABOUDJIAN M, Tadrist A, Lechevallier E
    Response to Editorial Comment: "Primary Complete Transurethral Resection of Bladder Tumor Using Photodynamic Diagnosis for High-risk Nonmuscle Invasive Bladder Cancer: Is a Restaging Photodynamic Transurethral Resection Really Necessary?" by Tadrist e
    J Endourol. 2021;35:1049-1050.
    Abstract     Related articles   

  1233. SLOVACEK H, Zhuo J, Taylor JM
    Approaches to Non-Muscle-Invasive Bladder Cancer.
    Curr Oncol Rep. 2021;23:105.
    Abstract     Related articles   

  1234. WANG Z, Han C, Xu Y, Yu X, et al
    The role of prostate-specific antigen and multiparametric magnetic resonance imaging in the diagnosis of granulomatous prostatitis induced by intravesical Bacillus Calmette-Guerin vaccine therapy in patients with nonmuscle invasive bladder cancer.
    J Cancer Res Ther. 2021;17:625-629.
    Abstract     Related articles   

  1235. TZELVES L, Xenou D, Skolarikos A, Varkarakis I, et al
    Association of obesity and other anthropometric characteristics with bladder cancer risk: a systematic review and meta-analysis of longitudinal cohort studies.
    J BUON. 2021;26:1040-1055.
    Abstract     Related articles   

  1236. GOKYER A, Kucukarda A, Kostek O, Sayin S, et al
    The relation between tissue galectin-3 level and platinum resistance in neoadjuvant bladder cancer treatment.
    J BUON. 2021;26:1034-1039.
    Abstract     Related articles   

  1237. CHEN H, Liu Y, Cao C, Xi H, et al
    CYR61 as a potential biomarker for the preoperative identification of muscle-invasive bladder cancers.
    Ann Transl Med. 2021;9:761.
    Abstract     Related articles   

  1238. WANG R, Zheng Z, Mao S, Zhang W, et al
    Construction and Validation of a Novel Eight-Gene Risk Signature to Predict the Progression and Prognosis of Bladder Cancer.
    Front Oncol. 2021;11:632459.
    Abstract     Related articles   

  1239. LAUKHTINA E, Mori K, D Andrea D, Moschini M, et al
    Incidence, risk factors and outcomes of urethral recurrence after radical cystectomy for bladder cancer: A systematic review and meta-analysis.
    Urol Oncol. 2021 Jul 12. pii: S1078-1439(21)00267.
    Abstract     Related articles   

  1240. HIRANO S, Matsumoto K, Shiono Y, Nakamura M, et al
    [Clinicopathological Characteristics of Adolescent and Young-Adult Patients with Bladder Cancer].
    Hinyokika Kiyo. 2021;67:221-224.
    Abstract     Related articles   

  1241. CHRYSOSTOMOU S, Roy R, Prischi F, Thamlikitkul L, et al
    Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer.
    Sci Transl Med. 2021;13.
    Abstract     Related articles   

  1242. SCHULZ GB, Todorova R, Braunschweig T, Rodler S, et al
    PD-L1 expression in bladder cancer: Which scoring algorithm in what tissue?
    Urol Oncol. 2021 Jul 11. pii: S1078-1439(21)00260.
    Abstract     Related articles   

  1243. WEYERER V, Stoehr R, Bertz S, Lange F, et al
    Prognostic impact of molecular muscle-invasive bladder cancer subtyping approaches and correlations with variant histology in a population-based mono-institutional cystectomy cohort.
    World J Urol. 2021 Jul 14. pii: 10.1007/s00345-021-03788.
    Abstract     Related articles   

  1244. HAO H, Chen H, Xie L, Liu H, et al
    YKL-40 promotes invasion and metastasis of bladder cancer by regulating epithelial mesenchymal transition.
    Ann Med. 2021;53:1169-1177.
    Abstract     Related articles   

  1245. ZHU J, Zhang F
    Circular RNA VANGL1 knockdown suppressed viability, promoted apoptosis, and increased doxorubicin sensitivity through targeting miR-145-5p to regulate SOX4 in bladder cancer cells.
    Open Med (Wars). 2021;16:1010-1021.
    Abstract     Related articles   

  1246. FERRO M, Baba DF, de Cobelli O, Musi G, et al
    Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy.
    Future Sci OA. 2021;7:FSO709.
    Abstract     Related articles   

  1247. SPASOVA V, Mladenov B, Rangelov S, Hammoudeh Z, et al
    Clinical impact of copy number variation changes in bladder cancer samples.
    Exp Ther Med. 2021;22:901.
    Abstract     Related articles   

  1248. CHEN M, Nie Z, Cao H, Gao Y, et al
    Rac3 Expression and its Clinicopathological Significance in Patients With Bladder Cancer.
    Pathol Oncol Res. 2021;27:598460.
    Abstract     Related articles   

  1249. JEONG H, Oh HE, Kim H, Lee JH, et al
    Upregulation of Fatty Acid Transporters is Associated With Tumor Progression in Non-Muscle-Invasive Bladder Cancer.
    Pathol Oncol Res. 2021;27:594705.
    Abstract     Related articles   

  1250. MEZA L, Salgia NJ, Patel KC, Pal SK, et al
    Learning from BISCAY: The future of biomarker-based trial design in bladder cancer.
    Cancer Cell. 2021;39:910-912.
    Abstract     Related articles   

  1251. OZGUL HA, Altay C, Basara Akin I, Bozkurt O, et al
    [Evaluation of solid pulmonary nodules in patients with bladder cancer with computed tomography based texture analysis method: Is it possible to differentiate metastatic - non-metastatic nodules?]
    Tuberk Toraks. 2021;69:227-236.
    Abstract     Related articles   

  1252. JENSEN JB
    The devil is in the selected details: second-look resection in T1 bladder cancer.
    Scand J Urol. 2021 Jul 13:1. doi: 10.1080/21681805.2021.1948099.
    Abstract     Related articles   

  1253. ZUBKOV AY, Nuriev IR, Sitdykova ME
    [Improvement of oncologic results of transurethral resection in the treatment of non-muscle-invasive bladder cancer].
    Urologiia. 2021;:110-113.
    Abstract     Related articles   

  1254. KOMYAKOV BK, Sergeev AV, Fadeev VA, Al-Attar TH, et al
    [Long-term results of radical surgery treatment of patients with bladder cancer].
    Urologiia. 2021;:104-109.
    Abstract     Related articles   

  1255. GHORBANI H, Zarifmahmoudi L, Sadeghi R, Soltani S, et al
    Bowel visualization on the lymphoscintigraphy images of a bladder cancer patient due to inadvertent injection of the tracer in the rectal wall.
    Asia Ocean J Nucl Med Biol. 2021;9:177-179.
    Abstract     Related articles   

  1256. JANEV A, Ramuta TZ, Tratnjek L, Sardoc Z, et al
    Detrimental Effect of Various Preparations of the Human Amniotic Membrane Homogenate on the 2D and 3D Bladder Cancer In vitro Models.
    Front Bioeng Biotechnol. 2021;9:690358.
    Abstract     Related articles   

  1257. DONG Y, Ma WM, Shi ZD, Zhang ZG, et al
    Role of NRP1 in Bladder Cancer Pathogenesis and Progression.
    Front Oncol. 2021;11:685980.
    Abstract     Related articles   

  1258. LUO C, Lei T, Zhao M, Meng Q, et al
    The Role of NPM1 in the Invasion and Migration of Drug Resistant Bladder Cancer.
    Urol J. 2021 Jul 6. pii: 6087. doi: 10.22037/uj.v18i.6087.
    Abstract     Related articles   

  1259. XU X, Xie B, Li S, Wang S, et al
    Association of dietary tomato intake with bladder cancer risk in a prospective cohort of 101,683 individuals with 12.5 years of follow-up.
    Aging (Albany NY). 2021;13.
    Abstract     Related articles   

  1260. SHEN C, Zhou K, Wang W, Zhang Y, et al
    The prognostic value of preoperative serum albumin in patients with bladder urothelial carcinoma undergoing transurethral resection of bladder tumor: A prospective cohort study.
    Medicine (Baltimore). 2021;100:e26548.
    Abstract     Related articles   

  1261. ERMAN A, Kamensek U, Dragin Jerman U, Pavlin M, et al
    How Cancer Cells Invade Bladder Epithelium and Form Tumors: The Mouse Bladder Tumor Model as a Model of Tumor Recurrence in Patients.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  1262. LOU Y, Ma C, Liu Z, Shi J, et al
    Antimony exposure promotes bladder tumor cell growth by inhibiting PINK1-Parkin-mediated mitophagy.
    Ecotoxicol Environ Saf. 2021;221:112420.
    Abstract     Related articles   

  1263. ZENGIN ZB, Meza L, Pal SK, Grivas P, et al
    Chemoimmunotherapy in urothelial cancer: concurrent or sequential?
    Lancet Oncol. 2021;22:894-896.
    Abstract     Related articles   

  1264. POWLES T, Csoszi T, Ozguroglu M, Matsubara N, et al
    Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.
    Lancet Oncol. 2021;22:931-945.
    Abstract     Related articles   

  1265. GEORGE S, Bell EJ, Zheng Y, Kim R, et al
    The Impact of Adverse Events on Health Care Resource Utilization, Costs, and Mortality Among Patients Treated with Immune Checkpoint Inhibitors.
    Oncologist. 2021;26:e1205-e1215.
    Abstract     Related articles   

  1266. TSAI CW, Chang WS, Xu Y, Huang M, et al
    Associations of genetically predicted circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 with bladder cancer risk.
    Mol Carcinog. 2021 Jul 22. doi: 10.1002/mc.23334.
    Abstract     Related articles   

  1267. KAO CC, Cheng YC, Yang MH, Cha TL, et al
    Demethoxycurcumin induces apoptosis in HER2 overexpressing bladder cancer cells through degradation of HER2 and inhibiting the PI3K/Akt pathway.
    Environ Toxicol. 2021 Jul 22. doi: 10.1002/tox.23332.
    Abstract     Related articles   

  1268. ZHANG Q, Hao L, Shen Z, Wang F, et al
    MiR-186-5p suppresses cell migration, invasion, and epithelial mesenchymal transition in bladder cancer by targeting RAB27A/B.
    Environ Toxicol. 2021 Jul 22. doi: 10.1002/tox.23331.
    Abstract     Related articles   

  1269. TIAN Y, Gao P, Dai D, Chen L, et al
    Circular RNA circSETD3 hampers cell growth, migration, and stem cell properties in bladder cancer through sponging miR-641 to upregulate PTEN.
    Cell Cycle. 2021 Jul 21:1-14. doi: 10.1080/15384101.2021.1954758.
    Abstract     Related articles   

  1270. DOWER K, Ford A, Sandford M, Doherty A, et al
    Retrospective evaluation of planning margins for patients undergoing radical radiation therapy treatment for bladder cancer using volumetric modulated arc therapy and cone beam computed tomography.
    J Med Radiat Sci. 2021 Jul 20. doi: 10.1002.
    Abstract     Related articles   

  1271. LEWIS S, Galsky M
    Editorial for "Preliminary Exploration of the Application of Vesical Imaging-Reporting and Data System (VI-RADS) in Post-Treatment Patients with Bladder Cancer: A Prospective Single-Center Study".
    J Magn Reson Imaging. 2021 Jul 19. doi: 10.1002/jmri.27843.
    Abstract     Related articles   

  1272. TU A, Said N, Muddiman DC
    Spatially resolved metabolomic characterization of muscle invasive bladder cancer by mass spectrometry imaging.
    Metabolomics. 2021;17:70.
    Abstract     Related articles   

  1273. BRANCO EA, Duro R, Brito T, Sarmento A, et al
    Granulomatous Hepatitis Following Intra-Vesical Instillation of Bacillus Calmette-Guerin for Treatment of Bladder Cancer.
    Infect Dis Rep. 2021;13:611-618.
    Abstract     Related articles   

  1274. AKGUL M, Baykan O, Cagman Z, Ozyurek M, et al
    Gas6 expression and Tyrosine kinase Axl Sky receptors: Their relation with tumor stage and grade in patients with bladder cancer.
    Arch Ital Urol Androl. 2021;93:148-152.
    Abstract     Related articles   

  1275. MITRAKAS L, Gravas S, Karasavvidou F, Zachos I, et al
    Endothelin-1 indicates unfavorable prognosis in primary high-grade non-muscle-invasive urothelial bladder cancer.
    Arch Ital Urol Androl. 2021;93:143-147.
    Abstract     Related articles   

  1276. POLINENI P, Ashack L, Kalapurakal J, Morgans A, et al
    Trimodality Treatment for Muscle-Invasive Bladder Cancer: An Institutional Experience.
    Adv Radiat Oncol. 2021;6:100718.
    Abstract     Related articles   

  1277. CHE X, Zhan J, Zhao F, Zhong Z, et al
    Oridonin Promotes Apoptosis and Restrains the Viability and Migration of Bladder Cancer by Impeding TRPM7 Expression via the ERK and AKT Signaling Pathways.
    Biomed Res Int. 2021;2021:4340950.
    Abstract     Related articles   

  1278. WEN J, Yang T, Mallouk N, Zhang Y, et al
    Urinary Exosomal CA9 mRNA as a Novel Liquid Biopsy for Molecular Diagnosis of Bladder Cancer.
    Int J Nanomedicine. 2021;16:4805-4811.
    Abstract     Related articles   

  1279. YANG C, Mou Z, Wu S, Ou Y, et al
    High-throughput sequencing identified circular RNA circUBE2K mediating RhoA associated bladder cancer phenotype via regulation of miR-516b-5p/ARHGAP5 axis.
    Cell Death Dis. 2021;12:719.
    Abstract     Related articles   

  1280. ZHANG F, Wu H
    MiR-599 targeting TOP2A inhibits the malignancy of bladder cancer cells.
    Biochem Biophys Res Commun. 2021;570:154-161.
    Abstract     Related articles   

  1281. SHAN G, Zhou X, Gu J, Zhou D, et al
    Correction to: Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/beta-catenin pathway and upregulating PTEN.
    Cell Oncol (Dordr). 2021 Jul 20. pii: 10.1007/s13402-021-00615.
    Abstract     Related articles   

  1282. ZHANG F, Wang X, Hu H, Yang Y, et al
    A hypoxia related long non-coding RNA signature could accurately predict survival outcomes in patients with bladder cancer.
    Bioengineered. 2021;12:3802-3823.
    Abstract     Related articles   

  1283. KIM IH, Lee HJ
    Perioperative Systemic Treatment for Muscle-Invasive Bladder Cancer: Current Evidence and Future Perspectives.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  1284. FERRO M, Lucarelli G, de Cobelli O, Dolce P, et al
    A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy.
    Future Oncol. 2021 Jul 19. doi: 10.2217/fon-2020-1298.
    Abstract     Related articles   

  1285. CHOU KY, Chen PC, Chang AC, Tsai TF, et al
    Attenuation of chloroquine and hydroxychloroquine on the invasive potential of bladder cancer through targeting matrix metalloproteinase 2 expression.
    Environ Toxicol. 2021 Jul 19. doi: 10.1002/tox.23328.
    Abstract     Related articles   

  1286. WANG Z, Wang X, Wang Y, Tang S, et al
    Transcriptomic Analysis of Gene Networks Regulated by U11 Small Nuclear RNA in Bladder Cancer.
    Front Genet. 2021;12:695597.
    Abstract     Related articles   

  1287. BESSA A, Bosco C, Cahill F, Russell B, et al
    Designing a Pragmatic Intervention to Help Improve the Bladder Cancer Patient Experience.
    Inquiry. 2021;58:469580211030217.
    Abstract     Related articles   

  1288. KOBAYASHI G, Takayanagi A, Shindo T, Hashimoto K, et al
    [A Case of Diagnosed Lynch Syndrome in a Patient with Ureteral Cancer].
    Hinyokika Kiyo. 2021;67:229-232.
    Abstract     Related articles   

  1289. BANCHEREAU R, Leng N, Zill O, Sokol E, et al
    Molecular determinants of response to PD-L1 blockade across tumor types.
    Nat Commun. 2021;12:3969.
    Abstract     Related articles   

  1290. DETTI B, Sardaro A, Maragna V, Mariotti M, et al
    Radiotherapy is effective in the management of rare penile metastases: Two case reports.
    Cancer Radiother. 2021;25:480-483.
    Abstract     Related articles   

  1291. BALLAS LK, Navarro S, Luo C, Fossum CC, et al
    Disparities in male versus female oncologic outcomes following bladder preservation: A population-based cohort study.
    Cancer Med. 2021;10:3004-3012.
    Abstract     Related articles   

  1292. BUSZEK SM, Ludmir EB, Grosshans DR, McAleer MF, et al
    Disease Control and Patterns of Failure After Proton Beam Therapy for Rhabdomyosarcoma.
    Int J Radiat Oncol Biol Phys. 2021;109:718-725.
    Abstract     Related articles   

  1293. STURARO G, Tasso A, Menilli L, Di Liddo R, et al
    4,6,4'-Trimethylangelicin Photoactivated by Blue Light Might Represent an Interesting Option for Photochemotherapy of Non-Invasive Bladder Carcinoma: An In Vitro Study on T24 Cells.
    Biomolecules. 2021;11.
    Abstract     Related articles   

  1294. LAUKHTINA E, Pradere B, Mori K, Schuettfort VM, et al
    Catalog of prognostic tissue-based biomarkers in patients treated with neoadjuvant systemic therapy for urothelial carcinoma of the bladder: a systematic review.
    Urol Oncol. 2021;39:180-190.
    Abstract     Related articles   

  1295. AMANO N, Matsumoto K, Shimizu Y, Nakamura M, et al
    High HNRNPA3 expression is associated with lymph node metastasis and poor prognosis in patients treated with radical cystectomy.
    Urol Oncol. 2021;39:196.
    Abstract     Related articles   

  1296. POSADA CALDERON L, Al Hussein Al Awamlh B, Shoag J, Patel N, et al
    The role of surgical experience in patient selection, surgical quality, and outcomes in robot-assisted radical cystectomy.
    Urol Oncol. 2021;39:6-12.
    Abstract     Related articles   

  1297. GRIGG CM, Livasy C, He J, Hartman A, et al
    Human epidermal growth factor receptor 2 overexpression is frequently discordant between primary and metastatic urothelial carcinoma and is associated with intratumoral human epidermal growth factor receptor 2 heterogeneity.
    Hum Pathol. 2021;107:96-103.
    Abstract     Related articles   

  1298. YANG R, Du Y, Weng X, Chen Z, et al
    Automatic recognition of bladder tumours using deep learning technology and its clinical application.
    Int J Med Robot. 2021;17:e2194.
    Abstract     Related articles   

  1299. KARDOUST PARIZI M, Margulis V, Compe Rat E, Shariat SF, et al
    The value and limitations of urothelial bladder carcinoma molecular classifications to predict oncological outcomes and cancer treatment response: A systematic review and meta-analysis.
    Urol Oncol. 2021;39:15-33.
    Abstract     Related articles   

  1300. LOUGHLIN KR
    Relentlessly make yourself obsolete: Robot-assisted radical cystectomy, the emerging standard of care.
    Urol Oncol. 2021;39:13-14.
    Abstract     Related articles   

  1301. SMITH AB, Samuel CA, McCabe SD, Deal A, et al
    Feasibility and delivery of patient-reported outcomes in clinical practice among racially diverse bladder and prostate cancer patients.
    Urol Oncol. 2021;39:77.
    Abstract     Related articles   

  1302. DRAKAKI A, Pantuck A, Mhatre SK, Dhillon PK, et al
    "Real-world" outcomes and prognostic indicators among patients with high-risk muscle-invasive urothelial carcinoma.
    Urol Oncol. 2021;39:76.
    Abstract     Related articles   

  1303. JAMAL A, Shahid I, Naveed Shahid M, Saleh Alshmemri M, et al
    Human Papillomavirus, MicroRNA and their Role in Cervical Cancer Progression, Diagnosis and Treatment Response: A Comprehensive Review.
    Pak J Biol Sci. 2020;23:977-988.
    Abstract     Related articles   

  1304. ZHOU Z, Gao Z, Wu J, Cui Y, et al
    Safety and efficacy of bipolar versus monopolar transurethral resection of bladder tumor: a systematic review and meta-analysis.
    World J Urol. 2021;39:2249-2250.
    Abstract     Related articles   

  1305. ZHU MMT, Burugu S, Gao D, Yu J, et al
    Evaluation of glucocorticoid-induced TNF receptor (GITR) expression in breast cancer and across multiple tumor types.
    Mod Pathol. 2020 Apr 29. pii: 10.1038/s41379-020-0550.
    Abstract     Related articles   

  1306. SHARMA G, Sharma AP, Mavuduru RS, Bora GS, et al
    Safety and efficacy of bipolar versus monopolar transurethral resection of bladder tumor: a systematic review and meta-analysis.
    World J Urol. 2021;39:377-387.
    Abstract     Related articles   

  1307. CHAN E, Garg K, Stohr BA
    Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer.
    Mod Pathol. 2020 Apr 20. pii: 10.1038/s41379-020-0543.
    Abstract     Related articles   

  1308. BEANO H, He J, Hensel C, Worrilow W, et al
    Safety of decreasing ureteral stent duration following radical cystectomy.
    World J Urol. 2021;39:473-479.
    Abstract     Related articles   

  1309. GUO L, Wu Q, Ma Z, Yuan M, et al
    Identification of immune-related genes that predict prognosis and risk of bladder cancer: bioinformatics analysis of TCGA database.
    Aging (Albany NY). 2021;13.
    Abstract     Related articles   

  1310. NGUYEN TP, Zhang CA, Sonn GA, Eisenberg ML, et al
    Consumption of cruciferous vegetables and the risk of bladder cancer in a prospective US cohort: data from the NIH-AARP diet and health study.
    Am J Clin Exp Urol. 2021;9:229-238.
    Abstract     Related articles   

  1311. LI H, Cao Y, Ma P, Ma Z, et al
    Novel Visualization Methods Assisted Transurethral Resection for Bladder Cancer: An Updated Survival-Based Systematic Review and Meta-Analysis.
    Front Oncol. 2021;11:644341.
    Abstract     Related articles   

  1312. HE H, Yi L, Zhang B, Yan B, et al
    USP24-GSDMB complex promotes bladder cancer proliferation via activation of the STAT3 pathway.
    Int J Biol Sci. 2021;17:2417-2429.
    Abstract     Related articles   

  1313. ZHENG H, Chen C, Luo Y, Yu M, et al
    Tumor-derived exosomal BCYRN1 activates WNT5A/VEGF-C/VEGFR3 feedforward loop to drive lymphatic metastasis of bladder cancer.
    Clin Transl Med. 2021;11:e497.
    Abstract     Related articles   

  1314. MEI Y, Wu Y, Ma L, Zhang H, et al
    Overexpression of ROCK1 promotes cancer cell proliferation and is associated with poor prognosis in human urothelial bladder cancer.
    Mamm Genome. 2021 Jul 28. pii: 10.1007/s00335-021-09896.
    Abstract     Related articles   

  1315. HUA S, Xie Z, Wang W, Wan Z, et al
    Identification and Validation of a Novel Immune-Related lncRNA Signature for Bladder Cancer.
    Front Oncol. 2021;11:704946.
    Abstract     Related articles   

  1316. ZHANG X, Li X, Fu X, Yu M, et al
    Circular RNA TAF4B Promotes Bladder Cancer Progression by Sponging miR-1298-5p and Regulating TGFA Expression.
    Front Oncol. 2021;11:643362.
    Abstract     Related articles   

  1317. GUPTA A, Gupta S, Siddeek RAT, Chennatt JJ, et al
    Demographic and clinicopathological Profile of Gall Bladder Cancer Patients: Study from a tertiary care center of the Sub-Himalayan region in Indo-Gangetic Belt.
    J Carcinog. 2021;20:6.
    Abstract     Related articles   

  1318. SEN S, Tuncyurek O, Ertekin E, Dundar M, et al
    The Effect of Spinal and General Anesthesia on Metastatic Lymph Node Flow in Bladder Cancer Surgery: A Pilot Study.
    Agri. 2021;33:142-147.
    Abstract     Related articles   

  1319. YU X, Liao B, Zhu P, Cheng S, et al
    beta-Caryophyllene induces apoptosis and inhibits cell proliferation by deregulation of STAT-3/mTOR/AKT signaling in human bladder cancer cells: An in vitro study.
    J Biochem Mol Toxicol. 2021 Jul 28:e22863. doi: 10.1002/jbt.22863.
    Abstract     Related articles   

  1320. LUO Y, Zhou J, Tang J, Zhou F, et al
    MINDY1 promotes bladder cancer progression by stabilizing YAP.
    Cancer Cell Int. 2021;21:395.
    Abstract     Related articles   

  1321. AMINZADEH Z, Ziamajidi N, Abbasalipourkabir R
    Anticancer Effects of Cinnamaldehyde through Inhibition of ErbB2/HSF1/LDHA Pathway in 5637 Cell Line of Bladder Cancer.
    Anticancer Agents Med Chem. 2021 Jul 26. pii: ACAMC-EPUB-116852.
    Abstract     Related articles   

  1322. WISNIOWSKI T, Bryda J, Kurzepa J, Watroba S, et al
    The role of matrix metalloproteinases in pathogenesis of human bladder cancer.
    Acta Biochim Pol. 2021 Jul 27. pii: 5600. doi: 10.18388/abp.2020_5600.
    Abstract     Related articles   

  1323. IIDA K, Miyake M, Murakami K, Komiyama M, et al
    Bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer outcomes in patients without radical cystectomy.
    Int J Clin Oncol. 2021 Jul 27. pii: 10.1007/s10147-021-01988.
    Abstract     Related articles   

  1324. PETZOLD AP, Lubianca FN, Passos LG, Keppler CK, et al
    The impact of preoperative immune checkpoint inhibitors on kidney and bladder cancer surgeries: a systematic review().
    Curr Probl Cancer. 2021 Jul 8:100765. doi: 10.1016/j.currproblcancer.2021.100765
    Abstract     Related articles   

  1325. HE H, Liu T, Han D, Li C, et al
    Incidence trends and survival prediction of urothelial cancer of the bladder: a population-based study.
    World J Surg Oncol. 2021;19:221.
    Abstract     Related articles   

  1326. YI E, Yoo YS, Lee S, Park H, et al
    The Experiences of Illness in Korean Bladder Cancer Patients With Radical Cystectomy.
    Cancer Nurs. 2021 Jul 21. pii: 00002820-900000000-98828.
    Abstract     Related articles   

  1327. YAO Y, Zhang C, Xiong Y, Han B, et al
    [miR-let-7c-5p inhibits invasion and migration of bladder cancer cells by targeting HMGA2].
    Nan Fang Yi Ke Da Xue Xue Bao. 2021;41:1022-1029.
    Abstract     Related articles   

  1328. ZHI X, Zhou J, Tian H, Zhou R, et al
    [SHOX2 promotes migration, invasion and stemness of bladder cancer cells in vitro].
    Nan Fang Yi Ke Da Xue Xue Bao. 2021;41:995-1001.
    Abstract     Related articles   

  1329. SINGH B, Kaur P, Gupta S, Guragai N, et al
    Complete Response With Immunotherapy: A Case of Metastatic Bladder Cancer.
    J Investig Med High Impact Case Rep. 2021;9:23247096211035603.
    Abstract     Related articles   

  1330. YANG C, Wu S, Mou Z, Zhou Q, et al
    Transcriptomic Analysis Identified ARHGAP Family as a Novel Biomarker Associated With Tumor-Promoting Immune Infiltration and Nanomechanical Characteristics in Bladder Cancer.
    Front Cell Dev Biol. 2021;9:657219.
    Abstract     Related articles   

  1331. JABRA E, Al-Omari A, Haddadin F, Alam W, et al
    Waterpipe Smoking among Bladder Cancer Patients: A Cross-Sectional Study of Lebanese and Jordanian Populations.
    J Smok Cessat. 2021;2021:6615832.
    Abstract     Related articles   

  1332. GAO D, Niu Q, Gong Y, Guo Q, et al
    Y-Box Binding Protein 1 Regulates Angiogenesis in Bladder Cancer via miR-29b-3p-VEGFA Pathway.
    J Oncol. 2021;2021:9913015.
    Abstract     Related articles   

  1333. LU H, Mei C, Yang L, Zheng J, et al
    PPM-18, an Analog of Vitamin K, Induces Autophagy and Apoptosis in Bladder Cancer Cells Through ROS and AMPK Signaling Pathways.
    Front Pharmacol. 2021;12:684915.
    Abstract     Related articles   

  1334. HINSENVELD FJ, Boormans JL, van der Poel HG, van der Schoot DKE, et al
    Intermediate-term survival of robot-assisted versus open radical cystectomy for muscle-invasive and high-risk non-muscle invasive bladder cancer in The Netherlands.
    Urol Oncol. 2021 Jul 21. pii: S1078-1439(21)00277.
    Abstract     Related articles   

  1335. WIGNER P, Szymanska B, Bijak M, Sawicka E, et al
    Oxidative stress parameters as biomarkers of bladder cancer development and progression.
    Sci Rep. 2021;11:15134.
    Abstract     Related articles   

  1336. GIL-JULIO H, Perea F, Rodriguez-Nicolas A, Cozar JM, et al
    Tumor Escape Phenotype in Bladder Cancer Is Associated with Loss of HLA Class I Expression, T-Cell Exclusion and Stromal Changes.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  1337. LEE TH, Heo JH, Jeong JY, Lee GH, et al
    Low Expression of EphB2, EphB3, and EphB4 in Bladder Cancer: Novel Potential Indicators of Muscular Invasion.
    Yonsei Med J. 2021;62:679-690.
    Abstract     Related articles   

  1338. ZOU J, Huang R, Chen Y, Huang X, et al
    Dihydropyrimidinase Like 2 Promotes Bladder Cancer Progression via Pyruvate Kinase M2-Induced Aerobic Glycolysis and Epithelial-Mesenchymal Transition.
    Front Cell Dev Biol. 2021;9:641432.
    Abstract     Related articles   

  1339. HUMAYUN-ZAKARIA N, Ward DG, Arnold R, Bryan RT, et al
    Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?
    Transl Androl Urol. 2021;10:2787-2808.
    Abstract     Related articles   

  1340. RUSSELL B, Kotecha P, Thurairaja R, Nair R, et al
    Endoscopic surveillance for bladder cancer: a systematic review of contemporary worldwide practices.
    Transl Androl Urol. 2021;10:2750-2761.
    Abstract     Related articles   

  1341. NAYAK A, Cresswell J, Mariappan P
    Quality of life in patients undergoing surveillance for non-muscle invasive bladder cancer-a systematic review.
    Transl Androl Urol. 2021;10:2737-2749.
    Abstract     Related articles   

  1342. PAN JW, Zhang X, Jin XW, Wang XJ, et al
    Hydropenia may accelerates the progression of orthotopic bladder cancer induced by N-methyl-N-nitrosourea by increasing the expression levels of AQP1, AQP3, and AQP4.
    Transl Androl Urol. 2021;10:2447-2453.
    Abstract     Related articles   

  1343. SHADAB R, Nerli RB, Saziya BR, Ghagane SC, et al
    5-ALA-Induced Fluorescent Cytology in the Diagnosis of Bladder Cancer-a Preliminary Report.
    Indian J Surg Oncol. 2021;12:415-420.
    Abstract     Related articles   

  1344. WANG C, Sun ZQ, Liu MY, Zhang JJ, et al
    [Prognostic analysis of patients with T1 stage high grade of bladder urothelial carcinoma and glandular differentiation].
    Zhonghua Zhong Liu Za Zhi. 2021;43:691-695.
    Abstract     Related articles   

  1345. GOLKA K, Bothig R, Jungmann O, Forchert M, et al
    [Occupational cancers in urology].
    Urologe A. 2021;60:1061-1072.
    Abstract     Related articles   

  1346. GOMEZ-MOYANO E, Martinez Garcia S, Hernandez Alcaraz D, Ayala-Blanca M, et al
    Metastatic urothelial carcinoma.
    An Bras Dermatol. 2021;96:519-520.
    Abstract     Related articles   

  1347. PATEL SY, Kubal TE, Li R, Manley BJ, et al
    Prevalence of Preoperative Iron Deficiency Anemia: A Case Series Among Patients Undergoing Radical Cystectomy.
    A A Pract. 2021;15:e01477.
    Abstract     Related articles   

  1348. YITGIN Y, Erdem S, Serilmez M, Duranyildiz D, et al
    Can serum matrix metalloproteinase-9 and SMAD-2 levels predict lamina propria invasion in bladder urothelial carcinoma?
    Int J Clin Pract. 2021;75:e14277.
    Abstract     Related articles   

  1349. ALBISINNI S, Martinez Chanza N, Aoun F, Diamand R, et al
    Immune checkpoint inhibitors for BCG-resistant NMIBC: the dawn of a new era.
    Minerva Urol Nephrol. 2021;73:292-298.
    Abstract     Related articles   

  1350. MAO X, Chen S, Li G
    Identification of a ten-long noncoding RNA signature for predicting the survival and immune status of patients with bladder urothelial carcinoma based on the GEO database: a superior machine learning model.
    Aging (Albany NY). 2021;13:6957-6981.
    Abstract     Related articles   

  1351. CHIN S, Song YP
    Double Trouble.
    Int J Radiat Oncol Biol Phys. 2021;109:844-845.
    Abstract     Related articles   

  1352. CHENG S, Zhong W, Xia K, Hong P, et al
    Prognostic role of stromal tumor-infiltrating lymphocytes in locally advanced upper tract urothelial carcinoma: A retrospective multicenter study (TSU-02 study).
    Oncoimmunology. 2021;10:1861737.
    Abstract     Related articles   

  1353. NAMBIYAR K, Mitra S, Das A, Bal A, et al
    Adenocarcinoma of the colon and urinary bladder: A fortuitous or an embryological phenomenon?
    Indian J Pathol Microbiol. 2021;64:132-135.
    Abstract     Related articles   

  1354. KARAKAYA YA, Oral E
    Correlation of cyclin D1, HER2, and AMACR expressions with histologic grade in bladder urothelial carcinomas.
    Indian J Pathol Microbiol. 2021;64:84-90.
    Abstract     Related articles   

  1355. OTTO W, Wieland WF
    [Interactions between radical prostatovesiculectomy and diagnosis of prostate cancer : A medical-historical inventory on the occasion of 20 years of robot-assisted treatment].
    Urologe A. 2021;60:1039-1050.
    Abstract     Related articles   

  1356. NGUYEN L, Nilforoushan N, Krane JF, Bose S, et al
    Should "suspicious for high-grade urothelial carcinoma" and "positive for high-grade urothelial carcinoma" remain separate categories?
    Cancer Cytopathol. 2021;129:156-163.
    Abstract     Related articles   

  1357. TIAN W, Shore KT, Shah RB
    Significant reduction of indeterminate (atypical) diagnosis after implementation of The Paris System for Reporting Urinary Cytology: A single-institution study of more than 27,000 cases.
    Cancer Cytopathol. 2021;129:114-120.
    Abstract     Related articles   

  1358. DINAN MA, Georgieva MV, Li Y, Zhang T, et al
    Real-world systemic therapy utilization in Medicare patients with locally advanced or metastatic urothelial carcinoma diagnosed between 2008 and 2012.
    J Geriatr Oncol. 2021;12:298-304.
    Abstract     Related articles   

  1359. ZHANG ML, Miki Y, Hang JF, Vohra M, et al
    A review of upper urinary tract cytology performance before and after the implementation of The Paris System.
    Cancer Cytopathol. 2021;129:264-274.
    Abstract     Related articles   

  1360. BABA Y, Kikuchi E, Shigeta K, Ogihara K, et al
    Effects of transurethral resection under general anesthesia on tumor recurrence in non-muscle invasive bladder cancer.
    Int J Clin Oncol. 2021 Aug 6. pii: 10.1007/s10147-021-02000.
    Abstract     Related articles   

  1361. CHOI JH, Yoo KH, Lee DG, Min GE, et al
    A Case of Incidental Schwannoma Mimicking Necrotic Metastatic Lymph Node from Bladder Cancer.
    Medicina (Kaunas). 2021;57.
    Abstract     Related articles   

  1362. YANG N, Gao J, Hou R, Xu X, et al
    Grape Seed Proanthocyanidins Inhibit Migration and Invasion of Bladder Cancer Cells by Reversing EMT through Suppression of TGF-beta Signaling Pathway.
    Oxid Med Cell Longev. 2021;2021:5564312.
    Abstract     Related articles   

  1363. XIONG H, Gao H, Hu J, Dai Y, et al
    Prognostic Implications of Immune-Related Gene Pairs Signatures in Bladder Cancer.
    J Oncol. 2021;2021:5345181.
    Abstract     Related articles   

  1364. DELLIS A, Zakopoulou R, Kougioumtzopoulou A, Tzannis K, et al
    Referral for "Neoadjuvant Chemotherapy" for Muscle-Invasive Bladder Cancer to a Multidisciplinary Board: Patterns, Management and Outcomes.
    Cancer Manag Res. 2021;13:5941-5955.
    Abstract     Related articles   

  1365. GALESLOOT TE, Grotenhuis AJ, Kolev D, Aben KK, et al
    Genome-wide Meta-analysis Identifies Novel Genes Associated with Recurrence and Progression in Non-muscle-invasive Bladder Cancer.
    Eur Urol Oncol. 2021 Aug 2. pii: S2588-9311(21)00120.
    Abstract     Related articles   

  1366. HORIBE Y, Ujike T, Fukuhara S, Fujita K, et al
    [A Case of Para-Aortic Lymph Node Metastasis 10 Years after Transurethral Resection for Non-Muscle Invasive Bladder Cancer].
    Hinyokika Kiyo. 2021;67:327-330.
    Abstract     Related articles   

  1367. EZEABIKWA B, Mondal N, Antonopoulos A, Haslam SM, et al
    Major differences in glycosylation and Fucosyltransferase expression in low-grade versus high-grade bladder cancer cell lines.
    Glycobiology. 2021 Aug 5. pii: 6338188. doi: 10.1093.
    Abstract     Related articles   

  1368. CHENG F, Zheng B, Si S, Wang J, et al
    The Roles of CircRNAs in Bladder Cancer: Biomarkers, Tumorigenesis Drivers, and Therapeutic Targets.
    Front Cell Dev Biol. 2021;9:666863.
    Abstract     Related articles   

  1369. FAN B, Mohammed A, Huang Y, Luo H, et al
    Can Aspirin Use Be Associated With the Risk or Prognosis of Bladder Cancer? A Case-Control Study and Meta-analytic Assessment.
    Front Oncol. 2021;11:633462.
    Abstract     Related articles   

  1370. LI Z, Li Y, Zhong W, Huang P, et al
    m6A-Related lncRNA to Develop Prognostic Signature and Predict the Immune Landscape in Bladder Cancer.
    J Oncol. 2021;2021:7488188.
    Abstract     Related articles   

  1371. BAUMANN BC, Sargos P, Efstathiou JA
    Standard Versus Hypofractionated Radiation Therapy for Bladder Cancer: New Insights, but Questions Remain.
    Int J Radiat Oncol Biol Phys. 2021;111:113-116.
    Abstract     Related articles   

  1372. ARIAFAR A, Zareinejad M, Soltani M, Vahidi Y, et al
    GM-CSF-producing lymphocytes in tumor-draining lymph nodes of patients with bladder cancer.
    Eur Cytokine Netw. 2021;32:1-7.
    Abstract     Related articles   

  1373. ULERI A, Hurle R, Contieri R, Diana P, et al
    Combination of AST to ALT and neutrophils to lymphocytes ratios as predictors of locally advanced disease in patients with bladder cancer subjected to radical cystectomy: Results from a single-institutional series.
    Urologia. 2021 Aug 4:3915603211035191. doi: 10.1177/03915603211035191.
    Abstract     Related articles   

  1374. DONG M, Nie A, Liu C, Zheng J, et al
    Psychological resilience of patients with bladder cancer after radical cystectomy and urinary diversion: a cross-sectional study.
    Psychooncology. 2021 Aug 3. doi: 10.1002/pon.5770.
    Abstract     Related articles   

  1375. YANG Z, Sun H, Ma W, Wu K, et al
    Down-regulation of Polo-like kinase 4 (PLK4) induces G1 arrest via activation of the p38/p53/p21 signalling pathway in bladder cancer.
    FEBS Open Bio. 2021 Aug 3. doi: 10.1002/2211-5463.13262.
    Abstract     Related articles   

  1376. DE QUEIROZ NMGP, Marinho FV, de Araujo ACVSC, Fahel JS, et al
    MyD88-dependent BCG immunotherapy reduces tumor and regulates tumor microenvironment in bladder cancer murine model.
    Sci Rep. 2021;11:15648.
    Abstract     Related articles   

  1377. ZHOU R, Liang J, Chen Q, Tian H, et al
    Development and validation of an intra-tumor heterogeneity-related signature to predict prognosis of bladder cancer: a study based on single-cell RNA-seq.
    Aging (Albany NY). 2021;13.
    Abstract     Related articles   

  1378. PACIOTTI M, Contieri R, Fasulo V, Casale P, et al
    Active surveillance for recurrent Non-Muscle Invasive Bladder Cancer (NMIBC): which lessons have we learned during COVID-19 pandemia?
    Minerva Urol Nephrol. 2021 Aug 2. pii: S2724-6051.21.04613.
    Abstract     Related articles   

  1379. KAFKASLI A, Yazici O, Can U, Dincer E, et al
    Testosterone status is not associated with bladder cancer parameters in adult male patients: results of a prospective controlled study.
    Aging Male. 2021;24:101-105.
    Abstract     Related articles   

  1380. XUE C, Chen X, Lin K, Tong Y, et al
    Identification of Notch signaling pathway gene mutations as a prognostic biomarker for bladder cancer.
    Future Oncol. 2021 Aug 2. doi: 10.2217/fon-2021-0110.
    Abstract     Related articles   

  1381. KUMAR A, Cherry DR, Courtney PT, Nalawade V, et al
    Outcomes for Muscle-invasive Bladder Cancer with Radical Cystectomy or Trimodal Therapy in US Veterans.
    Eur Urol Open Sci. 2021;30:1-10.
    Abstract     Related articles   

  1382. CHENARD S, Jackson C, Vidotto T, Chen L, et al
    Sexual Dimorphism in Outcomes of Non-muscle-invasive Bladder Cancer: A Role of CD163+ Macrophages, B cells, and PD-L1 Immune Checkpoint.
    Eur Urol Open Sci. 2021;29:50-58.
    Abstract     Related articles   

  1383. FROEHNER M, Koch R, Heberling U, Borkowetz A, et al
    Decreasing Non-bladder-cancer Mortality After Radical Cystectomy.
    Eur Urol Open Sci. 2021;29:15-18.
    Abstract     Related articles   

  1384. MAIBOM SL, Roder MA, Poulsen AM, Thind PO, et al
    Morbidity and Days Alive and Out of Hospital Within 90 Days Following Radical Cystectomy for Bladder Cancer.
    Eur Urol Open Sci. 2021;28:1-8.
    Abstract     Related articles   

  1385. WEISS S, Hallmann S, Koch S, Eidt S, et al
    Identifying the Molecular Mechanisms Contributing to Progression, Metastasis, and Death in Low-grade Non-muscle-invasive Bladder Cancer: A Case Report.
    Eur Urol Open Sci. 2021;27:29-32.
    Abstract     Related articles   

  1386. MUTO S, Lu Y, Ide H, Yamaguchi R, et al
    The Use of Urine Mycobacterium tuberculosis Complex Polymerase Chain Reaction as a Predictive Factor for Recurrence and Progression After Intravesical Bacillus Calmette-Guerin Therapy in Patients with Non-muscleinvasive Bladder Cancer.
    Eur Urol Open Sci. 2021;27:10-18.
    Abstract     Related articles   

  1387. PACIOTTI M, Casale P, Colombo P, Fasulo V, et al
    Long-term Follow-up After En Bloc Transurethral Resection of Non-muscle-invasive Bladder Cancer: Results from a Single-center Experience.
    Eur Urol Open Sci. 2021;26:64-71.
    Abstract     Related articles   

  1388. REZAEE ME, Ismail AAO, Okorie CL, Seigne JD, et al
    Partial Versus Complete Bacillus Calmette-Guerin Intravesical Therapy and Bladder Cancer Outcomes in High-risk Non-muscle-invasive Bladder Cancer: Is NIMBUS the Full Story?
    Eur Urol Open Sci. 2021;26:35-43.
    Abstract     Related articles   

  1389. REESINK DJ, van de Garde EMW, Somford DM, Meijer RP, et al
    Development of the First Patient-centred Set of Outcomes for Muscle-invasive and Metastatic Bladder Cancer: A Multicentre Initiative.
    Eur Urol Open Sci. 2021;26:18-26.
    Abstract     Related articles   

  1390. XU X, Wang H, Guo Y, Zhang X, et al
    Study Progress of Noninvasive Imaging and Radiomics for Decoding the Phenotypes and Recurrence Risk of Bladder Cancer.
    Front Oncol. 2021;11:704039.
    Abstract     Related articles   

  1391. XIE Y, Zhu S, Zang J, Wu G, et al
    ADNP prompts the cisplatin-resistance of bladder cancer via TGF-beta-mediated epithelial-mesenchymal transition (EMT) pathway.
    J Cancer. 2021;12:5114-5124.
    Abstract     Related articles   

  1392. ZHANG Y, Chen L, Luo G
    Long non-coding RNA PCAT6 regulates bladder cancer progression via the microRNA-143-3p/PDIA6 axis.
    Exp Ther Med. 2021;22:947.
    Abstract     Related articles   

  1393. NASPRO R, La Croce G, Finati M, Roscigno M, et al
    Oncological outcomes of concomitant carcinoma in situ at radical cystectomy in pure urothelial bladder cancer and in histological variants.
    Urol Oncol. 2021 Jul 29. pii: S1078-1439(21)00310.
    Abstract     Related articles   

  1394. HO P, Moran GW, Wang V, Li G, et al
    The effect of tumor grade heterogeneity on recurrence in non-muscle invasive bladder cancer.
    Urol Oncol. 2021 Jul 29. pii: S1078-1439(21)00304.
    Abstract     Related articles   

  1395. QIAN Z, Ding W, Zhou Q, Ge S, et al
    Increased Risk of Recurrence of Non-Muscle Invasive Bladder Cancer Associated with Psychological Distress: A Prospective Cohort Study.
    Psychiatry Investig. 2021 Aug 2. pii: pi.2021.0022. doi: 10.30773/pi.2021.0022.
    Abstract     Related articles   

  1396. FEUER Z, Matulewicz RS, Bjurlin MA
    Letter to the editor Re: Shore ND, Palou Redorta J, Robert G, et al. Non-muscle-invasive bladder cancer: An overview of potential new treatment options. Urol oncol. Published online june 21, 2021:S1078-1439(21)00221-0.
    Urol Oncol. 2021 Jul 28. pii: S1078-1439(21)00313.
    Abstract     Related articles   

  1397. KUFUKIHARA R, Kikuchi E, Shigeta K, Ogihara K, et al
    Diagnostic performance of the vesical imaging-reporting and data system for detecting muscle-invasive bladder cancer in real clinical settings: Comparison with diagnostic cystoscopy.
    Urol Oncol. 2021 Jul 28. pii: S1078-1439(21)00306.
    Abstract     Related articles   

  1398. SONMEZ G, Tolga Tombul S, Herdem N, Demirtas T, et al
    Superselective vesical artery embolization versus intravesical formalin for intractable hematuria in patients with bladder cancer.
    Actas Urol Esp. 2021 Jul 28. pii: S0210-4806(21)00121.
    Abstract     Related articles   

  1399. DAI R, Jiang Q, Zhou Y, Lin R, et al
    Lnc-STYK1-2 regulates bladder cancer cell proliferation, migration, and invasion by targeting miR-146b-5p expression and AKT/STAT3/NF-kB signaling.
    Cancer Cell Int. 2021;21:408.
    Abstract     Related articles   

  1400. ZHANG N, Hua X, Tu H, Li J, et al
    Isorhapontigenin (ISO) inhibits EMT through FOXO3A/METTL14/VIMENTIN pathway in bladder cancer cells.
    Cancer Lett. 2021 Jul 28. pii: S0304-3835(21)00374.
    Abstract     Related articles   

  1401. ROMER E, Esperto F, Dooldeniya M, Cumberbatch MG, et al
    Does minimally invasive surgery for bladder cancer result in unusual sites of metastasis?
    Actas Urol Esp (Engl Ed). 2021 Jul 27. pii: S2173-5786(21)00077.
    Abstract     Related articles   

  1402. SIKIC D, Eckstein M, Weyerer V, Kubon J, et al
    High expression of ERBB2 is an independent risk factor for reduced recurrence-free survival in patients with stage T1 non-muscle-invasive bladder cancer.
    Urol Oncol. 2021 Jul 27. pii: S1078-1439(21)00297.
    Abstract     Related articles   

  1403. PINTO A, Alvarez-Maestro M
    Adjuvant immunotherapy in muscle-invasive bladder cancer: Closer than it seems?
    Actas Urol Esp. 2021 Jul 27. pii: S0210-4806(21)00102.
    Abstract     Related articles   

  1404. LI C, Han D, Huang Q, Xu F, et al
    Competing-risks nomogram for predicting cancer-specific death in upper tract urothelial carcinoma: a population-based analysis.
    BMJ Open. 2021;11:e048243.
    Abstract     Related articles   

  1405. KHALIFA J, Supiot S, Pignot G, Hennequin C, et al
    Recommendations for planning and delivery of radical radiotherapy for localized urothelial carcinoma of the bladder.
    Radiother Oncol. 2021;161:95-114.
    Abstract     Related articles   

  1406. DO CARMO SILVA J, Babjuk M, Vesely S, Dusek P, et al
    Morbidity and mortality after open radical cystectomy and ileal diversion - 10 years experience and a comprehensive assessment in a single tertiary center.
    Neoplasma. 2021;68:882-891.
    Abstract     Related articles   

  1407. BOGDAN G
    Editorial Comment on: "Primary Complete Transurethral Resection of Bladder Tumor Using Photodynamic Diagnosis for High-Risk Nonmuscle Invasive Bladder Cancer: Is a Restaging Photodynamic Transurethral Resection Really Necessary?" by Tadrist et al.
    J Endourol. 2021;35:1047-1048.
    Abstract     Related articles   

  1408. GUO L, Wang X, Wang S, Hua L, et al
    Efficacy of immune-checkpoint inhibitors in PD-L1 selected or unselected patients vs. control group in patients with advanced or metastatic urothelial carcinoma.
    Oncoimmunology. 2021;10:1887551.
    Abstract     Related articles   

  1409. AL-OBAIDY KI, Cheng L
    Fibroblast growth factor receptor (FGFR) gene: pathogenesis and treatment implications in urothelial carcinoma of the bladder.
    J Clin Pathol. 2021;74:491-495.
    Abstract     Related articles   

  1410. DE LORENZIS E, Albo G, Longo F, Bebi C, et al
    Current Knowledge on Genomic Profiling of Upper Tract Urothelial Carcinoma.
    Genes (Basel). 2021;12.
    Abstract     Related articles   

  1411. KODAMA H, Yoneyama T, Tanaka T, Noro D, et al
    N-glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas.
    Cancer Med. 2021;10:1297-1313.
    Abstract     Related articles   

  1412. PINI GM, Uccella S, Corinti M, Colecchia M, et al
    Primary MiNEN of the urinary bladder: an hitherto undescribed entity composed of large cell neuroendocrine carcinoma and adenocarcinoma with a distinct clinical behavior : Description of a case and review of the pertinent literature.
    Virchows Arch. 2021;479:69-78.
    Abstract     Related articles   

  1413. VARGAS AC, Burchett I, Turner J, Delprado W, et al
    Monotypic Plasma Cell Proliferation of Uncertain Clinical Significance Mimicking Interstitial Cystitis: An Early Lesion of MALT Lymphoma?
    Am J Surg Pathol. 2021;Publish Ahead of Print.
    Abstract     Related articles   

  1414. MERDER E, Can O, Ariman A, Polat EC, et al
    Our laparoscopic cystectomy experiences.
    Urologia. 2021;88:30-33.
    Abstract     Related articles   

  1415. BEJI S, Wrist Lam G, Ostergren PB, Toxvaerd A, et al
    Diagnostic value of probe-based confocal laser endomicroscopy versus conventional endoscopic biopsies of non-muscle invasive bladder tumors: a pilot study.
    Scand J Urol. 2021;55:36-40.
    Abstract     Related articles   

  1416. CHIANCONE F, Fabiano M, Califano A, Langella NA, et al
    Massive intra-abdominal recurrence after robotic-assisted radical cystectomy: A case report and critical appraisal of literature.
    Urologia. 2021;88:21-24.
    Abstract     Related articles   

  1417. ESPANA-NAVARRO R, Rabadan-Marquez P, Perez-Arguelles D, Sanchez-Martinez N, et al
    Implementation of ERAS (Enhanced Recovery After Surgery) protocols for radical cystectomy patients: The pathway to standardization. A systematic review.
    Actas Urol Esp (Engl Ed). 2021;45:103-115.
    Abstract     Related articles   

  1418. WANG Y, Zhang Z, Shao J, Lu Y, et al
    Outcome of simultaneous thulium laser enucleation of bladder tumor and prostate in patients with non-muscle invasive bladder tumor and benign prostatic hyperplasia: a matched-pair comparison with a long-term follow-up.
    World J Urol. 2021;39:105-111.
    Abstract     Related articles   

  1419. GOUIN KH 3RD, Ing N, Plummer JT, Rosser CJ, et al
    An N-Cadherin 2 expressing epithelial cell subpopulation predicts response to surgery, chemotherapy and immunotherapy in bladder cancer.
    Nat Commun. 2021;12:4906.
    Abstract     Related articles   

  1420. XIAO S, Chen Y, Luan T, Huang Y, et al
    MicroRNA-20a Targeting LASS2 Promotes the Proliferation, Invasiveness and Migration of Bladder Cancer.
    Clin Lab. 2021;67.
    Abstract     Related articles   

  1421. XU X, Zhu Y, Ye S, Li S, et al
    Association of Dietary Carrot Intake With Bladder Cancer Risk in a Prospective Cohort of 99,650 Individuals With 12.5 Years of Follow-Up.
    Front Nutr. 2021;8:669630.
    Abstract     Related articles   

  1422. FERREIRA JM, Matheus LHG, de Almeida RVS, Melo PAS, et al
    High CD39 expression is associated with the non-muscle-invasive phenotype of human bladder cancer.
    Oncotarget. 2021;12:1580-1586.
    Abstract     Related articles   

  1423. SHARMA G
    Comment on "Pooled analysis of Xpert bladder cancer based on the 5 mRNAs for rapid diagnosis of bladder carcinoma".
    World J Surg Oncol. 2021;19:237.
    Abstract     Related articles   

  1424. KOBAYASHI M, Fujiyama N, Tanegashima T, Narita S, et al
    Effect of HLA genotype on intravesical recurrence after bacillus Calmette-Guerin therapy for non-muscle-invasive bladder cancer.
    Cancer Immunol Immunother. 2021 Aug 11. pii: 10.1007/s00262-021-03032.
    Abstract     Related articles   

  1425. TAYLOR CA, Tobert CM, Kahnoski RJ, Humphrey JE, et al
    The value of a comprehensive primary outcome - results of a negative randomized control trial in the non-muscle invasive bladder cancer population.
    Can J Urol. 2021;28:10756-10761.
    Abstract     Related articles   

  1426. AMAYA-FRAGOSO E, Dantes-Duran MA, Perez-Torres EK, Garcia-Perez CM, et al
    [Osteoclast-Like giant cell bladder carcinoma: Case report].
    Rev Med Inst Mex Seguro Soc. 2021;59:253-259.
    Abstract     Related articles   

  1427. LAI C, Wu Z, Li Z, Yu H, et al
    A robust signature of immune-related long non-coding RNA to predict the prognosis of bladder cancer.
    Cancer Med. 2021 Aug 10. doi: 10.1002/cam4.4167.
    Abstract     Related articles   

  1428. D'ANDREA D, Black PC, Zargar H, Zargar-Shoshtari K, et al
    Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer.
    World J Urol. 2021 Aug 9. pii: 10.1007/s00345-021-03793.
    Abstract     Related articles   

  1429. ABDO N, Alsoukhni M, Batieha A, Arqoub K, et al
    Survival of patients with urinary bladder cancer in Jordan, 2005-2014.
    East Mediterr Health J. 2021;27:648-655.
    Abstract     Related articles   

  1430. DONG B, Liang J, Li D, Song W, et al
    Identification of a Prognostic Signature Associated With the Homeobox Gene Family for Bladder Cancer.
    Front Mol Biosci. 2021;8:688298.
    Abstract     Related articles   

  1431. LUO C, Huang B, Wu Y, Xu Y, et al
    Identification of Lymph Node Metastasis-Related Key Genes and Prognostic Risk Model in Bladder Cancer by Co-Expression Analysis.
    Front Mol Biosci. 2021;8:633299.
    Abstract     Related articles   

  1432. IKEDA T, Hasegawa G, Kawaguchi G, Ikeda Y, et al
    Successful Response of Pembrolizumab Rechallenge after Radiotherapy for a Patient with Bladder Cancer of Nonresponse of Pembrolizumab First Challenge.
    Case Rep Urol. 2021;2021:9087529.
    Abstract     Related articles   

  1433. ZHU J, Huang Y, Zhang Y, Huang R, et al
    KCNMB2-AS1 Promotes Bladder Cancer Progression Through Sponging miR-374a-3p to Upregulate S100A10.
    Front Genet. 2021;12:655569.
    Abstract     Related articles   

  1434. ZHANG Q, Liu Y, Chen P, Shi X, et al
    Solute carrier family 12 member 8 (SLC12A8) is a potential biomarker and related to tumor immune cell infiltration in bladder cancer.
    Bioengineered. 2021;12:4946-4961.
    Abstract     Related articles   

  1435. ZHANG Z, Mou Z, Xu C, Wu S, et al
    Autophagy-associated circular RNA hsa_circ_0007813 modulates human bladder cancer progression via hsa-miR-361-3p/IGF2R regulation.
    Cell Death Dis. 2021;12:778.
    Abstract     Related articles   

  1436. BELUGINA R, Karpushchenko E, Sleptsov A, Protoshchak V, et al
    Developing non-invasive bladder cancer screening methodology through potentiometric multisensor urine analysis.
    Talanta. 2021;234:122696.
    Abstract     Related articles   

  1437. DE LIMA FRAGELLI BD, Camillo L, de Almeida Rodolpho JM, de Godoy KF, et al
    Antitumor Effect of IL-2 and TRAIL Proteins Expressed by Recombinant Salmonella in Murine Bladder Cancer Cells.
    Cell Physiol Biochem. 2021;55:460-476.
    Abstract     Related articles   

  1438. WIGNER P, Bijak M, Saluk-Bijak J
    The Green Anti-Cancer Weapon. The Role of Natural Compounds in Bladder Cancer Treatment.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  1439. ECKSTEIN M, Lieb V, Jung R, Sikic D, et al
    Combination of GP88 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Is an Independent Prognostic Factor for Bladder Cancer Patients.
    Cells. 2021;10.
    Abstract     Related articles   

  1440. HEPBURN AC, Lazzarini N, Veeratterapillay R, Wilson L, et al
    Identification of CNGB1 as a Predictor of Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  1441. ZHENG X, Wezel F, Azoitei A, Meessen S, et al
    Shorter Leukocyte Telomere Length Is Associated with Worse Survival of Patients with Bladder Cancer and Renal Cell Carcinoma.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  1442. ISHIBASHI Y, Yamaguchi K, Hayashi Y, Onuki T, et al
    [Clear Cell Variant of Invasive Urothelial Carcinoma of the Renal Pelvis: A Case Report].
    Hinyokika Kiyo. 2021;67:313-316.
    Abstract     Related articles   

  1443. SUGINO Y, Nishikawa K, Kato M, Sasaki T, et al
    [Initial Experience of Photodynamic Diagnosis-Assisted Transurethral Resection of Bladder Tumor (PDD-TURBT)].
    Hinyokika Kiyo. 2021;67:303-308.
    Abstract     Related articles   

  1444. BRAZAO ES JUNIOR, Coser DG, Meduna RR, da Costa WH, et al
    Simultaneous laparoscopic nephroureterectomy and robot-assisted anterior pelvic exenteration with intracorporeal ileal conduit urinary diversion: step-by-step video-illustrated technique.
    Int Braz J Urol. 2021;47:1072-1073.
    Abstract     Related articles   

  1445. ANAISSIE J, Dursun F, Wallis CJD, Klaassen Z, et al
    Dissecting the role of radical cystectomy and urinary diversion in post-operative complications: an analysis using the American College of Surgeons national surgical quality improvement program database.
    Int Braz J Urol. 2021;47:1006-1019.
    Abstract     Related articles   

  1446. ROUF BANDAY A, Onabajo OO, Lin SH, Obajemu A, et al
    Targeting natural splicing plasticity of APOBEC3B restricts its expression and mutagenic activity.
    Commun Biol. 2021;4:386.
    Abstract     Related articles   

  1447. CAO J, Li J, Yang X, Li P, et al
    Transcriptomics analysis for the identification of potential age-related genes and cells associated with three major urogenital cancers.
    Sci Rep. 2021;11:641.
    Abstract     Related articles   

  1448. DEUKER M, Stolzenbach LF, Colla Ruvolo C, Nocera L, et al
    Upper Urinary Tract Tumors: Variant Histology Versus Urothelial Carcinoma.
    Clin Genitourin Cancer. 2021;19:117-124.
    Abstract     Related articles   

  1449. DO OA, Ferris LA, Holt SK, Ramos JD, et al
    Treatment of Metastatic Urothelial Carcinoma After Previous Cisplatin-based Chemotherapy for Localized Disease: A Retrospective Comparison of Different Chemotherapy Regimens.
    Clin Genitourin Cancer. 2021;19:125-134.
    Abstract     Related articles   

  1450. SFAKIANOS JP, Salome B, Daza J, Farkas A, et al
    Bacillus Calmette-Guerin (BCG): Its fight against pathogens and cancer.
    Urol Oncol. 2021;39:121-129.
    Abstract     Related articles   

  1451. BHANVADIA RR, Khouri RK Jr, Ashbrook C, Woldu SL, et al
    Safety, Efficacy, and Impact on Quality of Life of Palliative Robotic Cystectomy for Advanced Prostate Cancer.
    Clin Genitourin Cancer. 2021;19:e129-e134.
    Abstract     Related articles   

  1452. RAZDAN S, Sljivich M, Pfail J, Wiklund PK, et al
    Predicting morbidity and mortality after radical cystectomy using risk calculators: A comprehensive review of the literature.
    Urol Oncol. 2021;39:109-120.
    Abstract     Related articles   

  1453. MORALES A, Siemens DR, Koti M
    At a time of global BCG shortage, attempts at optimizing BCG dose and schedule is no longer the answer.
    Urol Oncol. 2021;39:137-138.
    Abstract     Related articles   

  1454. HIRD AE, Magee DE, Cheung DC, Sander B, et al
    Neoadjuvant Versus Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A Microsimulation Model.
    Clin Genitourin Cancer. 2021;19:e135-e147.
    Abstract     Related articles   

  1455. DIAMANTOPOULOS LN, Holt SK, Khaki AR, Sekar RR, et al
    Response to Neoadjuvant Chemotherapy and Survival in Micropapillary Urothelial Carcinoma: Data From a Tertiary Referral Center and the Surveillance, Epidemiology, and End Results (SEER) Program.
    Clin Genitourin Cancer. 2021;19:144-154.
    Abstract     Related articles   

  1456. PIERCONTI F, Martini M, Fiorentino V, Cenci T, et al
    The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence?
    Urol Oncol. 2021;39:131.
    Abstract     Related articles   

  1457. QUHAL F, D'Andrea D, Soria F, Moschini M, et al
    Primary Ta high grade bladder tumors: Determination of the risk of progression.
    Urol Oncol. 2021;39:132.
    Abstract     Related articles   

  1458. AMIR M, Qureshi MA, Javed S
    Biomolecular interactions and binding dynamics of tyrosine kinase inhibitor erdafitinib, with human serum albumin.
    J Biomol Struct Dyn. 2021;39:3934-3947.
    Abstract     Related articles   

  1459. ROSIELLO G, Pecoraro A, Palumbo C, Knipper S, et al
    Radical cystectomy plus chemotherapy in patients with pure squamous cell bladder carcinoma: a population-based study.
    World J Urol. 2021;39:813-822.
    Abstract     Related articles   

  1460. MAZZONE E, D'Hondt F, Beato S, Andras I, et al
    Robot-assisted radical cystectomy with intracorporeal urinary diversion decreases postoperative complications only in highly comorbid patients: findings that rely on a standardized methodology recommended by the European Association of Urology Guideli
    World J Urol. 2021;39:803-812.
    Abstract     Related articles   

  1461. ZHONG W, Wang D, Yao B, Chen X, et al
    Integrative analysis of prognostic long non-coding RNAs with copy number variation in bladder cancer.
    J Zhejiang Univ Sci B. 2021;22:664-681.
    Abstract     Related articles   

  1462. ARNOLD CR, Lindner AK, Schachtner G, Tulchiner G, et al
    Vinorelbine in bladder-preserving multimodality treatment for muscle-invasive bladder cancer-a valid option for cisplatin-unfit patients?
    Strahlenther Onkol. 2021 Aug 19. pii: 10.1007/s00066-021-01837.
    Abstract     Related articles   

  1463. LIAO CH, Tsai CW, Chang WS, Wang ZH, et al
    Association of Matrix Metalloproteinase-1 Genotypes With Bladder Cancer Risk.
    In Vivo. 2021;35:2535-2540.
    Abstract     Related articles   

  1464. WELK B
    The argument against screening for bladder cancer in neuro-urological patients.
    World J Urol. 2021 Aug 19. pii: 10.1007/s00345-021-03802.
    Abstract     Related articles   

  1465. PENG M, Cheng X, Xiong W, Yi L, et al
    Integrated Analysis of a Competing Endogenous RNA Network Reveals a Prognostic lncRNA Signature in Bladder Cancer.
    Front Oncol. 2021;11:684242.
    Abstract     Related articles   

  1466. KATO Y, Ikarashi D, Kikuchi D, Takayama M, et al
    Dysuria therapeutic agents as an independent prognostic factor for the primary recurrence of non-muscle invasive bladder cancer: a propensity score matching study.
    J Int Med Res. 2021;49:3000605211037478.
    Abstract     Related articles   

  1467. WANG W, Zhang M, Huang Z, Wang L, et al
    Knockdown of CXCL5 inhibits the invasion, metastasis and stemness of bladder cancer lung metastatic cells by downregulating CD44.
    Anticancer Drugs. 2021 Aug 16. pii: 00001813-900000000-98308.
    Abstract     Related articles   

  1468. MIYATA H, Hirohashi Y, Yamada S, Yanagawa J, et al
    GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy.
    Cancer Immunol Immunother. 2021 Aug 18. pii: 10.1007/s00262-021-03025.
    Abstract     Related articles   

  1469. LIAO Y, Zou X, Wang K, Wang Y, et al
    Comprehensive analysis of Transcription Factors identified novel prognostic biomarker in human bladder cancer.
    J Cancer. 2021;12:5605-5621.
    Abstract     Related articles   

  1470. CHEN H, Pan Y, Jin X, Chen G, et al
    An immune cell infiltration-related gene signature predicts prognosis for bladder cancer.
    Sci Rep. 2021;11:16679.
    Abstract     Related articles   

  1471. FLOR JMS, Gaston MJFV, Lapitan MCM
    Pelvic lipomatosis associated with bilateral obstructive uropathy and proliferative cystitis.
    BMJ Case Rep. 2021;14.
    Abstract     Related articles   

  1472. HUANG R, Zheng Z, Xian S, Zhang J, et al
    Identification of prognostic and bone metastatic alternative splicing signatures in bladder cancer.
    Bioengineered. 2021;12:5289-5304.
    Abstract     Related articles   

  1473. PARK YM, Seo HI, Hong SB, Kim S, et al
    Curative resection of bladder cancer with pancreas head metastasis.
    Ann Hepatobiliary Pancreat Surg. 2021;25:440-444.
    Abstract     Related articles   

  1474. YEH J, Bressel M, Tai KH, Kron T, et al
    A retrospective review of the long-term outcomes of online adaptive radiation therapy and conventional radiation therapy for muscle invasive bladder cancer.
    Clin Transl Radiat Oncol. 2021;30:65-70.
    Abstract     Related articles   

  1475. YUAN JB, Gu L, Chen L, Yin Y, et al
    Annexin A8 regulated by lncRNA-TUG1/miR-140-3p axis promotes bladder cancer progression and metastasis.
    Mol Ther Oncolytics. 2021;22:36-51.
    Abstract     Related articles   

  1476. MIYAKE M, Nishimura N, Oda Y, Owari T, et al
    Intravesical Bacillus Calmette-Guerin treatment-induced sleep quality deterioration in patients with non-muscle invasive bladder cancer: functional outcome assessment based on a questionnaire survey and actigraphy.
    Support Care Cancer. 2021 Aug 16. pii: 10.1007/s00520-021-06468.
    Abstract     Related articles   

  1477. GUO W, Gai Q, Ma Y, Shan Z, et al
    LINC01410 leads the migration, invasion and EMT of bladder cancer cells by modulating miR-4319 / Snail1.
    Cancer Cell Int. 2021;21:429.
    Abstract     Related articles   

  1478. HUANG ZM, Wang H, Ji ZG
    Bladder mesenchymal stromal cell-derived exosomal miRNA-217 modulates bladder cancer cell survival through Hippo-YAP pathway.
    Inflamm Res. 2021 Aug 14. pii: 10.1007/s00011-021-01494.
    Abstract     Related articles   

  1479. FERNANDEZ AVILA C, Garcia-Baquero Garcia de Paredes R, Aguera Bitaube J, Caro Romero A, et al
    Extensive keratinising squamous metaplasia of bladder.
    Arch Esp Urol. 2021;74:635-636.
    Abstract     Related articles   

  1480. ZEUSCHNER P, Linxweiler J, Mohr R, van Heemskerk S, et al
    Robot-assisted versus open radical cystectomy: A cohort study on perioperative outcomes accounting for stage selection bias and surgical experience.
    Int J Med Robot. 2021;17:e2258.
    Abstract     Related articles   

  1481. ABEL M, Burkenroad A, Sun A, Lu E, et al
    The Evolving Landscape of Antibody-Drug Conjugates for Urothelial Carcinoma.
    Clin Genitourin Cancer. 2021;19:183-193.
    Abstract     Related articles   

  1482. LANGE K, Gorvet M, Raman S
    Laparoscopic right colectomy following an ileal orthotopic neobladder - a video vignette.
    Colorectal Dis. 2021;23:754-755.
    Abstract     Related articles   

  1483. AZIZ A, Raza SJ, Davaro F, May A, et al
    Stage Migration for Upper Tract Urothelial Cell Carcinoma.
    Clin Genitourin Cancer. 2021;19:e184-e192.
    Abstract     Related articles   

  1484. NELSON L, Alanee S, Ali A
    Robotic-assisted creation of a sigmoid neobladder following cystectomy - a video vignette.
    Colorectal Dis. 2021;23:329-330.
    Abstract     Related articles   

  1485. FOERSTER B, Abufaraj M, Mari A, Seisen T, et al
    The Performance of Tumor Size as Risk Stratification Parameter in Upper Tract Urothelial Carcinoma (UTUC).
    Clin Genitourin Cancer. 2021;19:272.
    Abstract     Related articles   

  1486. DU Y, Yang R, Chen Z, Wang L, et al
    A deep learning network-assisted bladder tumour recognition under cystoscopy based on Caffe deep learning framework and EasyDL platform.
    Int J Med Robot. 2021;17:1-8.
    Abstract     Related articles   

  1487. HALFORD Z, Anderson MK, Clark MD
    Enfortumab Vedotin-ejfv: A First-in-Class Anti-Nectin-4 Antibody-Drug Conjugate for the Management of Urothelial Carcinoma.
    Ann Pharmacother. 2021;55:772-782.
    Abstract     Related articles   

  1488. HALE O, Patterson K, Lai Y, Meng Y, et al
    Cost-effectiveness of Pembrolizumab versus Carboplatin-based Chemotherapy as First-line Treatment of PD-L1-positive Locally Advanced or Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Therapy in the United States.
    Clin Genitourin Cancer. 2021;19:e17-e30.
    Abstract     Related articles   

  1489. LOPEZ RAMIREZ C, Gomez Izquierdo L, Rodriguez Portal JA
    Granulomatous lung disease associated with the use of intravesical mytomycin.
    Med Clin (Barc). 2021;157:206-207.
    Abstract     Related articles   

  1490. SUAREZ-IBARROLA R, Braun L, Pohlmann PF, Becker W, et al
    Metabolic Imaging of Urothelial Carcinoma by Simultaneous Autofluorescence Lifetime Imaging (FLIM) of NAD(P)H and FAD.
    Clin Genitourin Cancer. 2021;19:e31-e36.
    Abstract     Related articles   

  1491. KAGAN J, Alemozaffar M, Carthon B, Osunkoya AO, et al
    Surgical Pathology Findings in Patients Who Have Undergone Radical Cystectomy/Cystoprostatectomy With Extended Versus Standard Lymph Node Dissection for Urothelial Carcinoma of the Bladder: A Contemporary Analysis.
    Int J Surg Pathol. 2021;29:150-154.
    Abstract     Related articles   

  1492. RAMMANT E, Van Hecke A, Decaestecker K, Albersen M, et al
    Supportive care needs and utilization of bladder cancer patients undergoing radical cystectomy: A longitudinal study.
    Psychooncology. 2021 Aug 27. doi: 10.1002/pon.5795.
    Abstract     Related articles   

  1493. NIKULAINEN I, Salminen AP, Jambor I, Merisaari H, et al
    Visual MRI T-category versus VI-RADS evaluation from multiparametric MRI in the detection of muscle-invasion in patients with suspected bladder cancer: single centre registered clinical trial (MIB-trial).
    Scand J Urol. 2021 Aug 27:1-7. doi: 10.1080/21681805.2021.1971290.
    Abstract     Related articles   

  1494. SIKIC D, Taubert H, Breyer J, Eckstein M, et al
    The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer.
    Cancer Manag Res. 2021;13:6567-6578.
    Abstract     Related articles   

  1495. KIM JH, Lee S, Kang SJ, Choi YW, et al
    Establishment of Three-Dimensional Bioprinted Bladder Cancer-on-a-Chip with a Microfluidic System Using Bacillus Calmette-Guerin.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  1496. HE C, Buongiorno LP, Wang W, Tang JCY, et al
    The Inhibitory Effect of Sulforaphane on Bladder Cancer Cell Depends on GSH Depletion-Induced by Nrf2 Translocation.
    Molecules. 2021;26.
    Abstract     Related articles   

  1497. CORMIO A, Busetto GM, Musicco C, Sanguedolce F, et al
    Mitofusin-2 Down-Regulation Predicts Progression of Non-Muscle Invasive Bladder Cancer.
    Diagnostics (Basel). 2021;11.
    Abstract     Related articles   

  1498. PEYROTTES A, Ouzaid I, Califano G, Hermieu JF, et al
    Neoadjuvant Immunotherapy for Muscle-Invasive Bladder Cancer.
    Medicina (Kaunas). 2021;57.
    Abstract     Related articles   

  1499. DOBRUCH J, Oszczudlowski M
    Bladder Cancer: Current Challenges and Future Directions.
    Medicina (Kaunas). 2021;57.
    Abstract     Related articles   

  1500. MAGRAY JA, Pandith AA, Qasim I, Khateeb M, et al
    Significant Implications of APOA1 Gene Sequence Variations and Its Protein Expression in Bladder Cancer.
    Biomedicines. 2021;9.
    Abstract     Related articles   

  1501. LIAO YA, Chiang CJ, Lee WC, Zhuang BZ, et al
    Extranodal Extension Predicts Poor Survival Outcomes among Patients with Bladder Cancer.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  1502. WANG SC, Chang YC, Wu MY, Yu CY, et al
    Intravesical Instillation of Azacitidine Suppresses Tumor Formation through TNF-R1 and TRAIL-R2 Signaling in Genotoxic Carcinogen-Induced Bladder Cancer.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  1503. YANG Y, Chen S, Li P, Jing Y, et al
    PFOI stimulates the motility of T24 bladder cancer cells: Possible involvement and activation of lncRNA malat1.
    Chemosphere. 2021;287.
    Abstract     Related articles   

  1504. SETTI BOUBAKER N, Gurtner A, Trabelsi N, Manni I, et al
    The diagnostic applicability of A-type Lamin in non-muscle invasive bladder cancer.
    Ann Diagn Pathol. 2021;54:151808.
    Abstract     Related articles   

  1505. ZHANG P, Zhang Y, Han X, Zhang X, et al
    Effect of individualized psychological intervention on negative emotion and sleep quality of patients after bladder cancer surgery: a randomized controlled trial.
    Transl Androl Urol. 2021;10:3021-3029.
    Abstract     Related articles   

  1506. SANDERS JA, Frasier C, Matulay JT, Steuerwald NM, et al
    Genomic analysis of response to bacillus Calmette-Guerin (BCG) treatment in high-grade stage 1 bladder cancer patients.
    Transl Androl Urol. 2021;10:2998-3009.
    Abstract     Related articles   

  1507. YU S, Wang S, Sun X, Wu Y, et al
    ST8SIA1 inhibits the proliferation, migration and invasion of bladder cancer cells by blocking the JAK/STAT signaling pathway.
    Oncol Lett. 2021;22:736.
    Abstract     Related articles   

  1508. ZHAO L, Sun J, Wang K, Tai S, et al
    Development of a New Recurrence-Free Survival Prediction Nomogram for Patients with Primary Non-Muscle-Invasive Bladder Cancer Based on Preoperative Controlling Nutritional Status Score.
    Cancer Manag Res. 2021;13:6473-6487.
    Abstract     Related articles   

  1509. BYUN SS, Kim FJ, Khandrika L, Kumar B, et al
    Retraction notice to "Differential effects of valproic acid on growth, proliferation and metastasis in HTB-5 and HTB-9 bladder cancer cell lines" [Canc. Lett. 281/2 (2009) 196-202].
    Cancer Lett. 2021 Aug 21. pii: S0304-3835(21)00399.
    Abstract     Related articles   

  1510. ZHOU F, Li Z, Dong L, Yang G, et al
    lncRNA ADAMTS9-AS1 promotes bladder cancer cell invasion, migration, and inhibits apoptosis and autophagy through PI3K/AKT/mTOR signaling pathway.
    Int J Biochem Cell Biol. 2021 Aug 21:106069. doi: 10.1016/j.biocel.2021.106069.
    Abstract     Related articles   

  1511. SAHU D, Huan J, Wang H, Sahoo D, et al
    Bladder Cancer Invasion is Mediated by mTORC2-Driven Regulation of Nitric Oxide and Invadopodia Formation.
    Am J Pathol. 2021 Aug 21. pii: S0002-9440(21)00350.
    Abstract     Related articles   

  1512. ZHAN X, Guo J, Chen L, Deng W, et al
    Prognostic significance of bladder neck involvement in non-muscle-invasive bladder cancer: A SEER database analysis with 19,919 patients.
    Cancer Med. 2021 Aug 23. doi: 10.1002/cam4.4219.
    Abstract     Related articles   

  1513. LI HJ, Gong X, Li ZK, Qin W, et al
    Role of Long Non-coding RNAs on Bladder Cancer.
    Front Cell Dev Biol. 2021;9:672679.
    Abstract     Related articles   

  1514. ZHANG X, Wang J, Lu J, Su L, et al
    Robust Prognostic Subtyping of Muscle-Invasive Bladder Cancer Revealed by Deep Learning-Based Multi-Omics Data Integration.
    Front Oncol. 2021;11:689626.
    Abstract     Related articles   

  1515. YANG L, Li C, Qin Y, Zhang G, et al
    A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer.
    Front Oncol. 2021;11:686044.
    Abstract     Related articles   

  1516. YAN X, Du GW, Chen Z, Liu TZ, et al
    CD86 Molecule Might Be a Novel Immune-Related Prognostic Biomarker for Patients With Bladder Cancer by Bioinformatics and Experimental Assays.
    Front Oncol. 2021;11:679851.
    Abstract     Related articles   

  1517. BISTAZZONI S, Bonetto S, Domenico Bellocchi S
    Solitary Calvarial Metastasis As the First Presentation of Urothelial Bladder Cancer.
    Cureus. 2021;13:e17257.
    Abstract     Related articles   

  1518. ZHANG Y, Xu Y, Li S
    Bibliometrics Analysis of Diagnostic Test Accuracy Studies of Bladder Cancer.
    Dis Markers. 2021;2021:8870353.
    Abstract     Related articles   

  1519. QIAN Z, Ding W, Zhou Q, Sun C, et al
    Depression Induced by CUMS Leads to Bladder Cancer Development and Local Tumor Immunosuppression in Mice.
    J Oncol. 2021;2021:5537523.
    Abstract     Related articles   

  1520. PAN YH, Zhang JX, Chen X, Liu F, et al
    Predictive Value of the TP53/PIK3CA/ATM Mutation Classifier for Patients With Bladder Cancer Responding to Immune Checkpoint Inhibitor Therapy.
    Front Immunol. 2021;12:643282.
    Abstract     Related articles   

  1521. LIN W, Sun J, Sadahira T, Xu N, et al
    Discovery and Validation of Nitroxoline as a Novel STAT3 Inhibitor in Drug-resistant Urothelial Bladder Cancer.
    Int J Biol Sci. 2021;17:3255-3267.
    Abstract     Related articles   

  1522. KOMINA S, Petrusevska G, Janevska V, Jovanovic R, et al
    Effect of bladder cancer variant histology on survival outcome in patients treated with radical cystectomy: A single-centre experience.
    Urol Ann. 2021;13:288-295.
    Abstract     Related articles   

  1523. SIKIC D, Weyerer V, Geppert CI, Bertz S, et al
    Utility of stromal tumor infiltrating lymphocyte scoring (sTILs) for risk stratification of patients with muscle-invasive urothelial bladder cancer after radical cystectomy.
    Urol Oncol. 2021 Aug 20. pii: S1078-1439(21)00343.
    Abstract     Related articles   

  1524. LONATI C, Baumeister P, Afferi L, Mari A, et al
    Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guerin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration.
    Eur Urol Focus. 2021 Aug 18. pii: S2405-4569(21)00195.
    Abstract     Related articles   

  1525. MARIAPPAN P
    The Scottish Bladder Cancer Quality Performance Indicators Influencing Outcomes, Prognosis, and Surveillance (Scot BC Quality OPS) Clinical Project.
    Eur Urol Focus. 2021 Aug 18. pii: S2405-4569(21)00191.
    Abstract     Related articles   

  1526. LAMM DL, Morales A
    A BCG success story: From prevention of tuberculosis to optimal bladder cancer treatment.
    Vaccine. 2021 Aug 17. pii: S0264-410X(21)01046.
    Abstract     Related articles   

  1527. FURUBAYASHI N, Negishi T, Sakamoto N, Tamura S, et al
    Clinical Outcomes of Mixed Response to Pembrolizumab in Advanced Urothelial Carcinoma After Platinum-based Chemotherapy.
    In Vivo. 2021;35:2869-2874.
    Abstract     Related articles   

  1528. HAMADA A, Sano T, Matsumoto K, Sakatani T, et al
    Modification of Platinum-based Systemic Chemotherapy for Advanced Urothelial Carcinoma in Patients With Suboptimal Renal Function.
    In Vivo. 2021;35:2821-2829.
    Abstract     Related articles   

  1529. NAGAI T, Naiki T, Isobe T, Sugiyama Y, et al
    Modified Glasgow Prognostic Score 2 as a Prognostic Marker in Patients With Metastatic Urothelial Carcinoma.
    In Vivo. 2021;35:2793-2800.
    Abstract     Related articles   

  1530. VUILLE-LESSARD E, Montani M, Bosch J, Semmo N, et al
    Autoimmune hepatitis triggered by SARS-CoV-2 vaccination.
    J Autoimmun. 2021;123:102710.
    Abstract     Related articles   

  1531. GMEINER J, Garstka N, Helbich TH, Shariat SF, et al
    Vesical Imaging Reporting and Data System (VI-RADS): Are the individual MRI sequences equivalent in diagnostic performance of high grade NMIBC and MIBC?
    Eur J Radiol. 2021;142:109829.
    Abstract     Related articles   

  1532. LAWACZECK L, Fischer AK, Norz V, Rausch S, et al
    [BCG-induced (bacillus Calmette-Guerin) abdominal granulomatosis after occult bladder perforation].
    Urologe A. 2021;60:1184-1187.
    Abstract     Related articles   

  1533. NEUMANN JM, Niehaus K, Neumann N, Knobloch HC, et al
    A new technological approach in diagnostic pathology: mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancer.
    Lab Invest. 2021;101:1281-1288.
    Abstract     Related articles   

  1534. ANDREEV-DRAKHLIN AY, Egoryan G, Shah AY, Msaouel P, et al
    The evolving treatment landscape of advanced urothelial carcinoma.
    Curr Opin Oncol. 2021;33:221-230.
    Abstract     Related articles   

  1535. TREGUNNA R
    Prior UTUC affects bladder tumour progression.
    Nat Rev Urol. 2021;18:190.
    Abstract     Related articles   

  1536. BUTLER DSC, Cafaro C, Putze J, Wan MLY, et al
    A bacterial protease depletes c-MYC and increases survival in mouse models of bladder and colon cancer.
    Nat Biotechnol. 2021;39:754-764.
    Abstract     Related articles   

  1537. WU YL, Lang L, Ma Q, Wu F, et al
    Perivascular Epithelioid Cell Tumor of Urinary Bladder.
    Am J Clin Pathol. 2021;156:56-71.
    Abstract     Related articles   

  1538. SIDAWAY P
    Intravesical therapy goes viral.
    Nat Rev Urol. 2021;18:72.
    Abstract     Related articles   

  1539. AL-SHARAKY DR, Abdelwahed M, Asaad N, Foda A, et al
    Stratification of urinary bladder carcinoma based on immunohistochemical expression of CK5, CK14 and CK20.
    J Immunoassay Immunochem. 2021;42:236-251.
    Abstract     Related articles   

  1540. KARAKAIDOS P, Rampias T
    Monitoring of Active Notch Signaling in Mouse Bladder Urothelium.
    Methods Mol Biol. 2021;2346:121-134.
    Abstract     Related articles   

  1541. DAS JP, Vargas HA, Ghafoor S, Goh AC, et al
    Clinical utility of (18)F-FDG PET/CT in staging and treatment planning of urachal adenocarcinoma.
    J Nucl Med. 2020 Sep 18. pii: jnumed.120.251561. doi: 10.2967/jnumed.120.251561.
    Abstract     Related articles   

  1542. IMAMURA K, Takada M, Umemoto K, Furukawa S, et al
    Laparoscopic parastomal herniorrhaphy utilizing transversus abdominis release and a modified Sugarbaker technique: A case report.
    Asian J Endosc Surg. 2021;14:106-108.
    Abstract     Related articles   

  1543. RODGERS SA, Williamson SR
    Xanthogranulomatous Ureteritis Mimicking Ureteral Involvement by Cancer in a Radical Cystectomy Specimen.
    Int J Surg Pathol. 2021;29:334-336.
    Abstract     Related articles   

  1544. MARTINEZ RODRIGUEZ RH, Amon Sesmero JH
    The search of new biomarkers in the prediction of BCG response in patients with high-risk NMIBC.
    World J Urol. 2021;39:629-630.
    Abstract     Related articles   

  1545. BALAR AV, Kamat AM, de Wit R
    Pembrolizumab monotherapy for high-risk, non-muscle invasive bladder cancer - Authors' reply.
    Lancet Oncol. 2021;22:e380.
    Abstract     Related articles   

  1546. RENTSCH CA, Hayoz S, Cathomas R
    Pembrolizumab monotherapy for high-risk, non-muscle-invasive bladder cancer.
    Lancet Oncol. 2021;22:e379.
    Abstract     Related articles   

  1547. LI S, Zhang D, Zeng S, Wu T, et al
    Prognostic Value of Preoperative Albumin-to-Fibrinogen Ratio in Patients with Bladder Cancer.
    J Cancer. 2021;12:5864-5873.
    Abstract     Related articles   

  1548. HIRD AE, Saskin R, Liu Y, Lee Y, et al
    Association between chronic bladder catheterisation and bladder cancer incidence and mortality: a population-based retrospective cohort study in Ontario, Canada.
    BMJ Open. 2021;11:e050728.
    Abstract     Related articles   

  1549. WU S, Chen X, Pan J, Dong W, et al
    An Artificial Intelligence System for the Detection of Bladder Cancer via Cystoscopy: A Multicenter Diagnostic Study.
    J Natl Cancer Inst. 2021 Sep 2. pii: 6362894. doi: 10.1093.
    Abstract     Related articles   

  1550. FRAGKOULIS C, Glykas I, Bamias A, Stathouros G, et al
    Novel treatments in BCG failure. Where do we stand today?
    Arch Esp Urol. 2021;74:681-691.
    Abstract     Related articles   

  1551. KURAMOTO T, Iguchi T, Iba A
    [Solitary Fibrous Tumor of the Urinary Bladder which was Incidentally Found by MRI : A Case Report].
    Hinyokika Kiyo. 2021;67:385-389.
    Abstract     Related articles   

  1552. PIJPERS OM, Hendricksen K, Mostafid H, de Jong FC, et al
    Long-term efficacy of hyperthermic intravesical chemotherapy for BCG-unresponsive non-muscle invasive bladder cancer.
    Urol Oncol. 2021 Aug 29. pii: S1078-1439(21)00337.
    Abstract     Related articles   

  1553. BAJORIN DF, Collette S, Galsky MD
    Adjuvant Nivolumab in Muscle-Invasive Urothelial Carcinoma. Reply.
    N Engl J Med. 2021;385:957.
    Abstract     Related articles   

  1554. MOLLICA V, Rizzo A, Massari F
    Adjuvant Nivolumab in Muscle-Invasive Urothelial Carcinoma.
    N Engl J Med. 2021;385:956-957.
    Abstract     Related articles   

  1555. CHITIKELA S, Kumar L, Sahoo RK
    Adjuvant Nivolumab in Muscle-Invasive Urothelial Carcinoma.
    N Engl J Med. 2021;385:956.
    Abstract     Related articles   

  1556. ZHENG B, Zhang P, Wang H, Wang J, et al
    Advances in Research on Bladder Cancer Targeting Peptides: a Review.
    Cell Biochem Biophys. 2021 Sep 1. pii: 10.1007/s12013-021-01019.
    Abstract     Related articles   

  1557. VEERATTERAPILLAY R, Gravestock P, Nambiar A, Gupta A, et al
    Time to Turn on the Blue Lights: A Systematic Review and Meta-analysis of Photodynamic Diagnosis for Bladder Cancer.
    Eur Urol Open Sci. 2021;31:17-27.
    Abstract     Related articles   

  1558. PORTNER R, Bajaj A, Elumalai T, Huddart R, et al
    A practical approach to bladder preservation with hypofractionated radiotherapy for localised muscle-invasive bladder cancer.
    Clin Transl Radiat Oncol. 2021;31:1-7.
    Abstract     Related articles   

  1559. CHATTERJEE A, Bakshi G, Pal M, Kapoor A, et al
    Perioperative therapy in muscle invasive bladder cancer.
    Indian J Urol. 2021;37:226-233.
    Abstract     Related articles   

  1560. DARDEER KT, Mohammed KA, Hussein TD, Elsheemy MS, et al
    Apolipoprotein A1 as a novel urinary biomarker for diagnosis of bladder cancer: A systematic review and meta-analysis.
    Indian J Urol. 2021;37:217-225.
    Abstract     Related articles   

  1561. SCHROECK FR, Ould Ismail AA, Perry GN, Haggstrom DA, et al
    Determinants of Risk-Aligned Bladder Cancer Surveillance-Mixed-Methods Evaluation Using the Tailored Implementation for Chronic Diseases Framework.
    JCO Oncol Pract. 2021 Aug 31:OP2100226. doi: 10.1200/OP.21.00226.
    Abstract     Related articles   

  1562. HUANG S, Bain J, Yiu TW, Gilbourd D, et al
    Accuracy of the Vesical Imaging-Reporting and Data System (VIRADS) for pre-treatment staging of bladder cancer in an Australian cohort.
    J Med Imaging Radiat Oncol. 2021 Aug 29. doi: 10.1111/1754-9485.13317.
    Abstract     Related articles   

  1563. SAWAZAKI H, Arai Y, Ito Y, Sato K, et al
    Expression of L-Type Amino Acid Transporter 1 is a Predictive Biomarker of Intravesical Recurrence in Patients with Non-Muscle Invasive Bladder Cancer.
    Res Rep Urol. 2021;13:603-611.
    Abstract     Related articles   

  1564. ZHANG Y, Zhu B, He M, Cai Y, et al
    N6-Methylandenosine-Related lncRNAs Predict Prognosis and Immunotherapy Response in Bladder Cancer.
    Front Oncol. 2021;11:710767.
    Abstract     Related articles   

  1565. SEGUIER D, Puech P, Kool R, Dernis L, et al
    Multiparametric magnetic resonance imaging for bladder cancer: a comprehensive systematic review of the Vesical Imaging-Reporting and Data System (VI-RADS) performance and potential clinical applications.
    Ther Adv Urol. 2021;13:17562872211039583.
    Abstract     Related articles   

  1566. ZENG B, Zhao Q, Sun Z, Liu D, et al
    SEC23A Is an Independent Prognostic Biomarker in Bladder Cancer Correlated With MAPK Signaling.
    Front Genet. 2021;12:672832.
    Abstract     Related articles   

  1567. DAEI S, Ziamajidi N, Abbasalipourkabir R, Khanaki K, et al
    Anticancer Effects of Gold Nanoparticles by Inducing Apoptosis in Bladder Cancer 5637 Cells.
    Biol Trace Elem Res. 2021 Aug 28. pii: 10.1007/s12011-021-02895.
    Abstract     Related articles   

  1568. GAO J, Shi Y, Zhou D, Zhang Y, et al
    Sarcopenia as an independent predictor for venous thromboembolism events in bladder cancer patients undergoing radical cystectomy.
    Support Care Cancer. 2021 Aug 28. pii: 10.1007/s00520-021-06423.
    Abstract     Related articles   

  1569. AVIRMED S, Khuanbai Y, Sanjaajamts A, Selenge B, et al
    Modifying Effect of Smoking on GSTM1 and NAT2 in Relation to the Risk of Bladder Cancer in Mongolian Population: A Case-Control Study.
    Asian Pac J Cancer Prev. 2021;22:2479-2485.
    Abstract     Related articles   

  1570. REXER H, Grimm MO Prof. Dr, Retz M Prof. Dr

    Aktuelle Urol. 2021;52:428-429.
    Abstract     Related articles   



  1571. Aktuelle Urol. 2021;52:412-414.
    Abstract     Related articles   

  1572. YIN D, Jiao W, Li X, Zhao J, et al
    Paraganglioma of the urinary bladder: A case report.
    Asian J Surg. 2021;44:1002-1003.
    Abstract     Related articles   

  1573. TAATJES DJ, Roth J
    In focus in HCB.
    Histochem Cell Biol. 2021;155:525-528.
    Abstract     Related articles   

  1574. YU Z, Xie X, Lu Q, Wang H, et al
    Primary transitional cell carcinoma of the inguinal region: A case report.
    Asian J Surg. 2021;44:788-789.
    Abstract     Related articles   

  1575. KITAZONO T, Tsubouchi K, Ibusuki R, Inoue K, et al
    A Rare Case of Pulmonary Tumor Thrombotic Microangiopathy Associated with Micropapillary Urothelial Carcinoma of the Urinary Bladder: An Autopsy Case.
    Intern Med. 2021;60:2843-2846.
    Abstract     Related articles   

  1576. WEN CY, Lin JT, Yu CC, Wang CJ, et al
    Non-touch ureteral manipulation of single J ureteral catheterization for robot-assisted cystectomy with intracorporeal ileal conduit.
    Asian J Surg. 2021;44:675.
    Abstract     Related articles   

  1577. HEATH EI, Rosenberg JE
    The biology and rationale of targeting nectin-4 in urothelial carcinoma.
    Nat Rev Urol. 2021;18:93-103.
    Abstract     Related articles   

  1578. YI W, Yu Y, Li Y, Yang J, et al
    The tumor-suppressive effects of alpha-ketoglutarate-dependent dioxygenase FTO via N6-methyladenosine RNA methylation on bladder cancer patients.
    Bioengineered. 2021;12:5323-5333.
    Abstract     Related articles   

  1579. KOSKINEN I, Bostrom PJ, Taimen P, Salminen A, et al
    Prediction of neo-adjuvant chemotherapy response in bladder cancer: the impact of clinical parameters and routine biomarkers.
    Scand J Urol. 2021 Sep 9:1-7. doi: 10.1080/21681805.2021.1962403.
    Abstract     Related articles   

  1580. ASIMAKOPOULOS AD, Colalillo G, Telesca R, Mauriello A, et al
    T1 Bladder Cancer: Comparison of the Prognostic Impact of Two Substaging Systems on Disease Recurrence and Progression and Suggestion of a Novel Nomogram.
    Front Surg. 2021;8:704902.
    Abstract     Related articles   

  1581. LIANG Y, Ye F, Cheng Z, Ou Y, et al
    Calculated identification of mutator-derived lncRNA signatures of genomic instability to predict the clinical outcome of muscle-invasive bladder cancer.
    Cancer Cell Int. 2021;21:476.
    Abstract     Related articles   

  1582. MUKHERJEE N, Ji N, Xi T, Lin CL, et al
    Bladder tumor ILC1s undergo Th17-like differentiation in human bladder cancer.
    Cancer Med. 2021 Sep 8. doi: 10.1002/cam4.4243.
    Abstract     Related articles   

  1583. MORSELLI S, Campi R, Gacci M, Sebastianelli A, et al
    Potential utility of a 4-marker immunohistochemistry panel to predict response to cisplatin-based neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: a single-center preliminary experience.
    Minerva Urol Nephrol. 2021;73:424-427.
    Abstract     Related articles   

  1584. ZENG S, Gao H, Li C, Xing S, et al
    Boosting Photothermal Theranostics via TICT and Molecular Motions for Photohyperthermia Therapy of Muscle-Invasive Bladder Cancer.
    Adv Healthc Mater. 2021 Sep 8:e2101063. doi: 10.1002/adhm.202101063.
    Abstract     Related articles   

  1585. YAN Y, Cai J, Huang Z, Cao X, et al
    A Novel Ferroptosis-Related Prognostic Signature Reveals Macrophage Infiltration and EMT Status in Bladder Cancer.
    Front Cell Dev Biol. 2021;9:712230.
    Abstract     Related articles   

  1586. SU Q, Wu H, Zhang Z, Lu C, et al
    Exosome-Derived Long Non-Coding RNAs as Non-Invasive Biomarkers of Bladder Cancer.
    Front Oncol. 2021;11:719863.
    Abstract     Related articles   

  1587. ZHENG Z, Lai C, Li W, Zhang C, et al
    Identification of a Novel Glycolysis-Related LncRNA Signature for Predicting Overall Survival in Patients With Bladder Cancer.
    Front Genet. 2021;12:720421.
    Abstract     Related articles   

  1588. PEREIRA FM, Melo MN, Santos AKM, Oliveira KV, et al
    Hyaluronic acid-coated chitosan nanoparticles as carrier for the enzyme/prodrug complex based on horseradish peroxidase/indole-3-acetic acid: Characterization and potential therapeutic for bladder cancer cells.
    Enzyme Microb Technol. 2021;150:109889.
    Abstract     Related articles   

  1589. PIAO XM, Kang H, Kim WJ, Yun SJ, et al
    Prominence of urinary biomarkers for bladder cancer in the COVID-19 era: From the commercially available to new prospective candidates.
    Investig Clin Urol. 2021;62:500-519.
    Abstract     Related articles   

  1590. QIU F, Jin Y, Pu J, Huang Y, et al
    Aberrant FBXW7-mediated ubiquitination and degradation of ZMYND8 enhances tumor progression and stemness in bladder cancer.
    Exp Cell Res. 2021 Sep 3:112807. doi: 10.1016/j.yexcr.2021.112807.
    Abstract     Related articles   

  1591. WU J, Tan Z, Li H, Lin M, et al
    Melatonin reduces proliferation and promotes apoptosis of bladder cancer cells by suppressing O-GlcNAcylation of CDK5.
    J Pineal Res. 2021 Sep 6:e12765. doi: 10.1111/jpi.12765.
    Abstract     Related articles   

  1592. SOARES LBM, Lima APB, Melo AS, Almeida TC, et al
    Additive effects of resveratrol and doxorubicin on bladder cancer cells.
    Anticancer Drugs. 2021 Aug 27. pii: 00001813-900000000-98278.
    Abstract     Related articles   

  1593. NI J, Wang K, Zhang H, Xie J, et al
    Prognostic Value of the Systemic Inflammatory Response Index in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Population-Based Study.
    Front Oncol. 2021;11:722151.
    Abstract     Related articles   

  1594. MURAKI PH, Donin NM
    Ureteritis cystica mimicking upper tract urothelial cancer in a patient with bladder cancer.
    Urol Case Rep. 2021;39:101822.
    Abstract     Related articles   


  1595. Enhanced Visualization Methods for First Transurethral Resection of Bladder Tumour in Suspected Non-muscle-invasive Bladder Cancer: A Health Technology Assessment.
    Ont Health Technol Assess Ser. 2021;21:1-123.
    Abstract     Related articles   

  1596. CUI Y, Zhou Z, Chai Y, Che X, et al
    Identification of a Nomogram from Ferroptosis-Related Long Noncoding RNAs Signature to Analyze Overall Survival in Patients with Bladder Cancer.
    J Oncol. 2021;2021:8533464.
    Abstract     Related articles   

  1597. WU W, Jia G, Chen L, Liu H, et al
    Analysis of the Expression and Prognostic Value of Annexin Family Proteins in Bladder Cancer.
    Front Genet. 2021;12:731625.
    Abstract     Related articles   

  1598. FENG C, Pan L, Tang S, He L, et al
    Integrative Transcriptomic, Lipidomic, and Metabolomic Analysis Reveals Potential Biomarkers of Basal and Luminal Muscle Invasive Bladder Cancer Subtypes.
    Front Genet. 2021;12:695662.
    Abstract     Related articles   

  1599. LIU Z, Tang Q, Qi T, Othmane B, et al
    A Robust Hypoxia Risk Score Predicts the Clinical Outcomes and Tumor Microenvironment Immune Characters in Bladder Cancer.
    Front Immunol. 2021;12:725223.
    Abstract     Related articles   

  1600. SINGLA N, Margulis V
    Differences between Upper Tract Urothelial Carcinoma and Bladder Cancer.
    AUA News. 2021;26:15-16.
    Abstract     Related articles   

  1601. LIU Y, Lou W, Chen G, Ding B, et al
    Genome-wide screening for the G-protein-coupled receptor (GPCR) pathway-related therapeutic gene RGS19 (regulator of G protein signaling 19) in bladder cancer.
    Bioengineered. 2021;12:5892-5903.
    Abstract     Related articles   

  1602. ZHANG Z, Sang Y, Liu Z, Shao J, et al
    Negative Correlation Between Circular RNA SMARC5 and MicroRNA 432, and Their Clinical Implications in Bladder Cancer Patients.
    Technol Cancer Res Treat. 2021;20:15330338211039110.
    Abstract     Related articles   

  1603. SHVERO A, Laufer M, Zilberman DE, Winkler H, et al
    [UPPER TRACT UROTHELIAL CARCINOMA].
    Harefuah. 2021;160:619-624.
    Abstract     Related articles   

  1604. LUWISCH H, Rabinovich I, Yutkin V, Frank S, et al
    [NEOADJUVANT CHEMOTHERAPY BEFORE RADICAL CYSTECTOMY - MIGHT IT BE OFFERED SELECTIVELY?]
    Harefuah. 2021;160:559-564.
    Abstract     Related articles   

  1605. ENGELSTEIN D

    Harefuah. 2021;160:556-558.
    Abstract     Related articles   

  1606. HUNG SY, Chen WF, Lee YC, Su JH, et al
    Rhopaloic acid A induces apoptosis, autophagy and MAPK activation through ROS-mediated signaling in bladder cancer.
    Phytomedicine. 2021;92:153720.
    Abstract     Related articles   

  1607. SARI H, Celik S, Caglar F, Aktas S, et al
    A candidate antineoplastic herbal agent for bladder cancer: Ankaferd bloodstopper.
    Int J Clin Pract. 2021 Sep 4:e14789. doi: 10.1111/ijcp.14789.
    Abstract     Related articles   

  1608. SMITH N, Luethcke KR, Craun K, Trepanier L, et al
    Risk of bladder cancer and lymphoma in dogs is associated with pollution indices by county of residence.
    Vet Comp Oncol. 2021 Sep 4. doi: 10.1111/vco.12771.
    Abstract     Related articles   

  1609. CROOCK R, Modai J, Avda Y, Shpunt I, et al
    Radical Cystectomy after Previous Radiation or Pelvic Surgery: Is It Associated with Increased Morbidity?
    Isr Med Assoc J. 2021;23:545-549.
    Abstract     Related articles   

  1610. ZHU X, Zhou M, Yu H, Kuang Y, et al
    Bladder paraganglioma managed with transurethral holmium laser resection: A case report.
    Medicine (Baltimore). 2021;100:e26909.
    Abstract     Related articles   

  1611. KURIWAKI I, Kameda M, Iikubo K, Hisamichi H, et al
    Synthesis and structure-activity relationships of pyrimidine derivatives as potent and orally active FGFR3 inhibitors with both increased systemic exposure and enhanced in vitro potency.
    Bioorg Med Chem. 2021;33:116019.
    Abstract     Related articles   

  1612. RODRIGUEZ PENA MDC, Salles DC, Epstein JI, Canete-Portillo S, et al
    Well-differentiated neuroendocrine tumors of the lower urinary tract: biologic behavior of a rare entity.
    Hum Pathol. 2021;109:53-58.
    Abstract     Related articles   

  1613. YAMADA T, Toyoda T, Matsushita K, Cho YM, et al
    Expression of stem cell markers as useful complementary factors in the early detection of urinary bladder carcinogens by immunohistochemistry for gamma-H2AX.
    Arch Toxicol. 2021;95:715-726.
    Abstract     Related articles   

  1614. KNEZ J, Nardelli F, van den Bosch T, Sladkevicius P, et al
    Imaging in gynecological disease: clinical and ultrasound characteristics of urinary bladder malignancies.
    Ultrasound Obstet Gynecol. 2019 Dec 25. doi: 10.1002/uog.21958.
    Abstract     Related articles   

  1615. HUANG X, Pan T, Yan L, Jin T, et al
    The inflammatory microenvironment and the urinary microbiome in the initiation and progression of bladder cancer.
    Genes Dis. 2020;8:781-797.
    Abstract     Related articles   

  1616. JIANG Z, Zhang Y, Zhang Y, Jia Z, et al
    Cancer derived exosomes induce macrophages immunosuppressive polarization to promote bladder cancer progression.
    Cell Commun Signal. 2021;19:93.
    Abstract     Related articles   

  1617. ZHOU BZ, Luo Q, Zhang Y
    Cross-talk and clinical value of m[superscript 6]A regulatory gene in bladder cancer.
    BMC Urol. 2021;21:127.
    Abstract     Related articles   

  1618. TANG H, Fang T, Ji M, Wang JP, et al
    UBE2S exerts oncogenic activities in urinary bladder cancer by ubiquitinating TSC1.
    Biochem Biophys Res Commun. 2021;578:7-14.
    Abstract     Related articles   

  1619. MIRZAEI S, Paskeh MDA, Hashemi F, Zabolian A, et al
    Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies.
    Life Sci. 2021 Sep 11:119948. doi: 10.1016/j.lfs.2021.119948.
    Abstract     Related articles   

  1620. SUN X, Chen Q, Zhang L, Chen J, et al
    Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines.
    Math Biosci Eng. 2021;18:6262-6287.
    Abstract     Related articles   

  1621. NAKAGAWA M, Naiki T, Naiki-Ito A, Ozawa Y, et al
    Usefulness of advanced monoenergetic reconstruction technique in dual-energy computed tomography for detecting bladder cancer.
    Jpn J Radiol. 2021 Sep 13. pii: 10.1007/s11604-021-01195.
    Abstract     Related articles   

  1622. HE L, Pan X, Wang X, Cao Y, et al
    Rab6c is a new target of miR218 that can promote the progression of bladder cancer.
    Mol Med Rep. 2021;24.
    Abstract     Related articles   

  1623. ZHOU X, Kurywchak P, Wolf-Dennen K, Che SPY, et al
    Unique somatic variants in DNA from urine exosomes of individuals with bladder cancer.
    Mol Ther Methods Clin Dev. 2021;22:360-376.
    Abstract     Related articles   

  1624. KOLAT D, Kaluzinska Z, Bednarek AK, Pluciennik E, et al
    Corrigendum: Fragile Gene WWOX Guides TFAP2A/TFAP2C-Dependent Actions Against Tumor Progression in Grade II Bladder Cancer.
    Front Oncol. 2021;11:735435.
    Abstract     Related articles   

  1625. ZHAO Y, Zhao B, Yan WH, Xia Y, et al
    Integrative Analysis Identified MCT4 as an Independent Prognostic Factor for Bladder Cancer.
    Front Oncol. 2021;11:704857.
    Abstract     Related articles   

  1626. DONG B, Liang J, Li D, Song W, et al
    Tumor Expression Profile Analysis Developed and Validated a Prognostic Model Based on Immune-Related Genes in Bladder Cancer.
    Front Genet. 2021;12:696912.
    Abstract     Related articles   

  1627. ZHANG P, Liu Z, Wang D, Li Y, et al
    Scoring System Based on RNA Modification Writer-Related Genes to Predict Overall Survival and Therapeutic Response in Bladder Cancer.
    Front Immunol. 2021;12:724541.
    Abstract     Related articles   

  1628. KAJAIA D, Kochiashvili D, Muzashvili T, Gachechiladze M, et al
    MOLECULAR CHARACTERISTICS OF THE HETEROGENEITY OF NON-INVASIVE PAPILLARY UROTHELIAL CARCINOMAS AND THE MARKERS OF THEIR RECURRENCE.
    Georgian Med News. 2021;.
    Abstract     Related articles   

  1629. ZHANG Y, He N, Zhou X, Wang F, et al
    Betulinic acid induces autophagy-dependent apoptosis via Bmi-1/ROS/AMPK-mTOR-ULK1 axis in human bladder cancer cells.
    Aging (Albany NY). 2021;13.
    Abstract     Related articles   

  1630. TAN P, Cai H, Wei Q, Tang X, et al
    Enhanced chemo-photodynamic therapy of an enzyme-responsive prodrug in bladder cancer patient-derived xenograft models.
    Biomaterials. 2021;277:121061.
    Abstract     Related articles   

  1631. CHANG E, Apolo AB, Bangs R, Chisolm S, et al
    Refining neoadjuvant therapy clinical trial design for muscle-invasive bladder cancer before cystectomy: a joint US Food and Drug Administration and Bladder Cancer Advocacy Network workshop.
    Nat Rev Urol. 2021 Sep 10. pii: 10.1038/s41585-021-00505.
    Abstract     Related articles   

  1632. ECKSTEIN M, Kimmel C, Bruendl J, Weber F, et al
    Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer.
    Sci Rep. 2021;11:17981.
    Abstract     Related articles   

  1633. ROVIELLO G, Catalano M, Santi R, Palmieri VE, et al
    Immune Checkpoint Inhibitors in Urothelial Bladder Cancer: State of the Art and Future Perspectives.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  1634. RUSSO GI, Sholklapper TN, Cocci A, Broggi G, et al
    Performance of Narrow Band Imaging (NBI) and Photodynamic Diagnosis (PDD) Fluorescence Imaging Compared to White Light Cystoscopy (WLC) in Detecting Non-Muscle Invasive Bladder Cancer: A Systematic Review and Lesion-Level Diagnostic Meta-Analysis.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  1635. KAWANO T, Tachibana Y, Inokuchi J, Kang JH, et al
    Identification of Activated Protein Kinase Calpha (PKCalpha) in the Urine of Orthotopic Bladder Cancer Xenograft Model as a Potential Biomarker for the Diagnosis of Bladder Cancer.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  1636. SUH J, Yuk HD, Jeong CW, Kwak C, et al
    Pyuria as a Predictive Marker of Bacillus Calmette-Guerin Unresponsiveness in Non-Muscle Invasive Bladder Cancer.
    J Clin Med. 2021;10.
    Abstract     Related articles   

  1637. GOMES ATPC, Neves MGPMS, Fernandes R, Ribeiro CF, et al
    Unraveling the Photodynamic Activity of Cationic Benzoporphyrin-Based Photosensitizers against Bladder Cancer Cells.
    Molecules. 2021;26.
    Abstract     Related articles   

  1638. LOU N, Niu YR, Yang F, Lu ZH, et al
    [Clinicopathological analysis of lung metastatic tumor].
    Zhonghua Bing Li Xue Za Zhi. 2021;50:1039-1044.
    Abstract     Related articles   

  1639. ZHANG HZ, Wang SY, Dong L, Yang XQ, et al
    [Inflammatory myofibroblastic tumors of the urinary bladder: a clinicopathological study of ten cases].
    Zhonghua Bing Li Xue Za Zhi. 2021;50:1024-1028.
    Abstract     Related articles   

  1640. LUO HL, Liu HY, Chang YL, Sung MT, et al
    Hypomethylated RRBP1 Potentiates Tumor Malignancy and Chemoresistance in Upper Tract Urothelial Carcinoma.
    Int J Mol Sci. 2021;22.
    Abstract     Related articles   

  1641. MURAKAMI K, Kita Y, Sakatani T, Hamada A, et al
    Antitumor effect of WEE1 blockade as monotherapy or in combination with cisplatin in urothelial cancer.
    Cancer Sci. 2021;112:3669-3681.
    Abstract     Related articles   

  1642. SANTOPIETRO AL, Einstein D, Bellmunt J
    Advances in the management of urothelial carcinoma: is immunotherapy the answer?
    Expert Opin Pharmacother. 2021;22:1743-1759.
    Abstract     Related articles   

  1643. ABD ELWAHAB KM, Desky EAE, Eldery MS, Mohammad FF, et al
    Apparent Diffusion Coefficient Value can Predict Poor Bacillus Calmette-Guerin Responders in T1HG/NMIBC: Prospective Cohort Study.
    Clin Genitourin Cancer. 2021;19:e248-e254.
    Abstract     Related articles   

  1644. CULINE S, Flechon A, Gravis G, Roubaud G, et al
    Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With or Without Panitumumab in Patients With Advanced Urothelial Carcinoma: Multicenter, Randomized, French Unicancer GETUG/AFU 19 Study.
    Clin Genitourin Cancer. 2021;19:e216-e222.
    Abstract     Related articles   

  1645. CHALLAPALLI A, Masson S, White P, Dailami N, et al
    A Single-arm Phase II Trial of Neoadjuvant Cabazitaxel and Cisplatin Chemotherapy for Muscle-Invasive Transitional Cell Carcinoma of the Urinary Bladder.
    Clin Genitourin Cancer. 2021;19:325-332.
    Abstract     Related articles   

  1646. ESTESO G, Aguilo N, Julian E, Ashiru O, et al
    Natural Killer Anti-Tumor Activity Can Be Achieved by In Vitro Incubation With Heat-Killed BCG.
    Front Immunol. 2021;12:622995.
    Abstract     Related articles   

  1647. WANG Q, Zhu SR, Huang XP, Liu XQ, et al
    Prognostic value of systemic immune-inflammation index in patients with urinary system cancers: a meta-analysis.
    Eur Rev Med Pharmacol Sci. 2021;25:1302-1310.
    Abstract     Related articles   

  1648. CHEN L, Shan G
    CircRNA in cancer: Fundamental mechanism and clinical potential.
    Cancer Lett. 2021;505:49-57.
    Abstract     Related articles   

  1649. NA J, Newman JA, Then CK, Syed J, et al
    SPRTN protease-cleaved MRE11 decreases DNA repair and radiosensitises cancer cells.
    Cell Death Dis. 2021;12:165.
    Abstract     Related articles   

  1650. KATLEBA K, Lombard AP, Tsamouri MM, Baek HB, et al
    Depletion of androgen receptor low molecular weight isoform reduces bladder tumor cell viability and induces apoptosis.
    Cancer Lett. 2021;504:49-57.
    Abstract     Related articles   

  1651. ACOSTA AM, Barletta J, Sonpavde G, Schnitt S, et al
    p-120 Catenin is a Useful Diagnostic Biomarker for Distinguishing Plasmacytoid and Sarcomatoid Variants From Conventional Urothelial Carcinoma.
    Arch Pathol Lab Med. 2021;145:1000-1008.
    Abstract     Related articles   

  1652. GALVEZ-LOPEZ R, Ruiz-Carazo E, Lainez-Ramos-Bossini AJ, Garcia Salguero AJ, et al
    Miliary tuberculosis secondary to intravesical instillation of Bacillus Calmette-Guerin. Report of two cases.
    Infect Dis Now. 2021;51:213-215.
    Abstract     Related articles   

  1653. DUCOURS M, Desclaux A, Dutronc H, Dauchy FA, et al
    About three cases of Mycobacterium bovis bone and joint infections after BCG therapy.
    Infect Dis Now. 2021;51:211-213.
    Abstract     Related articles   

  1654. TAMZALI Y, Jamme M, Bottet F, Gauthe M, et al
    Intravesical BCG instillation as a possible cause of acute and chronic kidney injury.
    Infect Dis Now. 2021;51:209-211.
    Abstract     Related articles   

  1655. JIANG L, Zuo Z, Lin J, Yang C, et al
    Orthodenticle homeobox OTX1 is a potential prognostic biomarker for bladder cancer.
    Bioengineered. 2021;12:6559-6571.
    Abstract     Related articles   

  1656. LEE W, Nam W, Lim B, Kyung YS, et al
    Impact of preoperative chemotherapy on pathologic nodal status in muscle-invasive bladder cancer: optimal lymphadenectomy in the preoperative chemotherapy era.
    J Cancer Res Clin Oncol. 2021 Sep 23. pii: 10.1007/s00432-021-03789.
    Abstract     Related articles   

  1657. SUN J, Yue W, You J, Wei X, et al
    Identification of a Novel Ferroptosis-Related Gene Prognostic Signature in Bladder Cancer.
    Front Oncol. 2021;11:730716.
    Abstract     Related articles   

  1658. COMPERAT E, Oszwald A, Wasinger G, Hansel DE, et al
    Updated pathology reporting standards for bladder cancer: biopsies, transurethral resections and radical cystectomies.
    World J Urol. 2021 Sep 23. pii: 10.1007/s00345-021-03831.
    Abstract     Related articles   

  1659. CAO R, Ma B, Wang G, Xiong Y, et al
    Characterization of hypoxia response patterns identified prognosis and immunotherapy response in bladder cancer.
    Mol Ther Oncolytics. 2021;22:277-293.
    Abstract     Related articles   

  1660. HAM WS, Park JS, Jang WS, Choi YD, et al
    Prognostic value of prostate volume in non-muscle invasive bladder cancer.
    Sci Rep. 2021;11:18784.
    Abstract     Related articles   

  1661. KRISHNA M, Kumar S, Parmar KM, Dhana Sekaran V, et al
    Unusual endophytic non-enhancing tumour in the renal pelvis: a diagnostic dilemma.
    BMJ Case Rep. 2021;14.
    Abstract     Related articles   

  1662. ALKANLI N, Ay A, Cevik G
    Investigation of the roles of IL-18 (-607 C/A) and IL-18 (-137 G/C) gene variations in bladder cancer development: case-control study.
    J Cancer Res Clin Oncol. 2021 Sep 22. pii: 10.1007/s00432-021-03808.
    Abstract     Related articles   

  1663. SCHULZ GB, Stief CG, Saar M, Vogeli TA, et al
    [Molecular diagnostics of bladder cancer-practical ramifications].
    Urologe A. 2021 Sep 22. pii: 10.1007/s00120-021-01640.
    Abstract     Related articles   

  1664. MHATRE S, Lacey B, Sherliker P, Chatterjee N, et al
    Reproductive factors and gall-bladder cancer, and the effect of common genetic variants on these associations: a case-control study in India.
    Int J Epidemiol. 2021 Sep 22. pii: 6373963. doi: 10.1093.
    Abstract     Related articles   

  1665. HEMISSI I, Ayed H, Naimi Z, Meddeb K, et al
    Polymorphisms in NQO1 and MPO genes and risk for bladder cancer in Tunisian population.
    Mol Genet Genomic Med. 2021 Sep 22:e1819. doi: 10.1002/mgg3.1819.
    Abstract     Related articles   

  1666. QIN Z, Tong H, Li T, Cao H, et al
    SPHK1 contributes to cisplatin resistance in bladder cancer cells via the NONO/STAT3 axis.
    Int J Mol Med. 2021;48.
    Abstract     Related articles   

  1667. HEKTOEN HH, Gislefoss RE, Stenehjem JS, Langseth H, et al
    Prediagnostic Serum 25-Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort.
    Clin Epidemiol. 2021;13:801-811.
    Abstract     Related articles   

  1668. GROBET-JEANDIN E, Pinar U, Roupret M
    Sequential Gemcitabine plus Docetaxel Is the Standard Second-line Intravesical Therapy for Bacillus Calmette-Guerin-unresponsive Non-muscle invasive Bladder Cancer: Con.
    Eur Urol Focus. 2021 Sep 17. pii: S2405-4569(21)00233.
    Abstract     Related articles   

  1669. RIPPING TM, Westhoff E, Aaronson NK, Van Hemelrijck M, et al
    Validation and reliability of the Dutch version of the EORTC QLQ-NMIBC24 Questionnaire Module for patients with non-muscle-invasive bladder cancer.
    J Patient Rep Outcomes. 2021;5:96.
    Abstract     Related articles   

  1670. ZHOU L, Wang B, Zhang Y, Yao K, et al
    Silencing circBIRC6 inhibits the proliferation, invasion, migration and epithelialmesenchymal transition of bladder cancer cells by targeting the miR4953p/XBP1 signaling axis.
    Mol Med Rep. 2021;24.
    Abstract     Related articles   

  1671. WANG L, Liu X, Yue M, Liu Z, et al
    Identification of hub genes in bladder cancer based on weighted gene co-expression network analysis from TCGA database.
    Cancer Rep (Hoboken). 2021 Sep 20:e1557. doi: 10.1002/cnr2.1557.
    Abstract     Related articles   

  1672. YANG Z, Xu Y, Bi Y, Zhang N, et al
    Immune escape mechanisms and immunotherapy of urothelial bladder cancer.
    J Clin Transl Res. 2021;7:485-500.
    Abstract     Related articles   

  1673. GUO Y, Yin J, Dai Y, Guan Y, et al
    A Novel CpG Methylation Risk Indicator for Predicting Prognosis in Bladder Cancer.
    Front Cell Dev Biol. 2021;9:642650.
    Abstract     Related articles   

  1674. GAN K, Gao Y, Liu K, Xu B, et al
    The Clinical Significance and Prognostic Value of HER2 Expression in Bladder Cancer: A Meta-Analysis and a Bioinformatic Analysis.
    Front Oncol. 2021;11:653491.
    Abstract     Related articles   

  1675. SUN J, Wei X, You J, Yue W, et al
    STC1 is a Novel Biomarker Associated with Immune Characteristics and Prognosis of Bladder Cancer.
    Int J Gen Med. 2021;14:5505-5516.
    Abstract     Related articles   

  1676. ARIAFAR A, Habibagahi M, Jaberipour M, Khezri A, et al
    Upregulation of Cytotoxic T-Lymphocyte-Associated Protein 4 and Forkhead Box P3 Transcripts in Peripheral Blood of Patients with Bladder Cancer.
    Iran J Med Sci. 2021;46:339-346.
    Abstract     Related articles   

  1677. AWADALLA A, Harraz AM, Abol-Enein H, Laymon M, et al
    Prognostic influence of microsatellite alterations of muscle-invasive bladder cancer treated with radical cystectomy.
    Urol Oncol. 2021 Sep 16. pii: S1078-1439(21)00385.
    Abstract     Related articles   

  1678. SHARMA G, Sharma A, Krishna M, Devana SK, et al
    Xpert bladder cancer monitor in surveillance of bladder cancer: Systematic review and meta-analysis.
    Urol Oncol. 2021 Sep 14. pii: S1078-1439(21)00380.
    Abstract     Related articles   

  1679. ZHANG Y, Sun C, Tuo Z, Zhou H, et al
    Laparoscopic Cystectomy with Totally Intracorporeal Versus Extracorporeal Orthotopic Neobladder for Bladder Cancer: A Single Center Experience.
    J Laparoendosc Adv Surg Tech A. 2021 Sep 17. doi: 10.1089/lap.2021.0519.
    Abstract     Related articles   

  1680. HUANG M, Liu L, Zhu J, Jin T, et al
    Identification of Immune-Related Subtypes and Characterization of Tumor Microenvironment Infiltration in Bladder Cancer.
    Front Cell Dev Biol. 2021;9:723817.